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Abstract
The Frank-Starling law states that the stroke volume of a regular cardiac beat increases
in response to an increase in the volume of blood filling the heart. If this law applies in
atrial fibrillation (AF) as well as in sinus rhythm (SR) then cardiac function will depend
on the duration of diastole in the preceding beat as well as the duration of the indexed
beat.
Aim: The aim of this thesis was to develop a series of tools which would allow an
assessment of the changes in cardiac function from one beat to the next in AF and
SR. A secondary aim was to find a means of describing rhythm in a way that reflected
possible functional change.
Methods: List-mode radionuclide ventriculography, RNVG, acquisitions of 373 patients
in AF and a comparative group of 385 patients in SR were made. Software was writ-
ten which allowed tightly defined preceding and indexed beat selection criteria to be
established. Left ventricular ejection fraction (LVEF) and other functional parameters
(pre-systolic volume, systolic time, the ratio of pre-systolic to end-diastolic volume, peak
filling rate and first third filling fraction) were calculated for images created using differ-
ent beat selection criteria based on the quartiles of beat length. Assessment used both
variable and fixed time formatting and included a comparison of results achieved in the
first and second half of the scan.
Traditional linear measures of heart rate variability together with descriptors of the
Poincare´ plot and cycle length entropy were used to describe rhythm in both AF and
SR patients.
Results: Substantial variation with indexed and preceding beat length was seen in both
SR and AF in all the systolic parameters measured and in particular in LVEF where the
standard deviation of LVEF for any one patient was found to be 8.2% in SR and 14.1%
in AF. A combination of descriptors of rhythm was found to have good correlation with
the range of LVEF measured. Examination of the results for LVEF in several clinical
sub-groups suggests that the range of LVEF may have clinical interest.
The techniques were applied in a small clinical study which considered the value of
radio-frequency ablation in patients with AF and heart failure. In this study, measures
of Sample entropy and the range of LVEF appeared to have prognostic value.
Conclusion: A tool which allows the investigation of beat-to-beat functional variation
in RNVG has been produced. It has been shown that the functional variation depend-
ing on beat selection criteria is substantial and may have clinical significance both in
patients with underlying pathology and prognostically in patients undergoing radiofre-
quency ablation (RFA).
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Chapter 1.
Introduction
CALVIN AND HOBBES c©1993 Watterson. Reprinted with permission of UNIVERSAL Uclick. All rights reserved.
Summary
This chapter is an overview of the hypothesis and the context in which it is made. It in-
cludes a review of basic cardiac physiology and pathology together with general measures
2
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of cardiac function. Atrial fibrillation - its nature, prevalence, principal characteristics
and treatment - is described within this context.
An introduction is given to measures of heart rate variability including entropy and the
Poincare´ plot. This is followed by a description of radionuclide ventriculography together
with the differences between fixed and variable time formatting, list mode acquisition
and assessments of function - including diastolic function and ejection fraction.
1.1. Cardiac physiology
As any secondary school biology student should be able to tell you, blood is the transport
system of the body, carrying the substances necessary to maintain life, e.g. oxygen, to
cells and taking waste products away. Movement of the blood is powered by the heart,
and in particular the left ventricle. The heart consists of four chambers, the left and
right atria and left and right ventricles. The atria act as collecting reservoirs which
feed the ventricles. The ventricles act as pumps: pushing blood around the lungs for
oxygenation (in the case of the right ventricle) and around the rest of body (in the case
of the left ventricle). Thus ventricular, and in particular left ventricular (LV) function
reflects how well the “motor” for the blood transport mechanism works.
At this point, let us move away from secondary school biology and consider the heart
and LV function in more detail.
1.1.1. Beating
A normal healthy heart beats regularly, with small variations, at a frequency which is
governed by several different physiological factors. This normal, regular rhythm, which
changes in response to varying physiological conditions, is known as sinus rhythm (SR).
Variations in cardiac output are regulated by a combination of processes, the main two
being the Frank-Starling mechanism and the autonomic nervous system. Other processes,
including humoral factors like the concentration of chatecolamines (e.g. adrenalin), also
have an effect[1]. Each beat can be divided into two fundamental, separate parts: emp-
tying (systole) and filling (diastole).
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The Frank-Starling law of the heart states that the stroke volume (the volume of blood
ejected) of a regular beat increases in response to an increase in the volume of blood
filling the heart at the start of the beat. Put simply: the fuller the ventricle, the greater
the volume of blood pumped out. Physiologically, if the heart fills with more blood
than usual the force of cardiac muscular contraction increases. This happens because
the extra volume causes an increased load on each muscle fibre with the result that it
stretches; the force that a single cardiac muscle fibre generates is proportional to the
initial length of that fibre (sarcomere)[2] (up to a maximum length). Thus stretching
the fibre causes a greater force and hence a greater volume blood is ejected. Although
the duration of systole does vary [3], it should be noted that in the Frank-Startling
mechanism it is the force, not the duration, of contraction which increases.
In the case of premature ventricular contraction, premature electrical signals cause the
ventricle to empty early. In most cases a premature beat will be followed by a compen-
satory pause as the next beat falls where it was expected to fall (the premature beat
does not reset the clock). This provides a longer filling time as a result of which the ven-
tricle will hold a greater volume of blood. As a result of the Frank-Starling mechanism
the force of the following contraction will be greater, causing an increased output and
approximately re-balancing the volume at end-systole.
The autonomic nervous system (ANS) acts to control many of the involuntary or semi-
involuntary functions of the body including digestion, respiratory rate, perspiration and
the diameter of the pupil. It also acts on heart rate and cardiac contractility, conduction
and output. The ANS is usually divided into two competing systems: the sympathetic
nervous system (SNS) and the parasympathetic nervous system (PNS). In the heart,
the SNS acts to increase heart rate and output in response to immediate changes e.g.
standing up. The PNS acts in the longer term to slow heart rate and reduce output.
Thus the heart rate at any one time is a balance of the SNS against the PNS [4].
The ANS acts through the flow of electrical signals within the nervous system; as a result
it responds quickly to the varying demands of the body. Since it is a “balancing” system
the ANS operates more slowly than the Frank-Starling mechanism while the effect of
changes in levels of catecholamines in the blood stream act even more slowly than the
ANS. Thus the Frank-Starling mechanism is the highest frequency mechanism regulating
changes in cardiac output.
In normal SR the duration of each beat does not vary substantially from one beat to
the next, although modulated by the ANS it may change significantly over time as the
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ANS responds to the needs of the heart. Thus the blood volume in the ventricle at the
beginning of one beat will be approximately the same as the volume at the beginning of
the next.
1.1.2. Electro-Mechanical Activation
Muscle contraction is caused by the unified depolarization of muscle cells. Electrical
activity in muscles cells is controlled by the flow of Na+, Ca+ and K+ ions across the
cell membrane causing current flow (and hence voltage changes) through the muscle.
The depolarization of the myocyte (cardiac muscle cell) causes it to contract. The
coordinated contraction of cells results in a contraction of the atrial or ventricular cavity
and the ejection of blood from the chamber.
Myocytes depolarize when their action potential reaches a threshold voltage, usually un-
der the stimulus of an adjacent cell. The action potential of a typical “normal” myocyte,
and the associated electrocardiogram (ECG) signal (see §1.1.3) is shown in Figure 1.1.
It is characterised by rapid depolarization and slower repolarization. There are several
different kinds of myocyte each with its own action potential and the variation between
these controls the coordination of contraction in the myocardium. In particular the sino-
atrial, SA, and atrial-ventricular, AV, node have action potentials which are much slower
to depolarize and much faster to repolarize. The SA and AV nodes have an intrinsic
“pacemaker” current which causes spontaneous contraction. Because the cycle is more
rapid in the SA node, it is the cardiac pacemaker in the normal heart.
In the normal heart, electrical activity originates in the SA node and travels through
the atrial muscle supported by inter-nodal bands (along which there is rapid conduction)
causing coordinated contraction through the atria. Inter-nodal bands merge at the AV
node through which there is slow conduction. The AV node bridges the atria and ven-
tricles and, normally, all electrical activity passes through the AV node before reaching
the ventricle. The slow conduction through the AV node ensures that atrial contraction
finishes before ventricular contraction starts. Although the AV node has its own pace-
maker current the signal from the SA node reaches the AV node and causes it to fire
before the potential in the AV node builds up sufficiently by itself to reach the threshold
potential.
1Image taken from http://ocw.tufts.edu/Content/50/lecturenotes/634463/634540 on 8.10.2011
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Figure 1.1.: Cardiac action potential1.
During the absolute refractory period (ARP), immediately post depolarization, any my-
ocyte is inexcitable. During the relative refractory period (RRP) immediately following
the ARP the cell gradually recovers its excitability. An action potential during this
period has a slower rate of depolarization, lower amplitude and shorter duration. The
slower an impulse is conducted through the AV node and the deeper it penetrates before
it is blocked, the longer the AV node will be refractory to subsequent impulses.
Electrical and mechanical events overlap considerably in time. Where a beat has an
abnormal aetiology, e.g. in AF or where there are ventricular ectopics, a second depo-
larization may occur abnormally early. If a second action potential is generated very
shortly into the RRP the second contraction is superimposed on the semi-relaxed phase
of the first contraction making it relatively weak. Thus an ectopic beat will usually
result in a relatively strong beat being followed by a weaker one.
1.1.3. ECG, rhythm strips and the Exercise Tolerance Test
(ETT)
The changes in the individual intracellular voltage which are described above combine
over all the cells of the myocardium to produce a constantly varying voltage signal which
can be measured using electrodes placed on the skin. These signals are the summed
voltages over all the cells on the path between the electrodes. This signal is the electro-
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Figure 1.2.: Principal features of the ECG2.
cardiogram (ECG). The signal will vary depending on where the electrodes are put but
the principal features of the ECG for a single beat are shown in Figure 1.2.
The main features of the ECG are:
P wave: This shows the coordinated depolarization activity of the atrium. The width
of the P wave approximates to the duration of contraction of the atrium.
QRS complex: This is the result of the coordinated depolarization of the ventricle, it
indicates the onset of electrical and mechanical contraction.
T wave: This is the result of ventricular repolarization as the ventricular myocytes
return to their base potential (see Figure 1.1).
PR interval: The time between onset of atrial depolarization and ventricular depolar-
ization.
ST segment: The time during which the entire ventricle is depolarized.
QT interval: The total time for ventricular depolarization and repolarization. It ap-
proximates to the duration of the action potential of the ventricular myocyte.
2Image taken from http://www.cvphysiology.com/Arrhythmias/A009.htm on 8.10.2011
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R-R interval: The total time between the onset of ventricular depolarization in one
beat and the onset in the next. Although not shown on this plot the R-R interval
is highly significant as it defines heart rate.
Each of these features is characteristic and variations from normal values may represent
an underlying pathology. Thus the absence of a P wave is distinctive of atrial fibrillation
(AF) (see §1.2); a prolonged PR interval suggests a problem with AV nodal conduction;
prolonged QRS complexes are indicative of poor conduction within the ventricle; ST
segment elevation or depression can result from ischaemia (see §1.1.4). As a result of
these and other pathological changes in the ECG, it is a very useful tool in diagnosing
cardiac problems.
Typically, a standard 12 lead ECG will involve the placement of 10 electrodes: 1 on
each limb and 6 on the chest surrounding the heart. Voltages are measured between the
limb electrodes (leads I-III), between each limb electrode and an average of the other
two (leads aVr, aVl, aVf ,) and between each of the chest electrodes and an average of
the limb leads. This yields a view of the electrical activity of the heart along 12 different
lines (leads). A much simpler tracing can be taken simply by placing 3 electrodes on the
limbs (usually at the top of both arms and the left leg). While theoretically this could
be used to produce 6 different tracings, when the main information that is required is
the rhythm a single lead (usually lead II) is recorded. This is known as a rhythm strip
and it gives an indication of rhythm without the detail of a standard 12 lead ECG.
If an ECG is recorded while a patient is “stressed”, usually by getting them to exercise,
the changing ECG patterns can be studied to show variation with increasing stress on
the myocardium. This is known as an exercise tolerance test (ETT) and it is particularly
useful for diagnosing ischaemia.
1.1.4. Ischaemic heart disease
Ischaemic heart disease, IHD, is characterised by reduced blood supply to the my-
ocardium, usually as a result of coronary artery disease (atherosclerosis). IHD affects
about 4.6% of the population of Scotland and is the most common cause of death in the
UK (1 in 5 men and 1 in 7 women die from IHD)[5].
Coronary artery disease is the narrowing of the coronary arteries due to the accumulation
of plaque within the walls. As this becomes more extensive it may result in IHD with
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symptoms including angina (chest pain) and breathlessness, particularly on exercise. As
ischaemia develops so too do the symptoms. The progression of symptoms has been well
described and is known as the ischaemic cascade. In this the ischaemic heart follows a
pattern whereby there is first an imbalance of bloody supply and demand; this is followed
by diastolic dysfunction, then systolic dysfunction, ECG changes and only finally anginal
pain [6].
Diagnosis
Ischaemic heart disease is diagnosed using ECG, ETT, coronary angiography and my-
ocardial perfusion imaging. ECG and ETT were discussed briefly in the previous section.
Diagnosis of IHD using ETT involves looking for ST segment elevation or depression on
stress when compared to rest. ST segment changes are caused by hypoxic cells which
have a different action potential and consequently produce different electrical signals
relative to the depolarized baseline (see §1.1.3). By stressing the myocardium a demand
is made by the heart for increased blood flow to support the extra work which is done
by the myocardium at increasing heart rate. Ischaemia is diagnosed if there is a change
in the ST segment on exercise which reflects hypoxia in the cells.
Coronary angiography involves looking for narrowing of the arteries by tracing the flow
of a radio-opaque contrast through the arteries under x-ray fluoroscopy. It is highly
sensitive to the build up of plaque on the macroscopic level but performs poorly if
lesions in the arteries or capillary networks are too small to be seen at the required
resolution.
Myocardial perfusion imaging (MPI) involves injecting a radioactive tracer into the blood
stream. The tracer is designed to be taken up by myocytes thus mimicking the effect
of more naturally occurring ions (e.g. K+). Uptake is proportional to blood supply
with poorer uptake where there is poorer supply. The difference between poor and
good supply can be exaggerated by stressing the patient and thus increasing myocardial
demand. As a result differing uptake on stress and at rest is indicative of ischaemia.
While the ECG / ETT changes occur late in the ischaemic cascade, MPI reflects early
changes making it sensitive at an early stage to the presence of ischaemia.
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Treatment
IHD is treated differently depending on the extent of the disease. It is most commonly
treated with medical therapy which may include β-blockers, anti-platelet agents, vaso-
dilators, calcium channel blockers and nitrates. For more serious disease the coronary
arteries can be widened by inserting a device which expands to open a clear channel
through the artery, a process known as percutaneous coronary intervention (PCI) or
coronary angioplasty; this can be augmented by the insertion of metallic stents which
may or may not be drug eluting. The more invasive treatment involves coronary artery
bypass grafting (CABG) in which a replacement channel (an artery or vein from else-
where in the body) is grafted to bypass a narrowing in the artery and thus improve
blood supply. In very extreme cases the heart may be transplanted.
1.1.5. LV function
LV function can be separated into two stages: systole, during which the left ventricle
empties and blood is pumped around the body, and diastole, during which the left
ventricle fills from the atrium under pressure exerted by the contraction of atrial muscle
augmented by the relaxation and active dilation of the LV cavity wall. Both of these are
affected by cardiac pathology and it is important to be able, quantitatively, to assess
both systolic and diastolic function as an indicator of cardiac health.
Assessing LV function
One would expect that in discussing “LV function” a common language is in use and yet
there are a variety of techniques for assessing LV function which, although they may have
similar results, are fundamentally different. The different techniques can be categorised
as measuring blood flow, pressure, wall motion or volume changes; with each assessment
modality involving a different technique as defined in Table 1.1.
There is a clear difference between assessments based on pressure, whether direct or
derived, and those based on volume. It has been shown that even between those tech-
niques which assess volume changes, and hence similar parameters, there is a significant
variation between measurements using the different modalities [7, 8]. For example Bel-
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Assessment technique Modality
Blood flow (derived pressure) Doppler echocardiography
Wall motion (derived volume) MRI, MPI and advanced echocardiography
Direct pressure Invasive catheterisation
Blood volume changes RNVG
Table 1.1.: Techniques and modalities used in assessing ventricular function. The table shows
the principal modalities associated with each assessment technique, although
there is not a one to one match and, for example, blood flow measurements may
be also made using MRI. Abbreviations: MRI = Magnetic resonance imaging,
MPI = myocardial perfusion imaging, RNVG = radionuclide ventriculography.
lenger et al. found mean LVEF in his group of heart failure patients to vary from 24%
by radionuclide ventriculography (RNVG) to 39% by M-mode echocardiography.
Invasive investigation of cardiac pressure is neither desirable nor practicable given the
number of patients involved, although it probably offers the most reproducible assess-
ment of LV function. Echocardiography is readily available and comparatively inex-
pensive; however, it is a difficult tool to use reproducibly, particularly if the patient
is not echocardiogenic. Cardiac magnetic resonance imaging (CMRI) is expensive and
not readily available. Although in SR it is the gold standard it does not work well
in patients with arrhythmias (this is discussed in greater detail in Chapter 8, §8.4.2).
RNVG while more expensive than echocardiography also has good availability and better
reproducibility.
The focus of this thesis is on measures of LV function which can be made from changes
in volume, and in particular from the LV volume-time curve. Although there are several
measures of systolic function which can be made from the volume-time curve, including
peak emptying rate, duration of systole and time to peak emptying, by far the most
common measure is ejection fraction: the proportion of the volume of blood in the
ventricle which is expelled from the ventricle during systole. LV ejection fraction (LVEF)
has been shown to have powerful prognostic value in groups of patients in numerous
papers [9–11]. In most studies the assessment of LV systolic function is limited to LVEF,
to the extent that the two terms are commonly treated synonymously. In the normal
healthy heart, systole is dominated by the single process of muscle contraction and a
single measure can reasonably be used.
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The assessment of diastolic function is much less well defined and no single parameter
fully describes the complexity of filling which, unlike emptying, is not dominated by a
single process. In those modalities for which assessment is based on volume-time curves
several measures that reflect single points on the curve have been investigated and found
to have diagnostic potential [12]. These include peak filling rate (PFR), time to peak
filling, and first third filling fraction (FTFF) - the change in volume over the first third of
filling expressed as a fraction of the overall volume change. While these have been found
to be clinically significant it should be acknowledged that they attempt to describe a
curve from a single point on that curve and this is inherently imprecise, even if the curve
follows a known shape. Experience has shown that, particularly in the case of diastolic
function, volume-time curves do not always follow a known shape.
1.2. Atrial Fibrillation (AF)
AF is the most common sustained cardiac arrhythmia. It affects ∼ 1% of the population
with its prevalence increasing with age from ∼ 0.5% in the 50-59 year group to ∼ 9.0% in
the 80-89 year group [13]. Recent records for England in 2008/2009 found that 1.35% of
patients registered with NHS GPs had AF [14] with a similar distribution in most other
western countries [15]. In Scotland the prevalence has been found to be 9.4/1000 in men
and 7.9/1000 in women increasing with age to 71/1000 in individuals aged > 85 years[16].
AF is associated with increased risk of stroke, congestive heart failure, fainting and over
time can lead to more severe cardiac and circulatory problems. Typically patients in AF
lose about 15% of their cardiac output and this is attributed to the absence of an atrial
kick during ventricular filling (diastole).
AF describes the uncoordinated fibrillation (quivering) of cardiac muscle in the atria and
it is characterised by the absence of a P wave, which represents depolarization of the
atria, on the ECG and by the resultant apparently random fluctuations in ventricular
beat length (R-R interval on the ECG).
1.2.1. Description, causes, risks and treatment
AF is characterised by irregularly irregular beats with R-R intervals ranging from the
very short, sometimes as low as 300 ms, to the very long, up to 1500 ms. Although
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Figure 1.3.: Tracings of three leads (I, II & III) from a 12 lead ECG showing typical AF.
there are no P waves typically the QRS complex is normal. R-R intervals are short and
irregular, frequently occurring before the ventricle is filled. Overall ventricular rate is
typically 150− 220 bpm (see Figure 1.3) before rate control. R-R intervals show marked
irregularity which lacks a discernible pattern (although at very rapid rates this is not
easy to diagnose).
There are many causes of AF, both cardiac and non-cardiac. Cardiac causes include:
ischaemic heart disease, rheumatic heart disease, hypertension and pre-excitation syn-
dromes such as Wolff-Parkinson-White. Non-cardiac causes include: pneumonia and
other acute infections, pulmonary embolism, lung carcinoma and thyrotoxicosis. AF is
also a common problem post cardiac surgery. Dietary and lifestyle factors, particularly
excessive alcohol or caffeine consumption, are also associated with an increased risk of
the development of AF [13].
AF may occur asymptomatically, but many patients experience chest pain, dizziness,
palpitations and even loss of consciousness. It can also lead to reduced exercise toler-
ance and impaired cognitive function. However, the main concern for patients in AF is
associated with a substantially increased risk both for developing associated pathologies
(e.g. stroke and thromboembolism) [17, 18] and for increased overall mortality where
the odds ratio3for death is 1.5 for men and 1.9 for women [19].
3Odds ratio:the ratio between the odds of an event occurring in one group compared to the odds of it
occurring in the other; in this case with and without AF at the same age. If p1 is the probability of
an event occurring in group 1 and p2 is the probability of the same event in group 2, the odds ratio
is calculated as:
OR =
p1/(1− p1)
p2/(1− p2) (1.1)
In AF this suggests an independent increase in the risk of death of between 50% and 90%.
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Treatment
Although AF has a typical pattern on the ECG which makes it clearly identifiable, it is
treated differently depending on the presentation of the patient. For this reason AF is
normally described in terms of its onset, frequency and persistence. A variety of terms
are used to describe AF [20] but the National Institute for Clinical Excellence (NICE)
recognises five forms4, each of which is treated differently [13]:
Paroxysmal AF occurs intermittently and terminates spontaneously after less than 7
days and usually after less than 48 hours. It is treated using rhythm control strate-
gies principally aimed at preventing recurrence of AF.
Persistent AF occurs intermittently but requires some form of intervention (either drug
treatment or electrical cardioversion) to terminate it. Both rate and rhythm control
strategies are used to treat it.
Permanent AF is established and ongoing and does not respond to intervention. It is
treated using pharmacologically based rate control strategies in conjunction with
anti-thrombotic drugs.
Acute onset AF is described for patients who present with acute haemodynamic insta-
bility. If this is life threatening, or if the patient is not known to be in permanent
AF, treatment is by cardioversion (rhythm control), otherwise pharmacological rate
control is used.
Post-operative AF may be transient and self-limiting. NICE recommend in general
that rhythm control is used.
1.2.2. AF Ablation
Treatment for AF generally takes the form of anti-thrombotic therapy and some form
of either rhythm or rate control, as discussed above. Rate control is generally achieved
using medical therapy while cardioversion is used in rhythm control. Cardioversion can
be either electric, in which the heart is shocked back into SR, or pharmacologic, in which
4The NICE guidelines were in many respects superseded by the European society of cardiology “Guide-
lines for the management of atrial fibrillation” [21] which use a slightly different categorisation,
although it is still based on the presentation of AF.
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drugs are used to bring the heart back into SR. Recently a third option which may be
used in conjunction with the others has become available: AF ablation.
In 1998 Haissaguerre et al. [22] investigated the origins of ectopic beats which seemed to
initiate AF in patients with persistent and paroxysmal AF. They found that in 94% of
cases the ectopic beat which seemed to lead to the onset of AF occurred in the pulmonary
veins. They found that, by using radio-frequencies to heat the tip of a catheter and ablate
the ectopic foci in the pulmonary veins, they were able to prevent the recurrence of AF
in the majority (62%) of patients.
Since then AF ablation has been used in several studies (e.g. [23–25]) which have
investigated the efficacy of the technique in a variety of situations with moderate success.
The technique, however, is still not widely used and while many of the papers have
reported reasonable results there is still doubt as to the long term benefit of a technique
which is moderately invasive and expensive.
1.2.3. Ventricular response to AF
AF is principally an atrial pathology, but it profoundly influences ventricular function
which has the greatest effect on cardiovascular health. Unfortunately the conduction
mechanisms of the AV node are not fully understood and in particular the role of AV
node physiology is still not known [26]. However, in the absence of conduction defects
apart from AF, all electrical activity passes through the AV node. Thus studying the
ventricular response to AF is akin to studying the effect on traffic flow out of Dover of a
French lorry drivers protest; or the effect of variations in water flow above a waterfall by
measuring the river flow below it. The effect will be profound but it is modulated by an
intermediate process (the AV node, cross channel ferries, the waterfall), and studying
variations in the ventricular function offers more insight into the behaviour of the AV
node, and the intrinsic behaviour of the ventricle than it does into the pathology of AF.
This study is ultimately more concerned with the physiology of ventricular function and
its variation than with AF.
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1.2.4. AF: the imaging challenge
In cardiac imaging, AF provides a significant challenge due to the beat-to-beat variation
in beat length (R-R interval). Cardiac imaging is rarely about imaging the atria, and
it is much more common for interest to be in imaging the ventricles, particularly the
left ventricle which is the principal determinant of cardiac output and blood flow. The
ventricular beats in AF have lower frequency than atrial beats (if atrial beats can be
identified). In AF ventricular rate is typically around 100 bpm (R-R interval: 600 ms)
after rate control, compared with 300 bpm (R-R interval: 200 ms) in the atria. The R-R
interval, however, varies substantially suggesting, as a result of the Frank-Starling law
(§1.1.1), that there will be substantial variation in beat-to-beat function. The investiga-
tion of this variation is the principal subject of this thesis and we will return to this in
more detail in §1.6.
1.3. Describing Rhythm
As we have seen, AF is usually described in terms of its onset and duration (§1.2.1);
however, these do not describe the characteristics of AF which would allow one to
compare one occurrence of AF with another. To compare the occurrence of AF at
one particular time with another at a different time or in a different patient we need to
be able to describe, quantitatively, the features of rhythm in each occurrence of AF.
While there will be a number of variables by which this can be described, most notably
the degree of variation in beat length, or regularity, there is no well defined common
standard for the description of AF.
A significant amount of research has been involved with this question in relation to
SR and particularly in patients with low R-R variability. There have been many fewer
studies, however, which have investigated descriptions in AF, and there have been no
studies which have compared descriptions in AF to those in SR.
In the following discussion let us consider two rhythms. Figure 1.4 shows a patient in
SR, with a relatively constant beat length and total variation of ∼ 150 ms, and a patient
in AF with a widely ranging beat length and a total variation of ∼ 1100 ms typical of
AF.
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Figure 1.4.: Showing forty consecutive beats from (a) a patient in SR and (b) a patient in AF.
(Note the differing scales which emphasise that there is a degree of variability in
both SR and AF).
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1.3.1. Heart Rate Variability
Heart rate variability (HRV) is used as an indicator of cardiac autonomic nervous tone
in patients in SR. In general, in patients with SR and excluding ectopic beats, it is
accepted that patients with poor heart rate variability, reflecting reduced PNS activity,
have a poorer prognosis than patients with a greater variability.[27, 28]
There are a number of standard linear measures used in the assessment of HRV in
patients including:
Mean NN: The mean NN interval where NN is the R-R interval between adjacent QRS
complexes from normal sinus node depolarizations.
NN range: The difference between the longest and shortest NN interval.
SDNN: The standard deviation (SD) of the NN interval.
SDANNx: The SD of the average on x NN intervals (e.g. SDANN5 is the SD after
every 5 beats have been averaged together).
RMSSD: The square root of the mean squared difference between successive NN inter-
vals.
NN50: The number of differences between successive intervals of greater than 50ms.
pNN50: The ratio of NN50 to the total number of NN intervals.
In SR, RMSSD and pNN50 are both moderated by the PNS although neither have
been shown to have prognostic implication in terms of all cause mortality. In contrast
Mean NN and SDNN appear to be reduced in conditions where there is sympathetic
over-activity [29].
Linear measures of heart rate variability have been used in many studies from the inves-
tigation of premature newborns[30] to mortality in heart failure[31] and the prediction
of recurrence of AF [32].
Generally, however, heart rate dynamics have not been found simply to follow linearity
and measures of non-linearity are also required. It is in this area that the Poincare´ plot
and analysis of entropy have been found to be particularly useful.
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preceding (s) indexed (s)
point 1 0.79 0.85
point 2 0.85 1.24
point 3 1.24 0.97
point 4 0.97 0.83
point 5 0.83 0.87
Table 1.2.: First 5 points of a
Poincare´ plot for a pa-
tient in AF.
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Figure 1.5.: Showing the evolution of the first 5
points of the Poincare´ plot with time.
1.3.2. Poincare´ plots
A Poincare´ plot (also known as a Lorenz plot) plots the indexed R-R interval against
the interval immediately following or, with similar effect, the preceding R-R interval
against the indexed one. Similar plots (known mathematically as return plots) were first
described by Poincare´ [33] and used by Lorenz [34] in a mathematical description of the
atmosphere as a long range predictor of weather. The most common use of the plot is
in assessing heart rate variability and was first described by Anan et al. [35]. The plot
can be considered to provide a global description in phase space of a system.
A phase space is a “space” in which all possible states of a system are represented, with
each possible state corresponding to a unique point in the phase space. If we consider the
states of the “cardiac beat system” as the different R-R durations then a Poincare´ plot
can be considered to be a phase space representation of that system. It demonstrates
the degree of self-similarity of the overall process of the beating heart.
Taking as an example a patient in AF, the first five points in this process are shown in
Figure 1.5 (although a standard Poincare´ plot will not show the connecting lines, but
simply the available states in the phase space).
Poincare´ plots corresponding to the two examples of Figure 1.4 are shown in Figures 1.6
and 1.7. These demonstrate typical distributions for SR: a tight grouping of points
around a central value and AF: a widely dispersed set of points with no clear structure
to the plot.
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Figure 1.6.: SR: Poincare´ plots for (a) the first 40 beats in and (b) the full acquisition (10
min, 727 beats) for a patient in SR.
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Figure 1.7.: AF: Poincare´ plots for (a) the first 40 beats in and (b) the full acquisition (15
min, 903 beats) for a patient in AF.
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Poincare´ plots have been used extensively as a research tool in SR [36–39] where it has
been clearly shown that there is poorer prognosis in patients with lower HRV (more
tightly clustered Poincare´ plots). To a lesser extent Poincare´ plots and HRV measures
have been used in AF [40, 41], principally to investigate the relationship between onset of
AF from SR or the maintenance of SR after AF rhythm control. The plot can be further
developed by adding a third dimension which represents the frequency with which a
state occurs. This is known as a Histographic Poincare´ plot.
Histographic Poincare´ plot
The Poincare´ plot demonstrates distribution of the available states in the phase space
but it does not represent the frequency of occurrence: it is quite possible that a point in
the plot may occur multiple times. This is not reflected in the standard Poincare´ plot;
however, by adding shading or colour to the plot, a third dimension can be added which
reflects the number of occurrences of a point in the plot [42]. When information about
frequency is included in the Poincare´ plot the relative importance of, for example, a single
ectopic beat among 1000 normal sinus beats is demonstrated and similarly structure and
clustering in a widely diffuse phase space (e.g. in AF) is more obvious. The histographic
Poincare´ plot is shown in Figure 1.8; in these examples the plot is shown for the full
727 beats (SR) and 903 beats (AF) of a typical acquisition in the department of Nuclear
Cardiology at Glasgow Royal Infirmary.
Quantifying the Poincare´ plot
The Poincare´ plot provides an excellent qualitative “image” of rhythm. Poincare´ plot
patterns are very distinctive and allow the user to establish a general impression of
rhythm, and in particular any structure to the rhythm, at a glance; however by them-
selves they do not provide quantitative data.
Multiple indices have been developed to characterise Poincare´ plots. These can be
divided into several categories: correlation; ellipse fitting; pattern fitting; density and
difference plots as well as some less well used measures including moments of inertia and
dispersion at different R-R intervals.
Smith and Reynolds [43] investigated 28 different indices (excluding those based on
density) and correlated them with SDNN, RMSSD and pNN50. Although they only
Introduction 23
R−R(i)
R
−R
(i+
1)
0.0
0.5
1.0
1.5
2.0
0.0 0.5 1.0 1.5 2.0
N
0
20
40
60
80
100
120
140
R−R(i)
R
−R
(i+
1)
0.0
0.5
1.0
1.5
2.0
0.0 0.5 1.0 1.5 2.0
N
0
2
4
6
8
Figure 1.8.: Showing histographic Poincare´ plots for the complete acquisition for the sample
patients in (a) SR and (b) AF. Colour scales show number of beats at each point
(points can only take integer values, even though colour scale is continuous).
looked at data from a single patient in SR in a variety of postures they found that
most published Poincare´ indices are correlated with SDNN and/or RMSSD. It has also
been shown [37] that although ellipsoid fitting is one of the more common means of
quantifying the Poincare´ plot (e.g. Toichi et al. [44]) the indices derived from the short
and long axes of ellipsoid plotting are mathematically related to SDNN and RMSSD
respectively.
A few indices, however, have been found to give separate independent measures of vari-
ability in particular: the Pearson correlation coefficient, rRR, between RRn and RRn−1
[45] and a measure of the compactness of the plot [46]. While other indices have been
developed (e.g. the complex correlation measure developed by Karmakar et al. [47])
which show some promise they have not been investigated in detail and have not been
considered in this study.
Delta Poincare´ plot
A variation on the Poincare´ plot has been proposed by Raetz et al. [48] who suggested
that plotting the changes in R-R intervals instead of the R-R intervals themselves allows
the observer to view changes without the distraction of the dominant high correlation
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Figure 1.9.: Example of a Delta Poincare´ plot from a patient in AF. The plot has the advan-
tage of removing the inherent correlation which may exist, particularly in SR,
between one beat and the next.
between one interval and the next. This allows the observer to determine whether there
is a consistent pattern to beat-to-beat variations. An example is shown in Figure 1.9.
Raetz et al. used the Delta Poincare´ plot to investigate R-R interval variation during
sleep and found that there was a significant difference in the pattern of beat changes in
SR between quiet sleep and REM sleep.
1.4. Entropy
While linear measures of heart rate variability and the Poincare´ plot offer insight into
beat-to-beat variations they say little about the regularity of the R-R interval sequence:
a sequence might be completely regular but still show sizable variation in these measures.
The concept of entropy, which was first introduced in thermodynamics, offers a means
of quantifying the regularity of a system.
1.4.1. Regularity vs. Complexity
Before we proceed it is important to understand the difference between measures of
regularity and measures of complexity. A measure of regularity is essentially a measure of
the frequency of occurrence of a pattern of arbitrary length. Complexity is a measure of
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the ease with which that pattern can be constructed. It is possible to have a system with
high regularity and low complexity (a straight line), low regularity and low complexity
(white noise), high regularity and high complexity (perhaps most easily envisaged as a
long computing algorithm, although most music also falls into this category) and low
regularity and high complexity (typical of AF).
1.4.2. Introducing entropy
Entropy is one of the fundamental concepts of thermodynamics where it defines the
Second Law of Thermodynamics: heat cannot generally flow from a material at a lower
temperature to a material at a higher temperature without the input of work. It is not
immediately obvious how this translates from the world of thermodynamics to that
of R-R variability but entropy can be considered to be a statistical property which
defines the likelihood of a system being found in any particular state. In basic terms, in
thermodynamics, the state of any given system describes the energy that each molecule
has: at very low temperatures the overall energy in the system is very low so the total
number of states is low and the overall entropy is low. In R-R variability the different
R-R intervals can be considered to provide the number of states of the system, thus
SR will have a lower entropy than AF where the number of possible R-R states is
much greater than in SR. The relationship between thermodynamic entropy, information
and the statistical states that other systems can take has been shown to be physically
measurable and is not just conceptual [49], however an explanation of this is beyond the
scope of this thesis.
A number of different measures of entropy have been described as measures of quantify-
ing regularity / irregularity of rhythm. They include approximate entropy (ApEn)[50],
sample entropy (SampEn)[51], corrected conditional entropy (CCE ) [52] and measure-
ments of Shannon Entropy involving some form of “coarse graining” of the data; notable
among the last category is the use of symbolic dynamics (SymDyn)[53]. Most of these
will be described in the following sections.
A measure of regularity has to have two principal characteristics: it must be self con-
sistent - i.e. for a given patient it must yield the same results during one period as
it does during another (provided that there are no physiological changes) and it must
differentiate between rhythms. Entropy appears to offer these characteristics.
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1.4.3. Shannon Entropy, ShanEnt
Shannon entropy is a concept of information theory which measures the uncertainty
associated with a random variable. It was introduced by Shannon in his “Mathematical
theory of communication” [54] but has been used extensively in other fields.
Shannon entropy is defined as:
H(x) = −
n∑
i=1
p(xi) logb(p(xi)) (1.2)
where p(xi) is the probability mass function of xi (effectively the probability of the state
i occurring from among all possible states) and b defines the units of measurement: bits
(b = 2), nats (b = e) or dits (b = 10).
By definition if p(xi) = 0 then
0 logb 0 ≡ 0 (1.3)
Which is consistent with the limit
lim
p→0
p logb p = 0
Shannon entropy forms the basis of all measures of entropy which have been used in
assessing R-R variability [50, 51, 53, 55–57].
1.4.4. Entropy in symbolic dynamics
Symbolic dynamics is a means of coarse graining a system. In essence it involves mod-
elling a smoothly varying dynamic system by discrete sequences of abstract symbols.
Each symbol corresponds to a state of the system as defined by the discrete model. The
sequence of symbols thus represents a coarse description of the original system.
Hao in his 1991 paper [55] described the use of symbolic dynamics to characterise com-
plexity and suggested that it could be used to establish a measure of entropy in complex
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systems. This work was taken into the cardiac domain by Voss et al. [56] who used
symbolic dynamics as a measure of non-linear dynamics in assessing heart rate variabil-
ity in 26 patients post myocardial infarction (MI). He found that the use of non-linear
dynamic measures improved the discrimination of patients with high risk of developing
malignant ventricular arrhythmia. The technique was further developed by Palazzolo
et al. [53] who used it to assess entropy of heart rate variation in dogs, suggesting that
in SR entropy reflected the parasympathetic modulation of heart rate. No further work
appears to have been done using symbolic dynamics in the investigation of heart rate
variability.
1.4.5. Approximate entropy (ApEn) and Sample entropy
(SampEn)
Given a sequence of n real numbers (e.g. a sequence of R-R intervals) then, depending
on the precision of measurement, it is possible that no single number in the sequence
occurs more than once.
Pincus describes a measure of regularity, based on the Kolmogorov entropy (a theoretical
measure of the rate of generation of new information) which he calls Approximate entropy
(ApEn) [50, 57, 58]. This is based on the conditional probability that a sequence of m
events which repeats B times in the complete series of N events also repeats when the
length of the sequence is increased by one. A sequence is considered to repeat if each
member of the sequence falls within a tolerance, r, of the corresponding member of the
initial sequence.
The ApEn process counts each sequence as matching itself. This overcomes the problem
which would occur if there were no other matching sequences because ln(0) is undefined;
however, part of the underlying theory of information entropy as described by Shannon
[54] is that entropy is an indicator of the rate of information production. Since no
new information is added by including self-matches this measure of entropy could be
considered false; although a change in ApEn would indicate a change in the rate of
information production. In the situation where there are no other matches ApEn is
found to be 1, as it would be if every pair matched (see §2.10.3 for a mathematical
treatment of ApEn). Thus ApEn is biased to give a high estimate of entropy, and the
bias will be more pronounced the smaller N is (and hence the fewer matches there will
be). It can also be shown [51] that ApEn is not consistent over all conditions; it is
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possible that when comparing two samples one may have a higher entropy under one set
of (m,r,N) conditions while the other may have a higher entropy under a different set of
(m,r,N) conditions.
To overcome this bias Richman and Moorman [51] suggest a related measure of entropy
which they call “Sample entropy” (SampEn). This has two substantive differences from
ApEn: instead of being the average of logarithms of the conditional probability it is a
logarithm of the average of conditional probabilities. The ith conditional probability is
also calculated differently.
Richman and Moorman showed that while there is still a very small bias in SampEn,
particularly for very low values of N (1 < N ≤ 100), there is considerably better agree-
ment between SampEn and predicted theoretical values. Additionally, except at very
low N , the measure shows both relative consistency (results between different patients
vary as expected) and self-consistency (serial measurements on the same patient offer
very similar measures of SampEn).
Both ApEn and SampEn are statistical estimates over N of underlying parameters which
should be independent of sample length. However the approximation has been shown
to be reasonable for ApEn for N > 10m to 30m while for SampEn the estimate should
be reasonable for much lower values ( N > 100).
Both of these statistics are, in practice, a “family” of statistics with each member of
the family being dependent on a different choice of r and m. With decreasing r the
tolerance in determining matches will decrease which should result in lower conditional
probability and hence lower SampEn or ApEn. Similarly increasing m will decrease
the potential number of matches since matches have to be longer resulting in lower
conditional probabilities and lower SampEn and ApEn. True entropy in either of these
parameters is defined in the limits r → 0,m→∞ and as N →∞. Thus we are clearly
left with a question, namely: how do we select parameters for m and r?
Most authors seem to use values of r between 0.1 and 0.25. Lake et al. [59] proposed
that the best value of r can be selected by choosing to minimise the maximum relative
error of SampEn and conditional probability from which SampEn is calculated for the
population.
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1.5. Radionuclide ventriculography (RNVG)
Equilibrium radionuclide ventriculography (RNVG) is a nuclear medicine technique for
assessing cardiac function. It was first established in the late 1970s [60] growing out
of first pass radionuclide ventriculography which was developed in the early 1970s (e.g.
Parker, Secker-Walker et al. 1972 [61]). Since then, RNVG has been extensively used in
the assessment of cardiac function.
1.5.1. Basic Principles
Red blood cells are labelled with 99mTc- a 140 keV gamma-ray emitting radionuclide -
and the position of detected gamma rays is measured using a gamma camera to produce
an image of the distribution of labelled red blood cells. The highest concentration of
red blood cells occurs in the heart which thus dominates the image, although in some
patients red blood cells in the liver can make a significant contribution to the image.
The number of detected gamma rays is, to a very good approximation, proportional
to the number of red cells in a given volume. Thus, after a few minutes during which
the distribution of labelled red cells equilibrates, the number of counts in, say, the left
ventricle is proportional to the volume of the ventricle [62] (ignoring factors such as
attenuation and scatter).
If we consider a single heart beat, the volume of blood in the ventricle changes over the
cardiac cycle from a maximum at end-diastole to a minimum at end-systole returning to a
new maximum at end-diastole again. By dividing the beat into a number of smaller parts
and summing the total number of detected γ photons over each of the parts (effectively
integrating the counts over the duration of each part) we can get an assessment of volume
change with time over the cardiac cycle. This volume-time curve is distinctive and, as
discussed in §1.1.5, various characteristics of the curve have been shown to have clinical
significance. Of particular interest is the Ejection Fraction (EF), which has been shown,
in SR, to have good prognostic power (see §1.1.5).
Nuclear medicine images are built up over time as gamma emissions are detected by the
camera. The sensitivity of the imaging system and the activity of the source is such
that a comparatively long acquisition time is needed (typically > 30 s) for an image
to be acquired with a sufficiently high signal to noise ratio. This is much longer than
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any single R-R interval and images are built up by acquiring data over many beats. A
representative image of an average beat is created by dividing each beat into several
equivalent parts (typically between 16 and 32) and summing them together in a process
known as gating.
1.5.2. Gating
Gating the image allows the end-diastolic and end-systolic points to be determined. This
is achieved by recording the ECG signal during imaging. Each beat (determined as being
from the start of one R wave to the start of the next on the ECG, the R-R interval)
can then be divided into a given number of segments (usually 16, 24 or 32) using either
fixed or variable time formatting. The counts from equivalent sections in each beat are
added together to create frames of a dynamic image which represent different stages of
an average beat. The method of dividing each beat (variable or fixed time) determines
the form that averaging takes. Beats can be excluded depending on the beat selection
criteria.
Fixed time formatting
Fixed time formatting is also known as MUGA (MUltiple Gated Acquisition). An
“average” beat length is determined and this is divided into the given number of segments
to give a fixed duration for each segment. Counts which fall within each time segment
are added together to give an average beat. Blurring occurs throughout the cardiac
cycle but particularly in the diastolic phase because small changes in the duration of
a beat are amplified when beats are added together (see curve D in Figure 1.10). The
distortions introduced are generally temporal.
Variable time formatting
Each beat is divided into the given number of segments. Corresponding segments from
each beat are then added together to give an average beat. There is a significant blurring
effect if the ratio of systolic time to diastolic time for each beat is not approximately
constant (see curve E in Figure 1.10). The distortions introduced are generally volumet-
ric.
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Figure 1.10.: Showing the difference between fixed and variable time processing. Vertical
lines (of which one has been thickened to make it easier to follow) show con-
tributing parts of theoretical frames. Curves A, B and C (on both sides of the
diagram) show theoretical contributing curves from three single beats. Curves
D and E show the representative beat created using fixed and variable time
formatting respectively from curves A, B and C. Fixed time formatting intro-
duces substantial distortion (curve D). Although in this example variable time
formatting appears not to distort the curve (curve E), if there are volumetric
changes these will cause distortions.
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1.5.3. Distinctiveness
RNVG has a number of characteristics which uniquely distinguish it from other tech-
niques for assessing cardiac function:
1. The image produced is an average picture of cardiac function over a large number
of beats.
2. The image provides a largely geometrically independent assessment of global func-
tion.
3. Changes in activity distribution with time show changes in the fluid volume rather
than in the edge of the ventricle. This makes it suitable for pixel by pixel amplitude
and phase (Fourier harmonic) analysis, showing the relative time of contraction of
regional segments of the left ventricle.
1.5.4. Developments
Since its initial conception a number of developments have broadened the scope of the
RNVG, including phase analysis [63] and the development of SPECT [64]; more recent
developments have sought to combine these [65].
1.5.5. List-mode Acquisition
List-mode is an alternative means of acquiring image data which allows data to be post-
formatted in multiple ways, using differently defined criteria. While an image is built up
by summing events detected in each pixel within a defined frame, a list-mode file is a one-
dimensional string of data in which the position and time of every event, whether it be a
scintillation detection, an ECG pulse or some other event marker, is recorded. Data are
formatted into image data by combining this information in defined ways. Thus a static
image can be created by summing scintillation events which occur in each pixel, without
regard to timing or other event markers (top line in Figure 1.11). A dynamic image is
created by summing scintillation events which occur in each pixel between given timing
markers for sequential sets of timing markers (middle line in Figure 1.11). A gated image
is created by summing scintillation events which occur in each pixel in corresponding
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Scintillation Event
Timing pulse
LEGEND
ECG pulse
Gated Format: Events between two ECG marks are divided on the basis of time. 
Here if they fall in the first half (~2time pulses) they contribute to frame 1
in the second half of each beat (between two ECG marks) they contribute to frame 2.
sequential frames for each time period
Dynamic Format: Events in a given time (here three time pulses) contribute to
Static format: Every event contributes to a single framed image.
Figure 1.11.: Showing how list-mode files can be formatted into multiple different file types.
A symbolic representation of the list-mode file is given on the left. On the
right is a representation of frames of an image. A static image consists of a
single frame. A dynamic image is a set of sequential frames created without
reference to ECG pulse (gating marker). A gated image is an amalgamation of
events which occur at equivalent points in time relative to a set of given gating
markers, in this case the ECG pulse. The list-mode file has regular timing
pulses which define the temporal resolution. Scintillation events are labelled
with the position of the event but time is given by the timing pulse. ECG
gating markers define the time of each R-R interval.
parts between each set of gating markers - in this case ECG pulses (bottom line in
Figure 1.11).
Acquiring in list-mode allows both rhythm data (in the form of the temporal location of
R waves) and image data (in the form of the temporal and spatial location of a detected
scintillation event) to be acquired in the same file in a much more complete way than if
the image is built up in real time.
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1.5.6. Ejection Fraction (EF)
In any given heart beat the volume of the ventricle changes from a maximum at end-
diastole of the preceding beat to a minimum at end-systole, returning to a maximum
at end-diastole. By measuring the total count at end-diastole and the total count at
end-systole the ejection fraction (change in volume as a proportion of the total volume
of the ventricle) can be determined.
Ejection Fraction (EF) can be calculated, as % of end-diastolic count, from an RNVG
from
EF =
(Ced − Cbd)− (Ces − Cbs)
(Ced − Cbd) × 100 (1.4)
Where:
Ced: Counts in ventricle at end-diastole.
Ces: Counts in ventricle at end-systole.
Cbd: Counts in background region at end-diastole.
Cbs: Counts in background region at end-systole.
There is ongoing debate about where background regions should be positioned relative
to the myocardium but in most cases the same background is used at both end-systole
and end-diastole in which case, the equation simplifies to:
EF =
(Ced − Ces)
(Ced − Cbd) × 100 (1.5)
Two different techniques can be used to determine Ced and Ces. A single region of interest
technique, as used in this study, outlines the ventricle at end-diastole and the change
of counts within this region is used to determine the minimum, end-systolic, point. In
a dual region of interest technique separate regions are used to define the end-diastolic
volume and the end-systolic volume. There are advantages and disadvantages to both
techniques and these are explored in greater detail in the discussion (§8.3.1).
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1.6. Assessing ventricular response to beat-to-beat
variation in AF
The relationship between ventricular systolic function and R-R variation has been inves-
tigated by a number of authors. Schneider et al. [66] and Gosselink et al. [67] used a
gamma probe to investigate beat-to-beat variation in 18 and 14 patients in AF respec-
tively. By using a gamma probe they were able to look at changes on a beat-to-beat
basis without averaging over multiple beats.
Schneider found that there was good agreement between mean LVEF, derived using the
gamma probe and LVEF measured using RNVG. He demonstrated that in the probe
studies LVEF was dependent on the relative end-diastolic volume (EDV) and on multiple
preceding R-R intervals, concluding that a single value for LVEF does not adequately
characterise LV function in AF.
Gosselink found that in patients with non-valvular chronic AF there was a positive re-
lation between LVEF and preceding R-R interval and proposed a model which included
EDV and pre-preceding beat length to approximate EF in any one beat. He suggested
that the contribution of the Frank-Starling mechanism remains in some doubt, partic-
ularly given that he found a significant negative correlation between LVEF and the
pre-preceding beat length. He and several other authors [68] attribute this agreement to
postextrasystolic potentiation (which suggests that contractions are greater than normal
following a weaker beat) or, possibly, to low afterload [69] (after a short beat only a small
amount of blood will be ejected and consequently there will be lower aortic impedance
during the current beat).
Tomotsugu et al. [70] used echocardiography to investigate the relationship between
several, principally diastolic, left ventricular functional parameters and the preceding
R-R intervals. He showed that in dogs there is a positive relationship between EDV
and R-R interval in the same beat and consequently a positive relationship between
EDV and peak LV systolic pressure. Tomotsugu concluded that LV diastolic function in
individual beats in AF depends strongly on peak LV systolic pressure and hence that the
principal advantage of a slower rhythm is that it promotes higher peak systolic pressure
and greater LV relaxation.
Tanabe et al. [71], using the end-systolic pressure/volume ratio as an index of contrac-
tility, suggested that beat-to-beat changes in contractility in AF could be estimated by
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the ratio of preceding to pre-preceding R-R interval, and that the pressure/volume ratio
correlated positively with preceding R-R interval and negatively with pre-preceding R-R
interval in both patients with depressed as well as preserved contractility.
These studies suggest that there is a definable relationship between preceding R-R in-
terval and measured LVEF and that this may well be related to the Frank-Starling
mechanism.
1.6.1. Modalities
Ventricular function is variously assessed using echocardiography, radionuclide ventricu-
lography, gated myocardial perfusion SPECT, magnetic resonance imaging, cardiac CT
and contrast angiography. While each of these modalities have different advantages and
disadvantages they have in common one key fact: they are each dependent on regular
SR. The assumption is made that the cycle over a representative beat, however that is
constructed, is indicative of cardiac function over every other beat. This fundamental
assumption is challenged in the presence of AF. This will be explored in more detail
in §8.4 but in general results regarding R-R dependence for any one modality will be
broadly applicable to other modalities.
This study concentrates on radionuclide ventriculography. RNVG has been chosen as
the vehicle for this exploration principally because it is independent of geometry. Addi-
tionally it is readily available, applicable in almost all patients, non invasive and based
on multiple beats. In list-mode RNVG yields data on both temporal and volumetric
changes from beat-to-beat and as a result the well defined beat sequence it offers is
particularly suitable for retrospective analysis.
1.7. The Hypotheses
The hypotheses of this thesis can be summarised in the following statements:
1. Beat-to-beat fluctuations in R-R interval are reflected in beat-to-beat changes in
cardiac function, consistent with Frank-Starling’s law of the heart: the greater the
fluctuations, the greater the variation in function.
Introduction 37
2. A variation in function will be seen in SR but will be much more pronounced in
AF where the R-R fluctuation is much greater.
3. The duration of the preceding R-R interval has a substantive effect on measures of
function, in particular LVEF, both in SR and AF.
4. AF can be reliably described using indices of rhythm which are also applicable to
SR.
5. Measures of rhythm will have a predictive relationship with measures of function.
6. Measures of rhythm and function in AF can be shown to have clinical utility.
By acquiring list-mode RNVG data and formatting it to create an R-R interval stream
and different images depending on the beats included in creating them, it is possible to
investigate these hypotheses in a moderately large patient sample. The results of this
wider study can then be investigated for their diagnostic / prognostic power in a small,
but complex, clinical study.
Chapter 2.
Methods: Describing Rhythm
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Summary
In which the methods which have been used to quantify rhythm are described. These
include linear (time domain) measures of heart rate variability, entropy, and measures
derived from the Poincare´ plot. A description of the rhythm review process is also
included as is a short discussion of some of the statistical techniques which will be used
in the study.
2.1. Introduction
Much of the focus of this thesis is on assessing functional changes with heart rate vari-
ability, particularly in AF but also in SR.
While a considerable amount of work has been done on assessing heart rate variability in
SR, little work has been done on variability in AF. Is it possible to define a quantitative
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measure, or series of measures that in AF, “normally described simply as irregularly
irregular”, would allow comparison of one rhythm against another?
The traditional linear indices of heart rate variability used in SR offer a suitable starting
place for the investigation of rhythm in AF; however, there are other measures, no-
tably entropy and some measures linked to the Poincare´ plot, which may provide useful
additional descriptors.
The following describes the investigations undertaken to determine whether any of these
measures provide useful information in the context of AF while corroborating some of
the findings in SR.
2.2. Patient selection
Radionuclide ventriculograms were acquired in list-mode format for ∼ 400 patients in
AF and ∼ 400 patients in SR. Patients were selected prospectively from those patients
referred to the Department of Nuclear Cardiology at Glasgow Royal Infirmary for routine
investigation either of myocardial perfusion (MPI) with radionuclide ventriculography
(RNVG) or simply for RNVG.
Initially the only criteria which were applied to the selection of patients were that the
patient should be clearly in either SR or AF and that the rhythm should have been
maintained for the duration of the investigation. Patients in AF also had to be willing
and able to have a slightly longer investigation as routine scanning times were increased
if the patient was in AF (see §2.5.2).
One year into the data collection a preliminary analysis of the data found that in the
SR group there was a predominance of patients with approximately normal LVEF and
patient selection criteria was modified to favour those patients who, from the scan request
card, seemed likely to have poorer ejection fraction (principally patients with known
ischaemic heart disease including previous myocardial infarction).
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2.3. Ethics
Preparatory to starting this study, ethics approval was sought in October 2006 from the
Glasgow Royal Infirmary local research ethics committee under the title “Developments
in radionuclide assessment of ventricular function” (ref. 06/S070484). The request was
granted in March 2007.
The ethics application, which was described as a pilot study and was fairly broad in
detail, sought permission to use any radionuclide ventriculogram and the associated
patient data, acquired in the course of routine diagnostic imaging between January 2002
and December 2008, extended for this study to December 2009. Data collected would
be anonymized, randomised if necessary, and used to investigate a variety of different
conditions including AF, diastolic function and regional wall motion.
The application included the following statement: “While the study must have clinical
relevance, the principal area of interest is in the physics and physiology involved. Further
study may be required to investigate the clinical significance of findings.” Thus the main
focus of the study described in this thesis is on how the physical and physiological
mechanisms involved in AF affect imaging and the quantitative results derived from it.
2.4. Summary characteristics of patients
Although patients were initially divided into two groups, AF and SR, a review of the
rhythms, described in §2.6, found that some of the pre-defined rhythms required reclas-
sification. Once this had been done the final rhythm groups consisted of:
• 375 patients in AF
• 396 patients in SR
• 5 patients with atrial flutter
• 7 patients described as having “paced AF”
• 12 patients whose rhythm was uncertain
• 3 patients for whom the data was unusable
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SR AF
Total With Perf. Total With Perf.
Total Studies 396 254 375 252
“No significant perfusion abnormality detected” in perfusion report – 67 – 34
“MI” in blood pool report 75 35 72 41
“Negative ETT” in Perfusion ETT report – 107 – 47
MI (from questionnaire) 107 61 113 73
PCI (from questionnaire) 49 37 28 22
CABG (from questionnaire) 43 20 51 29
HBP (from questionnaire) 165 122 187 131
PVD (from questionnaire) 42 23 47 36
CVA/TIA (from questionnaire) 54 35 67 56
Age range (years) 17 - 86 36 - 85 19 - 86 33 - 86
Mean age (years) 59 59 66 68
Normal perfusion, function and ETT - 28 - 2
Table 2.1.: Patient summary characteristics after ECG review. Numbers are given for the
whole data-set and for those patients who also attended for perfusion imaging.
This study investigated only those patients in definite AF or SR and although many of
the parameters investigated were calculated for the other patients they have not been
included in the subsequent analysis.
The patients involved in the study had a broad range of pathologies. Summary clinical
characteristics for the patients whose investigations were used in the study are shown
in Table 2.1. These characteristics were assessed from the standard pre-test assessment
based on information supplied on the scan request and by the patient before the start
of routine investigation in the department as well as from the results of MPI and ETT
investigations undertaken at the time of the RNVG. Reference was not made to the
patient notes.
As part of the pre-exam assessment patients are asked to supply a list of drugs which they
were taking. A summary of the principal drugs and drug types is shown in Table 2.2.
The analysis which was undertaken in this study did not account for the medical therapy
which patients were on because of the potential extent of such an investigation. A sub-
group analysis which considered pathology and interventional treatment was performed
(see §2.7.1).
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Drug therapy SR AF
Total Patients 396 375
ACE 85 (21%) 117 (31%)
Anti-ulcer 118 (30%) 108 (29%)
ARB 33 (8%) 40 (11%)
Aspirin 241 (61%) 133 (35%)
β-blocker 175 (44%) 218 (58%)
Ca channel antagonist 80 (20%) 92 (25%)
Clopidogrel 52 (13%) 21 (6%)
Digoxin 19 (5%) 154 (41%)
Statin 232 (59%) 216 (58%)
Oral Nitrate 120 (30%) 99 (26%)
Warfarin 28 (7%) 248 (66%)
Table 2.2.: Summary of drug therapy for patients in SR and AF. Percentages give the pro-
portion of patients with that rhythm on the given therapy.
2.4.1. Four patients
Unlike many other sciences, clinical science is curious because we tend to study popu-
lations and extrapolate results for an individual patient from the results found for the
population. Yet these results will often not be represented in an individual.
Four patients were selected for use as individual examples throughout this thesis, two in
AF and two in SR. The example patients were selected with the following criteria: one
for each rhythm group was selected because they exhibited the most extreme variations
in measured ejection fraction: patient A1, in AF, and patient S1, in SR. The other
two patients (A2 in AF, and S2 in SR) were selected at random from the subgroup of
patients for whom the minimum ejection fraction (measured in all the ways described
in §4.3) was normal. Poincare´ plots for patients A2 and S2 have already been shown in
the introduction (§1.3.2).
The characteristics of these patients are summarised below:
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Patient A1
66 year old female in AF with known previous MI, peripheral vascular disease and mitral
valve regurgitation. She was referred to the department for MPI to assess the degree
of ischaemia following her MI. Her drug therapy included: quinine, PPI (proton pump
inhibitor), statin, Adcal, warfarin, Spironolactone, Furosemide and Digoxin.
During her positive exercise stress testing she managed 150 s of exercise on the bike
at 50 W stopping with breathlessness. Heart rate changed from 57 bpm to 170 bpm;
blood pressure from 138/65 to 162/82. Her ECG changed on exercise from showing
infero-lateral ST depression to > 2 mm ST depression inferiorly and anteriorly.
Her thallium scan was reported as showing a small to moderate area of reversibility in
the territory supplied by the left anterior descending (LAD) artery while the blood pool
was reported as showing overall normal LV (> 40%) and good RV (> 30%) EF.
Patient A2
67 year old male in AF with known previous non-ST elevation MI. An ex-smoker, he
was referred to the department to investigate the extent of ischaemia, particularly in his
right coronary artery (RCA).
His exercise stress test was reported as inconclusive although his ECG showed minor
infero-lateral ST changes on exercise. His myocardial perfusion scan was reported as
showing RCA disease with a small posterior MI and a small area of significant reversibil-
ity. His blood pool was reported as showing overall normal LV (> 40%) and good RV
(> 30%) ejection fractions.
Patient S1
77 year old male in SR with known previous MI. He was referred to the department for
blood pool (RNVG) imaging only, as part of a study which investigated the benefits of
the β-blocker Bisoprolol.
His blood pool scan was reported as showing overall moderate (> 20%) LV and RV EFs
which were poorer than on a previous occasion.
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Time Event Patient state
On attendance 12-lead ECG followed by ETT Potentially nervous
Immediately following ETT Perfusion imaging on stress Recovering from exercise
Three hours later Perfusion imaging at rest Relaxed
1/2 hour later RNVG At rest having lain still for 1/2 hour.
Table 2.3.: Typical timings for a patient’s attendance for MPI and RNVG in the department
of Nuclear Cardiology, Glasgow Royal Infirmary.
Patient S2
60 year old female in SR. She was referred to the department following a troponin
negative, unstable admission to hospital with chest pain to investigate whether she
showed any evidence of ischaemia.
Her exercise stress test was negative and her perfusion imaging was reported as overall
showing no significant perfusion abnormality. Her blood pool imaging was reported as
showing normal (> 40%) LV and good (> 30%) RV ejection fraction.
2.5. Data acquisition and processing
Most patients who come to the department receive a two-part scan consisting of MPI and
RNVG. Perfusion images are taken immediately following stress and again, three hours
later, after redistribution while RNVG imaging immediately follows the redistribution
images. A number of patients attend the department for RNVG only. The majority of
the patients in this study came for both types of scan, not simply RNVG, thus for most
patients a 12-lead ECG, acquired as part of the morning exercise test, was available. This
was necessarily taken at a separate time from the acquisition of RNVG data although it
was acquired on the same day. The typical timings for a patient’s attendance are shown
in Table 2.3.
RNVG data was acquired in list-mode format (see §1.5.5). This allows each beat to be
separately recorded with the result that a list of successive R-R intervals can be produced
for the duration of the acquisition. This data provided the principal data used in the
analysis of rhythm, although clearly the data is very coarse in that it only provides R-R
interval and none of the other information which might be obtained from a typical ECG.
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Most patients also had a short (∼ 20 s) 3-lead rhythm strip acquired during the acqui-
sition itself. This could be used to confirm the rhythm at the time of the acquisition.
2.5.1. Stages of data acquisition and processing
Acquiring clinically useful data using RNVG is a multistage process each stage of which
has several factors that influence the final outcome: producing relevant and reproducible
numbers. The stages, in order, and their principal dependencies are:
1. Data acquisition
a) Temporal resolution
b) Spatial resolution
c) Position
d) Duration
e) Zoom / Magnification
2. Data processing: create rhythm files (both R-R listings and R-R histograms)
a) Temporal resolution
3. Data processing: create image files
a) Beat selection
b) Gating
c) Zoom / Magnification
d) Temporal resolution
e) Spatial resolution
f) Uniformity correction
4. Image processing: create curves
a) Image manipulation (e.g. smoothing)
b) Region of interest (ROI) morphology
5. Image analysis
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6. Curve analysis
a) Curve smoothing / filtering
b) Curve limits
c) Calculations
Several of these but most notably 3a and 3b have been identified as having particular
significance to the assessment of ventricular function.
Image, as opposed to curve, analysis plays a significant role in the reporting of RNVG but
until recently has largely involved qualitative assessment of the (relative) regional wall
motion. More recently other techniques have been developed which allow quantitative
assessment of the image (e.g. dissynchrony [72]) but these have not been addressed in
this thesis.
A process flow diagram for steps 1 to 3 is shown in figure 2.1.
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Figure 2.1.: Showing the processing algorithm by which each list-mode file was formatted into different images depending on preceding
and indexed beat selection criteria.
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2.5.2. Data acquisition
List-mode (see §1.5.5) files were acquired, for all patients, at best septal separation
(∼ 40 ◦) left anterior oblique (LAO) and 70 ◦ LAO projections. 40 ◦ LAO files were
acquired for 15 min if the patient was in AF or for 10 min if the patient was in SR. All
70 ◦ LAO projections were acquired for 5 min. The longer acquisition time for patients
in AF is used routinely in the department because beat selection techniques which are
used can significantly reduce the amount of data composing the final, formatted, image;
extending the acquisition time provides some compensation for this.
The 40 ◦ LAO list-mode files, with a temporal resolution of 100 µs, were formatted to
create a histogram of acquired beat lengths for each file; each beat being allocated to
the appropriate bin of width 25 ms.
2.5.3. Data processing: Rhythm data
In analysing rhythm in this study, both the 40 ◦ and 70 ◦ list-mode file were formatted to
extract sequential lists of R-R intervals over the duration of each list-mode acquisition.
This provided two separate data-sets of varying duration for each patient at approx-
imately the same time. These allow investigation of the reproducibility of different
measures used to describe the rhythm; it should be noted that this technique only pro-
vides R-R durations, it is not a complete ECG. R-R intervals were measured to 100 µs
precision, corresponding to the time resolution of the acquired list-mode files.
Text files listing each interval in the acquisition were created along with histograms of
R-R intervals with 100 ms bins showing the frequency distribution of R-R intervals over
the acquisition period. The histograms were used both in analysing rhythm and to define
limits for beat selection which excluded outlying R-R intervals in subsequent formatting
of the list-mode files to create images (see §4.3.2).
2.5.4. False triggering
The acquisition system has to discriminate the QRS complex from the rest of the three
lead ECG waveform. This discrimination is built into the hardware of the acquisition
system but it relies on the comparison between the ECG and a high pass filtered ECG
Methods: Describing Rhythm 49
which removes noise and smaller wavelets within the ECG. This may be supplemented
by an assessment of the gradient of the QRS complex to distinguish them from bigger
T waves which are not removed by the high pass filter.
The acquisition system triggers either on the rising or falling QRS, and in our department
is set to do so on the rising QRS.
In a normal ECG this should be enough to provide a clear beat length (including ectopic
beats), however there will occasionally be ECGs where the T wave, particularly, can be
mistaken for the QRS leading to false triggering which introduces false beat lengths into
the R-R interval stream.
2.5.5. Limiting beats
Ectopic beats and “beats” due to false triggering can lead to distorted results both for
function and rhythm analyses. To reduce the effect of this limits beyond which beats
were excluded were determined by reviewing the beat histograms. This is discussed in
greater detail in §4.3.2 and §5.2.2. In the following assessments of rhythm, where the
beat sequence did not form part of the index, calculations were made on beats after the
limits had been imposed, although comparison was also made with the results without
limits. By excluding beats outwith the limits the assessment of rhythm more closely
matches the assessments of function which will be made in Chapter 5.
2.6. ECG review
While an initial attempt was made to identify patients in SR or AF when the data was
acquired, these groupings were reviewed to ensure that only patients in AF or SR were
included. The review took two forms:
1. Review of the patients 12-lead ECG from their attendance in the morning. Where
this was not available or there was some dubiety then the 3-lead rhythm strip taken
in the afternoon was used.
2. Review of the Poincare´ plot for that patient (see §2.9). This was done both to
ensure that the pattern of the Poincare´ plot matched the rhythm described in the
ECG (there was a possibility that a patient with intermittent AF could have been
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in AF during stress and SR at rest, or vice-versa) and to determine limits which
would exclude any ectopic beats (regardless of aetiology) which might have been
seen.
The full 12-lead ECGs and the associated Poincare´ plot for patients in the AF group
were reviewed in conjunction with an experienced cardiologist specialising in electro-
physiology (Prof. Andrew Rankin). In addition to the rhythm and limits above or
below which a beat was considered to be ectopic, for the patients in the SR group the
author undertook a similar review. Where the rhythm was neither SR nor AF this was
described (e.g. “ventricular pacing from a permanent pacemaker”), although the patient
has been excluded from any subsequent analysis.
In AF, the ECG may show fine, high frequency, regular wavelets between R waves,
known as fibrillatory waves. These are distinct from T or P waves (see §1.1.3) and occur
multiply between R waves. The wavelets are indicative of atrial activity and suggest
an element of coordinated activity within atrial muscle, with greater amplitude waves
being indicative of a greater coordinated myocardial mass. Some authors [73–75] have
used the amplitude of these wavelets to define AF as coarse or fine grained. As part
of the review of ECG rhythm in AF a determination of graining was undertaken. If
ECG tracings in leads V1 or II had fibrillatory waves with with an amplitude > 2 mm
the rhythm was described as coarse; with amplitude < 1 mm rhythm was described as
fine and anything in between was described as medium (with ECG tracing running at
10 mm/mV).
2.7. Analysis
Several different measures, ranging from standard heart rate variability measures such
as mean R-R to more complex measures like entropy, were assessed. Each measure was
assessed by investigating the difference between AF and SR, the reproducibility of results
and the variation of results in different patient sub-groups.
The reproducibility of results was assessed by considering the variation, and correlation,
between measures taken using the longer (∼ 40 ◦ LAO) and shorter (∼ 70 ◦ LAO) acqui-
sitions. These two acquisitions were acquired separately but immediately sequentially
and should thus represent the patient in the same state.
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2.7.1. Patient subgroups
The variation of the measures was also assessed against several different patient sub-
groups:
• Ischaemic / Normally perfused. Determined from myocardial perfusion imaging
(MPI) using 201Tl as part of the patient’s assessment in the department. The
report included the phrase “No significant perfusion abnormality demonstrated”, a
standard phrase in the department.
• Patients with previous MI. Determined from the standard patient questionnaire
given to each patient on attendance in the department.
• Patients with known HBP. Determined from the standard patient questionnaire.
• Patients with CABG or PCI. Determined from the standard patient questionnaire.
• Patients by age.
• LV function as defined by the LV ejection fraction assessed using all beats.
• Positive / Negative ETT. Patients who had had a positive or clearly negative
exercise tolerance test (as part of their MPI). Inconclusive tests were excluded
although borderline positive tests were considered to be positive for this analysis.
• “Pure” ECG: those patients who had no ectopic beats on ECG or Poincare´ plot.
• For AF patients the “graining” of the rhythm.
2.7.2. Ectopic beats
Heart rate variability measures as described in §1.3.1 applied in SR typically exclude
ectopic beats, regardless of their aetiology. Thus uncharacteristic R-R intervals which
could potentially substantially affect an index (e.g. range measurements) are not in-
cluded.
The aim of this part of the investigation was to determine whether there are indices
which adequately describe heart rate variability in both AF and SR, with the ultimate
goal of determining whether such indices can be used to explain some of the functional
variation which is seen in AF.
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Given a stream of R-R intervals from a patient in AF, with no record of the detailed
morphology of the ECG, it is not possible to determine the aetiology of a single beat
and it is possible that ectopic beats will have a similar duration to other beats in the
distribution of beats in AF. This makes a generic rule by which such beats can be
removed from the analysis unachievable.
Many of the indices investigated (see §2.9, §2.10) consider the variation over patterns of
multiple beats and it is therefore unclear how a single beat should be removed.
For these reasons all beats were included in the analyses of rhythm which follow. In a
very few cases this included beats which are clearly the result of technical faults (e.g.
beats of duration 14s where the connection to the patient must have failed), but except in
the determination of linear heart rate variability measures these will play only a minimal
role in the overall assessment of any of the non-linear indices (entropy, Poincare´ indices).
Ectopic beats (and R-R intervals due to technical fault) will affect the standard, linear,
time domain measures of heart rate variability (e.g. R-R range) and these were also
calculated on the limited data (for details of how data was limited see §4.3.2).
2.8. Standard heart rate variability measures
As described in §1.3.1 there are several standard measures of heart rate variability in
the time domain. These are typically measured after ectopic beats have been filtered
out1[27]. By redefining the measures as being calculated with all R-R intervals, such that
any beat regardless of its aetiology is included, it is theoretically possible to calculate
comparable values for arrhythmia. In doing so we make the assumption that the length of
the R-R sequence is sufficient to represent an arbitrarily longer sequence2. Calculations
were also made for the standard measures after upper and lower limits had been applied
to the acceptable beat criteria (see §2.7.2 for further discussion). The indices which were
measured are: Mean RR, RR range, SDRR, RMSSDrr and pRR50.
An awk script (see appendix §A.1) was used to determine the following results from the
R-R interval stream obtained from the list-mode files for each patient.
1The exclusion of ectopic beats from the R-R interval stream in SR is normally represented by referring
to NN intervals (representing the normal R-R intervals selected out from the beat list).
2To avoid confusion the term “NN” is replaced with “RR” to indicate that all R-R intervals are
included and that the measure is applied to an arrhythmia
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Mean RR is simply the mean of included R-R intervals.
SDRR is the standard deviation (SD) of included R-R intervals.
RR range is the range (longest - shortest) of included R-R intervals.
RMSSD is the root mean square of the difference between one beat and the next of the
included R-R intervals
pRR50 is the fraction of included R-R intervals for which the difference between one
beat and the next differs by more than 50 ms.
Additionally the SD of R-R interval averaged over 5, 10 and 20 consecutive beats and
the variation between SD of the average of 5 and the average of 20 beats was calculated.
The results were compared against each other and for differences between SR and AF.
2.9. Poincare´ plots
Poincare´ plots (see §1.3.2) were created from the R-R interval stream for each of the
patients. This provided a qualitative means of assessing some of the non-linear charac-
teristics of the rhythm of each patient.
Each Poincare´ plot was reviewed both to ensure that the pattern was typical of the
defined rhythm and to assess limits on the ectopic beats.
After a visual assessment of the Poincare´ plots quantitative measures were sought to
establish parameters which allow plots to be compared. Although a large number of
potential indices have been suggested in the literature, consideration of these in the
context of AF is necessary. The most commonly reported indices are based on fitting an
ellipse to the data with the long axis aligned with the line of identity (x = y). The long
(SD1) and short (SD2) axes of the ellipse providing information on the gross variability of
time series data. However, Karmakar et al. [47] have shown that there is a mathematical
relationship between SDRR and SD1 and SD2 which implies that there should be good
correlation between them. This agrees with the findings, in one patient only, of Smith
and Reynolds [76].
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The results from these and other studies [38, 40, 43, 46] together with the shape of
the Poincare´ plot for AF suggested two promising measures to quantify the Poincare´
plot: correlation and compactness factor. While there may be others these two were
investigated in this study.
2.9.1. Correlation
The Poincare´ plot displays the preceding against the indexed R-R interval (although
this is normally described as being the indexed against the succeeding interval) and is
suitable for regression analysis. A correlation coefficient can be determined which will
give an indication of the degree to which one beat defines the next.
The correlation coefficient, r, was determined for the relationship between Ri and Ri−1.
No assumptions were made about the line of best fit and the correlation coefficient was
thus able to take any value between −1 and 1.
2.9.2. Compactness factor
The idea of compactness was introduced by Hnatkova et al. [46]. Although the detail of
their calculation is unclear from their paper, the basic concept is explained.
If the maximum density of points on the Poincare´ plot in increasing areas is plotted
against area a maximum density function can be determined which shows the way that
maximum density varies with area. For example a Poincare´ plot which consists of a single
point of high value will exhibit a maximum density function which decreases linearly
with increasing area because the same total count is divided over an increasing area.
By contrast the maximum density function for an absolutely uniform distribution will
not change as the area is increased because the total count will increase proportionately
with the area. Every Poincare´ plot will have a maximum density function which falls
somewhere between these two extremes and which is uniquely characteristic of that plot.
Since there may be a substantial difference in the number of beats included from one
patient to the next there is a need for normalisation. If each empirically derived function
is normalised to the maximum density for that patient then the curves can be compared.
The area under the curve, the function integral, should provide a single figure measure,
here called compactness factor, that is indicative of the spread of counts over the entire
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Poincare´ plot. In this measure, the more widely distributed the result the greater the
compactness factor.
Hnatkova describes a technique which seems to look at every possible area size over every
possible area position within the Poincare´ plot. This is dependent on the resolution of
points in the plot (Hnatkova used a resolution of 2 ms). It is also computationally
extremely time consuming with the number of calculations increasing enormously with
increasing resolution3. Hnatkova suggested there was an approximation which could be
used to reduce the computation time but again the details were unclear.
A new algorithm was written to assess compactness factor. A substantial time saving
can be achieved by requiring that the maximum count density for a smaller area must
always be within the larger area in which the maximum count density was found. This
is a reasonable assumption in a distribution in which each point in the x-axis is later
reflected in the y-axis. Thus it is possible to start with an area equal to the largest
resolution and search for the maximum density in areas of decreasing size only within
the previous area (see Figure 2.2a). In practice it was found that due to rounding errors
a more accurate conversion can be obtained if a small overlap is allowed. An example
of this can be seen in the image. The algorithm can be made still faster by modifying
the size of the step by which each area is moved in the search for an area of maximum
density. This results in approximate values but should give a reasonable representation
of the maximum density function - see Figure 2.2b. The integral of the function was then
calculated by adding the product of the mean of two adjacent numbers and the difference
between the two area sizes. The algorithm is shown in the script in appendix §A.2.
Hnatkova suggested that the integral should be against log(area) which gives a much
greater prominence to smaller areas. In AF the larger areas are likely to have significant
impact on the maximum density function and it is not clear that the integral should be
against the log of the area. Both integrals were therefore calculated for comparison.
3To calculate every point in the function the number of calculations required increases as:
N/2∑
n=1
n2
where N is the resolution along one axis.
When it was investigated for this thesis changing the resolution from 50 ms to 10 ms increased
the computation time from ∼ 10 s to ∼ 240 s
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Figure 2.2.: Showing how compactness factor is calculated. (a) Shows the changing areas
and their positions as each smaller area shows the position of maximum den-
sity within each larger area (a small overlap was permitted by the algorithm
to prevent rounding errors). (b) The maximum density function showing the
normalised maximum density as the size of area changes.
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2.9.3. Delta Poincare´ plots
The Delta Poincare´ plot shows (RRi − RRi−1) against (RRi−1 − RRi−2) (where RRi is
the ith R-R interval). It offers a means of removing the correlation information from the
Poincare´ plot.
The delta Poincare´ plot is divided into four quadrants about (0,0) XY axes. The four
quadrants are (clockwise from top left):
A: (top left quadrant) a shorter beat (-ve X) followed by a longer beat (+ve Y).
B: (top right quadrant) a longer beat (+ve X) followed by a longer beat (+ve Y).
C: (lower right quadrant) a longer beat (+ve X) followed by a shorter beat (-ve Y).
D: (lower left quadrant) a shorter beat (-ve X) followed by a shorter beat (-ve Y).
If the variation between successive beats is truly random it is to be expected that the
number of points in each quadrant will be the same since, within physiological limits,
any beat should be followed with equal probability either by a longer beat or a shorter
beat.
The number of points in each quadrant was calculated and a χ-squared test was used
to test the distribution against an equal distribution in each quadrant. Where the
distribution was found to be unequal (at a significance level of p = 0.05) the dominant
quadrants were determined from the residuals.
Residuals, R, are calculated as:
R =
(X − E)√
(X − E) (2.1)
Where:
E is the expected value (in this case 1/4 of the total number of points)
X is the actual value
The residuals gives a measure of how far the actual value is from the expected value.
Since we expect an equal number of counts, a positive residual (where the chi-squared
test shows an unequal distribution) will show which values are dominating. Thus a single
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positive residual with three negative residuals will demonstrate a quadrant is dominant.
Similarly if two quadrants share the dominance then they will both be positive and
if one quadrant is particularly weak it will have a sole negative value for the residual.
Any form of bias shows the rhythm to have a degree of structure and to deviate from a
random pattern.
Although the dominant quadrants describe rhythm in a very basic form they do not
provide a quantifiable measure of rhythm change by which one rhythm can be compared
against another. The delta Poincare´ plot suggests a new quantitative measure that has
been termed swing, which is the proportion of the beats which fall in quadrants “A” or
“C” and therefore the proportion of beats in which a beat is followed by a longer beat,
followed by a shorter beat or vice versa.
2.10. Entropy
As described in §1.4.2 there are several different measures of entropy which may be
suitable as indices of regularity in assessing R-R rhythms. Three different measures
were assessed. In increasing order of the information content of the index they are:
Shannon entropy (ShanEnt), Shannon entropy using symbolic dynamics (SymDyn) and
sample entropy (SampEn).
2.10.1. Shannon entropy (ShanEnt)
The Shannon entropy (see §1.4.3) is calculated from the R-R interval histogram - the
frequency with which different ranges of R-R intervals occur using the equation:
H = −
n∑
i=1
bi
N
log(
bi
N
) (2.2)
where
bi is the number of events in the i
th bin of n total bins.
N is the total number of events.
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Clearly the value for entropy is dependent on the size and number of bins forming the
R-R histogram: the greater the number of bins or the narrower the bin the greater the
entropy.
Since entropy assessments are based on the number of possible states which a system
can take, comparison between systems must consider the number of these states. It is
unreasonable to compare the entropy of a system which can only take, say, two states
with one which can take several million. The system with fewer states will necessarily
have a lower entropy. This suggests that accurate comparison of the ShanEnt of the
R-R variation in a patient study should require the same number of possible states, and
therefore the same number of bins. Using equal numbers of bins, however, may result in
bin-widths that vary dramatically from one patient to the next. This will be exaggerated
where there are ectopic beats.
To investigate these factors the ShanEnt was calculated using both limited and unlimited
data and both fixed bin widths (variable numbers of bins) and fixed bin numbers (variable
bin width). Fixed bin-widths were set at 10 ms and 25 ms, while fixed bin numbers were
set at 16 and 32. At 60 bpm (R-R interval: 1 s), 25 ms bins correspond to 40 bins while
10 ms bins correspond to 100 bins. Thus these selections provide a range of bin numbers
while also offering measures of ShanEnt for the bin-widths used in assessing rhythm in
the rest of this study (10 ms) and in the department generally (25 ms).
Histograms were created from the list of R-R intervals for each of these conditions and
for each of these histograms ShanEnt was calculated using the Perl script shown in
appendix §A.4.
The results were compared for AF and SR, for consistency between the two different
acquisitions (at 40 ◦ and 70 ◦) and for the subgroups discussed above (see §2.7).
Combining basic R-R interval histograms with the standard equation for ShanEnt (equa-
tion 1.2) gives a basic assessment of entropy in terms of the frequency of occurrence of a
given state (R-R interval); however, there is no information included in this calculation
on sequence of intervals. Thus the sequence ABCCBCBAA will have the same entropy
as the sequence AAABBBCCC, although there is considerably more regularity in the
second sequence than in the first. Inclusion of sequential information in the calcula-
tion of entropy requires a more complicated model such as that provided by symbolic
dynamics or in the calculation of SampEn.
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2.10.2. Entropy of symbolic dynamics (SymDyn)
Symbolic dynamics in heart rate variability measures can be considered as means of
quantifying the evolution of the Poincare´ plot. The plot is divided into segments, typi-
cally by SD, and each segment labelled with a symbol. Each point in the plot is assigned
the associated symbol in the order in which the points occur in time. This creates a
string of symbols which can be analysed to determine the frequency with which patterns,
“words”, of varying length occur. The frequency information is then used to calculate
the Shannon entropy for that frequency distribution.
The technique seems to offer two advantages over a simple assessment of ShanEnt : it
establishes a well defined set of states for a system, in this case R-R variability, and
therefore permits direct comparison of systems; it also incorporates information about
the evolution of the system over time in a way in which a direct calculation of ShanEnt
from the R-R histogram cannot. Thus SymDyn offers an increase in the complexity of
the measure of entropy compared to ShanEnt of the R-R histogram
From the Poincare´ plot for each patient symbolic dynamic sequences were established
and “word” frequencies determined using a Perl script (see appendix §A.5).
The process is most easily understood by considering an example.
Symbolic dynamic example. (Patient A2)
Figure 2.3 shows the Poincare´ plot for a patient in AF. The patient had 1142 beats
recorded over the 15 min acquisition, mean R-R interval of 0.69 s with a SD over all
beats of 0.22 s.
The first 11 R-R intervals are: 0.69, 0.80, 0.75, 0.63, 0.68, 0.66, 0.69, 0.76, 1.04, 0.75
and 1.32.
Plotting these on a Poincare´ plot, creates points with coordinates: (0.80, 0.69); (0.75,
0.80); (0.63, 0.75) etc. (see Figure 2.3b). Areas are then defined on the plot with area
A being the area below and more than 1 SD away from the line of identity. Area B is
the area between the line of identity and 1 SD less the line of identity. Area C is the
area between the line of identity and the 1 SD above it and area D is the area greater
than that. Each one of points with the coordinates given above correspond to areas: A,
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Figure 2.3.: Poincare´ plot of patient A2 in AF. (a) shows the complete plot, (b) shows the
first 10 points in the Poincare´ plot and the four area bands created using 1
SD. These areas define the symbols attached to each point to create a symbolic
dynamic sequence.
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Word Frequency Word Frequency Word Frequency Word Frequency
AAA - BAA 1 CAA 9 DAA -
AAB 1 BAB 1 CAB 35 DAB 1
AAC 5 BAC 9 CAC 27 DAC 5
AAD 4 BAD 21 CAD 36 DAD 2
ABA 1 BBA 9 CBA 20 DBA 2
ABB 21 BBB 49 CBB 78 DBB 11
ABC 14 BBC 68 CBC 79 DBC 20
ABD 3 BBD 33 CBD 19 DBD 1
ACA 6 BCA 21 CCA 19 DCA 61
ACB 21 BCB 92 CCB 62 DCB 21
ACC 16 BCC 67 CCC 31 DCC 2
ACD 3 BCD 1 CCD 3 DCD -
ADA 1 BDA 7 CDA - DDA -
ADB 11 BDB 19 CDB 3 DDB 1
ADC 51 BDC 27 CDC 4 DDC 2
ADD - BDD 3 CDD - DDD -
Table 2.4.: AF, symbolic dynamic 3 letter “word” frequency table.
B, C respectively. When the whole sequence is determined the first 60 points in that
sequence are:
BCCBCBBBBACCCBBBCBBDCBCBCACCBBBCBDACBBBCDBCBCBADCABCCBCBC...
Choosing to consider 3 letter “words” finds the first four three letter “words” to be:
BCC, CCB, CBC, BCB etc.
This process is applied to the complete 1141 letter sequence created from the 1142 beats
acquired and the frequencies of every possible three letter word (given 4 possible letters
- corresponding to areas defined by 1 SD) is calculated. This produces the frequency
table shown in Table 2.4.
When the Shannon entropy is calculated for these frequencies using the equation for
Shannon entropy (equation 2.2) this gives an entropy for this symbolic dynamic se-
quence of: 3.45 (for 1SD and 3 letter words). Other combinations, of word length and
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number of letters / SDs, give:
• 3.75 (for 2SD and 3 letter words)
• 2.62 (for 2SD and 2 letter words)
• 2.40 (for 1SD and 2 letter words)
Analysis
It is clear that entropy of the symbolic dynamic sequence for any given R-R interval
stream is dependent on the choice of word length, and the definition of areas on the
Poincare´ plot (number of letters).
In this investigation areas were defined using the SD of the R-R interval. Calculations
of entropy of symbolic dynamic series, SymDyn, were made for “word” lengths of 2 and
3 letters and using areas defined by 1 SD (4 areas / letters) and by 1 and 2 SDs (6 areas
/ words). These parameters are the same as those used by Palazzolo et al. [53] in their
paper investigating SymDyn in dogs. While other word lengths could be used, values of
2 and 3 correspond most closely to the parameters used in SampEn (§2.10.3) and thus
allow comparison of the measures. Similarly any other division of the phase space could
be used but SD offers an easily understood division and is self-normalising provided that
beat distributions from one patient to another are similar.
Once entropy measurements were made for the four combinations of these parameters
comparison was made of all four measures both for their ability to distinguish between
SR and AF and for differences in the measures over the shorter (5 min) acquisition.
2.10.3. Sample entropy (SampEn)
As described in §1.4.5 SampEn is really a family of entropy measures with the family
members defined by the two parameters r, the acceptance window for beats and m the
number of additional beats for which a match within the acceptance window must be
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found for a complete match to be accepted. This can be considered to be the number
of beats which form a pattern which is tested for subsequent matches.
Mathematical basis
Mathematically, in ApEn, a sequence of events starting at point j is considered to match
the initial sequence if
|uj+k − ui+k| ≤ r (2.3)
for k = 0, 1, . . . ,m− 1 and j = 0, 1, . . . , N −m.
The total number of such matches gives Bmi (r). The conditional probability used in
ApEn (m,r,N) is defined as the proportion of these sequences (Bmi (r)) for which it is
also true that |uj+m−ui+m| ≤ r (call this Ai, so that the conditional probability is given
by Ami (r)/B
m
i (r) for the given (m, r,N) in this sequence).
Approximate entropy (ApEn) is defined as the negative of the average over i = N−m+1
of the natural log of this conditional probability:
ApEn‘ < (m, r,N) = − 1
(N −m+ 1)
N−m+1∑
i=1
ln
(
Ami (r)
Bmi (r)
)
(2.4)
The process of defining conditional probability is shown graphically in Figure 2.4.
Consider event ui (marked on the figure as “u(i)”), which in this figure has coordinates
[16,0.89], this is followed by event ui+1 [17,1.24] which is followed by event ui+2 [18,0.85].
Assuming m = 2 there are two other pairs of events (marked “u(j)” and “u(j‘)”) which
fall within the acceptance bands (shown by the red and green bands) for r = 0.1. For
the series of events starting at ui, B
2
i (0.1) = 3. Of these three series of events only two
match ui+2: the one marked “u(i)” and the one marked “u(j‘)”, thus A
2
i (0.1) = 2.
This is done for sequences of m events for every recorded event; ApEn (m,r,N) is calcu-
lated from all of the resulting conditional probabilities (Ami (r)/B
m
i (r)).
As discussed in §1.4.5 SampEn was developed to overcome the biases introduced by
ApEn. In SampEn conditional probability is calculated such that: Bmi (r) is the number
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Figure 2.4.: How ApEn and SampEn are calculated. The three points in the centre of the
figure (indexed i) define the sequence with the red, blue and grey lines defining
the acceptance bands about each point respectively. In the first labelled sequence
(indexed j) the first two points in the sequence match those of the initial sequence
but the third point falls outside the band. In the second sequence (indexed j′)
all three points fall within the appropriate acceptance bands. The j sequence
will only be considered a match if m = 1 while the j′ sequence will match for
m = 1 and m = 2.
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of occurrences of the m length pattern in the complete series provided i 6= j expressed
as a fraction of (N − m + 1), the total possible number of expressions of sequence of
length m. Similarly Ami (r) is the number of occurrences of the m+ 1 length pattern in
the complete series provided i 6= j also expressed as a fraction of (N −m+ 1).
SampEn is then calculated as:
SampEn(m, r,N) = −ln
(
Am(r)
Bm(r)
)
(2.5)
where
Am(r) =
1
N −m
N−m∑
i=1
Ami (r) (2.6)
And similarly with Bm(r).
Normalisation:
By expressing the parameter r as a fraction of the SD of the data it is argued (e.g. by
Lake et al. [59]) that ApEn and SampEn become scale-invariant; this seems to have
become standard practice [77, 78].
The sampen [79] program (available from Physionet [80]) offers an option to normalise
data by subtracting the mean from the data and then dividing the data by its SD. i.e.
x′i =
xi − x¯
σx
(2.7)
where
xi is the i
th R-R interval
x′ is the normalised R-R interval
x¯ is the mean R-R interval
σx is the SD of the R-R interval.
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Figure 2.5.: Showing data “normalised” to the SD for AF and SR examples.
In this case each data point is modified by subtracting the mean from the data and then
dividing the data by its SD. i.e.
u′i =
ui − u¯
σu
(2.8)
where
ui is the i
th R-R interval
u′ is the normalised R-R interval
u¯ is the mean R-R interval
σu is the SD of the R-R intervals.
The effect of this is shown in Figure 2.5: each data point is now expressed in terms of
the number of SDs, and the scale variations which led us to show the two samples on
different scales have now been roughly eliminated.
Histogram: Given a histogram showing frequency of occurrence of each state, the
probability of any particular state, i, occurring is given by:
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p(xi) =
f(xi)
N
(2.9)
Where N is the total number of events (x), and f(xi) is the frequency with which an
event (x) in state i occurs.
Application
The selection of values form and r is not clearly defined although most authors (generally
working with SR) have typically used values of m = 2 and r = 0.1 . . . 0.25 ·SD [53,
58, 59, 77, 81], where the points have been normalised to the SD (see §2.10.3). Five
different values of r were chosen to investigate whether normalisation provides better
(more consistent / comparable) results over normalisation to the mean or whether using
a fixed time interval provides the most consistent results. These were: r = 100 ms
(which is comparable to the units into which the R-R histogram was divided in the later
functional analysis), r = 0.1R¯R (one tenth of the mean), and r = 0.02SD, r = 0.2SD
and r = 1SD which were chosen to cover the full range of possible R-R intervals. In
practice a value of r = 0.02SD when the mean SD of the R-R intervals (including both
AF and SR) is 0.1 s suggests a typical window width of just 2 ms. This will be very
close to having no allowable variation on the window width.
SampEn was measured for six values of m = 0 . . . 5, with a value of 0 implying only that
value was considered rather than a pattern of values. This ought to agree closely with
ShanEnt , which does not include sequential information.
SampEn was calculated using a freely available program [79] from the Physionet service
[80]. This program takes a stream of R-R intervals, normalises them to SD if required,
and calculates SampEn.
The various measures of SampEn obtained from the choices of r and m described above
were assessed for their agreement with each other, and with the shorter acquisitions.
From these results a single combination ofm and r that could be considered to adequately
describe entropy in both SR and AF was determined. This measure was analysed to
determine the agreement within the sub-groups.
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Correlation
coefficient
Descriptor
0.0-0.1 trivial, tiny, very {small, poor, weak}
0.1-0.3 low, minor, small, poor, weak
0.3-0.5 moderate, medium
0.5-0.7 major, large, high, good, strong
0.7-0.9 huge, excellent, very {large, high, good, strong}
0.9-1.0 nearly, practically, or almost: perfect, exceptionally good
Table 2.5.: Descriptors used to indicate importance of differing values of the correlation co-
efficients r and ρ.
2.11. Statistics
Although p values can be calculated to very high number of significant figures, a reporting
limit of p = 0.00001 has been used in this thesis. Any smaller p value is simply reported
as being less than that.
Correlation testing yields a value of r, in the case of Pearson product moment coefficients
(for normal data) or ρ in the case of Spearman rank correlation coefficients (for non
parametric data). The r value is the slope of the line between the two measures when
the SD of those measures is the same; or in the case of Spearman rank, ρ is the slope of
the line between the rank values of the measures. There is, however, no clear definition
of what a meaningful r value is: the closer r (or ρ) tends to 0 the less meaningful the
correlation, regardless of the associated p value (which gives a measure of the accuracy
of r not its importance).
The most significant work which has been done towards establishing meaning in r values
was done by Cohen [82], working in the social sciences. His scale simply defined three
groupings: small (r > 0.1), medium (r > 0.3), and large (r > 0.5). It has been pointed
out that this does not separate good correlations very well and a further development of
his table has been proposed [83] which gives a wider ranging scale. The scale with some
minor changes is shown in Table 2.5 and is used in this thesis. Wherever correlation is
discussed in this thesis these words have been used in the restricted context defined in
this table.
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2.12. Going forward
The measures which have been described in this chapter have been systematically made
in the groups of SR and AF patients and in the sub-groupings described in §2.7. Com-
parison has been made between the measures made in longer (10 min) and shorter (5
min) acquisitions. The results of these analyses are described in the following chapter
and will be taken forward to investigate whether variations in functional measurement
can be described by measures of rhythm.
Chapter 3.
Results: Describing Rhythm
CALVIN AND HOBBES c©1986 Watterson. Reprinted with permission of UNIVERSAL Uclick. All rights reserved.
Summary
In which the results of our investigations into methods of describing and classifying
differences in rhythm are presented. Investigations considered “classical” linear measures
such as mean R-R, as well as measures based on the Poincare´ plot and measures of
entropy.
3.1. ECG rhythm review
Review of the acquired patient ECG and Poincare´ plots found a variety of rhythms as
shown in Table 3.1. This table also shows the number of patients for whom there seemed
to be no ectopic beats on the Poincare´ plot. Rhythm determination was done firstly on
a resting 12 lead ECG taken on the day of the study. If that was unavailable it was done
from a resting 3 lead rhythm strip taken at the time of image acquisition. In both cases
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Patient group Number of patients
All patients “Pure” ECG
AF 378 185
SR 396 184
Paced AF 7 4
Atrial flutter 5 3
Unsure 12 8
Table 3.1.: Number of patients in each rhythm and the number who, from their Poincare´
plot, did not seem to have any ectopic beats.
the Poincare´ plot was also considered. Very strict criteria were established that required
the pattern to be indubitable before a rhythm could be assigned (it is this criteria that
leads to the number of “unsure” rhythms). Only the patients in the initial AF group
were assessed by the expert, patients in the initial SR group were assessed by the author,
the remaining groups were excluded from any further analyses. The results are shown
in Table 3.1.
For the 238 patients in AF for whom a 12 lead ECG was available a further subdivision
was made based on the “graining” of the ECG where 59 were found to be fine grained,
165 medium grained and 11 coarse grained (see §2.6 for a description of graining). There
were three patients, from the cohort of patients who were initially described as being in
AF, for whom a 12 lead ECG did not exist and the quality of the remaining data was so
poor it was impossible to determine a rhythm; these patients were removed from study.
3.2. Heart Rate Variability (HRV)
The principal time domain indices of R-R variability which were measured are: Mean
R-R, SDRR, RMSSDrr, pRR50 and the range of R-R intervals (see §2.8). Summary
results are shown in Table 3.2 with histograms showing the variation in the both the SR
(N = 396) and AF (N = 378) patient groups shown in Figures 3.1 to 3.5. These indices
have been calculated using R-R data from each patient that has been restricted within
the same set of limits as defined for the functional analysis; this excludes outlying ectopic
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beats and is discussed in detail in §5.2.2. (For comparison a set of results calculated
from the complete data set can be found in appendix B).
The results are broadly as expected, showing a much greater variation in R-R interval
from one beat to another, and a wider overall range of R-R intervals in AF than in SR
(Figures 3.1 to 3.5). All the patients in AF were under rate control which is designed to
slow the mean R-R interval to a rate comparable to that in SR. It is, then, unsurprising
to find that visually (Figure 3.1) there is little difference between mean R-R interval
in SR and AF although statistically the difference is significant (p < 0.00001) with AF
having slightly shorter R-R interval (see table 3.2). In comparing AF against SR, SDRR,
RMSSDrr, pRR50 and R-R range were all found to be significantly greater in AF than
in SR (p < 0.00001 for all the measures). With the exception of mean R-R there is good
separation between AF and SR for each of the indices (Figures 3.2 to 3.5), with the best
single differentiator being pRR50 (Figure 3.4). Particularly in SR, pRR50 separates
individual patients with the same underlying rhythm less well as can be seen from the
dominance of the smallest pRR50 bin in the histogram. This is best accomplished using
the R-R range which shows the widest distribution even after ectopic beats have been
excluded (Figure 3.5).
Figure 3.6 shows SDRR (as seen in Figure 3.2) together with variation in the SD of the
R-R interval as groups of 5, 10 and 20 beats are averaged together. There is reduced
variability and the distinction between AF and SR is lost as more beats are averaged
together suggesting that the variations in AF are short term (beat-to-beat). Longer
term variations in AF are similar to those in SR.
3.2.1. Consistency
Comparing the longer acquisition against the shorter acquisition provides a means of
determining whether results are consistent over time. In a clinical context, where a
degree of variation is expected a Bland-Altman style analysis [84, 85] is the technique of
choice. In this context, where measures were made immediately consecutively with no
change in the state of the patient, the measures should be the same. A paired Wilcoxon
and Spearman rank correlation offer two means of testing this. The results are shown
in Table 3.3.
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Min 1st Quartile Median 3rd Quartile Max Mean SD
Mean R-R (s) 0.51 0.79 0.87 0.97 1.35 0.89 0.15
SDRR (s) 0.000 0.020 0.030 0.040 0.090 0.029 0.015
RMSSD (s) 0.020 0.040 0.040 0.060 0.170 0.048 0.170
pRR50 (%) 0.10 0.30 1.50 7.20 80.40 6.60 11.39
R-R Range (s) 0.00 0.12 0.16 0.22 0.61 0.18 0.09
SDRR 5 (s) 0.001 0.015 0.024 0.030 0.071 0.024 0.012
SDRR 10 (s) 0.000 0.014 0.020 0.027 0.066 0.021 0.011
SDRR 20 (s) 0.000 0.012 0.017 0.023 0.064 0.018 0.010
(a) SR, N=396
Min 1st Quartile Median 3rd Quartile Max Mean SD
Mean R-R (s) 0.44 0.71 0.83 0.93 1.50 0.84 0.17
SDRR (s) 0.060 0.150 0.180 0.210 0.460 0.184 0.053
RMSSD (s) 0.090 0.210 0.250 0.300 0.700 0.263 0.078
pRR50 (%) 7.10 78.30 82.00 85.10 93.60 81.09 6.91
R-R Range (s) 0.36 0.80 0.92 1.09 1.80 0.95 0.22
SDRR 5 (s) 0.032 0.065 0.079 0.094 0.263 0.082 0.025
SDRR 10 (s) 0.022 0.045 0.055 0.065 0.248 0.057 0.0193
SDRR 20 (s) 0.009 0.030 0.038 0.046 0.239 0.041 0.0164
(b) AF, N=378
Table 3.2.: Summary results for linear HRV measures (a) SR group, (b) AF group.
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Figure 3.1.: Showing the variation in mean R-R over the whole patient sample, grouped by
rhythm. Bin-width = 0.02 s, N = 396 (SR) and N = 378 (AF).
Standard deviation of RR (s)
N
um
be
r o
f p
at
ie
nt
s
0
50
100
150
0.0 0.1 0.2 0.3 0.4
Rhythm
AF
SR
Figure 3.2.: Showing the variation in SDRR over the whole patient sample, grouped by
rhythm. Bin-width = 0.02 s, N = 396 (SR) and N = 378 (AF).
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Figure 3.3.: Showing the variation in RMSSDrr over the whole patient sample, grouped by
rhythm. Bin-width = 0.02 s, N = 396 (SR) and N = 378 (AF).
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Figure 3.4.: Showing the variation in pRR50 over the whole patient sample, grouped by
rhythm. Bin-width = 2%, N = 396 (SR) and N = 378 (AF).
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(a) R-R Range
Figure 3.5.: Showing the variation in R-R range over the whole patient sample, grouped by
rhythm. Bin-width = 0.05 s, N = 396 (SR) and N = 378 (AF).
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Figure 3.6.: Histograms showing SD of R-R interval averaged over every n = 1, 5, 10 and 20
beats.
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In all cases the comparison between the two different acquisitions is at least good and
in most cases it is very good or nearly perfect. The paired Wilcoxon signed ranks test
finds there to be a significant difference in the mean R-R interval in both SR and AF,
even though the correlation is almost perfect. Mean R-R interval results approximate
to a normal distribution and when a (parametric) paired t-test is applied no difference
is found between the two groupings in AF although there continues to be a change in
SR (p = 0.0154).
Imposing limits on the beats included makes little difference to the consistency of re-
sults except in the case of the range where correlation between the shorter and longer
acquisitions is substantially improved when the limits are imposed; this, however, is to
be expected as the same limits were imposed on both acquisitions limiting the potential
range equally.
3.2.2. Patient subgroups
Several different patient subgroups (see §2.7.1) were investigated to determine whether
there was any change in the measure between the patient in that subgroup and the rest
of the patients (for example comparing those who were known to have had MI and those
who had not). In most cases the groups consist of patients who had, or did not have,
a particular condition; however, in the case of function and graining (in AF) multiple,
different, ordered groups existed and in this case regression testing was used. In the
comparison with age, a simple Spearman rank correlation was used.
The numbers of patients, together with the mean result, for each subgroup are shown in
Tables 3.4 (SR) and 3.5 (AF).
The results of comparisons between patients within and outwith the subgroups are shown
in Table 3.6. As described below, several results are significant.
In both AF and SR, the “pure” group when compared with the “not pure” group had
a significantly lower RMSSDrr. In SR pRR50 and mean R-R were also significantly
lower in the “pure” group. These differences reflect the greater variation between beats
seen in rhythms in which there are ectopic beats. This difference is more pronounced in
SR than AF.
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Not Limited Without outliers
SR AF SR AF
Mean p < 0.00001 p = 0.004 p < 0.00001 p < 0.007
SDRR NS NS NS p = 0.014
RMSSD p < 0.00001 NS p < 0.00001 NS
pRR50 p = 0.010 NS p = 0.006 NS
R-R Range p < 0.00001 p < 0.00001 p < 0.00001 NS
(a) Paired Wilcoxon
Not Limited Without outliers
SR AF SR AF
Mean ρ = 0.980 ρ = 0.980 ρ = 0.989 ρ = 0.986
SDRR ρ = 0.640 ρ = 0.895 ρ = 0.838 ρ = 0.956
RMSSD ρ = 0.717 ρ = 0.897 ρ = 0.859 ρ = 0.953
pRR50 ρ = 0.848 ρ = 0.849 ρ = 0.886 ρ = 0.862
R-R range ρ = 0.506 ρ = 0.710 ρ = 0.916 ρ = 0.955
(b) Correlation coefficients
Table 3.3.: Results comparing heart rate variability measures from the longer, 40 ◦, acquisi-
tion and shorter, 70 ◦, acquisitions using (a) paired Wilcoxon (p value given) and
(b) Spearman rank correlation coefficients (ρ shown). Only significant values are
shown. Colours are used here to differentiate correlations as defined in Table 2.5.
N = 395 in SR and N = 374 in AF.
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Subgroup Number of patients Mean R-R SDRR RMSSD pRR50 R-R range
“Pure” ECG 185 0.88 0.027 0.052 5.68 0.155
“Not pure” ECG 213 0.90 0.030 0.055 7.12 0.173
With MI 111 0.92 0.027 0.053 5.57 0.153
Without MI 290 0.88 0.030 0.053 7.15 0.168
With HBP 231 0.87 0.027 0.051 5.17 0.152
Without HBP 170 0.90 0.031 0.055 7.84 0.174
Having had PCI &/or CABG 88 0.92 0.027 0.053 4.67 0.154
Without PCI /or CABG 313 0.88 0.030 0.053 7.28 0.167
Ischaemic on MPI 67 0.89 0.026 0.053 6.92 0.161
Not Ischaemic 329 0.87 0.032 0.052 6.00 0.181
Positive ETT 7 0.84 0.026 0.047 5.50 0.163
Negative ETT 107 0.85 0.033 0.052 7.23 0.185
LV EF < 20 51 0.90 0.025 0.052 7.95 0.153
20 ≤ LV EF < 40 54 0.91 0.031 0.054 8.96 0.175
LV EF ≥ 40 188 0.88 0.030 0.054 5.97 0.168
Table 3.4.: SR: Number of patients, and mean linear variability measures in each subgroup
in SR.
The increase in mean R-R in patients with previous MI, or HBP in both SR and AF are
indicative either of pathology or of drug treatment (e.g. β-blockers will slow heart rate)
and these changes are corroborated by the shorter mean R-R seen with poorer function
(although these were not found to be statistically significant). It is also notable that the
changes in mean R-R are not significant in patients with underlying ischaemia. In AF,
patients with HBP were found to have significantly lower RMSSDrr and SDRR while
patients with previous MI were found to have significantly higher RMSSDrr and SDRR.
(SDRR and RMSSDrr are closely related measures and follow similar patterns.)
There is a substantial difference in R-R range when comparing patients in SR who had
positive and negative ETTs, however the number of patients with positive ETTs is so
small (7) that it is not possible to show that these results are significant, and they are
not duplicated in AF.
In AF the results show that there is a relationship between the “graining” of the rhythm
and mean R-R, with more coarsely grained rhythms having shorter R-R duration.
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Subgroup Number of patients Mean R-R SDRR RMSSD pRR50 R-R range
“Pure” ECG 187 0.82 0.176 0.251 80.9 0.883
“Not pure” ECG 191 0.85 0.190 0.273 81.2 0.954
With MI 114 0.88 0.191 0.275 81.9 0.963
Without MI 263 0.82 0.180 0.258 80.7 0.900
With HBP 189 0.81 0.176 0.252 80.6 0.895
Without HBP 188 0.87 0.191 0.274 81.5 0.941
Having had PCI &/or CABG 67 0.91 0.176 0.276 82.0 0.946
Without PCI /or CABG 309 0.83 0.191 0.261 80.9 0.914
Ischaemic on MPI 34 0.84 0.191 0.264 81.1 0.923
Not Ischaemic 341 0.88 0.182 0.259 81.4 0.882
Positive ETT 30 0.82 0.185 0.263 81.4 0.935
Negative ETT 50 0.76 0.170 0.246 80.4 0.893
LV EF < 20 57 0.81 0.171 0.244 79.1 0.894
20 ≤ LV EF < 40 99 0.83 0.190 0.272 81.7 0.954
LV EF ≥ 40 97 0.87 0.180 0.259 81.2 0.887
Fine grained 59 0.91 0.188 0.270 81.5 0.893
Medium grained 165 0.82 0.178 0.255 80.6 0.904
Coarse grained 11 0.75 0.176 0.254 80.5 0.938
Table 3.5.: AF: Number of patients, and mean linear variability measures in each subgroup
in AF.
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Mean R-R SDRR RMSSDrr pRR50 R-R Range
“Pure” ECG p = 0.029 NS p = 0.016 p = 0.044 NS
MI p = 0.025 NS NS NS NS
HBP p = 0.042 NS p = 0.039 NS p = 0.046
Intervention p = 0.012 NS NS NS NS
Ischaemic NS p = 0.028 NS NS p = 0.048
Pos/Neg ETT NS NS NS NS NS
Function NS* NS* NS* NS* NS*
Age ρ = 0.166 ρ = −0.139 ρ = 0.136 NS ρ = −0.121
(a) SR
Mean R-R SDRR RMSSDrr pRR50 R-R Range
“Pure” ECG NS NS p = 0.033 NS p = 0.007
MI p = 0.0007 p = 0.030 p = 0.029 NS p = 0.020
HBP p = 0.0014 p = 0.020 p = 0.016 NS NS
Intervention p = 0.0002 NS NS NS NS
Ischaemic NS NS NS NS NS
Pos/Neg ETT NS NS NS NS NS
Function NS* NS* NS* NS* NS*
Age ρ = 0.173 NS NS NS NS
Graining p = 0.0001* NS* NS* NS* NS*
(b) AF
Table 3.6.: Comparing HRV measures between those within and outwith the different sub-
groups in (a) SR and (b) AF. Comparison used Wilcoxon signed ranks test except
those marked with a * where regression was used and Age in which the Spearman
rank correlation coefficient, ρ is reported. The numbers in each group are shown
in Tables 3.4 (SR) and 3.5 (AF).
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There is also a significant but weak, positive relationship between increased age and
mean R-R duration in both SR and AF. This agreement, seen using a Spearman rank
correlation, is corroborated both by Anova and regression testing.
3.3. Poincare´ Plot
A Poincare´ plot shows the indexed R-R interval against the preceding R-R interval for
every beat in an acquired sequence. The resulting plots differ for every patient but
the general shape of the plot is distinctive and provides useful information about the
rhythm.
Examples are shown in Figures 3.7 to 3.12 for each of the four example patients. Two
additional examples, one in AF and one in SR are also shown to demonstrate some other
characteristic plots. Figure 3.12 shows the plot for a patient with a demand pacemaker;
when the R-R interval gets too long (in this case about 1.8 s) the pacemaker fires, thus
the longest R-R interval is limited and the Poincare´ plot exhibits the typical square shape
shown in the figure. Figure 3.11 has characteristic features of ventricular parasystole
[35] and shows a typical pattern of “normal” sinus beat followed by a coupling beat of
varying length, followed by a compensatory beat, followed by another “normal” sinus
beat. This rhythm, which shows substantial beat-to-beat variation, and in which the P-
wave was not easily identified on ECG was initially mis-identified as AF. After reviewing
the rhythms in conjunction with the Poincare´ plot the true rhythm was identified and
the patient was excluded from further analysis.
It should be clear from these examples that while each patient has a unique Poincare´
plot, different rhythms have characteristics which are common to each plot. The basic
plot for SR is generally “tight” and well ordered while AF tends to be much more diffuse,
other features of the rhythm are then overlaid on these base characteristics.
3.3.1. Poincare´ correlation
The correlation coefficient to a linear regression line in the Poincare´ plot provides a
measure of the variation in rhythm[45]. In theory in SR the points should cluster around
a single point approximately on the line of identity. The lower the beat-to-beat variability
the smaller the area of the cluster and the better the correlation coefficient.
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Figure 3.7.: Poincare´ plot for patient S1. The plot shows a fairly moderately tight grouping
of beats with R-R intervals which range from ∼ 1.2 s to ∼ 1.5 s with two long
ectopic beats (> 2.3 s in length) and a small clustering of shorter beats of ∼ 1.1 s
duration which may be related to the ectopic beats.
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Figure 3.8.: Poincare´ plot for patient S2. The plot is typical of normal SR with all beats
clustered tightly together in a small range around 0.75 s. The patient has a
relatively fast heart rate (∼ 90 bpm), with no evidence of ectopic beats.
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Figure 3.9.: Poincare´ plot for patient A1. The plot shows a patient in AF with a wide range
of R-R intervals. Although there is some clear clustering in the plot around
0.9 s the plot shows that a beat of any R-R interval may be followed by a beat
of any other R-R interval. There is a hint of broad bands in the plot radiating
out from the cluster suggesting that longer beats may generally be followed by a
short beat. The clustering in the plot suggests a degree of coordination in R-R
intervals. It is possible to identify a line in the plot about 0.75 s below which
there are very few points. This line may suggest the ARP of the AV node (see
§8.2.4).
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Figure 3.10.: Poincare´ plot for patient A2. The plot is typical of a patient in AF with a
broad range of beats and no definable features within it. The most obvious
features of the plot are two lines (at 0.5 s and 0.25 s) and a small cluster at the
junction of 0.25 s and 0.5 s. It has been suggested that these may define the
ARP of the AV node and a second pathway within the AV node (see §8.2.4).
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Figure 3.11.: Poincare´ plot for patient with ventricular parasystole. The two pacemakers
(SA node, and an ectopic) each contribute to the rhythm, resulting in a spread
of beats as the two pacemakers asynchronously cause contractions. The prin-
cipal sinus beat occurs at ∼ 0.75 s. A “normal” beat may be followed by a
shorter beat (an interruption from the second, ectopic, pacemaker) which is
seen in the the near-vertical line. This line shows the range of coupling in-
tervals with the bottom of the line, the shortest interval, being indicative of
ventricular refractoriness. The short beat will be followed by a compensatory
longer beat (the diagonal line) which in turn is followed by a “normal” beat.
The straightness of the diagonal line shows that the sum of the coupling beat
and the compensatory beat is approximately constant.
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Figure 3.12.: Poincare´ plot for patient in paced AF. Plot shows the broad range of beats
typical of AF, but in this case a limit is imposed on the maximum R-R interval
by the pacemaker leading to a well defined line on the top and right which
shows the trigger level at which the pacemaker is set.
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Figure 3.13.: Showing the correlation coefficients obtained for Poincare´ plots in both AF
(N=387) and SR (N=395). (Bin-width = 0.2).
N Min 1st Quartile Median 3rd Quartile Max Mean SD
SR 395 -0.574 0.154 0.461 0.699 0.982 0.4209 0.339
AF 378 -0.418 -0.046 0.002 0.056 0.505 0.009 0.099
Table 3.7.: Summary results for Poincare´ correlation.
The correlation coefficient was calculated for all beats in each of the longer acquisitions.
The results are summarised in the histogram shown in Figure 3.13 and Table 3.7. The
results are obviously different in SR and AF; confirmed by a Wilcoxon signed ranks test
(p < 0.00001). The correlation coefficients cluster around 0 in AF; however, the wide
range of coefficients in SR means that as an index the correlation coefficient fails fully to
distinguish between SR and AF, although clearly a correlation coefficient nearer 1 will
indicate SR and not AF.
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When the results for the shorter acquisition are compared against the longer acquisition
a Wilcoxon signed ranks test finds no significant difference between the two acquisitions
in either AF or SR although assessing the correlation between the shorter and longer
acquisitions only finds good (and not excellent) correlation between the results (in SR
ρ = 0.667, in AF ρ = 0.588). This is possibly because ectopic beats, which have not
been excluded, have the potential to substantially distort the correlation line; however,
when the same comparison is made in the “pure” group only very similar results are
found (ρ = 0.656 in SR, ρ = 0.599 in AF).
Subgroups
The results of the subgroup analyses are summarised in Table 3.8. In SR there is a
very clear improvement in the correlation coefficient with improving function as well as
significant differences in between in several of the sub-groups with healthier cardiology
(non-MI, non-ischaemic, “pure” ECG etc.) having improved correlation when compared
with the opposing group. The only group for which this was not true was the comparison
of patients with positive and negative ETTs where the number of patients with positive
ETTs (N = 7) is almost too small for statistical comparison. In AF the differences
between the groups was insignificant.
3.3.2. Compactness factor
As discussed in §2.9.2 a measure of the variation in density over the Poincare´ plot is
offered by a calculation of compactness factor . Two methods have been employed in this
thesis for the calculation of compactness factor : the integral can be calculated against
the area, here termed compactness factor; or against the log of the area, here termed
compactness factor by log. Hnatkova et al. who did the initial work on compactness
calculated the integral using the log of the area [46] but doing so gives greater weight
to small areas and therefore to more tightly bound distributions in the Poincare´ plot.
Calculating the compactness factor using the area gives equal weight to distributions,
but may result in a poorer differentiation of SR, which is tightly bound.
While there is good correlation between the measures, a Wilcoxon signed ranks test
shows a very clear difference between them (see Table 3.9). Results for the two mea-
sures are summarised in Figure 3.14 which shows that while compactness factor clearly
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SR AF
Within Outwith Result Within Outwith Result
“Pure” ECG 0.55 0.30 p < 0.00001 0.004 0.01 NS
MI 0.31 0.46 p = 0.00006 0.01 0.007 p = 0.038
HBP 0.44 0.45 NS 0.004 0.01 NS
Intervention 0.37 0.44 NS -0.007 0.01 NS
Ischaemic 0.39 0.57 p = 0.00008 0.007 0.02 NS
Pos / Neg ETT 0.79 0.62 NS (p = 0.051) -0.004 -0.003 NS
Function 0.20 (Poor & Very poor) p < 0.00001 0.02 (Poor & Very poor) NS
0.33 (Moderate & Mild) 0.005 (Moderate & Mild)
0.51 (Normal) 0.01 (Normal)
Age - - ρ = −0.224 - - NS
Graining - - - 0.005 (FINE) NS
0.003 (MEDIUM)
0.008 (COARSE)
Table 3.8.: Subgroup analysis of Poincare´ correlation results. Comparing results for patients
within the group against results for patients outwith the group. The p value is
given where a significant difference was found (where there was no significant dif-
ference this is marked with “NS”). The group marked “Pos / Neg ETT” compares
those patients with positive ETT against those with negative ETT, patients with
inconclusive ETT have been excluded from this grouping. Numbers in each group
are given in Tables 3.4 (SR) and 3.5 (AF).
Paired Wilcoxon Correlation
All p < 0.00001 ρ = 0.586
SR only p < 0.00001 ρ = 0.670
AF only p < 0.00001 ρ = 0.690
Table 3.9.: Agreement between compactness factor and compactness factor by log.
.
distinguishes between AF and SR, there is no substantive difference using compactness
factor by log.
A statistical comparison of the indices for SR and AF finds that both compactness
factor and compactness factor by log are significantly different with p < 0.00001. There
is, however, such a degree of overlap in the compactness factor by log results that this
index could not be used to distinguish between AF and SR. Since the Poincare´ plots are
visually widely different it was felt that compactness factor offered considerably more
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(a) Compactness factor
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(b) Compactness factor by log
Figure 3.14.: Histograms showing variation over the patient groups of (a) compactness factor
(log scale, bin-width=0.1) and (b) compactness factor by log (bin-width=15).
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Min 1st Quartile Median 3rd Quartile Max Mean SD
Compactness factor : SR 0.040 0.353 0.620 1.018 10.020 0.842 0.843
Compactness factor : AF 0.150 3.780 5.840 8.910 73.130 7.912 7.674
Compactness factor by log: SR 102.7 187.6 214.3 235.2 449.7 213.3 43.95
Compactness factor by log: AF 105.4 192.8 228.5 265.2 536.6 231.6 61.60
Table 3.10.: Summary results for compactness factor measures.
information than compactness factor by log and all further analyses concentrated on
compactness factor .
When variations in compactness factor were examined in the subgroups which have
been described (§2.7.1) no difference was found in compactness factor in either SR or
AF except in the case of patients with or without high blood pressure in SR where
the mean compactness factor in patients with high blood pressure was 0.74 while in
patients without high blood pressure it was 0.88 (p = 0.03), suggesting that patients
with high blood pressure have a more tightly bound distribution than those without. It
is interesting to note that there is no significant difference when compactness factor by
log is used. (Compactness factor by log is 214 in patients with high blood pressure and
215 in those without).
3.3.3. Delta Poincare´ plot
The delta Poincare´ plot is described in §2.9.3 and consists of a plot of the difference
between one beat and the previous beat against the difference between the previous beat
and the one before that. An example of the delta Poincare´ plot is shown in Figure 3.15.
In SR there were 89 balanced delta Poincare´ plots (plots in which there were a statis-
tically equivalent number of points in each quadrant): in AF there were none. The
dominant quadrants or quadrant combinations as determined from the residuals are
shown in Table 3.11.
In both AF and SR the ac (top-left / bottom-right) combination dominates in the vast
majority of patients. This corresponds to a beat being followed either by a shorter beat
followed by a longer beat or by a longer beat followed by a shorter beat. There is a clear
structure in this which suggests that the beat sequence is not truly random. It can to
some extent be quantified by swing (see §2.9.3), which measures the proportion of beat
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Figure 3.15.: Showing the delta Poincare´ plot for Patient A1; quadrants are labelled a-d.
Swing for this patient is 0.65. (The Poincare´ plot for the same patient is
Figure 3.9).
Quadrant AF SR
ab - 1
abc - 13
ac 374 209
acd 1 14
b - 14
bd - 39
cd - 1
d - 16
Table 3.11.: Dominant quadrant(s) for each rhythm type.
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Figure 3.16.: Histogram showing swing , the proportion of the total number of beat changes
which fall in quadrants a or c of the delta Poincare´ plot, over all patients
(N = 395 in SR, N = 378 in AF).
changes which fall in quadrants a or c. Swing is illustrated in the two patient groups
in Figure 3.16. In AF generally between 60% and 70% of beat changes, mean 66%, for
a patient are in quadrants a or c suggesting an alteration of longer and shorter beats.
The range of swing , from 30% to 90% with a mean of 58%, is substantially greater in
SR suggesting that on a beat-to-beat basis there may be less order in the variation in
SR than in AF.
3.4. Entropy
As described in §2.10, the models used to describe the possible states of a system define
different measures of entropy. Three different model families were used; in order of
increasing complexity they were: (1) Shannon entropy, ShanEnt (2) Shannon entropy of
symbolic dynamic descriptors, SymDyn and (3) sample entropy, SampEn.
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Figure 3.17.: Showing the ShanEnt calculated using 25 ms bins from R-R interval stream
for the 40 ◦ view for those patients definitely identified as being in AF and SR.
(N = 395 in SR, N = 378 in AF, bin-width = 0.15).
3.4.1. Shannon Entropy (ShanEnt)
Assessment of ShanEnt is described in §2.10.1.
Eight different measures of ShanEnt were made depending on the bin-width / number
of bins and whether or not the included beats were limited (see §2.5.5).
Figure 3.17 shows a histogram of the results obtained for ShanEnt using the limited
R-R stream. There is good separation of AF and SR values when the bin width is fixed,
although having fixed numbers of bins reduces this separation but this is likely to reflect
the greater bin-width associated with the chosen number of bins, particularly in AF. It
is also interesting to note that the SR results are broader than the AF ones. When
calculations were made on the unlimited R-R interval stream a similar set of results was
obtained.
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Min 1st Quartile Median 3rd Quartile Max Mean SD
t=10 ms 0.000 3.662 4.020 4.230 4.760 3.893 0.583
t=25 ms 0.000 3.080 3.250 3.408 3.940 3.202 0.445
n=16 0.000 2.390 2.450 2.520 2.740 2.419 0.292
n=32 0.000 3.060 3.130 3.190 3.420 3.081 0.364
(a) AF
Min 1st Quartile Median 3rd Quartile Max Mean SD
t=10 ms 0.000 1.880 2.300 2.710 3.600 2.259 0.0612
t=25 ms 0.000 1.270 1.560 1.900 2.700 1.538 0.495
n=16 0.000 2.210 2.370 2.460 2.710 2.275 0.317
n=32 0.000 2.730 3.010 3.120 3.360 2.835 0.483
(b) SR
Table 3.12.: Summary results for differing ShanEnt measures using limited R-R intervals.
A summary of the results using the limited data is shown in Table 3.12. Analysing the
results to test whether there is a significant difference between SR and AF for ShanEnt
finds the entropy to be significantly different (using a Wilcoxon signed ranks test) for
all limited and unlimited measures with p < 0.00001 in all cases. However examination
of the plots shows that there is significant overlap with increasing bin size (decreasing
bin number).
Figure 3.18 shows the different measures of ShanEnt , depending on the definition of the
R-R interval bins, plotted against each other. This clearly shows that while there is
generally higher entropy in patients with AF the widest range of entropy measures is
found for the smaller bin-widths (10 ms and 25 ms). It can also be seen that there is a
plateau in the ShanEnt values determined for the fixed number of bins and a resultant
reduction in discrimination between different patients. As discussed previously there
is uncertainty whether the number of bins or the bin size should be held constant to
allow the best comparison. Since the best separation of the groups is achieved with the
smallest bin size (largest number of bins) this measure (bin-width of 10 ms) was carried
forward into the remainder of the analysis. The use of fixed bin-width over fixed bin
number is reasonable since a bin with no counts in it will not contribute to the overall
entropy value (consider equation 2.2 where bi = 0). Thus bins using a fixed bin-width can
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be considered to include all possible R-R interval times with most of them contributing
nothing to the overall measure of entropy.
Looking at the results for ShanEnt measured using a bin size of t = 10 ms a paired
Wilcoxon test finds a significant difference between the results for the long (10 min or
15 min) and the short (5 min) acquisitions in both SR and AF (p < 0.00001). However
a Spearman rank correlation finds almost perfect correlation with ρ = 0.904 in SR and
ρ = 0.969 in AF. This suggests that there is a systematic difference between results
for ShanEnt in longer and shorter acquisitions. This is confirmed by a Bland-Altman
style analysis[84, 85] which shows longer acquisitions to have a greater entropy than
shorter ones (see Figure 3.19). The difference (longer acquisition - shorter acquisition)
is however very small (0.08±0.26 in SR, and 0.09±0.17 in AF) and is not seen in all cases.
The most likely explanation for this difference is that the longer acquisition was always
performed first and there is potential that heart rate slowed as the patients relaxed on
the imaging table, this slowing may be accompanied by a reduction in entropy.
The subgroup analyses found significance as shown in Table 3.13. In general no sig-
nificant difference was found between the matched groups, although in AF there was
a general tendency that the healthier group had a lower entropy than the counterpart
group. For example patients in AF with previous MI had significantly higher entropy
than those without known MI. In SR this pattern is reversed: patients with known
pathology appear to have a lower entropy than those without; thus patients in SR with
known ischaemia generally had a lower entropy than did those with normal coronary
arteries.
3.4.2. Entropy of symbolic dynamics (SymDyn)
The use of symbolic dynamics has been discussed in §2.10.2. Two and three letter word
lengths, which define changes over three or four beats respectively, and plot areas defined
by 1 and 2 SDs, corresponding to 4 or 6 different areas, were used to define the symbolic
dynamic series. The results are summarised in Figure 3.20 and Table 3.14. Although
a Wilcoxon signed ranks test (Mann-Whitney) finds there to be a significant difference
(p < 0.00001) between SR and AF for measures of SymDyn using all four combinations
of word length and plot area, there is essentially nothing to distinguish between SR and
AF when only one boundary (at 1 SD) is defined. When two boundaries are defined a
difference between AF and SR becomes apparent.
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Figure 3.18.: ShanEnt using different bin sizes / numbers. Each of the measures is plotted
against entropy determined with R-R interval bins of 10 ms. Plotting in this
way explores whether there is a possible plateau in the results. The plots
present the same data with colour used in plot (a) to show the R-R interval
bin-widths and in plot (b) to show rhythm.
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Figure 3.19.: Bland-Altman style plot comparing ShanEnt measured on the longer and
shorted acquisition. In both AF and SR there is a systematic bias towards
higher entropy values in the longer acquisitions. Mean difference: 0.08 in SR
(N=395), 0.09 in AF (N=378).
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Figure 3.20.: Showing the change in SymDyn with increasing multiples of the SD horizontally
and increasing word length vertically from the ∼ 40 ◦ acquisition for those
patients definitely identified as being in AF and SR. It should be noted that
superpositions are shown as summed, not overlayed, data.
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SR AF
Within Outwith Result Within Outwith Result
“Pure” ECG 2.22 2.30 p = 0.035 3.92 3.97 NS
MI 2.17 2.30 NS 4.01 3.84 p = 0.003
HBP 2.19 2.31 NS 3.91 3.87 NS
Intervention 2.21 2.28 NS 3.97 3.88 NS
Ischaemic 2.23 2.42 p = 0.029 3.88 4.06 NS
Pos / Neg ETT 2.38 (+ve) 2.50 (-ve) NS 4.05 (+ve) 3.98 (-ve) NS
Function 2.05 (Poor & Very poor) NS 3.81 (Poor & Very poor) NS
2.20 (Moderate & Mild) 3.91 (Moderate & Mild)
2.35 (Normal) 4.00 (Normal)
Age - - ρ = −0.157 - - NS
Graining - - - 3.71 (FINE) NS
4.00 (MEDIUM)
4.09 (COARSE)
Table 3.13.: Subgroup analysis of ShanEnt using 10 ms bins and limited data. Mean values
are given together with the Wilcoxon signed ranks p values where a significant
difference was found (where there was no significant difference this is marked
with “NS”). Comparison against function used analysis of variance while com-
parison against age used linear regression. Number of patients in each group
can be found in Tables 3.4 (SR) and 3.5 (AF).
Rhythm Length Boundaries Min 1st Quartile Median 3rd Quartile Max Mean SD
AF 2 1 1.23 1.32 1.33 1.34 1.30 1.33 0.017
AF 2 2 1.57 2.59 2.62 2.64 2.69 2.58 0.216
AF 3 1 1.77 1.94 1.96 1.98 2.04 1.96 0.032
AF 3 2 2.30 3.75 3.81 3.86 3.94 3.76 0.197
SR 2 1 0.36 1.18 1.28 1.33 1.38 1.24 0.151
SR 2 2 0.42 1.29 1.41 1.60 2.58 1.45 0.299
SR 3 1 0.53 1.73 1.87 1.94 2.07 1.81 0.220
SR 3 2 0.63 1.86 2.04 2.28 3.76 2.08 0.413
Table 3.14.: Summary values for SymDyn.
On first glance this result seems to suggest that the difference between the distribution
of sequential beats in AF and SR is found at the margins. Although the scale of the
changes may be much greater in AF than in SR, the differences appear to be lost because
the symbolic dynamic technique collapses scale changes into variations with respect to
the SD. It is clear, however, from Figure 3.21 that, where only one SD defines the areas
used to determine appropriate symbols (in both AF and SR), the results plateau. This
demonstrates a limit to the upper value of entropy and suggests that collapsing the data
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l=2, s=1 l=2, s=2 l=3, s=1
l=2, s=2 ρ = 0.733
l=3, s=1 ρ = 0.904 ρ = 0.666
l=3, s=2 ρ = 0.743 ρ = 0.984 ρ = 0.730
(a) SR
l=2, s=1 l=2, s=2 l=3, s=1
l=2, s=2 ρ = 0.243
l=3, s=1 ρ = 0.922 ρ = 0.217
l=3, s=2 ρ = 0.256 ρ = 0.974 ρ = 0.260
(b) AF
Table 3.15.: Comparison of SymDyn in (a) SR and (b) AF. All results had significance of
p < 0.00001.
into only four areas does not give sufficient range to measure entropy in either SR or
AF.
The correlations between different measures are shown in Table 3.15. There is almost
perfect correlation, both in SR and AF, between the results in which the number of SDs
used to define the areas is the same regardless of whether this is one or two; there is
much poorer correlation otherwise, particularly in AF.
The best separation of AF and SR comes from using a “word” length of 3 letters and 6
areas defined by 2 SDs. This combination also avoids the plateau in the values described
above and it was this measure that was taken forward in the analyses. When this measure
was used to compare AF against SR they were found, perhaps not surprisingly, to be
significantly different (p < 0.00001).
In comparing the longer acquisition against the shorter one a paired Wilcoxon test found
the measures to be significantly different in both AF and SR (p < 0.00001 in both cases)
although there was good correlation with ρ = 0.761 in AF and ρ = 0.637 in SR. As in
the case of ShanEnt this suggests a systematic bias in the results and a Bland-Altman
analysis finds this to be slight with longer acquisitions having on average an entropy
0.07± 0.28 higher in SR and 0.06± 0.14 in AF than in the shorter acquisitions.
In the subgroup analysis no significant difference was found in any of the subgroups
other than the “pure” group in which there are no ectopic beats. Mean SymDyn in the
“pure” group was 2.03 in SR and 3.80 in AF; in the “not pure” group mean SymDyn
was 2.12 in SR and 3.71 in AF. These variations match the variations already seen in
ShanEnt (see table3.13).
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(b) Emphasising rhythm
Figure 3.21.: SymDyn using the techniques with the lower ranges plotted against the entropy
found using the parameter with the highest range (word length = 3 letters,
using areas defined by both 1 and 2 SD). The two plots present the same data
with colour used in plot (a) to show the different symbolic dynamic definitions
and in plot (b) to show differing rhythm.
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3.4.3. Sample entropy (SampEn)
The third measure of entropy which was investigated, SampEn, is the most complex
in that it incorporates the most information. SampEn is based on the conditional
probability of finding repeating sequences of length m + 1 within a window of width
r in the R-R interval stream (see §2.10.3).
The window width, r, may be expressed either in absolute terms or as a normalised
fraction of the SD, here described as rn (§2.10.3). SampEn was measured for five different
values of r: rn = {0.02, 0.20, 1.00} and for and r = 0.1 s and r = 0.1R¯R (10% of mean
R-R duration). These values of r were chosen to offer a very tight window, rn = 0.02,
a window comparable to that used in other studies in SR, rn = 0.2, a window which
is comparable to the division of the Poincare´ plot in SymDyn, rn = 1, a fixed window
r = 0.1 s and an alternative form of normalisation, r = 0.1R¯R. The number of additional
beats, after the first one, in the sequence required for the sequence to be considered to
match is defined by the parameter m. In this study assessments were made of SampEn
form = {0 . . . 5}. These values were chosen to offer values which would allow comparison
against ShanEnt (m = 0) and a standard sequence by which changes could be assessed.
The results for each combination of these measures are shown for rn in figure 3.22 and
for the alternative values of r in Figure 3.23.
The total number of patients for whom measures of SampEn could be calculated for
each combination of m and r in both SR and AF are shown in Table 3.16.
The value for SampEn using normalised r exhibit a noticeable decrease in SampEn with
increasing m for patients in AF. SampEn is incalculable in AF at larger m (m > 3) with
smaller rn (rn = 0.02); there is a corresponding increase in SampEn with increasing r.
These results seem intuitively correct so it is surprising that in SR there is little variation
in the distribution of SampEn with increasing m although increasing rn does reduce the
spread and there was a small reduction in the number of patients for whom a value of
SampEn could be obtained at very small r (rn = 0.02) and high m (m = 5).
Considering SampEn calculated with the alternative values of r, there is little difference
shown with increasing m. The fixed interval of r = 0.1 s gives a wider spread of entropy
values for AF than using an interval of r = 0.1R¯R. The two measures of r are likely to
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Figure 3.22.: Showing the change in SampEn with increasing values of m horizontally and
different values of rn vertically.(Bin-width = 0.2, Number of patients is shown
in Figure 3.16).
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Entropy using Sample Entropy (alternative r)
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Figure 3.23.: Showing the change in SampEn with increasing values of m horizontally and
different values of r, using r = 0.1 s (hundredms) and r = 0.1R¯R (tenth).
(Bin-width = 0.2, Number of patients is shown in Figure 3.16).
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m = 0 m = 1 m = 2 m = 3 m = 4 m = 5
Mean N Mean N Mean N Mean N Mean N Mean N
r = 0.1R¯R 0.102 388 0.057 388 0.053 388 0.049 388 0.046 388 0.045 388
r = 0.1 s 0.079 380 0.046 380 0.043 380 0.040 380 0.038 380 0.037 380
rn = 0.02 2.041 397 1.530 397 1.436 397 1.329 396 1.250 381 1.151 347
rn = 0.20 1.661 397 1.197 397 1.118 397 1.037 397 0.978 393 0.933 381
rn = 1.00 0.407 397 0.233 397 0.214 397 0.192 397 0.179 397 0.171 397
(a) SR
m = 0 m = 1 m = 2 m = 3 m = 4 m = 5
Mean N Mean N Mean N Mean N Mean N Mean N
r = 0.1R¯R 1.281 376 1.256 376 1.249 376 1.246 376 1.247 376 1.249 376
r = 0.1 s 1.089 376 1.069 376 1.065 376 1.063 376 1.064 376 1.062 375
rn = 0.02 3.808 376 3.756 376 3.669 338 2.693 116 1.420 19 0.737 7
rn = 0.20 1.970 376 1.935 376 1.925 376 1.920 376 1.955 375 1.894 330
rn = 1.00 0.563 376 0.557 375 0.555 375 0.555 375 0.554 375 0.554 375
(b) AF
Table 3.16.: Mean and number of successful SampEn calculations with varying r and m for
(a) SR and (b) AF.
be of the same order of magnitude as RR ∼ 1.3 s (80 bpm). Surprisingly there are few
differences in SampEn in SR with changes in either parameter.
SampEn correlation
The correlation between the different measures of SampEn is shown in correlation Fig-
ures 3.24 (SR) and 3.25 (AF).
There are several observations which can be made from these plots. Firstly, the corre-
lation between one member of a group defined by r and a member of another group,
defined by a different r, is largely matched by the correlation between other members
of the two groups; this can be seen in the clustering of colours in the plots which are
grouped by r. Secondly, the deep red clustering on the central diagonal in SR, and to
a lesser extent in AF, shows there is near perfect correlation between members of one
group and the other members of the same group when the groups are defined by r (this
is not true when the groups are defined by m). Thirdly, the clustering of colours when
grouping is done by r, which is not seen when the grouping is by m, suggests that r has
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(b) Grouped by “m” (number of matched beats)
Figure 3.24.: SR: Showing the correlation between different measures of SampEn in SR. The
colour shows the degree of correlation (with red being excellent correlation
and blue being a weak correlation etc.). Results which are significant at the
p < 0.05 level are flagged with a “*”. The top half of the plot is blank to
avoid reproducing results. The two plots show the same results grouped (a) by
the value of r (the window width) and (b) by the number of matched beats.
(Colour scale corresponds to the scale shown in Table 2.5).
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(b) Grouped by “m” (number of matched beats)
Figure 3.25.: AF: Showing the correlation between different measures of SampEn in AF. The
colour shows the degree of correlation (with red being excellent correlation
and blue being a weak correlation etc.). Results which are significant at the
p < 0.05 level are flagged with a “*”. The top half of the plot is blank to
avoid reproducing results. The two plots show the same results grouped (a) by
the value of r (the window width) and (b) by the number of matched beats.
(Colour scale corresponds to the scale shown in Table 2.5).
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a greater effect on the assessment of SampEn than does m. Fourthly when the plots are
considered as a whole, the dominance of blue and green in the plots, particularly in AF,
suggests that there is generally better correlation between the different family members,
defined by both r and m, in SR than there is in AF.
Which family member?
It is impractical to take all these measures of SampEn into any further analysis. Is there
a single combination of m and r which is likely to provide the most information about
about heart rate entropy?
Since SR is approximately regular while AF is irregular, it is to be expected that entropy,
which is essentially a measure of regularity rather than complexity (lower entropy being
indicative of greater regularity), should be greater in AF than in SR. The selection of
a single combination of m and r should give good separation of AF and SR (SR being
intrinsically better organised and therefore having lower entropy than AF) and a good
spread of values for entropy (it being unlikely that results will all be the same over the
350+ patients in each group). The combination must also be measurable in all situations
and should offer the same results regardless of duration.
Figure 3.26 shows the range of SampEn measurements for patients in SR and AF with
each of the combinations of r and m. It is clear from this that the combination of
r = 0.02SD and m = 0 . . . 3 gives the widest range and clearest division between SR
and AF.
The number of cases for which SampEn could be calculated are shown in Table 3.16,
and it can be seen from this table that, unsurprisingly, increasing the number of beats
considered reduces the number of calculable results. The highest m value for which
SampEn can be calculated in every case with r = 0.02SD is m = 1 which still gives
good separation of AF and SR although it offers only a small increase in information
content.
Figure 3.28 presents the correlation between the longer and shorter acquisitions in SR
and AF. The best overall correlation is with r = 0.02(SD) and m = 0 . . . 1.
There is a possibility that SampEn measures show a similar plateau as is found for
certain measures of SymDyn. The plot in Figure 3.27 shows this not to be the case. It
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Figure 3.26.: Showing the range of SampEn for different different metrics with Y-axis show-
ing different values of r and with separate plots grouped by m. Y-axis in each
plot shows the value for SampEn calculated from the long acquisition.
is therefore reasonable to take this measure (SampEn with r = 0.02SD and m = 1) into
the rest of the analysis.
SampEn with m = 1 and r = 0.02SD
Having selected a single combination ofm = 1 and r = 0.02SD for calculation of SampEn
these results were carried forward in a similar analysis to that of previous measures of
entropy and variability.
When the results were compared, for this combination of m and r, between the long
and short acquisitions a paired Wilcoxon test found there to be a significant difference
between the acquisitions in SR (p = 0.030) but not in AF. The Spearman rank correlation
between the acquisitions showed ρ = 0.951 in SR and ρ = 0.856 in AF (both with
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Figure 3.27.: Showing the values of SampEn with r = 0.02SD and m = 1 for all patients in
both SR and AF combined. Sorted by value to determine whether there is a
plateau in the results.
p < 0.00001). This suggests that in SR there is a slight change in entropy as the
acquisition time increases. This is confirmed by the Bland-Altman analysis which finds
the longer acquisition to have a slightly lower entropy with a mean difference (long -
short) in SR of −0.021 and in AF of −0.046. Although SampEn is intended to be
consistent over short time intervals, there is inevitably a duration of acquisition which
is too short for the calculation to be accurate. It is possible that a 5 min acquisition is
in this region.
Since the choice of m and r was visually made to ensure that there was good separation
between AF and SR it is unsurprising that a Wilcoxon signed ranks test finds that the
measured values of SampEn, summarised in Table 3.17a are significantly different with
p < 0.00001 for the comparison between AF and SR.
Looking at the subgroups, the comparison is shown in Table 3.18, a significant variation
was found in patients with ischaemia and with function in both SR and AF (summary
statistics shown for these results in Table 3.17b). There was also found to be a very
weak negative correlation with age in SR. There was no significant difference in any of
the other subgroups.
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Figure 3.28.: Showing the correlation in SampEn between the longer and shorter acquisitions
for each combination of r and m for which measurements were made in (a) SR
and (b) AF.
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Rhythm Min 1st Quartile Median 3rd Quartile Max Mean SD
AF 1.092 3.483 3.827 4.067 4.988 3.761 0.469
SR 0.069 1.102 1.527 1.955 3.268 1.531 0.575
(a) All Patients
Rhythm Subgroup Min 1st Quartile Median 3rd Quartile Max Mean SD
AF Ischaemic 3.081 3.841 4.003 4.093 4.388 3.928 0.318
AF Non-Ischaemic 1.092 3.459 3.804 4.058 4.988 3.744 0.479
AF Very poor function 2.973 3.250 3.459 3.543 3.751 3.395 0.296
AF Poor function 1.092 3.412 3.660 3.933 4.429 3.616 0.561
AF Moderate function 2.178 3.440 3.801 4.065 4.803 3.730 0.474
AF Mildly impaired function 1.531 3.487 3.847 4.072 4.600 3.792 0.437
AF Normal function 2.873 3.599 3.905 4.133 4.800 3.868 0.402
SR Ischaemic 0.180 1.324 1.706 2.001 3.268 1.670 0.571
SR Non-Ischaemic 0.069 1.073 1.488 1.892 2.956 1.503 0.573
SR Very poor function 0.531 0.906 1.095 1.464 1.958 1.191 0.405
SR Poor function 0.087 1.018 1.379 1.666 2.956 1.371 0.671
SR Moderate function 0.398 1.130 1.543 2.087 2.934 1.562 0.585
SR Mildly impaired function 0.06903 1.098 1.486 1.811 2.808 1.498 0.561
SR Normal function 0.406 1.181 1.623 2.009 3.268 1.612 0.559
(b) Subgroup
Table 3.17.: Summary values for SymDyn. Table (a) shows the results for the whole group,
table (b) for the subgroups.
3.4.4. Comparing entropy
The three different measures of entropy which have been measured in this study all
purport to offer a measure of regularity and hence it is to be expected that there should
some agreement between them. Each measure, however, uses a different set of variables
and, in the case of SampEn, a different equation by which the entropy is calculated.
Thus each of the three measures form a different approximation to the regularity of the
system.
It should be possible to determine a set of variables for each measure which allow them
to be compared. Since ShanEnt relies only on the bin-width / number of bins and there
is no sequencing information incorporated, measures of ShanEnt should be comparable
to measures of SampEn with m = 0 where there is also no sequencing information
included. It is unlikely that there will be a clear agreement with SymDyn since the
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SR AF
Within Outwith Result Within Outwith Result
“Pure” ECG 1.481 1.572 NS 3.765 3.768 NS
MI 1.445 1.563 NS 3.843 3.718 NS
HBP 1.479 1.569 NS 3.742 3.769 NS
Intervention 1.454 1.552 NS 3.819 3.743 NS
Ischaemic 1.501 1.670 p = 0.026 3.739 3.928 p = 0.012
Pos / Neg ETT 1.580 (+ve) 1.694 (−ve) NS 3.921 (+ve) 3.796 (−ve) NS
Function 1.315 (Poor & Very poor) p = 0.014 3.596 (Poor & Very poor) p = 0.006
1.562 (Moderate & Mild) 3.730 (Moderate & Mild)
1.612 (Normal) 3.868 (Normal)
Age - - ρ = −0.119 - - NS
Graining - - - 3.810 (FINE) NS
3.819 (MEDIUM)
3.916 (COARSE)
Table 3.18.: Subgroup analysis of SampEn using m = 1 and r = 0.02SD. The p value is
given where a significant difference was found (where there was no significant
difference this is marked with “NS”). Number of patients in each group are given
in Tables 3.4 (SR) and 3.5 (AF).
principal determinant of the number of states in the symbolic dynamic representation
is sequencing information and not bin-width 1. Similarly it might be expected that
there would be agreement between SymDyn and SampEn where r ∼ SD (rn = 1)
since measures of SymDyn have been made based on areas determined by the SD, SD.
However the calculation of SampEn, while based on Shannon theory, is not the same as
the calculation of Shannon entropy used in SymDyn and there is unlikely to be direct
agreement.
Figures 3.29 and 3.30 show correlation plots for selected measures of entropy using the
three different techniques in SR and AF respectively. The plots show the predicted
agreement (p = 0.98 in SR, p = 0.95 in AF) between ShanEnt and SampEn with m = 0
when r = 0.02SD. The agreement is still excellent, although slightly poorer, whenm = 1
(p = 0.82 in SR, p = 0.91 in AF). The expected agreement is not seen when SymDyn is
compared with SampEn where r = 1SD (or any other value of r). This is true in both
AF and SR although the difference is more pronounced in AF. The most likely reason
for the non-agreement is that in assessing SampEn the window position changes to be
centred on each beat. In SymDyn the areas are fixed, based on summary measures of
all beats and do not shift.
1In SymDyn the number of combinations of letters, Ns, increases according to the formula Ns = b
l
where b is the number of areas and l is the length of “word” (sequencing information)
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Figure 3.29.: SR: Showing the correlation between selected measures of entropy in SR.
(Colour scale corresponds to the scale shown in Table 2.5.)
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Figure 3.30.: AF: Showing the correlation between selected measures of entropy in AF.
(Colour scale corresponds to the scale shown in Table 2.5.)
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Figure 3.31.: SR: Showing the correlation between the different measures which have been
made to describe R-R variability in SR. (Colour scale corresponds to the scale
shown in Table 2.5.)
3.5. Comparing all measures of rhythm
The analysis of rhythm has considered six typical linear measures of variability (in the
time domain), two measures of the Poincare´ plot and three different measures of entropy.
How do these compare?
Figures 3.31 (SR) and 3.32 (AF) show the correlations between the various measures
which have been used to describe R-R variability in this thesis.
The good or excellent correlation between R-R range, SD and RMSSD is to be expected,
as “tighter” distributions are likely to have less variability. It is also reasonable to
expect that rhythms in which there is a lower pRR50 value will have lower RMSSDrr
and SDRR a low pRR50 suggests that beats are largely within 50 ms of each other.
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Figure 3.32.: AF: Showing the correlation between the different measures which have been
made to describe R-R variability in AF. (Colour scale corresponds to the scale
shown in Table 2.5.)
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There is a clear negative correlation between swing , the proportion of R-R changes on
the delta Poincare´ plot which fall in the top left or bottom right quadrants, and the
Poincare´ correlation - this suggests that “long - short - long - short” alternating beats
tend to alternate across the mean. “Long - short - long - short” appears to be a better
description in AF than in SR where the correlation is weaker.
There is a, perhaps surprisingly, good correlation between mean R-R interval and RMSSD
in both AF and SR. It is also unclear that there should be a moderate negative correla-
tion between swing and mean R-R interval in AF which is not seen in SR. This suggests
that in AF the faster the rhythm the fewer beats follow the “long-short-long” pattern.
The number of patients involved makes this likely to be a genuine result as the sample
group is relatively large.
In SR, SDRR, and RMSSD, correlate well with the chosen measures of entropy; this is
not true in AF. Similarly they correlate well with compactness factor in SR but not in
AF. The converse is also true: in SR there is a good or excellent correlation between
compactness factor and all three measures of entropy while there is only poor or moderate
correlation in AF. This shows that in SR the spread of beats (as measured using the
compactness factor) is closely associated with the regularity of the rhythm. In AF the
association is much less well defined.
In AF there is a good negative correlation between swing and the Poincare´ correlation
which suggests that the better the agreement between one beat and the next the lower
the proportion of “long-short-long” beats. This is intuitively unsurprising although the
Poincare´ correlation in AF is so poor that the result may have little import.
These measures allow a picture of the rhythm of an individual patient to be built up in
terms of the beat-to-beat relationships, and the pattern and spread of change seen within
them. These indices may be indicative of the functional variations seen within patients,
particularly those in AF, and will be taken forward (in Chapter 6) for comparison with
the functional measures which are discussed in Chapters 4 and 5.
Chapter 4.
Methods: Describing Function
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Summary
In which the initial postulate is described, together with modifications to the Link Med-
ical list-mode formatting program to permit beat selection on preceding R-R interval
criteria. An experiment to prove the effectiveness of these modifications is detailed
together with its results.
Later sections explain the process of data acquisition and formatting, the steps involved
in analysis, a summary of the parameters measured, and a description of the comparisons
made.
4.1. Beat to beat dependence
It seems intuitively likely that there is a relationship between one heart beat and the
next both in AF and SR; in particular we can hypothesise that the longer the ventricle
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has to fill, the greater the volume of blood within it. Since there is no clear mechanism
by which the duration of systole could be predicted by the pre-systolic volume, a longer
beat must cause either a greater change in the volume of blood in the heart during
subsequent systole or an increase in the total volume of blood in the ventricle.
Various studies [67–71, 86] have found evidence to support the hypothesis that behaviour
of the beat under investigation (the indexed beat) is dependent on characteristics of the
previous beat.
The first aim in describing function in both SR and AF was to determine whether there
was evidence to support the hypothesis that measured LVEF was dependent on the
preceding beat and, if so, to try to determine the parameters which most accurately
reflect cardiac function in patients in SR or AF. In particular, to what extent does
assessment of LVEF in patients with AF depend on the range of R-R intervals selected
for gating studies? To investigate this a number of questions can be asked:
• What is the range of EFs that can be measured by applying different R-R selection
parameters to the same patient / acquisition?
• Does the EF change if the same R-R selection parameters are applied at different
times in the acquisition?
• How does measured EF change with increasing R-R?
• How does measured EF for all beats relate to that determined using the selected
R-R interval?
• How does average measured EF using a variety of beat selection criteria compare
with measured EF for all beats?
• Are the results from the above true for fixed as well as variable time processing?
• Does processing based on the length of the previous beat reduce the range of EF
measured, if you process only on the previous beat?
• Does previous beat processing reduce the range of EFs measured if you process on
both the previous and the indexed beat?
A similar set of questions can also be asked about other measurements of ventricular
function such as pre-systolic volume, the duration of systole or peak filling rate. These
questions can be addressed by making use of list-mode acquisition which allows post-
processing on pre-defined criteria (see §1.5.5).
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4.2. Modifying and proving the program
4.2.1. Method
It is conceptually possible to format a list-mode file in any way you choose (see §1.5.5);
however, standard formatting programs produced by manufacturers, including Link Med-
ical Ltd., do not allow preceding beat selection criteria. A modification was made to the
original source code for list-mode formatting in the MAPS 10000 software (made avail-
able by Link Medical Ltd.) in the “C” programming language. Tests were performed
to prove that the modification is correct. These involved moving a pair of sources syn-
chronously with a bigeminy rhythm.
A bigeminy rhythm consists of regular beats with regular ventricular ectopic beats su-
perimposed in such a way that every normal beat is succeeded by an ectopic beat. Every
ectopic beat is followed by short pause and then a normal beat. The effect is to pro-
duce a regular “long - short - long - short” beat pattern which has an ECG trace and
histogram as shown in Figure 4.1
An ECG simulator was used to generate an absolutely regular bigeminy pattern. By
moving two sources of different activity along perpendicular lines such that one source
moves horizontally during, say, the long beats and the second source moves vertically
during the short beats, it should be possible to isolate movement in one or other direction
by selecting only the short or the long beats. This can be done in one of two ways: either
by selecting on the indexed beat, or by selecting on the preceding beat. Thus the image
which is generated (from the same list-mode file) when selecting on the short indexed
beat, should be the be same as that generated when selecting on the long preceding beat,
and vice versa.
Two ∼ 12MBq 99mTc sources of ∼ 0.5 ml in 10 ml vials were manually slid in perpendic-
ular directions across the surface of the collimator on the gamma camera. Each source
was moved ∼ 20 cm and back to the starting point. Movement of the sources was al-
ternated so that one source was moved vertically during the long beats and the second
source was moved horizontally during the short beats. Only one source was moved at a
time. Using this process a list-mode file was acquired over ∼ 82 s. Considerable rhyth-
mic skill is required to move one source in one direction with duration A and delay B
while moving a second source in a perpendicular direction with duration B and delay A
but with practice it was achieved.
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Figure 4.1.: Showing (a) part of a typical atrial bigeminy rhythm and (b) the resulting his-
togram for the same patient.
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Counts Accepted Beats Rejected Beats
Long Indexed 286232 55 56
Short Indexed 167235 55 56
Long Preceding 167235 55 56
Short Preceding 286232 55 56
Short - Short 0 0 111
Short - Long 286232 55 56
Table 4.1.: Counts in images for different beat selection criteria in absolutely regular bigeminy
rhythm used to test program modifications.
The effectiveness of the modifications can be assessed by comparing the images generated
by selecting beats on the following criteria.
1. Long indexed beat
2. Short indexed beat
3. Long preceding beat
4. Short preceding beat
5. Short preceding beat and short indexed beat
6. Short preceding beat and long indexed beat.
In the case of number 5 all beats should effectively be excluded (since a “short - short”
pattern should never occur), while the image produced for number 6 should be the same
as that produced for number 4. Otherwise the image and the total counts in the image
should be very similar for numbers 1 and 4 and for numbers 2 and 3.
4.2.2. Results
The resulting images are shown in Figure 4.2; the associated total counts in each image
are listed in Table 4.1. It is clear from these results that the modification to the program
is correct and subsequently the modification has been incorporated by Link Medical into
its standard list-formatting program.
It is notable that the ratio of counts in the short indexed beats, R-R interval: 0.54 s
(111 bpm), to those in the long indexed beats, R-R interval: 0.93 s (64 bpm), is the same
as the ratio of the R-R intervals (0.584 compared to 0.581). While this is to be expected
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Figure 4.2.: Images produced using different beat selection criteria in bigeminy rhythm to
prove the modifications to the list-mode formatting program. Short indexed
beats produce the same image as long preceding beats and vice versa thus prov-
ing the program modifications.
it demonstrates the statistical problem in comparing images made up of shorter beats
to those consisting predominantly of longer beats.
A minor difference in counts between those images with preceding beat selection criteria
and those selected only on the indexed beat would be expected because the initial beat
cannot be counted when processing on the preceding beat. However no difference is seen
because the formatting program is written such that when processing on the indexed
beat the initial beat is also ignored. Data acquired before the first ECG pulse, after the
last ECG pulse and between the first and second ECG pulses is ignored in all cases where
a gated image is acquired. This means that summing the total counts in the short and
long beat images (286232 + 167235 = 453467) gives fewer total counts than formatting
the whole list-mode file into a single image (461452 counts).
Overall the results showed the modifications that were made to the list-mode formatting
program to correctly select beats depending on criteria set for indexed and preceding
beats.
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4.3. Data acquisition and processing
The selection of patients and the initial acquisition of list-mode files has been described
in §2.2 and §2.5.2 respectively. While Chapters 2 and 3 investigated the sequence of
R-R intervals in the R-R interval stream obtained from the list-mode files, the analysis
of function described in this chapter investigated images that were produced from the
list-mode files.
4.3.1. Data acquisition
As described in §2.5.2 list-mode files were acquired at best septal separation (∼ 40 ◦)
left anterior oblique (LAO) and 70 ◦ LAO projections. In this part of the study, only the
best septal separation acquisitions are of interest as all functional measurements were
made from these. Quantitative functional measurements cannot be made from 70 ◦ LAO
projections because results are distorted by the overlap of the left and right ventricles.
The 40 ◦ LAO list-mode files were acquired for 15 min if the patient was in AF or for
10 min if the patient was in SR. List-mode files were acquired with a temporal resolution
of 100 µs and a spatial acquisition matrix of 1024 × 1024, corresponding to a spatial
resolution of ∼ 0.4 mm (this is considerably smaller than the system resolution of the
gamma camera with a low energy high sensitivity collimator, ∼ 4 mm).
Two different models of gamma camera were used: the IS2 Pulse and a GE Optima.
The IS2 cameras allow native list-mode acquisition with list-mode files being transferred
in a private DICOM format to the Link Medical MAPS 10000 system for processing.
List-mode acquisitions on the GE Optima camera are made through a third party (Link
Medical Ltd) hardware interface. Thus list-mode files are acquired directly on to the Link
Medical MAPS 10000 system from the GE Optima heads. Low energy, high sensitivity
collimators were used on both cameras (sensitivities at 140 keV: 330± 30 cts/MBq (GE
Optima), 308± 34 cts/MBq (IS2 Pulse)).
4.3.2. Data processing: Image files
Processing list mode files to create images for cardiac studies involves:
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1. Selecting which heart beats (R-R intervals) should be included and
2. Constructing a gated image from scintillation events occurring in the selected R-R
intervals within the list-mode study.
Dealing with each of these in turn:
Beat selection
Beat selection was done on the basis of:
1. Inclusion or exclusion of outlying beats
2. Indexed beat length (R-R interval) as each beat (from beat 2 to N) in the list mode
file is considered in turn
3. Preceding beat length (R-R interval) as each beat (from beat 1 to N − 1) in the
list mode file is considered in turn.
Outlying beats: The beat histogram (see §2.5.3) for the complete list-mode file was
examined and limits which excluded beats considered to be outliers were determined for
each patient, regardless of rhythm. Thus a patient in SR with a modal beat length of
0.9 s ranging from 0.85 s to 0.95 s but with a single ectopic beat of 1.5 s would have a
limit defined (say, at 1.3 s) between 0.95 s and 1.5 s which would exclude the single long
beat.
The subsequent formatting programme automatically determined limits from the longest
and shortest beats within the manually imposed limits. Thus in the above example the
final maximum limit would be defined as 0.95 s although the manual limit was placed
as 1.3 s.
Images were also created without limiting the R-R interval range and comparison was
made between the two sets of images to determine whether outliers had a substantial
effect on functional measures.
Beat length and formatting criteria: A text file was created from the list-mode file
listing individual beat lengths.1 By sorting the individual beat lengths and dividing the
total number of beats by 4, the beat length quartiles, Q1 to Q4, could be determined.
1Temporal resolution is limited by the frequency of time markers which in a list-mode file from the
IS2 pulse gamma cameras occurs every 100 µs.
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Q1 was defined as being the first N/4 beats with the shortest R-R interval, while Q4
was the N/4 beats with the longest R-R interval for each patient (where N , here, is the
total number of beats within overall acceptance limits). Each of these quartiles was then
used to define a series of limits of inclusion for both the indexed and preceding beat.
In most patients in SR the inter-quartile limit would occur between beats of the same
length, in which case beats of the same length were included in both “quartiles”.
Two further sets of limits were defined:
“All”: In which all beats are taken.
“Best”: Beat acceptance limits of 300ms centred on the most frequent group of beats
(100ms bins) in the beat histogram.
These two sets of limits were chosen because “All” offers the most comprehensive average
of the beats and therefore is likely best to represent average cardiac function. The
“Best” limits are most similar to the limits used in many Nuclear Medicine departments,
including the department of Nuclear Cardiology in Glasgow. They offer a fairly narrow
band of frequent beats which will cause little distortion of the curve from one beat to
the next.
The limits were applied both to preceding and indexed beats with preceding beat criteria
taking precedence over indexed beat criteria, so that where both preceding and indexed
beat criteria were applied, the indexed beat criteria were used only after selection of
beats had already been made on the preceding beat. The effect of this, in a perfectly
uniform, random distribution (which AF is not, as shown in Chapter 3), would be to
reduce the total number of counts in the image by a factor of 16. Taking a quartile of the
preceding beat would reduce the number of accepted beats by a factor of 4 with the full
range of indexed beats represented, taking quartiles of these reduces the remaining beats
by further factor of 4 thus reducing the total number of beats (and therefore counts) by
a factor of ∼ 16.
It should be remembered that selecting “All” preceding beats is the same as not applying
any preceding beat selection criteria; similarly using “All” indexed beats is equivalent
to not applying any indexed beat selection criteria.
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Image creation
Two distinct techniques exist for creating gated images: variable time and fixed time
formatting (see §1.5.2). Standard practice in the department is to use 24 frame gating.
This has been shown to be sufficient for an accurate determination of end-systole [87]
and functional parameters including EF and first third filling.
List files were formatted into 24 frame gated images using both fixed and variable time
formatting.
Each list-mode file was formatted using every combination of the three parameters: gat-
ing (fixed or variable), preceding beat selection (Q1-Q4, “All” and “Best”), and indexed
beat selection (Q1-Q4, “All” and “Best”), within the pre-determined R-R interval ac-
ceptance limits. In addition list-mode files were also divided into three time (ti = tall/2)
segments (start to middle, first quarter to third quarter, and middle to end) each of which
was formatted in both fixed and variable time for “All” and “Best” indexed and pre-
ceding beat selection criteria (and not Q1 to Q4). This was done to determine whether
results were consistent over time for a single patient. In total each list-mode file was
formatted into 84 different image files:
• 36 (6 × 6) preceding (Q1-Q4, “All” and “Best”) and indexed (Q1-Q4, “All” and
“Best”) criteria in fixed time mode.
• 36 (6 × 6) preceding (Q1-Q4, “All” and “Best”) and indexed (Q1-Q4, “All” and
“Best”) criteria in variable time mode.
• 12 (2 × 2 × 3) “All” and “Best” preceding and “All” and “Best” indexed criteria
for each of the three ti = t/2 segments in variable time.
4.3.3. Image processing
Each of the images resulting from the process described above (§4.3.2) was further anal-
ysed to produce a final set of images from which curves showing functional changes for
both left and right ventricles could be assessed.
All patients in this study came to the department for diagnostic imaging and all images
were routinely reported. The routine process involves formatting list-mode data using
beat selection limits which are manually defined around the principal peak in the R-R
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histogram. The resultant images are zoomed to create an image in which the pixel
size is constant over all three gamma cameras in the department and in which the heart
occupies most of the centre of the image (although clearly this will vary depending on the
size of the heart). The zoomed images are subsequently processed by drawing regions
of interest (ROIs) around the left and right ventricles and corresponding background
regions. A second set of regions is drawn to estimate the error in measurement.
A similar process was applied to each of the 84 images for each patient in this study.
1. The same zoom (both in terms of location and magnification factor) was applied
to each image as was applied to the images in the original report.
2. The zoomed and gated images were then smoothed twice using a 9 point [4,2,1]
Gaussian smooth 2, and twice more, cyclically, using a linear [1,2,1] temporal kernel.
3. The ROIs used in the routine clinical report, consisting of LV, LV background,
RV and RV background, each drawn twice to assess consistency, were applied to
the smoothed gated image to create two sets of curves for each region. The same
regions were used for every image. Each set of regions was separately checked by a
second observer against both the original, clinical image and the image produced
using all beats to ensure that the ROI was appropriately positioned.
4. Background curves were smoothed 100 times using a 3 point [1,2,1] Gaussian
smooth. This is a slightly curious way of averaging all the counts in the back-
ground curve. A similar result could be achieved simply by calculating an average
of the complete curve.
5. After accounting for the difference in area between the background and ventricular
regions, each of the massively smoothed background curves were subtracted from
each of the ventricular curves to give four curves (LV1−Bg1, LV1−Bg2, LV2−Bg1,
LV2 −Bg2) of counts vs. frame for each ventricle.
2Smoothing works by convolving a 2D image by a 2D kernel such that each point in the image is
weighted by the kernel. A 9 point [4,2,1] Gaussian smooth has a kernel:


1 2 1
2 4 2
1 2 1


The kernel is centred on each pixel; the pixel is assigned a new value based on the weighted average
of the 9 pixels covered by the kernel with the weighting given by the value in the kernel. This is
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To ensure that the ROIs were positioned correctly and the the correct zoom had been
applied each of the formatted and zoomed images, with all beats included, and their
regions were manually compared against the original, clinically reported, images. Where
an apparent difference was found (3 cases) the difference was investigated and corrected;
in each case it was because a different imaging head (on the same camera) had been
used.
An example of the regions of interest is shown in Figure 4.3.
4.3.4. Curve analysis
Analysis of the curves formed the principal assessment of function. Several different
analyses were carried out and are described in later sections; however, the principal
measures determined were:
• Left ventricular ejection fraction (LVEF)
• Pre-systolic volume (PSV )
• Pre-systolic vs. end-diastolic volume (EDV/PSV )
• Systolic time interval
• First third filling fraction (FTFF)
• Peak filling rate (PFR).
Although measurements were taken for both the left and the right ventricle the analysis
in this thesis has been limited to LV values.
done for every pixel in the image. At the edges, that part of the kernel which does not overlap a
pixel is simply ignored (although other options, such as wrapping, could be used).
Mathematically the new image O is expressed as:
O(i, j) =
m∑
k=1
n∑
l=1
I(i+ k − 1, j + l − 1)K(k, l)
Where 1 ≤ i ≤M −m+ 1; 1 ≤ j ≤M −m+ 1 and image I has dimensions (M,N) and kernel, K,
has dimensions (m,n).
A cyclical smooth applies the same thing but, instead of using X vs Y coordinates, the, orthogonal,
X vs Time coordinate system is used and the last frame is wrapped to be beside the first frame[88].
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Figure 4.3.: Showing how regions of interest were drawn: two regions for each of left ventricle,
right ventricle, left background, right background. Images show pre-systolic
image, end-systolic image, the stroke volume (pre-systole - end-systole) and
paradox (end-systole - pre-systole) images. Regions were drawn to be just inside
the stroke-volume envelope at pre-systole.
Methods: Describing Function 133
To analyse these parameters, each curve was passed through the ef analysis.awk script
(see appendix A.3) to identify the pre-systolic and end-diastolic points on the curve. The
curve was cropped to include only those points between pre-systole and end-diastole
(inclusive). The effect of this was to cut out potential up-sloping points before the pre-
systolic point, and to remove that portion of the curve after end-diastole which results
from averaging many beats of potentially widely varying lengths.
The cropped curve was passed through a Link Medical program (cardiac slope) to anal-
yse the characteristic properties of the curve including peak emptying and filling rates
and FTFF.
Finally, the cropped curve was again passed through ef analysis.awk to determine EF
and the error on EF.
4.3.5. Problems
Several problems were found which were not anticipated and which resulted in the entire
data-set needing to be reformatted and / or reprocessed before robust data was obtained.
1. List mode acquisitions were generally made using a specific imaging head that
depended on which camera was being used; however several of the acquisitions
were performed using an alternative imaging head (at 90 degree to the normal
acquisition). With automatic formatting, this could only be detected by examining
at least one image from every acquisition. Once detected the problem was resolved
by manually specifiying the alternative head in reconstructing the image from the
list-mode file.
2. Image files were zoomed before being analysed. When the zoom was omitted the
regions did not match the image.
3. Selecting beats automatically from the limits of the histogram gave excessive weight
to outliers and resulted in distorted beat acceptance windows. To overcome this the
beat histogram for each patient was viewed and manual acceptance limits imposed
as described in §4.3.2.
4. Beat by beat listings were made with two decimal place precision while beat ac-
ceptance testing against the defined window used five decimal place precision; by
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rounding beats lengths to the nearest value at that precision, it was possible that
beats that should have been included were, in practice, excluded.
5. The cardiac slope program was modified by Link Medical for an unrelated purpose.
The modification caused some real numbers to be seen as integers, with the result
that the measure of FTFF was incorrectly calculated.
4.4. Analysis of function
This study involved two groups of patients: AF and SR. Each of these groups was divided
into several subgroups of potential clinical interest as described in §2.7.1.
The principal investigation considered the effect of beat selection parameters involving
both the indexed beat and preceding beat on the functional indices listed in §4.3.4
(explained in more detail in §4.5). While variable time formatting was used as the base
technique, fixed time formatting was performed throughout the study and comparison
has been made between fixed and variable time formatting for each parameter measured.
While the changes in a measured parameter with beat selection criteria were considered,
so too was the overall range of values obtained for each patient. This was done simply
by subtracting the maximum and minimum measure giving the largest possible measure
of range. There are several other possibilities that could also have been considered as an
assessment of variation, e.g. some multiple of standard deviation or inter-quartile range,
but it was felt that showing the maximum measured range would be more indicative of
the clinical significance of changes.
An in-depth, sub-group analysis of patients according to the groups described in §2.7.1
was undertaken only for LVEF which is the functional parameter of greatest clinical
interest. As with the analysis of the groups as a whole, this analysis considered both
the variation with beat selection criteria, and the overall range.
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Figure 4.4.: Sample activity-time curve.
4.5. Measured functional parameters
A detailed description of the functional parameters that were measured follows. In each
case the parameters were taken from the curve produced by applying the appropriate
ROIs to each of the images created using the different beat selection criteria.
4.5.1. Sample curve
In the following discussion several points on the activity-time curve are described. An
example curve is shown in Figure 4.4.
The principal points are:
Pre-systole: The initial peak point in the curve.
Systole: That initial falling segment of the curve during which activity decreases re-
flecting the reducing volume of the ventricle.
End-systole: The bottom of the curve after systole. After this point the activity (re-
flecting the volume) increases.
Diastole: The part of the curve following end-systole during which the curve rises,
reflecting the increasing volume of the ventricle, to a peak at end-diastole.
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End-diastole: The peak point which marks the end of diastolic filling. This may be
followed by another down-sloping segment, but this reflects methodological “error”
rather than physiological change.
The measured parameters divide into two groups depending on whether they are associ-
ated with diastole or systole.
4.5.2. Left ventricular ejection fraction (LVEF)
Ventricular EF is the proportion of blood pushed from the ventricle during systole. Ex-
pressed as a percentage, it is the change in ventricular volume divided by the pre-systolic
volume. (Although most investigators would not differentiate between pre-systolic and
end-diastolic volume, considering the curve to be cyclical. As a result they would be
more likely to express EF as the change in volume divided by the end-diastolic volume).
In radionuclide ventriculography detected count is, approximately, proportional to vol-
ume; thus the pre-systolic count, Cps is proportional to the pre-systolic volume and the
end-systolic count, Ces is proportional to the end-systolic volume. EF can either be
calculated incorporating a background correction as described in equation 1.4 or, as in
this case, it can be determined after background subtracting the complete curve (see
§4.3.3) in which case:
EF =
(C ′ps − C ′es)
C ′ps
(4.1)
where the “′” (prime) mark here indicates the value after subtraction of the background
curve.
Pre-systolic and end-systolic counts were taken from the background subtracted cropped
curves as described in §4.3.3. EF calculations were done for the LV using both fixed and
variable time formatting with all beat selection criteria.
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4.5.3. Pre-systolic volume (PSV )
Since detected count is proportional to volume3, a measure of pre-systolic volume is
given by the count in a frame, normalised to the duration of the frame and the number
of beats which contribute to the overall count in the image.
Vps =
Cps
N ·T (4.2)
which has actually been calculated as:
Vps =
F ·Cps
N ·R (4.3)
Where:
Cps is the pre systolic count
F is the number of frames
R is the mean RR interval for variable time formatting or the mid-range RR interval
for fixed time formatting
N is the number of beats which contributed
T is the mean time per frame for variable time formatting or mid-range time per frame
for fixed time formatting
Vps is a measure approximately proportional to the pre-systolic volume.
Pre-systolic volume may vary substantially for different patients depending on the at-
tenuation of each patient.
Pre-systolic counts were taken from the background subtracted, cropped curves as de-
scribed in §4.3.3. Pre-systolic volume calculations were done for LV only using both
fixed and variable time formatting with all beat selection criteria.
3The concentration of radio-labelled blood cells is assumed to be constant throughout the blood (it
has a constant specific activity) with the result that changes in the volume of red blood cells are
reflected in a change in the count rate. This also assumes that attenuation is uniform, and although
it is not, the approximation is acceptable [89].
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4.5.4. Pre-systolic vs. end-diastolic volume (EDV/PSV )
In normal SR, the pre-systolic and end-diastolic points on the volume-time are approxi-
mately equal. In AF, however, normal ventricular beats may be interrupted by irregular
firing of the AV node or may be prolonged causing the ventricle to fill for longer than
expected. As a result the end-diastolic volume, for a beat which has been prematurely
interrupted, may be considerably smaller than the pre-systolic volume in the same beat.
Similarly it is possible that in a beat which has filled for longer than expected the
end-diastolic volume may be substantially greater than the pre-systolic volume.
To explore this, the ratio of counts at end-diastole to those at pre-systole (corresponding
to the volume ratios) was calculated: the counts being taken from the background
subtracted, cropped curves. This was done for the LV only using both fixed and variable
time formatting with all beat selection criteria.
4.5.5. Systolic time interval
As discussed in Chapter 1 (see §1.1.1) the Frank-Starling mechanism, on which some of
the basic hypotheses of this thesis are predicated, expects that beat-to-beat changes in
systole are reflected more in volume change than in variations in the duration of systole.
Thus a change in beat length is primarily exhibited as a variation in the duration of
diastole which, in turn, determines the pre-systolic volume of the subsequent beat.
Although systolic time is defined as the time between end-diastole and end-systole, there
is a question as to whether this is the time between the electrical activation (onset of the
R wave) or mechanical activation (pre-systole on our sample curve, see Figure 4.4). Since
changes in volume in radionuclide ventriculography reflect changes in the morphology of
the ventricle and not electrical activation (despite the R wave being used as a trigger), it
was decided to use the pre-systolic point as the marker for the onset of systole and hence
the cropped curves, which accepted only that part of the curve between pre-systole and
end-diastole, were used to determine the systolic time.
Assessment of systolic time is limited by the number of frames as it can only be measured
to an accuracy equal to the frame time. Sampling theory defining the accuracy to be:
σ =
tframe
2
(4.4)
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Systolic time was measured by determining the frame time from the mid-range (for
fixed time formatting) or the mean (for variable time formatting) beat and dividing by
the number of frames (24), and then simply multiplying by the frame number of the
end-systolic point on the cropped curve.
Systolic time calculations were performed only for the LV using both fixed and variable
time formatting with all beat selection criteria.
4.5.6. Peak filling rate (PFR)
Rumberger and Reed [90] found that both peak emptying and PFR in SR were dependent
on end-diastolic volume. Examining the PFR allowed this finding to be tested in the
context of AF. Together with peak emptying rate, it offers a measure of ventricular
compliance.
The Link Medical cardiac slope program was used to assess PFR in the background
corrected, cropped curve. This program assesses the PFR by calculating the gradient
over both 3 and 4 points in the curve giving two slightly different measures. It was
decided to use the 4 point value as this should be slightly less susceptible to random
count fluctuations which may be significant in potentially low count data.
4.5.7. First third filling fraction (FTFF)
FTFF is the most commonly quoted measure of diastolic filling. It is the proportion of
end-diastolic volume at 1/3 of the diastolic time; as such it is dependent on an accurate
assessment of diastolic time. Since it is expected that patients in AF will have widely
differing diastolic times from one beat to the next this may not be measurable in a
consistent manner.
FTFF was assessed from the background corrected, cropped curve using Link Medical
cardiac slope program which calculates FTFF from a linear extrapolation of the activity
in the frames either side of the first third of diastole, determined as the time between
end-systole and the end of the cropped curve.
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4.6. Statistics
In all of the following statistical analyses the interest is in the changes in a measured
value, e.g. LVEF, introduced by three different variables: formatting mode (fixed or
variable time), preceding beat selection and indexed beat selection.
It is appropriate to consider the differences between variable and fixed time formatting
separately, as they are of secondary interest in this investigation. While they may show
a statistically significant difference, centres for Nuclear Cardiology will generally use one
or the other without “mixing” results.
The beat selection options used divide into two types: quartiles which provide a pseudo-
normalised numerical measure and hence lend themselves to numerical analyses, and
the categorical groupings of “All” and “Best” beats, to which can be added a grouping
that combines all the results based on quartiles into a single group. The statistical
analyses for these types are different, even though they have been treated as the same in
formatting and processing the data. Changes with increasing quartile are best assessed
using multi-variate regression (with two explanatory variables: preceding and indexed
beat selection criteria). Changes within the categorical grouping must be assessed with
a two way analysis of variance, Anova.
4.6.1. Regression
Regression allows two interval variables to be compared - in this case changes in func-
tional measure with preceding or indexed beat length as represented by the quartile
(expressed as a number) or the mid point of the quartile range (expressed in seconds).
Neither all the beats nor the “Best” beats can be expressed as interval (numeric) val-
ues and so they cannot be included in a regression except as fixed terms in either the
preceding or indexed beat.
By taking a linear regression against the quartile values, linear changes with preceding
or indexed beat length can be determined. This is preferable to analysing differences
between every possible combination of beat selection criteria which is liable to produce
“false” significances both on a patient-by-patient basis and if the group is considered as
a whole.
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While there is a theoretical possibility that some other form of regression may model
the changes more accurately (e.g. a quadratic) there are two reasons to use the linear
model: (1) the data appear to be approximately normally distributed (see appendix
§C.1) suggesting that a linear regression will suffice; and (2) the four points defined by
taking quartiles are insufficient to determine higher order models.
There are two very different means of regressing the results. They can be considered on
a patient-by-patient basis or they can be considered in the group as a whole, possibly
included in a mixed effects model where patients are included as a random effect. By
considering the results in the group as a whole, gross changes can be determined with a
high degree of significance but the form of the change is obscured by the variation within
the group - because there is no means of normalising individual R-R ranges. The form of
the change can only be seen on a patient-by-patient basis by regressing against individual
quartiles. Including patient variation as a random effect in a mixed effects model adds
considerably to the complexity of the statistical analysis without substantially changing
the results. The results become less easily understandable. The decision was taken
not to pursue the mixed effects model after it was tested for changes in LVEF with beat
selection criteria and for variation of LVEF with pre-systolic volume; in neither situation
was any substantial difference found when compared with linear regression in the group
as a whole.
Considering the results on a patient-by-patient basis allows the patient specific form of
the change to be determined; however the significance of the result will be weakened
by the poor number of points (4) which can be included. Regression in this form can
be taken against both quartile and time (represented by the mid-point of each quartile
range). All three of these analyses (whole group, patient-by-patient on quartile and
patient-by-patient on time) have been investigated (results for regression on a patient-
by-patient basis with time are reported in appendix C.3).
In each situation a linear regression model was used. This can be described as:
LV EF = a+ βpQp + βiQi + βpiQpQi (4.5)
where
a & βx are constants
Qp is the preceding quartile (or midpoint of quartile R-R range in seconds).
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Qi is the indexed quartile (or midpoint of quartile R-R range in seconds).
Similarly linear regression (with only one variable) was used to investigate whether there
were trends when either the preceding or indexed beat criteria were fixed (either “All”
or “Best”).
Where regression was done on a patient-by-patient basis an index (e.g. LVEF, systolic
time) was weighted by the inverse of the standard deviation of the index (1/SD) using
the lm function in the R statistical package. The SD was obtained by determining the
index from the four combinations of two myocardial and two background regions of
interest. It reflects the accuracy with which regions were drawn but will also reflect the
total count in each image and hence the noise in the image. Taking the inverse gives
more weight to the points with smaller error [91].
Individual results obtained on a patient-by-patient basis which were found not to be
significant were discarded. The mean r2 of the remaining results has been reported.
4.6.2. Analysis of Variance
Analysis of variance compares measures made using the different variables with a base
measure. It is used here to investigate whether there is a significant difference between
functional measures obtained with the nominal beat selection criteria: “All”, “Best” and
“Quartiles” (in which all quartile results are clumped together in a single group). In this
model there are two different variables: preceding and indexed beat selection criteria
each of which can take one of three values: “All”, “Best” or “Quartiles”. Analysis of
variance was only used for the group as a whole and not on a patient-by-patient basis.
The base measure against which all other measures are compared is the result obtained
with all preceding and indexed beat selection criteria.
4.6.3. Comparing tables
In several places in this thesis it is necessary to compare tables of count data, e.g. the
number of patients for whom each combination of beat selection criteria gave valid results
in fixed vs. variable time formatting (this example is worked out in §5.4.4).
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The comparison involves a successive reduction technique using a log-linear model with
a Poisson predictor as described in The R book by Michael Crawley [92]. This technique
treats the data as a single multi-dimensional table with initially every possible term
included in the model. The table is compared against a Poisson distribution. If a
term is removed and a comparison of the models, using a chi-squared test, proves to be
insignificant that term can be considered to have no impact as a descriptor. Where two
tables, with the same descriptors (e.g. beat selection criteria) are compared the term
which links the tables is the complete interaction term, in the above case it would be
preceding : indexed : framemode. If this term is removed without affecting the model
the statistical inference is that there is no interaction between the tables indicating
similar relationships, in this case similar results with beat selection criteria, in the two
tables.
4.7. Going forward
The measures and techniques which have been described in this chapter have been
systematically applied to each of the images produced using the different criteria defined
by the beat selection and formatting technique in the group of patients in AF and SR.
The results of these analyses are presented in the following chapter. In Chapter 6 the
results are compared with the analyses of rhythm described in Chapters 2 and 3.
Chapter 5.
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Summary
In which we look at the results from measures of function of the LV, both systolic and
diastolic, which have been derived from the RNVG. The results are considered both for
the group of patients in AF and the group in SR. In the case of left ventricular ejection
fraction, LVEF, analysis has also been performed on several clinical subgroups.
Comparison is made between fixed and variable time formatting, and between the differ-
ent measures: LVEF, pre-systolic volume, systolic time interval, the ratio of pre-systolic
to end-diastolic volume, first third filling fraction and peak filling rate.
5.1. Introduction
As discussed in §4.3.2 each acquired list was formatted into 84 different images, each of
24 frames. These included different time spans (the whole acquisition, the first half, the
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second half or the middle two quarters of the acquisition); different formatting techniques
(variable time or fixed time); and different beat selection methods based on the duration
of the preceding beat, the indexed beat or both.
The resulting images were each processed by applying the same ROIs to create curves
as discussed in §4.3.3. The results allow us to investigate several different questions,
notably:
• Do functional parameters change depending on beat selection criteria?
• If functional measures do change is there a trend in the relationship?
• Does variable time framing produce similar results as fixed time framing for the
defined functional parameters ?
• Given the beat selection criteria is there self consistency for functional measures
acquired at approximately the same time?
5.2. “Cleaning” the data
Before any meaningful conclusions could be drawn from the data it was necessary to
ensure that the data were reasonable in that they were not skewed by artifacts. Al-
though the process was evolutionary it can be summarised in three parts: removal of
unanalysable curves, exclusion of outlying beats and filtering of results.
5.2.1. Unanalysable curves
The process of determining beat selection criteria, formatting the list-mode file on the
acceptable beats only, and producing a curve from the resulting image was followed in
an identical manner for every image created. The resulting curve, however, was not
always found to be analysable, in that it might not not have yielded a clearly defined
pre-systolic, end-systolic and end-diastolic point (see Figure 4.4). In this case the curve
would be considered to be unanalysable. Several aspects of the curve might make it
unanalysable: the curve must start at, or rise to, a maximum (pre-systolic) point before
falling to a minimum (end-systolic) point. It was a requirement of the analysis program
(see appendix §A.3) that the curve should rise (without further falling) by a minimum
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of 1/3 of the difference between the count at pre-systole and end-systole before the
end-systolic point could be considered to have been found. The end-diastolic point
would then be considered to be the first maximum after this point. Where these points
could not be determined the curve was defined as being unanalysable. There are several
possible reasons for this to occur but the most likely are (in no particular order):
1. The limits on acceptable beats have been incorrectly set.
2. The total count in the image is too low to give accurate results (see §5.2.3).
3. The limitations of the formatting technique lead to inappropriate smoothing or
truncation of the curve.
We will return to these in the discussion in Chapter 8 (§8.3.2, §8.3.3).
5.2.2. Limiting the beat selection criteria
Initially beat selection quartiles were based on the full range, including outliers, of R-R
intervals. This caused problems, particularly with fixed time formatting, because only
one or two beats might significantly distort the duration of the mid-range beat about
which all beats in that quartile were grouped.
This problem is demonstrated in the histograms in Figure 5.1. Considering the SR
example, it can be seen that the mid-range beat when the outlying beats are included is
around 1.8 s, substantially greater than almost all the beats in the histogram. The effect
of this, particularly where fixed time formatting is used, is to compress all the data into
the first half of the curve, causing a serious distortion of the “real” curve.
To avoid this methodological error each histogram was reviewed and limits were deter-
mined outside of which beats were excluded from the analysis. Two separate observers
were involved in this review and where there was disagreement a consensus view was
agreed. The data was then reformatted using beat acceptance limits with quartiles
calculated based on these manually defined limits.
The effect of this was to substantially reduce the number of curves defined as un-
analysable (see Table 5.1). An example of the effect that limiting the acceptable beats
has on the curve is shown in Figure 5.2. It can be seen that in the curve that is not lim-
ited the first and final few frames show very reduced activity (volume) which is clearly
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Figure 5.1.: Sample histograms for (a) SR (patient S1) and (b) AF (patient A1) showing
outlying beats and (in red) manually determined beat acceptance limits.
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AF SR
Not limited 2123 1866
Limited 2036 78
Total possible curves 36000 38016
Table 5.1.: Effect of limiting the acceptable range of R-R intervals on the number of un-
analysable (null) LVEF values.
not physiological. Additionally the end-systolic point does not occur in the same frame,
or at the same time, in both curves because the unlimited curves have longer frames
with the result that the true end-systolic point is captured in an earlier frame than in
the limited curves. Thus the temporal resolution of the unlimited curves is poorer than
in the limited curves.
It is noticeable that the curve produced from limiting the acceptable beats appears to
have fewer counts than the unlimited curve, and further examination of curves of other
patients showed this to be true in all cases in both SR and AF. This apparent discrepancy
is due to two factors: the unlimited curve is condensed into the first 16 or 17 frames while
the limited curve occupies all 24 frames. Since there are approximately similar counts
in each image the counts in each frame must be at least 1/3 greater in the unlimited
curve. This is compounded by the background which in both cases is smoothed over the
full 24 frames with the result that a lower background is removed in the unlimited case.
Overall the reduction is in line with the number of beats removed. In this case 21 of 541
beats were discarded (∼ 4%). In the unlimited curve there are 11,189,296 counts while
the limited curve has 10,675,076 counts, a difference of ∼ 4.6%. The slight increase is
to be expected since a greater number of longer beats (which have more counts in them)
were discarded.
5.2.3. Filtering data
The same ROIs and the same initial data acquisition were used to produce each of our
images. In theory this should mean that all of the images produce acceptable curves
for analysis; however, it has already been noted that a proportion of the curves could
not be analysed to give an adequate LVEF. While the remaining curves do provide an
assessment of LVEF, some images included so few beats that random noise and the
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Figure 5.2.: Sample change in curve as a result of limiting acceptable R-R intervals in SR
(patient S1). The same curve is shown in (a) by frame number and (b) by time.
(Formatting parameters: Fixed time: p:All,c:All).
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statistical fluctuations of the decay process are such as to invalidate the measurement
of LVEF.
There are two principal sources of error: error due to the random nature of radioactive
emissions which is modelled by the Poisson distribution; and error due to positioning of
the ROI, which is modelled by the SD of calculated EF.
EF Poisson error
Detected count is a statistical process which follows a Poisson distribution such that
the statistical error on measured count is the square root of the detected count. It can
therefore be shown that for ejection fraction, EF :
EF =
(Cd − Cs)
Cd
(5.1)
Where:
Cd is the pre-systolic (end-diastolic) count after background subtraction.
Cs is the end-systolic count after background subtraction.
The error due to the Poisson noise, ∆EF , in this calculation is:
∆EF = EF ×
√(√
Cd
Cd
)2
+
(√
Cd + Cs
Cd − Cs
)2
(5.2)
A limitation was placed on the Poisson error of ±10%, such that curves / images with
an error in LVEF greater this were discarded from any further analysis.
Error due to ROI positioning
Every image resulting from the different beat selection criteria would produce, for each
ventricle, four separate curves obtained from the combinations of two ventricular and
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two background ROIs. The mean and SD, σEF , for each parameter was measured from
these curves (after filtering as applied above) to give an estimate of the error due to
positioning of the ROI. A further filter was applied to the summary data which required
that any curve for which σEF > 10% was excluded, thus an image which produced a
mean LVEF of 40% would be excluded if the SD of the LVEF was greater than 4% (EF
units).
Pre-systolic point
Several curves were found to have pre-systolic points that were several frames into the
24 frame gate. A delay of one or two frames could be expected due to delayed onset
of mechanical contraction after electrical “firing”. It was decided that a delay in onset
could be considered to be “real” provided that it was less than or equal to three frames
(this corresponds to a delay of ∼ 0.19 s in a slow heart beat of 40 bpm). Any curve in
which the pre-systolic frame was > 3 was excluded.
Filtering summary data
The effect of these filters on the overall number of acceptable curve values, after each
value had been averaged over the four possible curves as described above (§5.2.3) is
shown in Table 5.2. In many cases the same curve may have been excluded by more
than one criterion so the total after filtering is not simply the cumulative difference from
the number available before filtering. There is a small possibility that excluding almost
one third of the curves will skew some of the statistical analyses, however, the exclusions
are justified and there are sufficient remaining data that statistical conclusions are well
validated. Table 5.3 shows the number of scans remaining by beat selection criteria. It is
clear that the shorter the beat the more likely it is that the curve will be excluded. It is
also noticeable that the curve is more likely to have been included if all the beats (either
preceding or indexed) were accepted. Both of these results suggest that the principal
exclusion criterion was having insufficient counts since shorter beats will have fewer
counts than do longer, ones and including all the beats will cause the least limitation on
the number of counts in the image.
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AF SR
Total 36000 38016
No LVEF 2123 1866
ES count < 100 22 450
∆LV EF > 10% 9311 7680
σLV EF > 10% 355 290
PS frame > 3 824 713
Total after filtering 24236 27755
Table 5.2.: Effect of filtering on numbers of acceptable curves for LV in SR and AF.
Indexed beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 385 385 357 361 366 367
Best 385 385 357 361 364 367
Q1 355 355 159 192 196 210
Q2 361 362 189 219 229 231
Q3 367 367 196 229 242 230
Q4 365 364 198 221 231 245
(a) SR, Variable time
Indexed beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 387 384 354 361 365 373
Best 386 382 355 363 365 371
Q1 362 354 160 189 195 222
Q2 362 361 185 217 225 245
Q3 365 364 188 224 235 247
Q4 366 364 193 216 225 246
(b) SR, Fixed time
Indexed beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 372 360 312 346 349 349
Best 341 301 221 255 278 284
Q1 274 194 89 128 133 156
Q2 327 252 134 174 199 211
Q3 347 284 153 205 226 249
Q4 360 306 182 241 265 273
(c) AF, Variable time
Indexed beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 275 340 223 346 358 371
Best 281 298 165 267 285 335
Q1 291 208 87 127 139 216
Q2 279 253 105 196 211 280
Q3 276 290 124 211 240 310
Q4 277 301 147 252 274 321
(d) AF, Fixed time
Table 5.3.: Number of acceptable scans, after limiting and filtering, by beat selection criteria
in SR and AF.
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SR AF
Variable Fixed Variable Fixed
No. patients No. curves No. patients No. curves No. patients No. curves No. patients No. curves
Not limited, Not filtered 396 13412 375 13415 396 13273 375 12211
Not limited, filtered 386 9405 373 8833 392 9418 375 8581
Limited, not filtered 396 14239 375 13422 395 14171 375 12290
Limited, filtered 387 10753 373 9130 391 10756 375 8959
Table 5.4.: Number of patients and curves included in the analysis after beat limiting and
filtering.
5.2.4. Effect of limitations and filtering on overall data
The effect of the limitations and filters on the range (max - min) of LVEF on a per-
patient basis is shown in Figure 5.3. This shows, for each patient the number of different
measures of LVEF which could potentially contribute to the maximum range, EFmax −
EFmin, of LVEF measurements for that patient plotted against the range. The separate
effects of limiting the beat selection window and filtering the data can be seen: the
limitation reduces the range but has little effect on the spread of selection techniques.
Filtering reduces the range further but also reduces the available pool of measures from
which the range can be determined.
As an example, using fixed time formatting on the whole list-mode file, 36 images would
be created, of these 35 give non-null values of LVEF producing a range of 19% (EF
units) between the maximum and minimum LVEF for that patient with those image
parameters. Filtering the curves, as described above, reduces the number of acceptable
measures to 26 and the range to 17%. Limiting the acceptable beats makes it possible
to measure LVEF in all 36 curves but increases the range of measures LVEF to 26% for
that patient. When a filter is applied again there are found to be 28 acceptable measures
with a range of 18%.
The number of patients and curves contributing to each plot can be seen in Table 5.4
from which it is clear that limiting the beat selection criteria actually increases the total
number of curves which were available for analysis. From this point on only the limited
and filtered data will be used.
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Figure 5.3.: Showing the range (max - min for each patient) of LVEFs calculated for each pa-
tient, using variable time formatting on the whole list-mode file, plotted against
the number of different beat selection techniques which produce unfiltered re-
sults. The effect of both limiting the acceptable range of R-R intervals (limited)
and filtering the curves (filtered) is shown. The number of patients and curves
in each situation are shown in Table 5.4.
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5.3. Presentation of results
Before we can progress to considering the functional measures, a short digression is
required to explain the presentation of results.
5.3.1. Terminology
Applying different beat selection criteria produces a variety of different values for the
indices being measured. The difference between the maximum and the minimum value
(max(x) − min(x)) has, in this thesis, been termed range and is referred to with the
symbol: m.
5.3.2. Notation
In much of the discussion that follows, it is necessary to describe the beat selection crite-
ria used to achieve a specific result. This is done using the notation “p:preceding c:indexed”
where preceding gives the preceding beat selection criteria and indexed gives the indexed
(current) beat selection criteria. So p:Q1 c:Best would mean that the preceding beat
selection criteria required beats to be in the first quartile (Q1) and the indexed beat
criteria took only the “Best” beats (the beats in a 300 ms window centred on the modal
beat length) (see§4.3.2).
5.3.3. Box-plots
Results are presented in tables detailing the mean and SD of a measure for different
preceding and indexed beat criteria; however trends are more clearly seen graphically
and the data has also been presented in the form of two sets of grouped box-plots. Each
set of box-plots presents the same data grouped either by preceding or indexed beat. An
example set is shown in Figure 5.4b.
Each set of box-plots comprises six separate plots, each one of which shows the median,
quartile, range and outliers for each indexed or preceding criterion (see Figure 5.4a).
Thus in our example (Figure 5.4b, which shows data for LVEF in AF grouped by indexed
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Figure 5.4.: Example of two parts of the box-plot display, showing (a) a single box-plot
corresponding to indexed beat criteria in which all beats were selected, and (b)
set of box-plots each one showing one of the possible indexed beat selection
criteria. Plot (a) is the same as the first group in plot (b). Box plots show
median, inter-quartile range and outliers.
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beat) the single plot (Figure 5.4a), which shows the data for each preceding beat selection
criterion with all indexed beats being accepted, corresponds to the first plot in the set.
In presenting the results two sets of plots are shown, the first groups the results by
preceding beat criteria, the second groups them by the indexed beat selection criteria.
By plotting two sets, trends in either grouping can be seen.
Statistical analysis used regression and analysis of variance as, described in §4.6, to-
gether with Wilcoxon signed ranks test (for comparing non-normal unpaired data),
paired Wilcoxon (for comparing non-normal, paired data) and Spearman rank corre-
lation (for determining relationship between non-normal, paired indices). Significant
results are highlighted.
5.3.4. Regression
Regression results are presented in different tables for the two types of regression under-
taken. In both tables (Table 5.9 can be taken as an example) where a beat selection
criterion has been marked as “(Constant)” it has been held constant and only the other
beat selection criterion has been used in the regression calculation (from Q1 to Q4).
Thus in a row in which the preceding beat is shown to be “Best (Constant)” with the
indexed beat shown to be “Q1 - Q4”, the regression calculation has been made on the
results from images created using the “Best” preceding beat with indexed beats ranging
from Q1 to Q4.
Whole group regression
A single table is presented showing SR and AF results side-by-side. The r2 and p values
are given with significant results highlighted.
Patient-by-patient regression
A table is presented for each of SR and AF. Each table shows the results (mean ± SD of
the R2 value, and the number) of patients who showed a significant (p > 0.05) regression
separated into those for whom the regression showed a positive correlation and those for
whom the regression was negative. A final column (labelled “NC”) shows the number of
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patients for whom no calculation could be performed (because there were fewer than 3
points in the regression equation). The total number of patients in each of SR and AF
is given in the caption.
As an example the first line in Table 5.9a shows the regression, in SR, with varying
indexed beat (Q1-Q4) for “All” preceding beats. 371 patients in SR were included, 140
patients had a positive regression (with mean R2 = 0.78 ± 0.14) and 40 patients had
a negative regression (with mean R2 = 0.76 ± 0.13). There were 4 patients for whom
a calculation was not possible, leaving 371 − 140 − 40 − 4 = 87 patients for whom the
regression was not significant.
In the case of multiple regression, where both indexed and preceding beat were varied,
the table shows the mean ± SD R2 value for those patients who showed a significant
regression the number of patients who showed a correlation are indicated in the appro-
priate “N (+ve)” or “N (-ve)” column with preceding beat correlations indicated with
“(p)” and indexed beat correlations marked with “(i)”.
5.3.5. Anova
Anova results are shown in a single table which presents the p values for SR and AF side
by side. The comparison for each combination of beat selection criteria against a base
value (here the result when all beats are included) is shown. All results achieved using
any quartile for that particular beat selection criterion are grouped together. Significant
results are highlighted.
5.4. LVEF
Once an acceptable subset of the acquired data had been determined, attention turned
to the functional measures of interest; in particular LVEF.
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Rhythm No. Pats Minimum 1st Quartile Median 3rd Quartile Maximum Mean SD
SR 387 4.2 33.1 42.1 49.7 86.8 41.4 13.6
AF 373 5.7 27.1 35.4 43.1 76.2 35.4 11.6
Table 5.5.: LVEF: Summary statistics for measured LVEFs (variable time formatting) show-
ing the distribution of LVEF in SR and AF.
5.4.1. LVEF in SR and AF
A range of different beat selection criteria were applied to produce images from which
LVEF can be calculated as discussed in §4.5.2. This produces a range1 of LVEFs, denoted
hereafter by mLVEF, as shown in Figures 5.5 (SR) and 5.6 (AF). These figures show (a)
a histogram of the ranges of LVEF measured per patient which demonstrates that most
patients show ejection fractions which differ by between 5% and 12% in SR and between
10% and 20% in AF. It can be seen from (b) the plots of range against the number of
images which contribute to determining that range that in AF the range is substantial
even when there are few contributing images. In SR a larger number of images may be
required to see full range. Since the number of contributing images is determined by the
number of images which have been filtered out, as discussed in § 5.2, this may suggest
that there is a wider range where the underlying data is more robust.
Examining these figures, there are some clear outliers in both SR and AF but review
of these found no reason to exclude them from the analysis, and they were deemed
to be genuine. There did not appear to be any definable trend in the beat selection
criteria which caused the outliers: the maximum ranges occurred, for example, between
p:Q1 c:Q1 and p:All c:Q3 in one instance and p:Q2 c:All and p:Q4 c:Q2 in another.
Table 5.5 summarises the LVEF results for all patients and all beat selection criteria while
the variation in mLVEF (LV EFmax−LV EFmin) is summarised in Table 5.6. From these
it can be seen that a substantially greater range of LVEFs is normally measurable on
a per-patient basis in AF, although there is little difference in the maximum range and
the median LVEFs are comparable in the two patient groups.
Given the substantial range of measurements of LVEF that can occur for each patient,
is there a relationship between the beat selection criteria and LVEF?
1See note on terminology §5.3.1
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Figure 5.5.: SR, mLVEF: Showing (a) the histogram of mLVEF obtained for all patients in SR
and (b) a plot of the mLVEF against the number of contributing beat selection
preceding:indexed pairings for patients in SR using variable time mode (N=387).
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Figure 5.6.: AF, mLVEF: Showing (a) the histogram of mLVEF obtained for all patients in
AF and (b) a plot of mLVEF against the number of contributing beat selection
preceding:indexed pairings for patients in AF using variable time mode (N=373).
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Rhythm No. Pats Minimum 1st Quartile Median 3rd Quartile Maximum Mean SD
SR 387 0.00 5.3 7.8 10.5 42.8 8.2 5.1
AF 373 0.00 10.2 14.0 17.8 46.1 14.3 6.6
Table 5.6.: mLVEF: Summary statistics for mLVEFs (in EF units) showing the distribution of
mLVEF (the difference between maximum and minimum LVEF for each patient)
in SR and AF (variable time formatting).
Indexed beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 38.2± 14.6 38.2± 14.7 40.0± 13.1 40.2± 13.3 40.1± 13.7 40.4± 13.9
Best 38.2± 14.6 38.2± 14.7 40.0± 13.2 40.3± 13.3 40.2± 13.6 40.4± 13.8
Q1 40.3± 13.0 40.3± 13.1 45.3± 12.4 45.2± 12.4 45.6± 11.6 46.0± 12.1
Q2 40.2± 13.4 40.1± 13.5 45.6± 12.5 44.4± 12.8 44.7± 12.1 45.6± 12.4
Q3 39.9± 13.7 39.8± 13.7 44.5± 12.5 44.4± 12.8 44.4± 12.6 45.1± 12.4
Q4 40.3± 13.7 40.4± 13.6 45.0± 12.5 44.4± 12.3 45.1± 12.3 45.6± 12.6
Table 5.7.: SR, LVEF: Mean ± SD LVEF in SR with variable time formatting for different
beat selection criteria. (Note: The box-plots show the median not the mean).
The number of patients contributing to each measure is given in table 5.3
LVEF results are summarised, for SR, in Figure 5.7 and Table 5.7 and for AF in Fig-
ure 5.8 and Table 5.8 (it should be noted that the table reports mean and SD while the
box-plots show the median value). A detailed explanation of the form of the figures can
be found in §5.3.
Indexed beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 28.2± 11.2 32.7± 11.9 34.8± 11.0 33.9± 11.6 33.7± 11.6 32.1± 11.5
Best 28.7± 10.5 34.3± 11.0 37.6± 10.1 36.5± 10.5 35.5± 10.9 34.0± 10.5
Q1 28.2± 9.7 35.3± 10.0 40.1± 10.3 38.1± 9.9 37.8± 9.3 36.2± 9.7
Q2 29.6± 10.3 36.3± 10.8 40.9± 10.2 39.4± 10.5 38.7± 10.5 36.9± 10.5
Q3 31.1± 10.6 37.5± 11.3 42.0± 10.3 40.1± 10.9 39.5± 11.4 37.5± 10.9
Q4 33.4± 11.1 39.5± 12.0 43.7± 11.5 42.0± 11.5 41.1± 11.5 39.3± 11.4
Table 5.8.: AF, LVEF: Mean± SD LVEF in AF with variable time formatting for different
beat selection criteria. The number of patients contributing to each measure is
given in table 5.3
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Figure 5.7.: SR, LVEF: Box-plots showing median and inter-quartile ranges for LVEF mea-
sured in variable time mode for patients in SR using variable time formatting.
The two plots show the same data grouped either by (a) preceding beat selection
criteria or (b) indexed beat selection criteria (N=387).
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Figure 5.8.: AF, LVEF: Box-plots showing median and inter-quartile ranges for LVEF mea-
sured in variable time mode for patients in AF rhythm using variable time
formatting. The two plots show the same data grouped either by (a) preceding
beat selection criteria or (b) indexed beat selection criteria (N=373).
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In both SR and AF, the LVEF is higher where beat selection has involved quartiles in
either the preceding or the indexed beat. While there does not appear to be any signifi-
cant systematic variation with R-R interval in SR, it is clear from the two presentations
of the data that in AF there is a positive correlation with increasing preceding beat
length (quartile) and a negative one with increasing indexed beat length.
Regression analysis was performed as discussed in §4.6.1. Results for the regression
performed on a patient-by-patient basis are shown in Table 5.9 and summarised by
quartile in Figure 5.9 for the multiple regression comparing both preceding and indexed
beat.
The high number of positive correlations on a patient-by-patient basis with preceding
beat variation (299 when all indexed beats are taken) in AF suggest a very strong rela-
tionship with preceding beat criteria. There are substantially fewer negative correlations
with indexed beat (98 when all preceding beats are taken) suggesting that the correlation
with indexed beat in AF is much weaker.
The relationship is much weaker in SR: fewer than half of the patients exhibited a
significant dependence on beat selection criteria. In those that did, there was a balance
between the effects of preceding and indexed beat leading to both positive and negative
correlation coefficients. Where there was a relationship it was generally good, but weaker
than the similar relationship in AF.
To try to quantify this further regression analysis was performed on a global basis; the
results of this are shown in Table 5.10. In SR there is no significant linear variation of
LVEF with R-R interval duration (either preceding or indexed), while in AF there is
a highly significant relationship with both indexed and preceding beat criteria. These
results support the patient-by-patient findings presented in Table 5.9.
Considering all patients together, analysis of variance found that the use of quartiles,
particularly the interaction term between indexed and preceding beat length, contributed
significantly to measured LVEF in both SR and AF with all the quartile results grouped
together. However, particularly in SR, there was little difference between the results
obtained with “Best” beats and those obtained with all beats, either preceding or indexed
(see Table 5.11).
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Preceding Indexed Mean ± SD (+ve) N (+ve) Mean ± SD (-ve) N (-ve) NC
All (Constant) Q1 - Q4 0.78± 0.14 130 0.76± 0.13 40 4
Best (Constant) Q1 - Q4 0.79± 0.15 129 0.76± 0.13 41 4
Q1 - Q4 All (Constant) 0.77± 0.15 107 0.78± 0.16 55 7
Q1 - Q4 Best (Constant) 0.75± 0.15 107 0.76± 0.16 63 6
Q1 - Q4 Q1 - Q4 0.60± 0.14 45 (p), 49(i) 29 (p), 25(i) 38
(a) SR
Preceding Indexed Mean ± SD (+ve) N (+ve) Mean ± SD (-ve) N (-ve) NC
All (Constant) Q1 - Q4 0.77± 0.16 20 0.77± 0.13 98 7
Best (Constant) Q1 - Q4 0.75± 0.17 15 0.78± 0.16 88 26
Q1 - Q4 All (Constant) 0.89± 0.12 299 0.66± 0.22 2 13
Q1 - Q4 Best (Constant) 0.86± 0.12 192 – 0 34
Q1 - Q4 Q1 - Q4 0.74± 0.15 158 (p), 26(i) 0 (p), 133(i) 55
(b) AF
Table 5.9.: LVEF: showing the regression results by quartile on a patient-by-patient basis
for LVEF in (a) SR, and (b) AF. The form of these tables is described in §5.3.4.
Total numbers of patients: 371 in SR (308 for multiple regression), 357 in AF
(303 for multiple regression).
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Figure 5.9.: LVEF regression: histogram showing the number of patients in each band (0.02
wide) of r2 coefficients for the multiple regression comparing both indexed and
preceding beat criteria. Only results which have significance at p < 0.05 level
have been shown.
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SR AF
Preceding Indexed r2 p r2 p
All (Constant) Q1 - Q4 7.7× 10−5 0.73 6.6× 10−3 0.003
Best (Constant) Q1 - Q4 6.3× 10−5 0.76 1.5× 10−2 < 1× 10−5
Q1 - Q4 All (Constant) 9.6× 10−6 0.91 3.2× 10−2 < 1× 10−5
Q1 - Q4 Best (Constant) 1.7× 10−6 0.96 1.8× 10−2 1× 10−5
Q1 - Q4 Q1 - Q4 5.6× 10−4 0.59 3.1× 10−2 < 1× 10−5
Table 5.10.: Regression results showing significance of preceding and indexed beat selection
on LVEF (variable time formatting).
SR, p AF, p
p:All c:All vs. p:Best c:All 9.6× 10−1 5.8× 10−1
p:All c:All vs. p:Quartiles c:All 9.0× 10−3 1.0× 10−4
p:All c:All vs. p:All c:Best 9.8× 10−1 < 1× 10−5
p:All c:All vs. p:All c:Quartiles 9.0× 10−3 < 1× 10−5
p:All c:All vs. p:Best c:Best 9.6× 10−1 3.6× 10−1
p:All c:All vs. p:Quartiles c:Best 9.8× 10−1 1.9× 10−2
p:All c:All vs. p:Best c:Quartiles 9.7× 10−1 6.0× 10−2
p:All c:All vs. p:Quartiles c:Quartiles 9.9× 10−4 < 1× 10−5
Table 5.11.: LVEF: p values from analysis of variance comparing LVEF with preceding and
indexed beat selection criteria grouping all quartile results together for all pa-
tients using variable time formatting.
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Indexed beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 6 5 32 15 15 8
Best 7 7 36 12 15 7
Q1 20 15 20 12 8 10
Q2 16 16 11 6 4 9
Q3 14 16 7 11 8 5
Q4 6 6 11 6 10 9
(a) Minima
Indexed beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 3 4 8 4 6 9
Best 4 4 11 5 4 7
Q1 0 1 17 18 11 29
Q2 4 5 15 8 15 28
Q3 6 8 11 12 25 13
Q4 12 12 15 14 30 38
(b) Maxima
Table 5.12.: SR, LVEF: Showing the number of patients for whom the given combinations of
preceding and indexed beat selection gave rise to the minimum (a) and maximum
(b) measured LVEF in SR.
Indexed beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 20 0 0 1 0 3
Best 30 1 0 0 1 0
Q1 186 3 3 0 2 6
Q2 15 0 1 0 0 0
Q3 1 1 0 0 0 0
Q4 0 0 0 1 0 0
(a) Minima
Indexed beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 4 2 3 1 3 0
Best 0 2 2 2 2 2
Q1 0 0 2 0 2 0
Q2 0 3 1 2 1 3
Q3 0 4 10 7 9 3
Q4 11 36 52 73 77 30
(b) Maxima
Table 5.13.: AF, LVEF: Showing the number of patients for whom the given combinations of
preceding and indexed beat selection gave rise to the minimum (a) and maximum
(b) measured LVEF in AF.
In considering the source of the difference in measured LVEF the beat selection combi-
nations that contribute to the minima and maxima are shown in Tables 5.12 (SR) and
5.13 (AF).
Although it is not obvious in SR, when the tables are compared (see §4.6.3) they are
found to be significantly different (p = 0.039). In AF the tables are self evidently
different and there are too many singularities for a statistical comparison.
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Subgroup No. Pats Minimum 1st Quartile Median 3rd Quartile Maximum Mean SD
“Pure” 176 4.4 30.5 40.8 48.4 82.3 39.5 15.0
“Not pure” 211 4.3 27.6 39.0 46.0 74.6 37.1 14.3
MI 105 4.4 18.9 28.8 42.6 77.5 31.2 16.0
Not MI 278 4.4 35.1 41.5 48.4 82.2 40.9 13.18
HBP 164 7.0 34.8 40.8 49.2 82.3 41.3 13.7
Not HBP 219 4.3 25.0 38.5 46.0 77.5 36.0 14.9
PCI &/ CABG 83 8.6 23.1 38.0 46.4 77.2 36.5 16.1
Neither PCI nor CABG 300 4.3 30.0 40.1 47.6 82.3 38.8 14.2
Normal coronary perfusion 67 29.9 40.1 45.4 53.3 82.2 47.7 10.5
Ischaemic 320 4.3 25.2 38.4 45.9 77.5 36.2 14.6
Negative ETT 107 27.8 39.2 44.2 50.5 79.8 45.4 9.6
Positive ETT 7 24.9 36.4 42.4 49.2 53.8 41.7 10.1
Normal 188 38.4 43.8 47.2 53.9 82.3 49.8 8.3
Moderate & Mildly impaired 146 20.6 26.9 33.1 37.2 40.1 32.1 5.9
Very poor & poor 51 4.3 9.1 13.0 16.8 19.7 12.9 4.5
Table 5.14.: SR subgroups, LVEF: Summary statistics for LVEFs for subgroups for patients
in SR using variable time formatting.
5.4.2. Comparing LVEF with mLVEF
Since a poorly functioning ventricle should not be able to produce beats with good EFs
while a well functioning ventricle may produce beats with poor EFs, it is to be expected
that mLVEF for each patient will be closely associated with LVEF. The comparison is
shown in Figure 5.10 where it can be seen that patients with poorer LVEF also generally
show a lower mLVEF in both SR and AF. A Spearman rank correlation finds there to be
good correlation between LVEF and mLVEF with r = 0.66 in SR and r = 0.62 in AF.
5.4.3. Subgroups
Several different subgroups were investigated in both SR and AF as detailed in §4.4 and,
while a full analysis was performed for each of the subgroups, the majority of the results
followed similar patterns as for AF and SR as a whole. The LVEF summary statistics
for each of the subgroups are given in Tables 5.14 (SR) and 5.16 (AF) while summary
statistics for mLVEF are given in Tables 5.15 (SR) and 5.17. A summary of the results
for each subgroup in both SR and AF aggregated by beat selection criteria can be found
in appendix C (§C.2).
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Figure 5.10.: Comparing mean LVEF with mLVEF using variable time formatting. Mean
LVEF is calculated as the mean of all measured LVEFs after filtering using the
whole list-mode file.
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Subgroup No. Pats Minimum 1st Quartile Median 3rd Quartile Maximum Mean SD
“Pure” 176 0.0 5.2 8.3 10.5 40.5 8.4 5.2
“Not pure” 211 0.0 5.0 7.4 10.5 42.8 8.0 5.1
MI 105 0.0 3.2 6.4 9.7 40.5 7.2 5.6
Not MI 278 0.0 5.8 8.4 10.8 42.8 8.6 4.9
HBP 164 0.0 6.10 8.57 10.88 42.78 9.01 5.3
Not HBP 219 0.0 4.78 7.07 10.18 40.47 7.67 4.93
PCI &/or CABG 83 0.0 5.5 7.7 9.8 22.7 7.8 4.3
Neither PCI nor CABG 300 0.0 5.2 8.0 10.7 42.8 8.4 5.3
Normal coronary perfusion 67 3.7 8.00 10.0 12.6 32.8 11.0 6.0
Ischaemic 320 0.0 4.8 7.2 9.8 40.5 7.6 4.7
Negative ETT 107 3.7 7.4 9.3 12.0 42.8 10.3 5.0
Positive ETT 7 6.1 8.5 9.6 9.6 10.6 8.9 1.5
Normal 188 1.3 7.9 9.7 12.2 28.2 10.1 3.8
Moderate & mildly impaired 146 1.6 5.2 6.5 8.7 42.8 7.7 5.6
Poor & very poor 51 0.0 1.0 1.9 3.6 20.0 2.9 3.5
Table 5.15.: SR subgroups, mLVEF: Summary statistics for mLVEF for each of the separate
subgroups for patients in SR.
o
Subgroup No. Pats Minimum 1st Quartile Median 3rd Quartile Maximum Mean SD
“Pure” 185 5.7 20.6 29.0 37.8 63.4 29.5 11.4
“Not pure” 187 5.8 19.1 26.0 34.8 64.8 27.0 10.8
MI 113 5.7 17.4 26.0 34.2 64.8 26.4 10.8
No MI 259 5.8 20.3 28.9 36.8 63.4 29.1 11.3
HBP 187 5.9 21.4 29.5 37.0 64.8 29.8 11.7
No HBP 185 5.7 18.2 26.6 35.3 49.5 26.8 10.4
PCI &/or CABG 67 9.4 19.2 27.2 34.7 63.4 28.1 11.4
Neither PCI nor CABG 306 5.7 20.1 27.9 36.6 64.8 28.3 11.1
NCP 34 17.1 31.2 36.6 41.9 55.8 37.0 9.1
No NCP 339 5.7 19.2 26.6 35.3 64.8 27.4 11.0
Negative ETT 50 8.6 20.7 27.9 37.1 64.8 29.0 11.6
Positive ETT 30 10.7 20.6 27.5 35.5 58.2 28.8 11.4
Very poor & poor 57 5.7 10.9 13.0 16.0 20.0 13.4 3.5
Moderate & Mildly impaired 206 12.6 22.2 26.5 30.9 38.1 26.7 5.7
Normal 97 27.4 38.1 40.1 45.4 64.8 42.1 6.5
Table 5.16.: AF subgroups, LVEF: Summary statistics for measured LVEFs in AF, assessed
by subgroup with variable time formatting.
Opposing groups (e.g. patients with and without previous known MI), each one of which
will be discussed separately in the following sections, were compared using a Wilcoxon
signed ranks test to determine whether there was any significant difference in LVEF,
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Subgroup No. Pats Minimum 1st Quartile Median 3rd Quartile Maximum Mean SD
“Pure” 185 0.0 10.6 14.2 18.4 41.9 15.0 6.7
“Not pure” 187 0.0 9.7 13.5 17.2 46.1 13.7 6.4
MI 113 0.00 9.1 12.5 18.8 41.9 13.6 6.7
Without MI 259 0.0 10.7 14.4 17.7 46.1 14.7 6.5
HBP 187 0.0 10.9 14.9 18.2 40.1 14.8 6.7
Without HBP 185 0.0 9.9 13.3 17.1 46.1 13.9 6.5
CABG &/or PCI 67 1.8 10.1 12.7 16.6 33.0 13.5 5.5
Without CABG & PCI 306 0.0 10.3 14.2 18.0 46.1 14.5 6.8
Normal Perfusion 34 8.5 14.1 16.6 18.8 30.7 16.8 4.5
Ischaemic 339 0.0 9.8 13.4 17.4 46.1 14.1 6.7
Negative ETT 50 1.6 10.4 14.6 16.9 32.3 14.1 5.5
Positive ETT 30 3.8 12.3 15.9 19.3 41.9 16.6 7.4
Very poor & poor 57 0.7 4.8 7.6 11.2 23.6 8.2 4.5
Moderate & Mildly impaired 206 4.2 10.7 13.3 16.4 46.1 14.2 5.7
Normal 97 6.8 15.6 18.0 22.1 34.6 18.7 5.6
Table 5.17.: AF subgroups, mLVEF: Summary statistics for mLVEF in AF, subgroups with
variable time formatting.
SR AF
“Pure” vs. “Not pure” p = 8.2× 10−2 p = 3.4× 10−2
MI vs. No MI p < 1× 10−5 p = 4.5× 10−2
HBP vs No HBP p = 0.0012 p = 2.7× 10−2
PCI or CABG vs. No intervention p = 1.2× 10−1 p = 6.9× 10−1
Normal coronary perfusion vs. Ischaemic p < 1× 10−5 p < 1× 10−5
Positive ETT vs Negative ETT p = 5.4× 10−1 p = 9.1× 10−1
Table 5.18.: LVEF, subgroups: Wilcoxon signed ranks tests comparing LVEF measured using
all beats in opposing groups except in the case of the functional groups where a
Wilcoxon is not appropriate because there are more than two functional groups
and an Anova is used instead.
when all beats were taken, and in mLVEF. The results of this analysis are shown for
both AF and SR in Tables 5.18 and 5.19. Regression results on a patient-by-patient
basis in each group were also compared yielding the results shown in Tables 5.20 (SR)
and 5.21 (AF).
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SR AF
“Pure” vs. “Not pure” p = 3.1× 10−1 p = 1.1× 10−1
MI vs No MI p = 7.9× 10−4 p = 9.2× 10−2
HBP vs No HBP p = 4.0× 10−3 p = 1.0× 10−1
PCI or CABG vs. No intervention p = 5.4× 10−1 p = 2.4× 10−1
Normal coronary perfusion vs. Ischaemic p < 1× 10−5 p = 2.0× 10−3
Positive ETT vs Negative ETT p = 5.4× 10−1 p = 1.6× 10−1
Anova comparing functional groups p < 1× 10−5 p < 1× 10−5
Table 5.19.: mLVEF, subgroups: Wilcoxon signed ranks tests comparing LVEF ranges in
opposing groups except in the case of the functional groups where a Wilcoxon
is not appropriate because there are more than two functional groups and an
Anova is used instead.
Wilcoxon comparisons used the LVEF obtained when all beats were taken (without the
inclusion of beat selection criteria) to provide a common comparison value. It should
be noted that when the Wilcoxon test was performed with every possible measured
LVEF using each pair of beat selection criteria in all cases there was a highly significant
difference with p < 1 × 10−5. This reflects the substantial variation obtained in LVEF
for any one patient and the very large number of values being compared, and as a result
offers little insight into the variation between opposing subgroups.
“Pure” ECG
Patients with an ECG with no ectopic beats and a Poincare´ plot that could not be
considered to have any obvious outliers were considered to have a “pure” ECG.
When a Wilcoxon rank-sum (Mann-Whitney) test was used to compare LVEF (deter-
mined using all beats) in the “pure” and “not pure” groups no difference was found
between the groups in SR. In AF, however, the two groups were found to be signifi-
cantly different with “pure” rhythms showing a higher LVEF than “not pure” rhythms
(Table 5.18). When a similar test was used to compare mLVEF, no difference was found
between those patients with and without a “pure” ECG in either SR or AF.
Regression and Anova results are shown for the “pure” and not “pure” groups in SR
and AF in Tables 5.22 (regression) and 5.23 (Anova). Although regression analysis
in the “pure” and “not pure” subgroups found a similar pattern to that of the whole
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p:All c:Q p:Best c:Q p:Q c:All p:Q c:Best p:Q c:Q
“Pure” ECG 0.80 0.80 0.75 0.74 0.57
N = 78 (2) N = 79 (2) N = 77 (3) N = 79 (2) N = 34 (17)
“Not pure” ECG 0.78 0.79 0.80 0.78 0.62
N = 95 (2) N = 95 (2) N = 88 (4) N = 96 (4) N = 40 (21)
Wilcox comparison p = 0.42 p = 0.76 p = 0.09 p = 0.08 p = 0.13
MI 0.76 0.77 0.77 0.78 0.57
N = 49 (0) N = 52 (0) N = 43 (1) N = 43 (1) N = 18 (10)
No MI 0.80 0.80 0.77 0.75 0.60
N = 124 (3) N = 122 (3) N = 119 (6) N = 129 (5) N = 52 (28)
Wilcox comparison p = 0.12 p = 0.14 p = 0.92 p = 0.28 p = 0.48
HBP 0.78 0.77 0.76 0.74 0.61
N = 74 (0) N = 76 (0) N = 62 (2) N = 68 (1) N = 23 (22)
No HBP 0.79 0.80 0.78 0.77 0.58
N = 99 (3) N = 98 (3) N = 100 (5) N = 104 (5) N = 47 (16)
Wilcox comparison p = 0.55 p = 0.17 p = 0.35 p = 0.20 p = 0.40
PCI or CABG 0.79 0.78 0.75 0.77 0.58
N = 37 (0) N = 37 (0) N = 37 (2) N = 39 (1) N = 17 (11)
No intervention 0.78 0.80 0.78 0.75 0.60
N = 136 (3) N = 137 (3) N = 125 (5) N = 133 (5) N = 53 (27)
Wilcox comparison p = 0.66 p = 0.66 p = 0.44 p = 0.48 p = 0.61
Normal MPI 0.77 0.75 0.76 0.72 0.63
N = 27 (0) N = 26 (0) N = 29 (0) N = 33 (0) N = 11 (5)
Ischaemic 0.79 0.80 0.78 0.77 0.59
N = 146 (4) N = 148 (4) N = 136 (7) N = 142 (6) N = 63 (33)
Wilcox comparison p = 0.59 p = 0.11 p = 0.42 p = 0.10 p = 0.48
Positive ETT 0.87 0.84 0.91 0.91 0.59
N = 3 (0) N = 3 (0) N = 3 (0) N = 3 (0) N = 1 (2)
Negative ETT 0.78 0.78 0.77 0.74 0.64
N = 43 (0) N = 43 (0) N = 41 (0) N = 45 (0) N = 14 (10)
Wilcox comparison p = 0.42 p = 0.52 p = 0.08 p = 0.02 p = 0.67
Table 5.20.: SR subgroups, LVEF: Showing the mean R2 value for patient-by-patient re-
gression in each subgroup in SR and the results of a Wilcoxon rank sum test
comparing the matched groups. The number in brackets gives the number of
incalculable results (any others were not significant). In this table “Q” indicates
the beat selection criteria (preceding or indexed) against which regression was
performed. Total numbers for each group can be found in Table 5.14.
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p:All c:Q p:Best c:Q p:Q c:All p:Q c:Best p:Q c:Q
“Pure” ECG 0.78 0.86 0.90 0.89 0.76
N = 64 (2) N = 65 (10) N = 159(6) N = 116 (21) N=81 (26)
“Not pure” ECG 0.79 0.79 0.89 0.87 0.72
N = 64 (2) N = 64 (16) N = 165 (7) N = 116 (13) N=78 (29)
Wilcox comparison p = 0.44 p = 0.02 p = 0.74 p = 0.33 p = 0.10
MI 0.77 0.85 0.89 0.89 0.72
N = 39 (4) N = 43 (8) N = 100 (4) N = 70 (11) N = 54 (19)
No MI 0.79 0.80 0.90 0.88 0.76
N = 90 (3) N = 86 (18) N = 224 (9) N = 162 (23) N = 106 (36)
Wilcox comparison p = 0.54 p = 0.22 p = 0.55 p = 0.86 p = 0.13
HBP 0.76 0.83 0.89 0.89 0.76
N = 66 (3) N = 62 (15) N = 160 (6) N = 118 (15) N = 79 (27)
No HBP 0.81 0.81 0.90 0.88 0.72
n = 63 (4) N = 67 (11) N = 164 (7) N = 114 (19) N = 81 (28)
Wilcox comparison p = 0.06 p = 0.70 p = 0.64 p = 0.69 p = 0.12
PCI or CABG 0.78 0.80 0.90 0.88 0.72
N = 21 (1) N = 28 (4) n = 64 (2) N = 49 (7) N = 36 (8)
No intervention 0.79 0.83 0.89 0.88 0.75
N = 108 (6) N = 102 (22) N = 261 (11) N = 184 (27) N = 123 (47)
Wilcox comparison p = 0.92 p = 0.42 p = 0.71 p = 0.40 p = 0.13
Normal MPI 0.69 0.84 0.87 0.86 0.73
N = 13 (0) N = 7 (3) N = 31 (0) N = 21 (2) N = 15 (6)
Ischaemic 0.80 0.82 0.90 0.89 0.75
N = 116 (7) N = 123 (23) N = 294 (13) N = 212 (32) N = 144 (49)
Wilcox comparison p = 0.01 p = 0.80 p = 0.47 p = 0.38 p = 0.65
Positive ETT 0.77 0.86 0.92 0.89 0.74
N = 11 (1) N = 15 (2) N = 24 (1) N = 20 (3) N = 15 (5)
Negative ETT 0.81 0.87 0.90 0.89 0.76
N = 23 (3) N = 14 (6) N = 43 (4) N = 28 (5) N = 17 (7)
Wilcox comparison p = 0.36 p = 0.98 p = 0.61 p = 0.69 p = 0.82
Table 5.21.: AF subgroups, LVEF: Showing the mean R2 value for patient-by-patient re-
gression in each subgroup in AF and the results of a Wilcoxon rank sum test
comparing the matched groups. The number in brackets gives the number of
incalculable results (any others were not significant). In this table “Q” indicates
the beat selection criteria (preceding or indexed) against which regression was
performed. Total numbers for each group can be found in Table 5.16.
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SR AF
Preceding Indexed “Pure” r2 “Pure” p “Not pure” r2 “Not pure” p “Pure” r2 “Pure” p “Not pure” r2 “Not pure” p
All (Constant) Q1 - Q4 3.9× 10−5 0.87 1.2× 10−4 0.76 5.3× 10−3 5.5× 10−2 8.4× 10−3 1.8× 10−1
Best (Constant) Q1 - Q4 2.6× 10−5 0.90 1.0× 10−4 0.77 1.5× 10−2 4.0× 10−3 1.5× 10−2 5.0× 10−3
Q1 - Q4 All (Constant) 1.8× 10−5 0.92 9.2× 10−5 0.79 3.4× 10−2 < 1× 10−5 3.2× 10−2 < 1× 10−5
Q1 - Q4 Best (Constant) 8.1× 10−5 0.82 3.9× 10−5 0.77 2.0× 10−4 1.0× 10−3 1.6× 10−2 2.0× 10−3
Q1 - Q4 Q1 - Q4 1.7× 10−4 0.96 1.0× 10−4 0.54 3.2× 10−2 < 1× 10−5 3.1× 10−2 < 1× 10−5
Table 5.22.: p values from regression tests for patients in SR and AF with “pure” and “not
pure” ECGs using variable time formatting.
SR AF
“Pure” p “Not pure” p “Pure” p “Not pure” p
p:All c:All vs. p:Best c:All 0.943 0.996 0.900 0.372
p:All c:All vs. p:Quartiles c:All 0.088 0.045 0.009 0.004
p:All c:All vs. p:All c:Best 0.985 0.990 0.0003 < 1× 10−5
p:All c:All vs. p:All c:Quartiles 0.077 0.049 < 1× 10−5 < 1× 10−5
p:All c:All vs. p:Best c:Best 0.946 0.993 0.324 0.720
p:All c:All vs. p:Quartiles c:Best 0.939 0.972 0.043 0.184
p:All c:All vs. p:Best c:Quartiles 0.947 0.986 0.073 0.371
p:All c:All vs. p:Quartiles c:Quartiles 0.069 0.005 0.0002 0.002
Table 5.23.: LVEF, pure subgroup: Analysis of variance results comparing LVEF with pre-
ceding and indexed beat selection criteria, grouping all quartile results together,
for patients in SR and AF with a “pure” ECG using variable time formatting.
(Significant values are highlighted).
groups, there are two notable differences: the “pure” group in SR exhibited no significant
difference with beat selection criteria in either the regression analysis or the Anova; and
in the “not pure” group in AF there was found to be no significant difference between
the base measure (with all beats included) and that taken with p:Quartiles c:Best.
Myocardial infarction (MI)
Patients in the MI group had reported a known previous MI as part of the routine pre-
exam assessment based on the referral letter and information supplied by the patient.
Aggregated LVEF results are summarised for the groups with and without known pre-
vious MI using all beats in Tables 5.14 for SR and 5.16 for AF. A Wilcoxon rank-sum
test (see Table 5.18) shows there to be a highly significant difference between LVEFs
Results: Describing Function 177
LVEF range
co
u
n
t
0
5
10
15
20
25
30
0 10 20 30 40
Previous MI
No
Yes
Figure 5.11.: SR, MI subgroup, mLVEF: Histogram showing variation of mLVEF with beat
selection techniques for patients with and without known previous MI in SR
(variable time formatting). (N=387).
measured using all beats between the MI (mean: 31.2) and non-MI (mean: 40.4) groups
in SR which is matched by a less significant difference in AF (mean 26.4 in MI group,
29.1 in the non-MI group).
Despite the apparently similarity of the ranges shown in Table 5.15 a Wilcoxon rank-sum
(Mann-Whitney) test against the ranges of LVEF comparing patients with and without
known previous MI finds the two groups to be significantly different in SR but not in
AF (see Table 5.19). This is demonstrated graphically in Figure 5.11.
Regression analysis found no significant linear relationships between LVEF and beat
selection techniques for patients in SR with or without known previous MI. In AF there
was a significant relationship in all comparisons in the group without known MI, although
in the group with MI there was no significant linear relationship with indexed beat,
although there was with preceding beat where LVEF increases with preceding beat
duration.
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Figure 5.12.: SR, HBP subgroup, mLVEF: Histogram showing variation of measured range
of LVEF with beat selection techniques for patients with and without known
hypertension in SR (N=387).
The Anova comparison found a similar pattern of dependence in both groups in AF and
in the SR group without MI. The SR group with MI showed a significant difference only
when both quartiles in both indexed and preceding beats were selected.
Hypertensive
Patients with hypertension, HBP, declared that they had high blood pressure as part
of the routine pre-exam assessment. Patients would have been on therapy to treat high
blood pressure. Thus, in some cases, the patient currently did not exhibit hypertension.
As in the case of the patients with MI there is a significant difference in LVEF in both
SR and AF between those patients who had HBP and those who did not (Tables 5.14,
5.16 and 5.18); patients with HBP having generally higher LVEF than those without.
In SR, patients with HBP had a significantly greater mLVEF than did those without
HBP (demonstrated graphically for SR in Figure 5.12). This difference was not seen in
AF (Tables 5.15, 5.17 and 5.19).
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Regression analysis found no significant dependence on beat selection criteria in SR with
a highly significant but extremely weak significance in AF except where all preceding
beats were taken (p = 0.065). The analysis of variance found significance in the HBP
group in SR only where beat selection involved quartiles in both indexed and preceding
beats. In the group without HBP as well as both groups in AF the Anova showed no
difference from that of the AF and SR group as a whole.
CABG and / or PCI
Patients were included in this group if they declared on the routine pre-exam question-
naire that they had a previous PCI or CABG, or if the request form specified this.
In neither the SR nor AF groups was a significant difference seen in either LVEF or
range of LVEFs (see Tables 5.14, 5.16, 5.18, 5.15, 5.17 and 5.19). Regression testing
revealed no substantive difference in the group who had had neither PCI nor CABG from
the AF and SR groups as a whole (no relationship in SR, in AF a highly significant, very
weak, dependence). Similarly the Anova showed a relationship following the same form
as for the whole group. A significant difference was revealed in SR if both indexed and
preceding beat selection criteria involved quartiles, otherwise there was no dependence
in SR with AF following the same pattern as the group as a whole.
Ischaemic
Patients were considered not to be ischaemic if they had an associated myocardial per-
fusion scan in which the report used the phrase “No significant perfusion abnormality
detected”, a standard reporting phrase used in the department for patients who did not
exhibit signs of ischaemia.
A Wilcoxon rank sum test found both LVEF and mLVEF to be significantly different
when comparing those patients in the ischaemic and non-ischaemic groups both in SR
and AF (Tables 5.14, 5.16, 5.18, 5.15, 5.17 and 5.19); patients without ischaemia
having a generally higher LVEF and greater mLVEF. Regression and analysis of variance
results followed the same pattern as the group as a whole in both AF and SR.
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Positive vs. Negative ETT
Patients who had a clearly positive or negative ETT as part of their attendance for MPI
and RNVG in the department were compared. Thus, for example, a patient who failed
to reach target heart rate during exercise would not be included as their ETT would
have been inconclusive. Unfortunately this left only seven patients in SR with a positive
ETT compared with 107 in the group of patients in SR with a negative ETT. The small
numbers in the positive ETT group (N=7) mean that statistical comparison is likely to
be flawed and results are unlikely to be significant.
The number of patients in the two groups in AF are more statistically valid with 50
patients having negative ETTs and 30 having positive ETTs.
No difference was found in either SR or AF between LVEF (Tables 5.14, 5.16, 5.18) or
mLVEF (Tables 5.15, 5.17 and 5.19).
In SR, regression testing showed that there was no significant dependence of LVEF on
preceding or indexed beat selection criteria in either the positive ETT or negative ETT
group. This follows the same pattern as for the SR group as a whole. However in AF,
unlike in the whole AF group, there was also no significant dependence found except
very weakly in patients with positive ETT with indexed beat (see Table 5.24). This may
simply be due to the smaller numbers involved as a plot of the results shows similar
trends (see figure 5.13). The analysis of variance also showed little significant variation,
particularly with preceding quartile.
Analysis of variance, in SR, found significant differences only between p:All c:All and
p:Quartiles c:All in the positive ETT group and between p:All c:All and p:Quartiles c:Quartiles
in the negative ETT group. In AF Anova results for patients with both positive and
negative ETT were broadly similar to those of the whole AF group.
LV Systolic Function
It is standard practise in the department to label LVEF according to the criteria shown
in Table 5.25. These labels provide a quick clinical summary of cardiac function.
Results: Describing Function 181
Preceding Indexed Negative ETT p Positive ETT p
All (Constant) Q1 - Q4 0.157 0.044
Best (Constant) Q1 - Q4 0.153 0.072
Q1 - Q4 All (Constant) 0.057 0.072
Q1 - Q4 Best (Constant) 0.199 0.461
Q1 - Q4 Q1 - Q4 0.062 0.424
(a) Regression
Negative ETT p Positive ETT p
p:All c:All vs. p:Best c:All 0.630 0.841
p:All c:All vs. p:Quartiles c:All 0.113 0.164
p:All c:All vs. p:All c:Best 0.062 0.047
p:All c:All vs. p:All c:Quartiles 0.001 0.005
p:All c:All vs. p:Best c:Best 0.741 0.683
p:All c:All vs. p:Quartiles c:Best 0.253 0.473
p:All c:All vs. p:Best c:Quartiles 0.287 0.337
p:All c:All vs. p:Quartiles c:Quartiles 0.019 0.056
(b) Analysis of variance
Table 5.24.: AF, ETT subgroup, LVEF: (a) Regression and (b) Anova results showing signif-
icance of preceding and indexed beat selection on LVEF in patients in AF with
normal coronary perfusion or ischaemia using variable time formatting.
EF Label
LV EF < 10% Very Poor
10% ≤ LV EF < 20% Poor
20% ≤ LV EF < 30% Moderate
30% ≤ LV EF < 40% Mildly impaired
40% ≤ LV EF Normal
Table 5.25.: LVEF functional categories.
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Function SR Number AF Number
Very poor 16 6
Poor 35 53
Moderate 54 100
Mildly impaired 92 108
Normal 188 98
Table 5.26.: Number of SR patients in functional groups.
The patients in this study were found, during routine reporting, to fall into these func-
tional categories as shown in Table 5.26. In order to ensure adequate numbers for
statistical analysis the reduced function groups were grouped in pairs: Very poor &
poor, moderate & mildly impaired.
By definition the groups will have significantly different LVEF and no testing was carried
out to determine whether there were significant differences between LVEFs. However
when analysis of variance was used to compare mLVEF these were found to be signifi-
cantly different in both AF and SR (see Tables 5.15, 5.17 and 5.19). This is in keeping
with the results of the direct comparison between LVEF and mLVEF (§5.4.2).
Regression analysis on each of the functional groups found no significant correlation
with either preceding or indexed beat criteria in SR. The analysis of variance found a
difference only in the mild & moderate group when quartiles were used in both indexed
and preceding beats and in the poor & very poor group only when quartiles were used
in either indexed or preceding beat criteria (but not both).
The results for the regression and Anova analyses in AF are shown in Table 5.27 and
show results which are also broadly in line with those for the whole group, although the
small numbers in the poor & very poor group affect the significance of results.
5.4.4. Comparing variable time with fixed time formatting
In comparing LVEF in variable and fixed time formatting in SR there are four questions
to be investigated:
Results: Describing Function 184
Preceding Indexed Normal p Mildly impaired & Moderate p Poor & Very poor
All (Constant) Q1 - Q4 0.112 0.005 0.099
Best (Constant) Q1 - Q4 0.039 0.00002 0.227
Q1 - Q4 All (Constant) < 1× 10−5 < 1× 10−5 < 1× 10−5
Q1 - Q4 Best (Constant) < 1× 10−5 < 1× 10−5 0.001
Q1 - Q4 Q1 - Q4 < 1× 10−5 < 1× 10−5 0.114
(a) Regression
Normal p Mild & Moderate p Poor & Very poor p
p:All c:All vs. p:Best c:All 0.202 0.403 0.971
p:All c:All vs. p:Quartiles c:All 0.632 0.009 0.0002
p:All c:All vs. p:All c:Best < 1× 10−5 < 1× 10−5 0.009
p:All c:All vs. p:All c:Quartiles < 1× 10−5 < 1× 10−5 < 1× 10−5
p:All c:All vs. p:Best c:Best 0.8653 0.383 0.468
p:All c:All vs. p:Quartiles c:Best 0.5637 0.080 0.305
p:All c:All vs. p:Best c:Quartiles 0.6112 0.080 0.093
p:All c:All vs. p:Quartiles c:Quartiles 0.043 0.0001 0.0002
(b) Analysis of variance
Table 5.27.: AF, function subgroups, LVEF: Regression and analysis of variance results show-
ing significance (p only) of preceding and indexed beat selection on LVEF in
patients in AF grouped by systolic function using variable time formatting. r2
values are uniformly very weak.
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1. Can LVEF be obtained equally well using both formatting techniques?
2. Are measures of LVEF comparable?
3. Is the range of LVEF similar with both formatting techniques?
4. Are the factors which contribute to variation in LVEF the same in both fixed and
variable time formatting?
Considering first the number of acceptable LVEFs measured using each technique (after
beat limiting and data filtering - see §5.2). The cross tabulation of the number of valid
LVEF measurements is shown in Tables 5.28 for SR and 5.29 for AF.
In SR these look very similar while in AF there is a reduction in the total number of
acceptable LVEF measurements when fixed time mode is used. It is also interesting to
note that in AF there were more acceptable LVEFs measured when either preceding or
indexed beat were “All” or “Best” in variable time than in fixed time mode, and that
regardless of formatting mode there is poor acceptability in the Q1:Q1 group.
To compare the tables a log-linear successive reduction technique as described in §4.6.3
was used. The initial model used in both SR and AF analyses was:
count ∼ p+ i+ f + p : i+ p : f + i : f + p : i : f (5.3)
where:
p: is the preceding beat selection criteria
i: is the indexed beat selection criteria
f: is the frame mode.
In both AF and SR the successive reduction technique found that the inclusion of the
p : i : f term which defines differences between the two tables made no difference to the
model; from which it can be concluded that there is no significant three way interaction
and therefore that there is no significant difference between the behaviour with beat
selection criteria when using fixed time compared with variable time. In SR further re-
duction found that the frame-mode term could be removed from the model completely,
suggesting that frame-mode has no significant effect on the number of acceptable mea-
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Indexed beat
All Best Q1 Q2 Q3 Q4 TOTAL
Preceding
beat
All 385 385 357 361 366 367 2221
Best 385 385 357 361 364 367 2219
Q1 355 355 159 192 196 210 1467
Q2 361 362 189 219 229 231 1591
Q3 367 367 196 229 242 230 1631
Q4 365 364 198 221 231 245 1624
TOTAL 2218 2218 1456 1583 1628 1650 10753
(a) Variable time
Indexed beat
All Best Q1 Q2 Q3 Q4 TOTAL
Preceding
beat
All 387 384 354 361 365 373 2224
Best 386 382 355 363 365 371 2222
Q1 362 354 160 189 195 222 1482
Q2 362 361 185 217 225 245 1595
Q3 365 364 188 224 235 247 1623
Q4 366 364 193 216 225 246 1610
TOTAL 2228 2209 1435 1570 1610 1704 10756
(b) Fixed time
Table 5.28.: SR: Number of acceptable LVEF by beat selection technique in (a) variable and
(b) fixed time mode in SR.
Indexed beat
All Best Q1 Q2 Q3 Q4 TOTAL
Preceding
beat
All 372 360 312 346 349 349 2088
Best 341 301 221 255 278 284 1680
Q1 274 194 89 128 133 156 974
Q2 327 252 134 174 199 211 1297
Q3 347 284 153 205 226 249 1464
Q4 360 306 182 241 265 273 1627
TOTAL 2021 1697 1091 1349 1450 1522 9130
(a) Variable time
Indexed beat
All Best Q1 Q2 Q3 Q4 TOTAL
Preceding
beat
All 275 340 223 346 358 371 1913
Best 281 298 165 267 285 335 1631
Q1 291 208 87 127 139 216 1068
Q2 279 253 105 196 211 280 1324
Q3 276 290 124 211 240 310 1451
Q4 277 301 147 252 274 321 1572
TOTAL 1679 1690 851 1399 1507 1833 8959
(b) Fixed time
Table 5.29.: AF: Number of acceptable LVEFs by beat selection technique in (a) variable
and (b) fixed time mode in AF.
surements of LVEF at all (this is consistent with the finding that there is only a very
weak dependence of LVEF on beat selection criteria in SR - see §5.4.1).
The relationship between LVEF in variable and fixed time is shown in Figures 5.14 (SR)
and 5.15 (AF). In both AF and SR a Spearman rank (non-parametric) correlation test
finds there to be a nearly perfect, highly significant correlation in both SR (ρ = 0.997,
p < 1 × 10−5) and AF (ρ = 0.979, p < 1 × 10−5) from which we conclude that there is
little difference in LVEF measured using fixed and variable time.
The Bland-Altman [85] type analysis finds that in SR there is a mean difference of
0.19±2.07 (mean ± 2SD) which is not clinically significant and well within the expected
error of any measurement of LVEF. (This compares with SD over all LVEFs as assessed
from the combination of two LV ROIs and two background ROIs of 0.686 and from
count rate variation of 2.096 in variable time mode, 0.676 and 2.079 respectively in fixed
time mode). In AF the Bland-Altman analysis finds that there is a mean difference of
−0.54 ± 4.84 (mean ± 2SD) which, again, is unlikely to be clinically significant and is
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Indexed beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 37.8± 14.5 38.0± 14.4 40.0± 13.0 39.9± 13.2 39.9± 13.6 39.7± 13.8
Best 37.9± 14.4 38.1± 14.4 40.0± 13.1 39.8± 13.4 39.9± 13.6 39.7± 13.5
Q1 39.7± 12.9 40.3± 12.9 45.4± 12.1 44.7± 12.3 44.9± 12.3 44.6± 12.0
Q2 40.0± 13.0 40.2± 13.3 45.5± 12.7 44.2± 12.9 44.6± 12.3 44.5± 12.0
Q3 39.8± 13.1 39.9± 13.5 44.7± 12.6 44.4± 12.8 44.1± 12.5 44.2± 12.2
Q4 39.7± 13.2 40.1± 13.5 44.8± 12.7 44.0± 12.3 44.3± 12.5 44.6± 12.5
Table 5.30.: SR, LVEF (fixed time): Mean±SD LVEF in SR with fixed time formatting for
different beat selection criteria.
Indexed beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 33.4± 9.7 33.8± 11.5 36.7± 11.4 34.2± 11.4 33.4± 11.3 31.2± 9.8
Best 32.1± 9.7 34.3± 11.0 38.4± 10.4 36.0± 10.5 35.1± 10.5 31.8± 9.4
Q1 30.3± 9.1 34.5± 10.3 40.3± 10.2 37.2± 9.6 36.8± 9.2 32.0± 9.1
Q2 33.0± 9.5 36.2± 10.7 41.4± 10.5 38.4± 10.7 37.8± 10.6 33.3± 9.5
Q3 34.6± 9.7 37.1± 11.2 42.9± 10.5 39.7± 10.9 38.6± 10.9 34.6± 9.4
Q4 36.7± 10.0 39.9± 11.5 44.3± 11.4 41.5± 11.4 40.4± 11.2 36.7± 9.8
Table 5.31.: AF, LVEF (fixed time): Mean LVEF in AF with fixed time formatting for
different beat selection criteria.
within the expected error of any measurement of LVEF. It is clear from the plots that in
AF at lower LVEFs, variable time formatting slightly underestimates LVEF compared
with fixed time formatting and that at higher LVEFs this is reversed, however the overall
changes are not large.
The variation in measured LVEF with different beat selection techniques using fixed
time formatting is shown for SR in Figure 5.16 and Table 5.30 (this can be compared
with the plot for variable time formatting, Figure 5.7). In AF the variation in measured
LVEF with different beat selection techniques is shown in Figure 5.17 and Table 5.31
(this can be compared with the plot for variable time formatting, Figure 5.8). These
changes are broadly in line with the changes seen using variable time formatting.
The range of LVEF (mLVEF) obtained for each patient is shown in Figure 5.18 (SR)
and Figure 5.19 (AF). This is clearly broadly the same distribution of ranges as that for
variable time shown in Figures 5.5 and 5.6 respectively.
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Figure 5.14.: SR, LVEF:Showing relationship between fixed and variable time mode for
LVEF in SR. (In direct plot, red line shows best fit linear correlation, green line
shows line of equality; in Bland-Altman plot red line shows 2 SDs and green
line shows mean.) (N=10528).
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(b) Bland - Altman style
Figure 5.15.: AF, LVEF: Showing relationship between fixed and variable time mode for
LVEF in AF. (In direct plot, red line shows best fit linear correlation, green
line shows line of equality; in Bland-Altman plot red line shows 2 SDs and
green line shows mean.) (N=8230).
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Figure 5.16.: SR, LVEF (fixed time): Box-plots showing median and inter-quartile ranges for
LVEF measured for patients in SR using fixed time formatting. The two plots
show the same data grouped either by (a) preceding beat selection criteria or
(b) indexed beat selection criteria.
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Figure 5.17.: AF, LVEF (fixed time): Box-plots showing median and inter-quartile ranges
for LVEF measured for patients in AF using fixed time formatting. The two
plots show the same data grouped either by (a) preceding beat selection criteria
or (b) indexed beat selection criteria.
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Figure 5.18.: Showing (a) the histogram ranges (independent of mean LVEF) obtained for all
patients and (b) a plot of the range (independent of mean LVEF) against the
number of contributing beat selection preceding:indexed pairings for patients
in SR using fixed time mode.
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Figure 5.19.: Showing (a) the histogram ranges (independent of mean LVEF) obtained for all
patients and (b) a plot of the range (independent of mean LVEF) against the
number of contributing beat selection preceding:indexed pairings for patients
in AF using fixed time mode.
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Figure 5.20.: Showing the relationship between LVEF ranges obtained using fixed and vari-
able time formatting in SR.
A comparison of the ranges for variable vs. fixed time is shown in Figures 5.20 (SR)
and 5.21 (AF). The data are not normally distributed and, in SR, a Spearman rank
correlation finds an almost perfect, highly significant correlation (ρ = 0.92, p < 1×10−5).
In AF, a Spearman rank correlation finds an excellent, highly significant correlation
(ρ = 0.807, p < 1× 10−5).
The ranges are a result of the differences between maxima and minima. The beat selec-
tion preceding:indexed pairings which give rise to the maximum and minimum LVEFs
for each patient are shown cumulatively in Tables 5.32 (SR) and 5.33 (AF).
A visual comparison of the maxima and minima tables with the same tables in variable
time (Tables 5.12 for SR and 5.13 for AF) suggests that there is a difference between
the two modes, however a log-linear analysis similar to that carried out to compare the
number of LVEFs assessed (see also §4.6.3) finds that removing the interaction term
between all three variables makes no significant difference to the model and therefore
that the difference between the tables is not significant. This is true in both SR and AF,
both for the maxima (p = 0.824 in SR, p = 0.827 in AF) and minima (p = 0.977 in SR,
p = 0.612 in AF) tables.
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Figure 5.21.: Showing the relationship between LVEF ranges obtained using fixed and vari-
able time formatting in AF.
Indexed beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 6 3 27 15 8 11
Best 7 4 29 14 9 7
Q1 20 9 16 9 10 9
Q2 14 13 10 11 4 8
Q3 8 11 6 8 5 13
Q4 13 4 8 7 7 8
(a) Minima
Indexed beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 3 1 6 2 3 11
Best 0 1 8 3 2 12
Q1 2 5 15 11 10 25
Q2 2 6 13 12 11 32
Q3 3 5 13 14 20 25
Q4 9 7 22 12 23 40
(b) Maxima
Table 5.32.: LVEF, SR (fixed time): Showing the number of patients for whom the given
combinations of preceding and indexed beat selection gave rise to the (a) min-
imum and (b) maximum measured LVEF in patients in SR using fixed time
formatting.
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Indexed beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 0 5 3 6 19 20
Best 3 5 1 5 4 26
Q1 78 21 0 6 12 88
Q2 3 4 1 2 0 15
Q3 0 0 0 0 1 1
Q4 0 0 0 0 0 2
(a) Minima
Indexed beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 0 1 1 2 3 2
Best 0 1 5 2 0 3
Q1 0 0 3 1 2 0
Q2 0 0 2 1 5 3
Q3 2 5 15 8 5 4
Q4 17 49 50 66 56 41
(b) Maxima
Table 5.33.: AF, LVEF (fixed time): Showing the number of patients for whom the given
combinations of preceding and indexed beat selection gave rise to the (a) mini-
mum and (b) maximum measured LVEF in patients with AF using fixed time
formatting.
At no point in answering the four questions by which the comparison of different for-
matting modes was approached (see page 183) has a significant difference between fixed
and variable time formatting in SR been found. In AF too, although there were fewer
LVEFs rejected from the analysis in variable time formatting and there is a small differ-
ence between the measures, overall there seems to be no significant difference between
fixed and variable time formatting. Additionally, the broad agreement in mLVEF using
the two formatting modes, suggests that the range of LVEFs measured for each patient
is likely to be real and not simply methodological.
5.4.5. Assessing the consistency of results
Any measure of function that is to be clinically useful must have good reproducibility.
In SR, LVEF has been shown to have good reproducibility. To test the methodologi-
cal reproducibility of LVEF assessment in AF compared with SR, list-mode files were
formatted in two separate halves and the differences between the first and second half
compared using a Bland-Altman style analysis [84, 85].
Comparisons were only made between LVEF using either All or “Best” preceding beats
and All or “Best” indexed beats. These criteria most closely mimic those used in clinical
practice and it was felt that there would be insufficient counts in other images after the
acquisition duration was halved and subsequently formatted using beat selection criteria
based on quartiles. This conclusion is to some extent corroborated by the results shown
in Table 5.3 (§5.2.3) which demonstrate that reduced count substantially affects the
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Rhythm Half Preceding Indexed Number of studies
SR First All All 375
SR First All Best 375
SR First Best All 374
SR Second All All 371
SR Second All Best 371
SR Second Best All 371
AF First All All 362
AF First All Best 343
AF First Best All 324
AF Second All All 356
AF Second All Best 317
AF Second Best All 284
Table 5.34.: Number of contributing studies comparing consistency of LVEF in two halves
of each study.
number of acceptable curves and that in both AF and SR there are substantially more
acceptable results with the “Best” beats (either preceding or indexed) than when quar-
tiles were used. Despite these results, the lack of quartiles in assessing the consistency
of results is a limitation of the study and offers an area for further investigation.
The number of studies that contributed to each measurement is shown in Table 5.34 while
the mean ± 2SD of the differences between the first and second half of the study are
shown in Table 5.35. There is little difference between the results in SR; however in AF,
although not clinically significant, there is a substantially smaller difference between
LVEFs where all beats are taken (p:All c:All) and where the “Best” beats are taken
(either preceding or indexed). This suggests that taking all beats may give the most
consistent results. The Bland-Altman plot (not shown, to conserve space) showed a
very slight tendency towards larger differences between the two halves at higher LVEF
in both SR and AF.
Investigation of the average beat for the different halves found that there was a only a
very small deviation in beat length as shown in Table 5.35b. In both AF and SR these
differences can be considered to be minimal and have been shown to be substantially
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SR AF
First Second Difference First Second Difference
p:All c:All 38.4 39.3 −0.75± 2.38 28.6 29.4 −0.68± 2.24
p:Best c:All 38.6 39.3 −0.72± 2.45 29.4 31.5 −0.91± 2.87
p:All c:Best 38.4 39.3 −0.75± 2.48 33.4 35.3 −1.00± 3.43
p:Best c:Best 38.4 39.3 −0.75± 2.49 35.9 38.0 −1.43± 3.68
(a) LVEF changes
SR AF
First Second Difference First Second Difference
p:All c:All 0.885 0.888 −0.0023± 0.0180 0.836 0.841 −0.0021± 0.0268
p:Best c:All 0.885 0.888 −0.0027± 0.0186 0.849 0.861 −0.0031± 0.0261
p:All c:Best 0.884 0.888 −0.0.0026± 0.0189 0.762 0.771 −0.0071± 0.0802
p:Best c:Best 0.883 0.888 −0.0030± 0.0197 0.770 0.776 −0.0008± 0.0732
(b) Average beat changes (s)
Table 5.35.: Showing the mean value and Mean ± SD of the difference between (a) LVEF
and (b) average beat length in first and second half of study with different beat
selection criteria.
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smaller than the variations in LVEF (∼ 2% for LVEF compared with ∼ 0.2% for average
beat length).
5.5. Pre-systolic LV volume (PSV)
It is to be expected that pre-systolic volume, PSV , will change with preceding beat crite-
ria. Short preceding beats in which the time for diastolic filling is, presumably, reduced
should result in reduced end-diastolic volumes from the preceding beat (corresponding
to the pre-systolic volume of the indexed beat).
PSV is, to an excellent approximation, proportional to the count and therefore a measure
of pre-systolic volume (with units of cts/s), can be calculated as:
PSV =
Cps
Na( ¯TRR/F )
(5.4)
Where
Cps is the pre-systolic count
Na is the number of accepted beats
¯TRR is the mean (in variable time) or mid-point (in fixed time) RR interval
F is the number of frames.
The variation of PSV , with beat selection criteria in SR is shown in Figure 5.22 and for
AF in Figure 5.23.
PSV is not normally distributed (see Figure C.5 in appendix C, §C.1) and a more
normal distribution can be achieved by taking the logarithm of PSV . After taking the
logarithm of PSV , regression testing confirmed the visual conclusion that there is no
significant linear variation in PSV with either indexed or preceding beat length in SR or
AF. However when regression is done on a patient-by-patient basis (against log(PSV ))
the results shown in Table 5.36 are found. It is clear from these results that in some
patients there is an exceptionally good R2 suggesting that in these patients there is a
high dependency of PSV on beat selection criteria. The variation between these results
is due to a lack of normalisation. While individually there is a very strong dependency
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(b) PSV in SR indexed beat grouping
Figure 5.22.: SR, PSV : Showing the variation in PSV with varying indexed and preceding
beat selection criteria in SR using variable time formatting. (a) shows the
variation grouped by preceding beat selection criteria and limiting the extent
of the y-axis so that some outliers are excluded. (b) shows PSV grouped by
indexed beat - this plot includes all outliers to show their extent.
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(a) PSV in AF preceding beat grouping
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(b) PSV in AF indexed beat grouping
Figure 5.23.: AF, PSV : Showing the variation in PSV with varying indexed and preceding
beat selection criteria in AF using variable time formatting. (a) shows the
variation grouped by preceding beat selection criteria and limiting the extent
of the y-axis so that some outliers are excluded. (b) shows PSV grouped by
indexed beat - this plot includes all outliers to show their extent.
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Preceding Indexed Mean ± SD (+ve) N (+ve) Mean ± SD (-ve) N (-ve) NC
All (Constant) Q1 - Q4 0.86± 0.13 196 0.79± 0.16 37 4
Best (Constant) Q1 - Q4 0.87± 0.12 199 0.79± 0.15 35 4
Q1 - Q4 All (Constant) 0.85± 0.12 155 0.79± 0.16 48 7
Q1 - Q4 Best (Constant) 0.84± 0.12 149 0.79± 0.16 45 6
Q1 - Q4 Q1 - Q4 0.71± 0.15 96 (p), 111(i) 22 (p), 7(i) 38
(a) SR
Preceding Indexed Mean ± SD (+ve) N (+ve) Mean ± SD (-ve) N (-ve) NC
All (Constant) Q1 - Q4 0.96± 0.05 335 0.94±NA 1 7
Best (Constant) Q1 - Q4 0.94± 0.07 243 NA 0 26
Q1 - Q4 All (Constant) 0.83± 0.14 137 0.80± 0.15 33 13
Q1 - Q4 Best (Constant) 0.79± 0.14 75 0.77± 0.14 29 34
Q1 - Q4 Q1 - Q4 0.90± 0.09 140 (p), 225(i) 83 (p), 0(i) 55
(b) AF
Table 5.36.: PSV : showing the regression results by quartile on a patient-by-patient basis
for PSV in (a) SR, and (b) AF. The form of these tables is described in §5.3.4.
Total numbers of patients: 371 in SR (308 for multiple regression), 357 in AF
(303 for multiple regression).
on beat selection criteria, globally the spread of PSV is such as to mask the individual
dependency.
The analysis of variance of the data found that there is a significant difference between
beat selection criteria which included quartiles (in either the preceding or indexed beat)
in SR but not in AF (see Table 5.37).
Analysis of variance on the log transformed data found no significance in the beat selec-
tion criteria in SR and only weak significance in AF.
Comparing the ranges can be done either by comparing the difference between the
maximum and minimum PSV or by comparing the ratio of minimum to maximum. The
problem with comparing the differences is that there may be substantial variation in the
underlying volumes of the LV (hearts are not a uniform size) and therefore there is no
standard of comparison. By comparing the ratios, a natural normalisation is introduced
and the results can be considered on the same scale.
Figures 5.24 (SR) and 5.25 (AF) show in plot (a) a histogram showing the number of
patients with absolute volume ranges falling in 20 ms bins and in plot (b) the fractional
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SR p AF p
p:All c:All vs. p:Best c:All 0.724 0.076
p:All c:All vs. p:Quartiles c:All 0.026 0.604
p:All c:All vs. p:All c:Best 0.989 0.0002
p:All c:All vs. p:All c:Quartiles 0.030 0.253
p:All c:All vs. p:Best c:Best 0.798 0.946
p:All c:All vs. p:Quartiles c:Best 0.953 0.861
p:All c:All vs. p:Best c:Quartiles 0.729 0.601
p:All c:All vs. p:Quartiles c:Quartiles 0.017 0.189
Table 5.37.: PSV : Analysis of variance results considering contribution of preceding and
indexed beat selection criteria to measurement of PSV with variable time for-
matting.
change as a function of the minimum volume. It is interesting to note that there is a
greater absolute change in volume in SR than there is in AF when all the results are
considered, although if the outliers in SR are excluded the results are similar with the
bulk of patients having PSV between 500 and 1000 cts/s. The mean ratio of minimum
to maximum PSV is 0.831±0.097 in SR and 0.875±0.056 in AF. A Mann-Whitney test
shows these to be significantly different, although clinically the difference is unlikely to
prove significant.
5.5.1. Comparing Pre-systolic volume (PSV ) with mPSV
It can be seen from Figure 5.25b that there is a tendency towards smaller PSV variations
in patients who have a high minimum PSV . A similar result is achieved if the plot is made
against mean PSV . The result is however affected by the number of patients in each
volume range. Since there are many more patients with lower volumes it is unsurprising
that there is a greater change. A Spearman rank correlation finds a moderate, but highly
significant (p < 0.00001 in both AF and SR), correlation in both SR (ρ = 0.29) and AF
(ρ = 0.31) between the fractional range and the mean PSV .
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Figure 5.24.: SR, PSV ranges: Showing the range of PSV for each patient in SR. (a) Shows
a histogram of the range (max - min) (bin-width = 20), (b) shows the fractional
change (min / max) as a function of the minimum. (N=387.)
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Figure 5.25.: AF, PSV ranges:Showing the range of PSV for each patient in AF. (a) Shows a
histogram of the range (max - min) (bin-width = 20), (b) shows the fractional
change (min / max) as a function of the minimum. (N=373).
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5.5.2. Comparing variable time with fixed time formatting
The comparison between fixed and variable time formatting is shown for SR in Fig-
ure 5.26 and for AF in Figure 5.27. There is exceptionally good correlation between the
two techniques in both SR (ρ = 0.998, p < 1× 10−5), and AF (ρ = 0.986, p < 1× 10−5).
Bland-Altman analysis [85] yields a mean difference of −8.737 and a SD of 23.12 with
a mean “volume” of 831.9 counts in SR. In AF the analysis yields a mean difference of
−81.2 and a SD of 101.0 with a mean “volume” of 928.2 counts. Although the Spearman
rank correlation is exceptionally good in both cases it is noticeable that in AF the mean
difference is an order of magnitude larger although the mean “volume” is of the same
order of magnitude.
In both SR and AF variable time formatting underestimates volume compared to fixed
time formatting. This is because variable time formatting leads to a greater blurring in
volume than in time, while this is reversed in fixed time formatting (see Figure 1.10 in
§1.5.2). Any blurring in volume will have the effect of reducing the assessment of volume
when averaged over all selected beats.
5.6. Pre-systolic volume vs. end-diastolic volume
(EDV/PSV )
In SR, the ratio of end-diastolic to pre-systolic volume, EDV/PSV , should, in a normal
beat, be approximately equal to 1. The volume time curve is expected to start and end
at roughly the same volume on a beat-to-beat basis and averaging over all the selected
beats ought to increase the probability of achieving equal pre-systolic and end-diastolic
volumes. In AF, however, beat length is random and normal filling may be interrupted
or prolonged. Thus it might be expected that a short preceding beat, followed by a
long indexed beat (short followed by long filling time) would have a high EDV/PSV
while similarly a long preceding beat followed by a short indexed beat would have a low
(EDV/PSV ).
The variation in EDV/PSV with beat selection criteria is shown in Figures 5.28 (SR)
and 5.29 (AF) with values tabulated in Tables 5.38 and 5.39. In SR there seems to a
be a weak correlation between indexed beat length and EDV/PSV with longer beats
giving lower EDV/PSV . There is no obvious correlation with preceding beat length.
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(b) Bland - Altman style
Figure 5.26.: SR, PSV : Showing relationship between fixed and variable time mode for PSV
in SR. (In direct plot, red line shows best fit linear correlation, green line shows
line of equality; in Bland-Altman plot red line shows 2 SDs and green line shows
mean.) (N=10528).
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(b) Bland - Altman style
Figure 5.27.: AF, PSV : Showing relationship between fixed and variable time mode for PSV
in AF. (In direct plot, red line shows best fit linear correlation, green line
shows line of equality; in Bland-Altman plot red line shows 2 SDs and green
line shows mean.) (N=8230).
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Indexed beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 0.996± 0.032 0.996± 0.032 1.001± 0.040 0.997± 0.039 0.997± 0.039 0.994± 0.037
Best 0.996± 0.032 0.996± 0.032 1.000± 0.040 0.998± 0.039 0.997± 0.039 0.994± 0.038
Q1 0.996± 0.039 0.996± 0.039 0.999± 0.042 0.995± 0.048 0.990± 0.045 0.986± 0.043
Q2 0.995± 0.040 0.995± 0.040 1.000± 0.048 0.995± 0.038 0.989± 0.042 0.988± 0.045
Q3 0.998± 0.039 0.998± 0.040 1.006± 0.046 0.995± 0.043 0.992± 0.045 0.992± 0.046
Q4 0.998± 0.037 0.998± 0.037 1.003± 0.047 1.000± 0.043 0.996± 0.038 0.988± 0.044
Table 5.38.: SR, EDV/PSV : Mean ± SD EDV/PSV ratio for patients in SR using variable
time formatting.
Indexed beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 1.016± 0.023 1.000± 0.044 0.948± 0.060 1.006± 0.033 1.034± 0.029 1.055± 0.031
Best 1.024± 0.038 1.008± 0.051 0.957± 0.074 1.014± 0.038 1.043± 0.039 1.062± 0.041
Q1 1.062± 0.039 1.045± 0.054 0.992± 0.049 1.050± 0.043 1.081± 0.059 1.101± 0.057
Q2 1.019± 0.031 1.007± 0.048 0.960± 0.066 1.011± 0.041 1.040± 0.035 1.061± 0.044
Q3 1.002± 0.035 0.989± 0.053 0.938± 0.079 0.995± 0.044 1.022± 0.034 1.047± 0.034
Q4 0.987± 0.041 0.974± 0.057 0.925± 0.087 0.978± 0.049 1.008± 0.038 1.032± 0.038
Table 5.39.: AF, EDV/PSV : Mean ± SD EDV/PSV ratio for patients in AF using variable
time formatting.
These conclusions are confirmed by regression analysis, the results of which are shown in
Table 5.41. Although there is a highly significant correlation when both sets of quartiles
are considered, neither the preceding beat nor the interaction term between preceding
beat and indexed beat were significant in the analysis of variance which found no signif-
icance with any of the beat selection criteria. Overall this suggests that preceding beat
had no significant effect on EDV/PSV in SR.
In AF it is clear, from Figure 5.29 and Table 5.39, that beat selection criteria have a
substantial impact on EDV/PSV in AF and this is shown to be highly significant in the
regression analysis where both preceding and indexed beat (and the interaction term)
have a high significance (p < 1 × 10−5), see Table 5.41. Interestingly the analysis of
variance which compares the categorical beat selection criteria finds that only the “Best”
indexed beat gives a significant result (p = 0.0002).
Results for patient-by-patient regression against beat selection criteria are shown in
table 5.40. There is a very strong positive relationship with indexed beat length and a
negative relationship with preceding beat length in AF. The same effect is not seen in
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(a) EDV/PSV in SR preceding beat grouping
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(b) EDV/PSV in SR indexed beat grouping
Figure 5.28.: SR, EDV/PSV : Showing the variation in EDV/PSV ratio with varying in-
dexed and preceding beat selection criteria in SR using variable time format-
ting.
Results: Describing Function 211
Indexed beat selection criteria
ED
V/
PS
V
0.7
0.8
0.9
1.0
1.1
1.2
1.3
All
All
Best
Q1 Q2 Q3 Q4
Best
All
Best
Q1 Q2 Q3 Q4
Q1
All
Best
Q1 Q2 Q3 Q4
Q2
All
Best
Q1 Q2 Q3 Q4
Q3
All
Best
Q1 Q2 Q3 Q4
Q4
All
Best
Q1 Q2 Q3 Q4
(a) EDV/PSV in AF preceding beat grouping
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(b) EDV/PSV in AF indexed beat grouping
Figure 5.29.: AF, EDV/PSV : Showing the variation in EDV/PSV ratio with varying in-
dexed and preceding beat selection criteria in AF using variable time format-
ting.
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Preceding Indexed Mean ± SD (+ve) N (+ve) Mean ± SD (-ve) N (-ve) NC
All (Constant) Q1 - Q4 0.78± 0.14 51 0.75± 0.15 93 4
Best (Constant) Q1 - Q4 0.78± 0.14 55 0.76± 0.15 102 4
Q1 - Q4 All (Constant) 0.78± 0.13 75 0.76± 0.15 65 7
Q1 - Q4 Best (Constant) 0.79± 0.14 74 0.76± 0.15 64 6
Q1 - Q4 Q1 - Q4 0.72± 0.16 34 (p), 17(i) 23 (p), 40(i) 38
(a) SR
Preceding Indexed Mean ± SD (+ve) N (+ve) Mean ± SD (-ve) N (-ve) NC
All (Constant) Q1 - Q4 0.84± 0.12 297 NA NA 7
Best (Constant) Q1 - Q4 0.84± 0.13 201 0.80± 0.15 4 26
Q1 - Q4 All (Constant) 0.79± 0.16 4 0.83± 0.13 227 13
Q1 - Q4 Best (Constant) 0.79± 0.14 16 0.81± 0.14 132 34
Q1 - Q4 Q1 - Q4 0.75± 0.15 13 (p), 172(i) 158 (p), 0(i) 55
(b) AF
Table 5.40.: EDV/PSV : showing the regression results by quartile on a patient-by-patient
basis for EDV/PSV in (a) SR, and (b) AF. The form of these tables is described
in §5.3.4. Total numbers of patients: 371 in SR (308 for multiple regression),
357 in AF (303 for multiple regression).
SR AF
Preceding Indexed r2 p r2 p
All (Constant) Q1 - Q4 0.004 0.02 0.467 < 1× 10−5
Best (Constant) Q1 - Q4 0.003 0.03 0.358 < 1× 10−5
Q1 - Q4 All (Constant) 0.0004 0.444 0.326 < 1× 10−5
Q1 - Q4 Best (Constant) 0.0007 0.312 0.171 < 1× 10−5
Q1 - Q4 Q1 - Q4 0.014 < 1× 10−5 0.424 < 1× 10−5
Table 5.41.: EDV/PSV : Regression results showing the effect of differing beat selection
criteria on EDV/PSV ratio using variable time formatting.
.
SR where, in those patients for whom a relationship was actually exhibited, there was a
balance between the positive and negative influences of both the indexed and preceding
beat. These results support the findings of the regression in the group as a whole.
Having ascertained that in AF the beat selection criteria have a significant impact on
EDV/PSV it is worth investigating this further. A histogram showing the range of
EDV/PSV for each patient in AF using variable time formatting is shown in Figure 5.30.
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Figure 5.30.: AF, mEDV/PSV : Showing the range (max - min) of measured EDV/PSV
for patients in AF using variable time formatting.
The relationship between min and max EDV/PSV and the range is shown in Figure 5.31.
It is noticeable that in only a very few instances is the minimum greater than 1.0 or
the maximum less than 1.0, and that there is very good (Spearman rank) correlation
between range and both minimum (ρ = −0.880, p < 1×10−5) and maximum (ρ = 0.799,
p < 1× 10−5). This suggests that the variation is systematic and the patterns displayed
here and in Table 5.39 confirm the “interrupted beat” hypothesis. Images for which the
preceding and indexed beat fall in the same quartile (e.g. p:Q2 c:Q2) showed a mean
EDV/PSV ≈ 1 while those in which the preceding beat was shorter than the indexed
beat (e.g. p:Q1 c:Q4) showed a mean EDV/PSV > 1. Those images formed where the
preceding beat was longer than the indexed beat (e.g. p:Q4 c:Q1) had EDV/PSV < 1.
The results beg the question: is the extent of variation in EDV/PSV reflected in the
range of beat lengths? This question will be addressed in Chapter 6.
5.6.1. Comparing EDV/PSV with mEDV/PSV
A visual comparison of EDV/PSV with mEDV/PSV (see Figure 5.32) does not show
any clear association, although statistically a Spearman rank correlation finds a weak
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(b) EDV/PSV range vs max in AF
Figure 5.31.: AF, EDV/PSV : Showing the variation in EDV/PSV ratio with varying in-
dexed and preceding beat selection criteria in AF using variable time format-
ting.
Results: Describing Function 215
positive correlation in SR and weak negative correlation in AF and the spread of
mEDV/PSV appears to be greater for AF. It is difficult to understand physiologically
why there should be a relationship between the two since the range of EDV/PSV should
reflect the difference in duration of short-short and long-long beat combinations.
5.6.2. Comparing variable time with fixed time formatting
A very similar pattern is seen using fixed time formatting as using variable time format-
ting.
In SR the Spearman rank correlation between fixed and variable time formatting finds
very strong correlation with ρ = 0.818, p < 1 × 10−5. The Bland-Altman analysis [85]
finds mean difference in EDV/PSV to be 0.014 and the SD of the difference to be 0.024.
These results have to be understood beside the very small variation in EDV/PSV which
is seen in SR.
In AF there is still is good correlation between fixed and variable time results (ρ =
0.688, p < 1× 10−5), although it is weaker than in SR. The Bland-Altman analysis, see
Figure 5.34, finds the mean difference to be greater than in SR to be 0.039 with a SD
of difference to be 0.059. It is clear that, compared to fixed time formatting, variable
time formatting increases the difference at lower EDV/PSV , and therefore increases
the overall measurable difference in EDV/PSV in AF.
5.7. Systolic time
One of the principal predicates of this thesis is that variation in R-R interval is primarily
reflected in the duration of diastole. For this to be true the systolic time interval should
not vary substantially from one beat to the next for any patient. Although the systolic
time interval has been shown to vary [3], for the Frank-Starling mechanism to work the
principal variation in systole from one beat to the next should be in the force and not the
duration of contraction. The corollary of this is that longer filling times will be reflected
in a fuller ventricle, which therefore has a greater volume of blood which can be ejected,
resulting in a higher LVEF. This assumes a healthy heart which is not affected by other
pathologies which might affect systole.
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Figure 5.32.: EDV/PSV : Showing the variation of mEDV/PSV with mean EDV/PSV in
(a) SR and (b) AF using variable time formatting.
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Figure 5.33.: Showing relationship between fixed and variable time mode for EDV/PSV in
SR. (In direct plot, red line shows best fit linear correlation, green line shows
line of equality; in Bland-Altman plot red line shows 2 SDs and green line
shows mean.)
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Figure 5.34.: Showing relationship between fixed and variable time mode for EDV/PSV in
AF. (In direct plot, red line shows best fit linear correlation, green line shows
line of equality; in Bland-Altman plot red line shows 2 SDs and green line
shows mean.)
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Indexed beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 0.307± 0.045 0.307± 0.046 0.304± 0.046 0.309± 0.047 0.310± 0.046 0.316± 0.046
Best 0.306± 0.046 0.307± 0.046 0.303± 0.046 0.309± 0.046 0.309± 0.046 0.316± 0.048
Q1 0.306± 0.045 0.306± 0.046 0.309± 0.048 0.313± 0.050 0.310± 0.047 0.313± 0.044
Q2 0.306± 0.046 0.306± 0.046 0.307± 0.050 0.313± 0.044 0.312± 0.049 0.315± 0.053
Q3 0.309± 0.047 0.310± 0.047 0.310± 0.049 0.313± 0.047 0.316± 0.047 0.317± 0.049
Q4 0.313± 0.046 0.313± 0.045 0.310± 0.050 0.312± 0.049 0.320± 0.071 0.315± 0.045
Table 5.42.: Mean ± SD Systolic time intervals for patients in SR using variable time for-
matting.
To test this principle, the variation in systolic time was investigated in both the AF and
SR groups.
Systolic time, Ts was calculated as
Ts = (Pps − Pes)× TRR
Nf
(5.5)
Where
Pps: Pre-systolic frame number
Pes: End-systolic frame number
TRR: Mean (in variable time) or mid-range (in fixed time) R-R interval for the group
of beats in use
Nf : Number of frames in the image (in this study Nf = 24).
The variation in systolic time with variable time formatting is shown for SR in Figure 5.35
and in tabular form in Table 5.42. The results for AF, which are very similar, are shown
in Figure 5.36 and Table 5.43. In SR there appears to be only a very small variation in
systolic time which is even smaller in AF.
When regression testing, for which the results are shown in Table 5.44, was used to
consider the effect of varying the beat acceptance criteria, both preceding and indexed,
it was found that in SR there is a highly significant, but extremely weak, correlation
between indexed beat length and systolic time (seen when preceding beat criteria are
“All” or “Best”). The correlation with preceding beat criteria, in SR, has much weaker
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Figure 5.35.: SR, systolic time: Box-plot showing systolic time interval for all patients in SR
for each combination of preceding and indexed beat selection techniques with
indexed beat changes shown in blocks. (a) variable time, (b) fixed time format-
ting. (Note: These plots remove a single outlier in each at 1.1s.) (N=387).
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Figure 5.36.: AF, systolic time: Box-plot showing systolic time interval for all patients in
AF for each combination of preceding and indexed beat selection techniques
with indexed beat changes shown in blocks. (a) variable time, (b) fixed time
formatting. (N=373).
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Indexed beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 0.266± 0.040 0.286± 0.039 0.288± 0.037 0.290± 0.042 0.295± 0.044 0.294± 0.039
Best 0.269± 0.040 0.289± 0.044 0.292± 0.041 0.291± 0.044 0.301± 0.044 0.292± 0.040
Q1 0.270± 0.041 0.288± 0.043 0.292± 0.044 0.298± 0.045 0.303± 0.045 0.289± 0.043
Q2 0.272± 0.043 0.296± 0.043 0.293± 0.040 0.297± 0.044 0.305± 0.046 0.299± 0.052
Q3 0.270± 0.042 0.293± 0.044 0.297± 0.044 0.299± 0.047 0.299± 0.042 0.297± 0.041
Q4 0.272± 0.041 0.294± 0.044 0.296± 0.041 0.298± 0.045 0.302± 0.043 0.299± 0.044
Table 5.43.: Mean ± SD Systolic time intervals for patients in AF using variable time for-
matting.
SR AF
Preceding Indexed r2 p r2 p
All Q1 - Q4 0.007 0.0008 0.004 0.027
Best Q1 - Q4 0.008 0.0006 0.001 0.315
Q1 - Q4 All 0.004 0.017 1× 10−5 0.904
Q1 - Q4 Best 0.003 0.033 0.0009 0.341
Q1 - Q4 Q1 - Q4 0.0025 0.035 0.0007 0.553
Table 5.44.: Regression results showing the effect of differing beat selection criteria on systolic
time interval using variable time formatting.
.
significance. In AF the only significant, extremely weak, correlation was seen when all
preceding beats were taken.
The corresponding analysis of variance found no significant contribution for either pre-
ceding or indexed beat selection criteria in SR when quartiles are considered together.
In AF, the analysis found that systolic time with beat selection based on indexed beat
differed significantly for “Best” and quartile beat selection although there was no signif-
icance to the interaction term. The preceding beat had a much weaker significance for
quartile beat selection and found no difference for “Best” beats (see Table 5.45). This
suggests that taking tighter limits on indexed beat affects the systolic time interval. In
AF, since there was no significance in the regression results, this suggests the effect is
a result of averaging fewer beats in a tighter band and, while the systolic time interval
is not constant, it is largely independent of preceding beat length (and therefore also of
systolic volume which has been shown to be dependent on the duration of the preceding
beat - see §5.5).
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SR p AF p
p:All c:All vs. p:Best c:All 0.88 0.298
p:All c:All vs. p:Quartiles c:All 0.52 0.043
p:All c:All vs. p:All c:Best 0.94 < 1× 10−5
p:All c:All vs. p:All c:Quartiles 0.32 < 1× 10−5
p:All c:All vs. p:Best c:Best 0.93 0.828
p:All c:All vs. p:Quartiles c:Best 0.94 0.592
p:All c:All vs. p:Best c:Quartiles 0.94 0.783
p:All c:All vs. p:Quartiles c:Quartiles 0.62 0.642
Table 5.45.: Analysis of variance results considering contribution of preceding and indexed
beat selection criteria to measurement of systolic time.
This analysis is corroborated by the regression results for individual patients which are
shown in Table 5.46. These do not demonstrate any clear dominance with beat selection
criteria in AF. In SR there is a suggestion that there is a positive relationship between
systolic time interval and indexed beat length with longer beats having longer systole.
In these situations the Frank-Starling mechanism cannot be the principal cause of beat-
to-beat variation as it affects the systolic time.
Each measurement of systolic time is made with a sampling error which is given by:
Es =
1
2
· TRR
Nf
(5.6)
Although there is a very small but significant increase in systolic time with increasing
beat length (both preceding and indexed), it is possible that this is a reflection of the
decreasing precision of the measurement (TRR increases). If this is the case it is to be
expected that the difference between mean and measured values should fall within the
sampling error Es. Counting the number of values which fall outwith this should provide
a measure of consistency of measured systolic time. The results, by beat selection criteria,
are shown in Tables 5.47 (SR) and 5.48 (AF) and for patients in SR on a patient-by-
patient basis in the histogram shown in Figure 5.37
There is no appreciable difference in deviation of systolic time interval for beat selection
techniques based on preceding or indexed quartiles, however there are markedly fewer
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Preceding Indexed Mean ± SD (+ve) N (+ve) Mean ± SD (-ve) N (-ve) NC
All (Constant) Q1 - Q4 0.83± 0.15 114 0.67± 0.13 33 4
Best (Constant) Q1 - Q4 0.87± 0.14 118 0.70± 0.13 25 4
Q1 - Q4 All (Constant) 0.80± 0.14 97 0.69± 0.12 55 7
Q1 - Q4 Best (Constant) 0.80± 0.15 103 0.71± 0.12 52 6
Q1 - Q4 Q1 - Q4 0.62± 0.18 14 (p), 20(i) 13 (p), 7(i) 39
(a) SR
Preceding Indexed Mean ± SD (+ve) N (+ve) Mean ± SD (-ve) N (-ve) NC
All (Constant) Q1 - Q4 0.77± 0.14 79 0.72± 0.16 44 7
Best (Constant) Q1 - Q4 0.75± 0.15 43 0.74± 0.16 31 26
Q1 - Q4 All (Constant) 0.75± 0.14 103 0.72± 0.15 42 14
Q1 - Q4 Best (Constant) 0.80± 0.14 71 0.80± 0.15 35 34
Q1 - Q4 Q1 - Q4 0.56± 0.16 17 (p), 13(i) 3 (p), 7(i) 55
(b) AF
Table 5.46.: Systolic time: showing the regression results by quartile on a patient-by-patient
basis for systolic time in (a) SR, and (b) AF. The form of these tables is described
in §5.3.4. Total numbers of patients: 371 in SR (308 for multiple regression),
357 in AF (303 for multiple regression).
Indexed beat
All Best Q1 Q2 Q3 Q4 TOTAL
Preceding
beat
All 4 4 38 27 44 52 169
Best 5 3 46 27 44 52 177
Q1 49 46 40 44 39 41 259
Q2 44 45 40 39 47 61 276
Q3 33 30 37 49 49 46 244
Q4 36 33 45 44 48 45 251
TOTAL 171 161 246 230 271 297 1376
Table 5.47.: SR, Systolic time: Systolic time interval outwith sampling error by beat selec-
tion in SR using variable time. (Total numbers in each category are given in
Table 5.3b)
deviations when all beats or the “Best” group of beats (both indexed and preceding)
are taken, particularly in SR. Overall the deviations account for 12.8% of the measured
values in SR compared with 9.5% in AF.
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Indexed beat
All Best Q1 Q2 Q3 Q4 TOTAL
Preceding
beat
All 43 12 17 14 26 24 136
Best 37 16 11 16 28 24 132
Q1 50 16 15 12 11 14 118
Q2 40 24 10 16 21 20 131
Q3 37 27 15 26 24 32 161
Q4 42 33 19 31 35 33 193
TOTAL 249 128 87 115 145 147 871
Table 5.48.: AF, Systolic time: Systolic time interval outwith sampling error by beat selec-
tion in AF using variable time. (Total numbers in each category are given in
Table 5.3d)
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Figure 5.37.: Showing the number of measurements of systolic time resulting from different
beat selection criteria (from a total of 36) which deviate from the mean by more
than the sampling error for patients in SR using variable time formatting.
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> Es > 2Es No. measured
SR Variable 1376 112 10753
SR Fixed 1226 109 10756
AF Variable 871 35 9130
AF Fixed 351 13 8959
Table 5.49.: Number of systolic time intervals outwith sampling error.
Although it has been shown that systolic time intervals are not constant and that the
differences cannot simply be explained by changes in the sampling error it is interesting
to know the degree of change. This can be shown by considering the ratios of the
minimum and maximum systolic times and is shown in Figure 5.38a from which it can
clearly be seen that in both AF and SR there is typically a ratio of ∼ 70%−75% between
the minimum and maximum systolic time intervals.
5.7.1. Comparing Systolic time with mSystolic time
Comparing systolic time with the range of systolic time intervals shows a tendency for
there to be a greater range of intervals when the mean is greater in both AF and SR.
This is to be expected as small fractional changes in longer intervals will have a greater
impact than in shorter ones.
5.7.2. Comparing variable time with fixed time formatting
As can be seen from Figure 5.35 there is very similar behaviour in fixed time and variable
time formatting and, as Table 5.49 shows, there were a similar number of measurements
in SR outwith the sampling error. In AF however there were substantially more mea-
surements outwith the sampling error in variable time formatting than in fixed time.
This also corroborates the suggestion that in AF the duration of systole does not vary
substantially, particularly in relation to the duration of the whole beat.
A plot of systolic time interval for fixed vs. variable time formatting in SR is shown in
Figure 5.39 from which it is clear that there is good general agreement (within the same
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Figure 5.38.: Showing the ratio of minimum to maximum systolic time intervals for each
patient.
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range as the agreement between minimum and maximum systolic times for variable time
formatting) between fixed and variable time formatting.
In SR, a Pearson product moment correlation (the results are approximately normally
distributed) test finds a highly significant, very good correlation (r = 0.82, p < 1×10−5).
The angle on the best fit line suggests that there is a slightly wider distribution of systolic
time intervals when variable time formatting is used than when fixed time formatting
is used, although there is generally reasonable agreement between them. This is in
agreement with the results shown in Table 5.49. The Bland-Altman analysis shows that
variable time formatting slightly overestimates systolic time (by 0.010 s with a SD of
0.027 s).
In AF, the correlation is not as good as it is for SR (r2 = 0.706, p < 1× 10−5). Bland-
Altman analysis (see Figure 5.40) gives mean difference of 0.010 s and SD of 0.322 s.
5.8. First third filling fraction (FTFF)
First third filling fraction (FTFF), the proportion of pre-systolic volume by which the
volume of the ventricle has increased from end-systole 1/3 of the way into diastole, is the
most common measure of diastolic function. It can be assessed from the activity time
curve in radionuclide ventriculography. In this investigation it has been used to assess
whether, in AF, there is a beat-to-beat variation in diastolic function. In this analysis
diastolic time has been determined from the cropped activity time curves.
The variation in FTFF in SR and AF is shown in Figures 5.41 and 5.42 respectively. In
SR there appears to be a mild positive relationship between both preceding and indexed
beat quartile and FTFF. In AF there appears to be a strong negative relationship with
preceding beat and a very strong positive relationship with indexed beat.
Regression results, shown in Table 5.50, found that both preceding and indexed beat had
a significant effect on measured FTFF in SR but that there was no significance in the
interaction term. In AF there was a significant contribution from both preceding and
indexed beat. It is noticeable that there is a much better correlation when all preceding
beats are taken and that there is no significance to the correlation with preceding quartile
when the “Best” indexed beats are taken.
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Figure 5.39.: Systolic time, SR: Showing the relationship between systolic time using fixed
and variable time formatting in SR. (a) Direct plot, The green line shows the
best fit correlation, the red line shows the line of equality. (b) green line shows
mean difference, red lines show 2SD limits.
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Figure 5.40.: Systolic time, AF: Showing the relationship between systolic time using fixed
and variable time formatting in AF. (a) Direct plot, The green line shows the
best fit correlation, the red line shows the line of equality. (b) green line shows
mean difference, red lines show 2SD limits.
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Figure 5.41.: SR, FTFF: Showing the variation in FTFF with varying indexed and preceding
beat selection criteria in SR using variable time formatting.
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Figure 5.42.: AF, FTFF: Showing the variation in FTFF with varying indexed and preceding
beat selection criteria in AF using variable time formatting.
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SR AF
Preceding Indexed r2 p r2 p
All (Constant) Q1 - Q4 0.011 0.00006 0.414 < 1× 10−5
Best (Constant) Q1 - Q4 0.021 < 1× 10−5 0.091 < 1× 10−5
Q1 - Q4 All (Constant) 0.006 0.002 0.086 < 1× 10−5
Q1 - Q4 Best (Constant) 0.006 0.003 0.00017 0.67
Q1 - Q4 Q1 - Q4 0.002 0.079 0.002 1× 10−5
Table 5.50.: FTFF: Regression results showing the effect of differing beat selection criteria
on FTFF using variable time formatting.
.
Preceding Indexed Mean ± SD (+ve) N (+ve) Mean ± SD (-ve) N (-ve) NC
All (Constant) Q1 - Q4 0.79± 0.14 129 0.76± 0.13 40 4
Best (Constant) Q1 - Q4 0.79± 0.15 128 0.78± 0.13 41 4
Q1 - Q4 All (Constant) 0.76± 0.15 106 0.78± 0.16 55 8
Q1 - Q4 Best (Constant) 0.75± 0.15 106 0.76± 0.16 63 6
Q1 - Q4 Q1 - Q4 0.50± 0.20 95 (p), 103(i) 72 (p), 64(i) 21
(a) SR
Preceding Indexed Mean ± SD (+ve) N (+ve) Mean ± SD (-ve) N (-ve) NC
All (Constant) Q1 - Q4 0.76± 0.16 20 0.77± 0.13 100 7
Best (Constant) Q1 - Q4 0.75± 0.17 15 0.79± 0.16 90 27
Q1 - Q4 All (Constant) 0.89± 0.12 299 0.66± 0.22 2 14
Q1 - Q4 Best (Constant) 0.86± 0.12 191 NA 0 34
Q1 - Q4 Q1 - Q4 0.69± 0.19 219 (p), 36(i) 3 (p), 189(i) 28
(b) AF
Table 5.51.: FTFF: showing the regression results by quartile on a patient-by-patient basis
for FTFF in (a) SR, and (b) AF. The form of these tables is described in §5.3.4.
Total numbers of patients: 371 in SR (308 for multiple regression), 357 in AF
(303 for multiple regression).
In SR, analysis of variance, grouping all quartiles together, found no significant difference.
In AF, as with SR, there was no difference found between quartile, “All” and “Best”
groups in either preceding or indexed beat selection criteria. Considering mean regression
on a patient-by-patient basis yields the results shown in Table 5.51 which corroborate
the results for regression in the group as a whole and using analysis of variance.
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The very strong relationship seen between indexed beat length and FTFF in AF is likely
to be methodological and probably has little relevance in the assessment of diastolic func-
tion. There is no clear definition of diastolic time since any beat may be “interrupted”
by another with the result that measures are made at a different time after end-diastole
in each of the different quartiles and are not therefore comparable. It is probable, since
there is no clear physiological reason, that the negative relationship which is seen with
preceding beat simply reflects the approximate alternation between long and short beats
which has been shown to occur in AF (see Chapter 3, particularly §3.3.3). This alter-
nation would mean that a short beat (e.g. Q1) is typically followed by a longer beat
(and thus longer diastole and greater FTFF) and vice-versa with the result that there
appears to be a negative relationship between long and short beats.
5.9. Peak filling rate (PFR)
One of the underlying assumptions of RNVG is that the dynamics of the emptying
and filling processes are the same from one beat to the next. This is the assumption
that is made in the process of gating from multiple images. It has been shown in the
previous sections that for systole, even in SR, this assumption is false since different beat
selection criteria lead to different measurements of a variety of systolic indices. In AF
this variation becomes more pronounced. There is a good physiological explanation for
this, as the pre-systolic volume has been shown to vary substantially and to be dependent
on the duration of the preceding beat.
Investigating the variation in PFR provides a means of determining whether the assump-
tion is true for diastole or not. If filling progresses in approximately the same way in
each beat until the beat is interrupted then, provided that an interruption occurs after
peak filling, PFR should be constant.
The variation in PFR with preceding and indexed beat is shown in Figure 5.43 for SR
and in Figure 5.44 for AF. It can be seen from these that there is little variation in SR
but there does appear to be a systematic change in PFR with both indexed (positive)
and preceding (negative) beat length in AF.
These impressions are corroborated by regression testing which found that in SR there
is no significant change in PFR with increasing quartile, preceding or indexed. In AF
however there is a highly significant, if weak, dependence of PFR on quartile, both
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Figure 5.43.: SR, PFR: Showing the variation in PFR with varying indexed and preceding
beat selection criteria in SR using variable time formatting.
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Figure 5.44.: AF, PFR: Showing the variation in PFR with varying indexed and preceding
beat selection criteria in AF using variable time formatting.
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Preceding Indexed Gradient r2 P
All Q1 - Q4 10.19 0.032 < 1× 10−5
Best Q1 - Q4 8.07 0.019 < 1× 10−5
Q1 - Q4 All -1.59 0.002 0.136
Q1 - Q4 Best -3.41 0.004 0.048
Q1 - Q4 Q1 - Q4 -1.13* 0.019 < 1× 10−5
Table 5.52.: AF, PFR regression: Regression results showing the effect of differing beat se-
lection criteria on PFR in AF using variable time formatting. *This shows the
gradient of the interaction term.
.
Preceding Indexed Mean ± SD (+ve) N (+ve) Mean ± SD (-ve) N (-ve) NC
All (Constant) Q1 - Q4 0.69± 0.11 53 0.71± 0.13 20 4
Best (Constant) Q1 - Q4 0.67± 0.10 59 0.69± 0.12 22 4
Q1 - Q4 All (Constant) 0.68± 0.11 52 0.65± 0.10 20 8
Q1 - Q4 Best (Constant) 0.66± 0.12 52 0.64± 0.10 26 6
Q1 - Q4 Q1 - Q4 0.41± 0.18 72 (p), 56(i) 29(p), 43(i) 21
(a) SR
Preceding Indexed Mean ± SD (+ve) N (+ve) Mean ± SD (-ve) N (-ve) NC
All (Constant) Q1 - Q4 0.72± 0.13 133 0.80± 0.15 12 7
Best (Constant) Q1 - Q4 0.72± 0.13 76 0.79± 0.16 12 27
Q1 - Q4 All (Constant) 0.71± 0.13 61 0.67± 0.12 16 14
Q1 - Q4 Best (Constant) 0.78± 0.14 43 0.72± 0.12 14 34
Q1 - Q4 Q1 - Q4 0.50± 0.21 81 (p), 101(i) 34 (p), 17(i) 28
(b) AF
Table 5.53.: PFR: showing the regression results by quartile on a patient-by-patient basis
for PFR in (a) SR, and (b) AF. The form of these tables is described in §5.3.4.
Total numbers of patients: 371 in SR (308 for multiple regression), 357 in AF
(303 for multiple regression).
preceding and indexed, with indexed quartile having a more dominant effect (gradient
is substantially greater) than does the preceding quartile (see Table 5.52). These results
also agree with mean patient-by-patient regression results (shown in Table 5.53).
In SR, analysis of variance found that there was a significant difference between results
when quartiles were taken in either preceding or indexed beat (see Table 5.54). Similarly
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Preceding Indexed SR p AF p
Best - 0.886 0.056
Quartiles - 0.003 < 1× 10−5
- Best 0.831 < 1× 10−5
- Quartiles < 0.00006 < 1× 10−5
Best Best 0.913 0.351
Quartiles Best 0.897 0.053
Best Quartiles 0.912 0.050
Quartiles Quartiles 0.0007 0.00004
Table 5.54.: Analysis of variance results considering contribution of preceding and indexed
beat selection criteria to measurement of PFR.
in AF the analysis of variance shows that there is a significant difference in PFR between
groups depending on the beat selection criteria.
This measure should be less dependent on diastolic filling time, and therefore on R-R
interval, than FTFF; however, there will still be a dependence particularly when the
R-R interval is short and peak filling may not have been reached before the beat is
interrupted. It is also particularly noticeable that PFR is substantially lower when all
indexed beats are included.
Overall the results suggest that the assumption that filling progresses the same way
from beat-to-beat until “interrupted” by the next beat is false. There is a physiological
variation from one beat to the next. The mechanism for this is unclear, but, although
it has not been possible to investigate in this thesis, it may reflect a varying base line:
end-systolic volume is not constant.
5.10. Comparing the measures
To investigate the relationship between the measures previously considered (LVEF, PSV ,
EDV/PSV , Systolic time, FTFF, and PFR) Spearman rank correlation testing was used.
Comparisons were made both against individual values measured from a single image
and against the range of measures made on a patient-by-patient basis.
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Spearman rank correlation was used because many of the ranges investigated are not nor-
mally distributed (see appendix C, §C.1). This ensured uniformity of analysis whereby
non-parametric statistics have been used throughout. Where data are actually normally
distributed a Spearman rank correlation will underestimate the strength of a correlation,
where one is seen.
The results summarising the comparison between functional measures can be found in
figures 5.45 (for SR) and 5.46 (for AF). These show a comparison both in the groups
as a whole and on a patient-by-patient basis.
Correlating the paired ranges (m) on a per patient basis leads to the results shown in
Figures 5.47 (SR) and 5.48 (AF).
It is noticeable that when the comparison between functional measures is considered
on a patient-by-patient basis using a Spearman rank correlation a different pattern of
agreement is found than when all the measures are correlated as a group. In particular
there are disagreements between the two statistics when comparing LVEF with both
PFR and PSV ; and comparing PFR with PSV in both SR and AF. In the case of PSV
these differences reflect the lack of normalisation which leads to different results when
all patients are included than when variation is considered against a single patient. In
the case of PFR the difference is likely to be in part statistical, since correlation on a
patient-by-patient basis can only include up to four points. It may also reflect the fact
that patients may have diastolic dysfunction without having systolic dysfunction while
the reverse is not true. Thus an individual patient may not show substantial agreement
between changes in LVEF and changes in PFR although the group as a whole may do
so.
A summary of the most significant relationships between the functional indices which
have been measured follows:
5.10.1. LVEF vs. systolic time
In both AF and SR there seems to be little agreement between the LVEF and systolic
time interval, although a Spearman rank (non-parametric) correlation test yields a highly
significant (but very weak) correlation with ρ = 0.041, p = 0.00002 in SR and ρ = 0.085
and p < 1× 10−5 in AF. This is corroborated by the patient-by-patient analysis.
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Figure 5.45.: SR, comparing measures: Showing (a) the correlation between the six func-
tional measures investigated in SR. A * indicates significance at the p < 0.05
level. (b) the mean correlation coefficient on a patient-by-patient basis exclud-
ing patients where p < 0.05. In plot (b) the number of patients, n, included
in the mean is also shown. (In both plots the colour scale corresponds to the
scale shown in Table 2.5, N=387).
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Figure 5.46.: AF, comparing measures: Showing (a) the correlation between the six func-
tional measures investigated in AF. A * indicates significance at the p < 0.05
level. (b) the mean correlation coefficient on a patient-by-patient basis exclud-
ing patients where p < 0.05. In plot (b) the number of patients, n, included
in the mean is also shown. (In both plots the colour scale corresponds to the
scale shown in Table 2.5, N=373).
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Figure 5.47.: SR, mcomparison: Showing the correlation between the ranges of the six func-
tional measures investigated in SR. A * indicates significance at the p < 0.05
level. (Colour scale corresponds to the scale shown in Table 2.5).
Comparing the ranges there is a better correlation in SR than in AF, with SR yielding
a highly significant moderate positive correlation between the changes (ρ = 0.425, p <
1× 10−5) while in AF the correlation was weak (ρ = 0.179, p = 0.0005).
Taken together these results show that while there is no direct relationship between
systolic time and LVEF in SR, a patient who has a more widely varying systolic time
interval will also have a more widely varying LVEF. This may reflect cardiac health as
poor variation in beat length in SR is a marker of poor cardiac health.
5.10.2. LVEF vs. EDV/PSV
In both AF and SR there is effectively no (very weak in AF) correlation between
EDV/PSV and LVEF when the measures are compared on an individual basis, but
when mEDV/PSV is compared with mLVEF there is a good correlation (ρ = 0.736,
p < 1 × 10−5 in SR, ρ = 0.685, p < 0.0001 in AF). This is demonstrated in AF in the
plots of Figure 5.49.
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Figure 5.48.: AF, mcomparison: Showing the correlation between the ranges of six functional
measures investigated in AF. A * indicates significance at the p < 0.05 level.
(Colour scale corresponds to the scale shown in Table 2.5).
Measured LVEF has been shown, particularly in AF, to be affected by both preceding
and indexed beat length, as has EDV/PSV . Both preceding and indexed beat length
are determinants of EDV/PSV since preceding beat length will directly affect PSV
and indexed beat length will affect EDV. In contrast, on a beat-to-beat basis, LVEF
is only affected by the preceding beat length which determines PSV - the inclusion of
the indexed beat in determining measured LVEF is likely to be methodological and not
physiological. The comparison of LVEF and EDV/PSV reflects this as there is only
poor agreement in absolute values but the ranges, which in both cases are principally
affected by beat-to-beat variation, do show an agreement.
5.10.3. LVEF vs. PSV
There is a strong negative correlation between LVEF and PSV in both SR and AF
(ρ = −0.622, p < 1 × 10−5 in SR and ρ = −0.594 and p < 1 × 10−5 in AF); however,
there is no significant correlation between range of LVEF and PSV . Plots showing this
effect in AF are shown in Figure 5.50.
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Figure 5.49.: AF: Showing (a) a plot of LVEF against EDV/PSV and (b) a plot of mLVEF
vs. mEDV/PSV in AF using variable time formatting.
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(b) Ranges: LVEF vs. log(PSV )
Figure 5.50.: Showing a plot of LVEF against log(PSV ) in AF using variable time format-
ting.
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Although the negative correlation suggests that a better LVEF is achieved with a lower
PSV , when correlation is done on a per patient basis (Figure 5.51), it is clear that
the majority of patients have a positive correlation (greater LVEF with greater PSV )
with AF generally showing better correlation (mean ρ = 0.46) compared with SR (mean
ρ = 0.18).
This suggests that the pathological phenomenon whereby an enlarged LV has poorer
ejection fraction is more dominant than the variation of ventricular volume with ejection
fraction for any one patient. That there should be no correlation between the ranges is
surprising and reflects the complexity of a mechanism in which the Frank-Starling effect
is not the only influence on cardiac output.
5.10.4. LVEF vs. FTFF
There is a significant, but weak, correlation between LVEF and FTFF in SR and a very
weak correlation in AF, corroborated by correlation on a patient-by-patient basis. There
is also a strong correlation between range of LVEF and range of FTFF in SR with a
moderate correlation in AF. This is demonstrated in AF in Figure 5.52.
Although these results can be explained physiologically, they may also be the result of
methodological error. It has been shown that shorter indexed beats have lower LVEF.
Since the measure of FTFF is dependent on a determination of the duration of diastole
this is also dependent on the length of the indexed beat (as has been shown in §5.8). If
there is significant variation in the duration of diastole, as there may be in AF, there
may be substantial variation in FTFF with longer beats giving greater FTFF. Thus it
is to be expected that there should be a moderate agreement between range of LVEF
and range of FTFF without any substantial agreement between the measures.
5.10.5. LVEF vs. PFR
A very good correlation is seen between PFR and LVEF in both SR and AF (ρ = 0.836,
p < 1 × 10−5 in SR, ρ = 0.823, p < 1 × 10−5 in AF); however on a patient-by-patient
basis the correlation is much weaker. There is also a strong correlation between the
ranges (ρ = 0.716, p < 1× 10−5 in SR, ρ = 0.675, p < 1× 10−5 in AF).
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Figure 5.51.: LVEF vs. log(PSV ): Showing the Spearman rank correlation coefficients on
a patient-by-patient basis for LVEF against log(PSV ) in (a) SR and (b) AF
using variable time formatting.
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Figure 5.52.: Showing a plot of LVEF against FTFF in AF using variable time formatting.
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As discussed in the introduction to this section (page 239) the discrepancy between the
whole group comparison and that done on a patient-by-patient basis may in part be a
result of the poor statistics involved in regressing with only four points for each patient.
It may also reflect the possibility that a patient may have diastolic dysfunction without
systolic dysfunction while the converse is unlikely.
5.10.6. PSV vs. PFR
There is a highly significant, strong, correlation between PSV and PFR (ρ = −0.535,
p < 1× 10−5 in SR, ρ = −0.513, p < 1× 10−5 in AF) when the group is considered as a
whole. However this is not seen on a patient-by-patient basis nor when the ranges are
compared. See figure 5.53 for the changes seen in AF.
This also reflects the pathological effect of a dilated ventricle and suggests that the
assessment of PFR is likely to reflect physiology rather than a methodological variation
since it is to be expected that the dilated ventricle will have poorer diastolic function.
If the variation in PFR were purely methodological it is unlikely that there would be
such a good correlation when the whole group is considered and it would be reasonable
to expect a better correlation on a patient-by-patient basis.
5.10.7. Systolic time vs. FTFF
There is a highly significant, moderate, correlation between systolic time and FTFF in
both AF and SR (ρ = 0.493, p < 1× 10−5 in SR, ρ = 0.323, p < 1× 10−5 in AF). This
is corroborated by the patient-by-patient analysis and is matched by a good correlation
(ρ = 0.549, p < 1× 10−5) in SR and a weak correlation in AF (ρ = 0.206, p = 0.00006)
between the ranges.
5.10.8. Systolic time vs. PFR
There is a highly significant, but weak, correlation between systolic time and PFR
(ρ = 0.187, p < 1× 10−5 in SR, ρ = 0.190, p < 1× 10−5 in AF). On a patient-by-patient
basis the agreement is shown to be better in AF than it is in SR. When the ranges are
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Figure 5.53.: Showing a plot of the log of PSV against PFR in AF using variable time
formatting. Plot (a) shows a comparison on an image by image basis; (b)
shows the comparison of range on a patient-by-patient basis.
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compared there is found to be good correlation in SR (ρ = 0.470, p < 1 × 10−5) and
weak correlation in AF (ρ = 0.205, p = 0.00006).
5.10.9. EDV/PSV vs. FTFF
A highly significant poor correlation is seen when comparing EDV/PSV and FTFF
(ρ = 0.173, p < 1× 10−5) in SR. In AF the correlation is good (ρ = 0.599, p < 1× 10−5)
as illustrated in Figure 5.54. The agreement here actually looks like it is exponential
and a more natural regression line is achievable if the log of FTFF is taken, Figure 5.54c
(although because the Spearman rank correlation is non-parametric this doesn’t change
the correlation coefficient). These results agree with those achieved when the correlation
is considered on a patient-by-patient basis.
Comparing the ranges shows a moderate correlation in SR(ρ = 0.384, p < 1× 10−5) and
AF (ρ = 0.468, p < 1× 10−5).
EDV/PSV is a measure of the variation in filled volume from one beat to the next, as
such it offers a means of determining how consistently a fixed volume is achieved during
filling. Thus EDV/PSV is a surrogate marker for variation in diastole and since FTFF
is determined by the duration of diastole there is likely to be good correlation in AF
where the duration of diastole changes significantly but not in SR where there is little
change in the duration of diastole.
5.10.10. EDV/PSV vs. PFR
There is a highly significant weak correlation between EDV/PSV and PFR (ρ = 0.162,
p < 1 × 10−5 in SR, ρ = 0.312, p < 1 × 10−5 in AF) with good correlation between
the ranges in both SR and AF (ρ = 0.691, p < 1 × 10−5, ρ = 0.597, p < 1 × 10−5)
respectively. More rapid filling is likely to result in a greater end-diastolic volume and
the plateau phase of diastole will be reached more quickly. It is, then, to be expected
that there will be a relationship between PFR and EDV/PSV .
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Figure 5.54.: Showing (a) a plot of EDV/PSV against FTFF in AF using variable time
formatting. (b) A plot of the range of EDV/PSV against range of FTFF. (c)
A plot of EDV/PSV against log(FTFF) where a more linear relationship is
found.
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5.10.11. FTFF vs. PFR
It is to be expected that there will be good correlation when comparing between both
the individual values and the ranges of FTFF and PFR. Physiologically both FTFF
and PFR are indices of diastolic filling, methodologically they are both affected by the
duration of diastole. The good correlation is confirmed in both SR and AF although it
unclear whether the correlation has a physiological or methodological aetiology.
5.11. Going forward
Having determined these results and, for most variables, demonstrated substantial vari-
ation in the functional measures being investigated with differing beat selection criteria,
it is now possible to consider whether there is any relationship between the functional
measures and the indicators of rhythm described in Chapter 3. This will be the subject
of the following chapter.
Chapter 6.
Results: Comparing Rhythm and
Function
CALVIN AND HOBBES c©1990 Watterson. Reprinted with permission of UNIVERSAL Uclick. All rights reserved.
Summary
In which we look at the relationship between rhythm and function as described in this
thesis. The comparison is made using Spearman Rank correlation for uni-variate com-
parison and regression testing to allow multivariate models to be used.
6.1. Introduction
The principal measure of left ventricular function in the clinical context is left ventricular
ejection fraction (LVEF). As a result, while several measures of both diastolic and systolic
function have been investigated, this thesis has concentrated on LVEF. It has been shown
in Chapter 5 that in both SR and AF there is a substantial, and significant, variation
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in LVEF depending on the beat selection criteria. In AF the variation (mean mLVEF
of 14.3 EF units) has been shown to have a clear dependence on the beat selection
criteria: in particular there is a very strong positive correlation with the duration of the
preceding beat and a weaker negative correlation with the length of the indexed beat.
In SR, although there is a substantial variation (mean mLVEF of 8.2 EF units), it does
not correlate with either preceding or indexed beat length.
In Chapter 3 several measures were investigated to describe the rhythm. These measures
were selected in an attempt to provide a complete description of rhythm covering not
simply the mean and range of R-R intervals but also measures which describe the pattern,
regularity and complexity of the rhythm.
Since the variation in LVEF for any patient is achieved by varying the indexed and
preceding beat selection criteria, it is reasonable to expect that there will be some level
of agreement between measures of rhythm and functional variation.
6.2. Correlation
A correlation matrix comparing individual measures of rhythm with the SD of each
measure of function are shown in Figures 6.1 (SR) and 6.2 (AF). The SD has been chosen
as the measure of choice rather than the maximum range because it is less influenced
by single outliers. A comparison against the maximum range in functional measurement
can be found in appendix D.
In addition to the comparison against SD, a comparison of the mean functional result
(over all measured combinations of preceding and indexed beat using variable time for-
matting) has been performed. The results of this are shown in Figures 6.3 and 6.4.
The correlations with SD of the functional measures are, at best, moderate in both SR
and AF and many of them are not significant. This is surprising as there are several
measures e.g. EDV/PSV which could be expected to be well described by some measure
of rhythm variability.
When the agreement between mean functional measure and the indices of rhythm are
considered, the majority of the results are either not significant or show only a weak
correlation although there are several which show a strong agreement.
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StDev of function index
Age
Mean RR
SDRR
RMSSD
pRR50
RR Range
Correlation
Compactness
Shannon E
Symdyn E
Sample E
Swing
−0.31 *0.1 * −0.13 *−0.32 * −0.23 * −0.35 *
0.27 *−0.01 0.27 *0.31 * 0.27 * 0.33 *
0.05 0.01 0.14 *0.08 0.16 * 0.06 
0.2 *0.03 0.22 *0.3 * 0.27 * 0.32 *
0.11 *0.04 0.22 *0.18 * 0.2 * 0.2 *
0.21 *−0.01 0.06 0.24 * 0.12 * 0.3 *
0.12 *0.03 0.16 *0.19 * 0.2 * 0.23 *
0.08 −0.01 0.19 *0.13 * 0.15 * 0.16 *
0.05 0.07 0.27 *0.1 * 0.15 * 0.22 *
0.12 *0.04 0.16 *0.21 * 0.2 * 0.25 *
−0.07 0.21 * 0.3 *−0.05 0.09 0.05 
−0.08 0.1 0.04 −0.08 −0.16 * −0.02 
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Figure 6.1.: SR: Showing the correlation between measures of R-R variability and the SD of
measures of function (per patient) in SR. (N=387).
Results: Comparing Rhythm and Function 257
StDev of function index
Age
Mean RR
SDRR
RMSSD
pRR50
RR Range
Correlation
Compactness
Shannon E
Symdyn E
Sample E
Swing 0.1 −0.1 0.11 *0.1 0 −0.12 *
0.11 *−0.19 * 0.18 *0.25 * 0.09 0.18 *
0.16 *0.08 −0.13 *0.03 0.2 * 0.25 *
0.12 *−0.17 * 0.19 *0.29 * 0.13 * 0.17 *
0.08 0.04 0.19 *0.13 * 0.07 −0.02 
−0.12 *0.15 * −0.06 −0.12 * 0.03 0.08 
−0.07 0.15 * 0.23 *0.16 * 0.3 * 0.06 
0.01 0.11 * 0.17 *0.15 * 0.32 * 0.18 *
−0.09 0.23 * 0.12 *0.13 * 0.39 * 0.2 *
−0.1 0.25 * 0.12 *0.13 * 0.4 * 0.2 *
−0.46 *0.17 * −0.02 −0.27 * 0.16 * 0.12 *
0 0.09 −0.08 −0.11 * 0.08 0.2 *
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Figure 6.2.: AF: Showing the correlation between measures of R-R variability and the SD of
measures of function (per patient) in AF. (N=373).
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Mean function index
Age
Mean RR
SDRR
RMSSD
pRR50
RR Range
Correlation
Compactness
Shannon E
Symdyn E
Sample E
Swing 0.07 0.28 * 0.17 *−0.3 * 0.01 −0.27 *
−0.07 −0.14 * 0.36 *0.16 * 0.37 * 0.27 *
−0.02 0.02 0.19 *−0.09 0.15 * 0 
−0.09 −0.12 * 0.24 *0.15 * 0.34 * 0.25 *
−0.08 −0.01 0.39 *0.03 0.35 * 0.14 *
−0.09 −0.27 * −0.07 0.31 * 0.08 0.27 *
−0.09 −0.06 0.27 *0.06 0.26 * 0.15 *
−0.02 0 0.36 *−0.02 0.28 * 0.1 
−0.06 0.01 0.61 *0.04 0.59 * 0.18 *
−0.15 *−0.06 0.3 *0.09 0.3 * 0.17 *
0.01 0.2 * 0.67 *−0.08 0.67 * 0.07 
0.04 0.09 0.23 *0.03 −0.07 −0.03 
LV
EF
PS
 vo
l
FT
F
PF
R
ED
V/
PS
V
ES
 ti
m
e
Correlation
rho
1.0
0.9
0.7
0.5
0.3
0.1
0.0
−0.1
−0.3
−0.5
−0.7
−0.9
−1.0
Figure 6.3.: SR: Showing the correlation between measures of R-R variability and the mean
measures of function (per patient) in SR. (N=387).
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Mean function index
Age
Mean RR
SDRR
RMSSD
pRR50
RR Range
Correlation
Compactness
Shannon E
Symdyn E
Sample E
Swing
−0.16 *−0.08 −0.18 *−0.11 * −0.24 * −0.17 *
0.12 *−0.23 * 0.06 0.15 * 0.21 * 0.12 *
0.08 −0.02 0.08 0.17 * 0.15 * 0.2 *
0.12 *−0.2 * 0.04 0.1 * 0.22 * 0.08 
−0.09 0.01 −0.03 −0.01 −0.01 −0.06 
0.11 *0.13 * 0.14 *0.05 0.19 * 0.11 *
0.1 *0.16 * 0.25 *−0.1 0.31 * −0.05 
0.18 *0.11 * 0.25 *0.03 0.4 * 0.07 
0.24 *0.22 * 0.39 *0.01 0.51 * 0.12 *
0.23 *0.23 * 0.38 *−0.01 0.51 * 0.1 
0.47 *0.27 * 0.66 *0.13 * 0.77 * 0.3 *
0.16 *0.02 0.34 *0.22 * 0.24 * 0.29 *
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Figure 6.4.: AF: Showing the correlation between measures of R-R variability and the mean
measures of function (per patient) in AF. (N=373).
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The individual results are discussed in §6.4 to §6.9; however, while correlation between
individual variables offers an initial insight into the potential for indices of rhythm to
act as descriptors for functional change it is more likely that multiple indices of rhythm
will be required. This can be investigated through regression modelling.
6.3. Regression modelling
The absence of a strong correlation between the range of LVEF and any individual
measure of R-R variability is not surprising as it has been shown that on a patient-
by-patient basis there is a strong correlation with both preceding and indexed beat.
No single measure reflects this; however, since beat selection criteria appear to be the
principal determinants of mLVEF in AF, it should be possible to determine a combination
of measures which are predictive of the range of LVEF.
If the range of R-R intervals is very small it is unlikely that there will be a substantial
variation in LVEF while a large range of R-R intervals offers scope for a greater variation
in LVEF. Thus it is to be expected that the range of R-R interval will be a significant
factor in determining LVEF range, to some extent this is corroborated by the weak
correlation between LVEF and R-R range which is seen in both AF (ρ = 0.19 in SR,
ρ = 0.16 in AF).
The range of R-R interval does not, by itself, offer a model of range of LVEF, since it
does not include any information about the sequential beat patterns (e.g. a beat in Q1,
followed by a beat in Q3, followed by a beat in Q4 followed by a beat in Q1 etc.) which
is included in selecting beats based on both the preceding and indexed beat. There are
several different measures which reflect this variation and which, when included with
a measure of R-R range, may contribute to an accurate model of the extent of LVEF
variability.
Entropy measures provide an assessment of the regularity of the R-R interval stream:
effectively a measure of the repeating patterns of R-R variability. While ShanEnt offers
a very basic measure, both SampEn and SymDyn attempt to incorporate information
about patterns of different lengths and therefore offer an assessment of pattern as opposed
to beat regularity.
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Swing is a measure of the frequency with which the R-R intervals alternate in a “short-
long” or “long-short” pattern. It is a crude measure in that it does not include any
information about the size of the swing, just that swing occurs. Thus an R-R interval
stream which followed the pattern (4,3,4,2,4,3) would have the same swing as a stream
in which the beats followed the pattern: (4,1,4,1,4,1) although in the second case there
is a bigger swing and higher regularity (and lower entropy).
Compactness factor gives a measure of clustering within the Poincare´ plot: the more
clustered the data, the lower the compactness factor. This could be considered to be a
measure of complexity (as opposed to regularity). Because the measure is taken from
the Poincare´ plot it incorporates information about the association between one beat
and the next as well as about the range of R-R intervals.
Poincare´ correlation gives a measure of how well one beat agrees with the next, but does
not address long term variation at all.
6.3.1. Modelling
Any model should adhere to several fundamental rules: the model should not involve an
excessive number of terms (in an extreme situation a model which has as many terms as
there are elements to be modelled will give a perfect, and perfectly meaningless, model).
The model should include enough terms to have predictive value1 (effectively a significant
and high value for R2) and it should not include terms which do not significantly change
or improve the model (either explicitly or implicitly - e.g. R-R range is reflected both in
the range and in the SD). Ideally, in this study, it should also work in both AF and SR.
The uni-variate correlation tables, shown in Figure 6.1 and Figure 6.2, offer a starting
point for determining a suitable model as it is unlikely that a term will be significant in
a multivariate model if it is not significant in a uni-variate analysis, although this clearly
can not be true for interaction terms.
The format of Table 6.1 presents an easy means of determining potentially significant
contributors to the multivariate model. The table allocates a tick (X) for every 0.1 in
the uni-variate (Spearman rank) correlation coefficient: the greater the number of ticks
the higher the uni-variate correlation.
1R is used here to indicate that parametric statistics have been used, by contrast ρ is used to indicate
non-parametric correlation.
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AF SR
Age X
Mean R-R XX
SDRR X X
RMSSD X X
pRR50 X X
R-R Range X X
Correlation X XX
Compactness factor X X
ShanEnt XX XXX
SymDyn
SampEn XX XXX
Swing X XXX
Table 6.1.: Showing the potential terms for inclusion in the model of LVEF. Each “X” marks
a change of 0.1 in the uni-variate regression coefficient.
Initial models in the regression analysis were chosen to include the most significant terms
in both AF and SR combined. A successive reduction technique was then used to find
the smallest possible predictive model: the least significant terms in the model were
successively removed and the new model compared (using an Anova technique) against
the old one. If no significant difference was found, that element was removed from the
model otherwise it was kept in. This technique is fully described in “The R book” [93].
While the successive reduction technique was applied in all cases, it results in different
final models for SR and AF and the elements removed from the model are typically
interaction terms (e.g. mean RR:SampEn) that describe an element which only has
effect in combination. This thesis has been considering potential rhythm descriptors for
the function measures but it is beyond the scope of the thesis to investigate the detail of
all the interaction terms. Thus, to allow the reader an easier understanding, the initial
model and the R2 value for that model have been reported; the final minimum adequate
model, which might typically consist of eight or ten interaction terms, has not been
reported. Since successive removal of multiple elements does affect the value of R2 the
R2 value for the minimum adequate model has also been given.
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6.4. LVEF
It can be seen from Figures 6.1 to 6.4 that in terms of mean LVEF there is a moderate
correlation with Poincare´ correlation and swing in SR and with age in AF. Otherwise
the correlation is either weak or not significant. When mLVEF, expressed in terms of
the SD, is considered there is a moderate negative correlation with mean R-R interval
in AF, with only a poor negative correlation in SR. In SR there is moderate correlation
between mLVEF and swing, the proportion of beat-to-beat changes which follow a pattern
of being either “short-long” or “long-short”, and with both SampEn and ShanEnt . In
AF a correlation between mLVEF and SampEn and ShanEnt is found but there is only
poor correlation with swing . Curiously there is a moderate positive correlation with
Poincare´ correlation in SR, but a weak negative correlation in AF.
A consideration of Figure 6.1 and the summary table, 6.1 suggests that the most promis-
ing measures of R-R variability which might be used in predictive model are: ShanEnt ,
SampEn, swing , SDRR, and Poincare´ correlation; in AF, mean R-R is also significant.
ShanEnt and SampEn have been shown to be closely related and are likely simply to
duplicate information. This suggests the following possible model2:
m LV EF ∼ SampEn ∗mean RR ∗ swing ∗ correlation ∗ SDRR
This model gives a good correlation with R2 = 0.307, R = 0.554 (R2 = 0.252, R = 0.502
after successive reduction) in AF and R2 = 0.300, R = 547 (R2 = 0.287, R = 0.536 after
successive reduction) in SR.
Although the correlation is not perfect LVEF variation is well described by a combination
of the traditional measures of mean R-R and SDRR, the correlation of the Poincare´ plot,
which describes how well related one beat is to the next, the swing, which describes
the regularity of the short-long-short beat pattern and SampEn which describes the
repetitiveness of beat patterns. Each of these indices clearly define a different aspect of
rhythm variation. Although each aspect does not in itself have a substantial impact on
LVEF, in combination they have a large determining effect. There will be other effects,
most notably pathology, which will also affect LVEF and which have not been included
in this investigation.
2Notation in defining models: “∼” can be interpreted as “is modelled by”; “+” separates the elements
of the model; “:” implies the interaction between elements which it separates and “*” is a shorthand
for “+” including the interaction term. Thus A ∼ B ∗C ∗D is shorthand for A ∼ B +C +D +B :
C +B : D + C : D +B : C : D
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6.5. EDV/PSV
Both EDV/PSV and mEDV/PSV (expressed by SD) show a moderate correlation with
mean R-R interval in AF (Figures 6.2 and 6.4) but not in SR (Figures 6.1 and 6.3) for
which there are no indices of rhythm that show more than a weak correlation with mean
EDV/PSV . In SR there is a moderate correlation between mEDV/PSV and swing,
and a correlation in the upper range of “poor” between mEDV/PSV and SampEn.
Examination of Figures 6.2 and 6.1 suggests that the most promising R-R variability
indices for correlation against EDV/PSV are: swing, SampEn, correlation and mean
R-R, suggesting an initial model in which:
m EDV/PSV ∼ swing ∗ SampEn ∗ correlation ∗mean RR
This model gives a correlation of R2 = 0.291, R = 0.540 (R2 = 0.278, R = 0.527 after
model simplification) in AF and R2 = 0.192, R = 0.438 (R2 = 0.127, R = 0.356 after
model simplification) in SR.
This appears to a be a good model in AF but only a moderate model in SR. It is
surprising that the R-R range does not appear to substantially affect m EDV/PSV in
either AF or SR as it would be expected that a very short beat followed by a very long
beat would give a high value for EDV/PSV , similarly a very long beat followed by a
very short beat would be expected to give a low value for EDV/PSV . Two conclusions
can be determined from these results and those of §5.6: the variation in volume in SR
is insufficient to cause marked variation in EDV/PSV and the pattern of beat change
as described by swing and SampEn, is more significant than the extent of beat change.
This can be understood by considering that if the longest beats are never preceded or
followed by the shortest beats the variation in PSV or EDV will never be maximised
resulting in a reduced mEDV/PSV .
6.6. PSV
Investigation of Figures 6.1 to 6.4 finds that in both AF and SR there are no indices of
rhythm which show even a moderate correlation with either PSV or mPSV (as described
by the SD) although there are several for which ρ > 0.2.
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When considering mean PSV the most significant correlations are with mean R-R,
SDRR, RMSSD and SampEn (negative) in AF while in SR the most significant de-
scriptors are mean R-R, Poincare´ correlation (negative) and swing. These results are
generally in line with theory which would suggest that longer R-R intervals allow greater
filling and that the more chaotic the rhythm (increased SampEn) the more blurred (and
therefore reduced) the result. In SR a higher Poincare´ correlation generally suggests a
poorer R-R variability, which is associated with reduced function.
In terms of mPSV , the most significant correlation in SR is with mean R-R intervals
while in AF it is with RMSSD and SDRR. None of these offer a clear set of indices
against which multivariate regression can be performed. A model which includes mean
R-R, SDRR, swing and SampEn was investigated against log(PSV ) which has been
shown to be more closely normally distributed.
log(PSV ) ∼ mean RR ∗ swing ∗ SampEn ∗ SDRR
This model gives only moderate correlation R2 = 0.144.R = 0.379 (R2 = 0.133, R =
0.365 after successive reduction) in AF and R2 = 0.109, R = 0.33 (R2 = 0.079, R = 0.281
after successive reduction) in SR. In the reduction in SR the swing term falls out of the
model in all but the complete interaction term.
These results suggest that while PSV has been shown to vary significantly with beat
selection criteria (§5.5) the variation is poorly explained by indices of rhythm.
6.7. Systolic time
In both SR and AF there is a strong correlation between systolic time interval and mean
R-R. While there is also a strong correlation with RMSSD in SR, the correlation is only
moderate in AF. The correlation between mean R-R and systolic time is to be expected
as systolic time is a component of the R-R interval. The relationship between systolic
time and RMSSD is less clear, suggesting that the greater the variability between beats
the longer the systolic time interval. This may reflect pathology (shorter beats producing
less output) or it may be a statistical error resulting from the inclusion of longer beats.
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The range of systolic time (msystole) correlates poorly with all measures of R-R variabil-
ity in both AF and SR with the best agreement being with R-R range in AF and with
mean R-R, SampEn, compactness factor and RMSSD in SR.
This suggests a multivariate regression model in which m systole ∼ mean RR ∗
SampEn ∗ compactness ∗RR range
In AF this gives R2 = 0.158, R = 0.397 (R2 = 0.147, R = 0.383 after successive reduc-
tion). In SR, R2 = 0.144, R = 0.379 (R2 = 0.119, R = 0.344 after successive reduction).
These results suggest that the rhythm indices chosen describe systolic time variation
only moderately well.
6.8. FTFF
Mean FTFF shows strong correlation in both AF and SR with mean R-R interval and
RMSSD. In AF there is also a strong correlation with SDRR although the correlation is
only moderate in SR.
mFTFF in SR shows a weak correlation with ShanEnt and SampEn and with swing, but
otherwise does not correlate with any of the other functional measures. In AF, however,
there is moderate correlation between the variation in mFTFF and RMSSD, SDRR, R-R
range and pRR50.
It is difficult to see how these can be combined in a multivariate model which describes
both AF and SR and although several models were tried they did not substantially add
to the description of variation of FTFF in either SR (where R2 = 0.05, R = 0.22) or AF
where the model: m FTFF ∼ RR range ∗ SDRR ∗ pRR50 ∗RMSSD
gave R2 = 0.157, R = 0.396 (p < 0.00001). Successive reduction could not improve these
results.
The inconsistency of these results in AF and SR suggests, as has been discussed previ-
ously, that FTFF in the context of AF (or SR if there are ectopic beats) is methodolog-
ically flawed.
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6.9. PFR
PFR correlates moderately well with age and mean R-R interval in AF, but not in SR
where there is better correlation with entropy, swing (negative) and Poincare´ correlation.
mPFR correlates only poorly with any of the indices of rhythm in AF, although there
is moderate correlation between mPFR and SampEn, swing (negative) and Poincare´
correlation in SR.
As with FTFF, no consistent multivariate regression model could be found that described
mPFR in both SR and AF. In AF, no model could be found that added to the description
of the variation. In SR the model:
m PFR ∼ swing ∗ SampEn ∗ correlation ∗RMSSD
found R2 = 0.235, R = 0.484 (R2 = 0.226, R = 0.475).
This suggests that the measurement of PFR in AF may be flawed as there is no clear
descriptor for it, although the moderate correlation with age is unexpected and suggests
there may be a valid physiological explanation for the measurements which are seen.
In SR the principal descriptors of mPFR have been shown to be associated with beat-to-
beat change, with generally more variable rhythms leading to higher PFR. This suggests
that variability in PFR may be a marker of cardiac health, because in SR HRV has also
been shown to be indicative of cardiac health.
6.10. Going forward
A clear relationship between the functional parameters and patterns of beats (in this
case sequences of just two beats) has been demonstrated in Chapter 5. In this chapter
we have seen that overall indices of rhythm do not individually describe variations in
the functional parameters that have been measured in this study. However in assessing
variation in systolic parameters, combinations of rhythm descriptors - in particular Sam-
pEn, swing , mean R-R and the Poincare´ correlation - have been shown to have much
better predictive value than any single index alone.
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These results will be brought together in the general discussion (Chapter 8). In order
to put the measures in a clinical context, they have been investigated in a small clinical
study. This will form the subject of the next chapter.
Chapter 7.
Clinical Application: AF Ablation
CALVIN AND HOBBES c©1988 Watterson. Reprinted with permission of UNIVERSAL Uclick. All rights reserved.
Summary
In which the AF ablation study is described together with the general results that were
found. The study is used to assess any predictive potential of rhythm and functional
measures investigated in this thesis, and to compare rhythm measures on a serial basis.
7.1. Introduction
It has been shown that there is a substantial variation in functional measures for patients
in AF and that different methodological techniques can produce results which represent
significant physiological change. These differences result from physical beat-to-beat vari-
ations in cardiac function which, although they are seen to a limited extent in SR, are
particularly prevalent in AF. Patients in AF experience a variety of symptoms which
269
Clinical Application: AF Ablation 270
are, at least in part, a direct result of the beat-to-beat changes, but there a remains
a question as to whether beat-to-beat changes are clinically significant. A second, re-
lated, question is: how is function best measured in patients with AF where functional
measures appear to change so much?
The department of Nuclear Cardiology at Glasgow Royal Infirmary was involved in a
study investigating the effect of radio-frequency ablation (RFA) in patients with persis-
tent AF and advanced heart failure. This study offered the opportunity to apply the
techniques which have been described in the rest of this thesis in a clinical context: a
small series of patients in AF who were assessed pre and post randomised intervention.
7.2. AF ablation study
The AF ablation study, which has since been published by McDonald et al. [94], consid-
ered the response of patients to RFA. 41 patients were recruited to the study if despite
optimal medical therapy they had New York Heart Association functional class II - IV,
ongoing symptoms despite, LV EF < 35% (as measured using RNVG), and persistent
AF. Patients were randomised to either RFA (22 patients) or medical therapy (19 pa-
tients). All patients had received optimal medical therapy for at least 3 months.
Patients randomised to medical therapy remained on optimal medical therapy; patients
randomised and treated with RFA to isolate the pulmonary veins had isolation of all 4
veins, with additional ablation at sites of complex fractionated electrocardiograms. If
after RFA the patient remained in AF, SR was restored by cardioversion. On follow-up
(six months after the initial randomisation) if the patient had returned to AF a second
RFA procedure was carried out and the patient had a final follow-up 3 months later
(approximately 9 months after the initial baseline assessment).
The following assessments were made, in both groups of patients, at baseline and in the
final visit: physical examination, 12 lead ECG, 24 hour ambulatory ECG, six minute
walk test, and LVEF measured using both cardiovascular magnetic resonance imaging,
CMRI, and RNVG. A change in LVEF by CMRI was defined as the primary end-point.
The study was funded by the Office of the Chief Scientist, Scotland (grant number:
CZB4475) and was given ethical approval by the West Glasgow Research Ethics Com-
mittee.
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Intervention No in group Mean R-R pre (s) Mean R-R post (s) Mean LVEF pre (%) Mean LVEF post (%) No in SR post
Ablation 20 0.863 0.857 16.1 23.3 10
Medical therapy 17 0.848 0.886 19.6 21.04 0
Table 7.1.: AF ablation summary results for LVEF and rhythm calculated from RNVG.
7.2.1. Summary results
Table 7.1 shows the principal results (in terms of RNVG) for the two groups of patients.
After six months (three months if a second RFA was required) 10 patients remained in
SR. Post hoc analysis showed a significant increase in LVEF assessed by both CMRI
and RNVG for those in SR. This improvement could be seen (using CMRI) as early as
one week after RFA. In the remaining patients however, no significant change was found
in LVEF by CMRI (p = 0.6) or in other factors (BNP, 6 minute walk and quality of life
score) although an increase in LVEF 1 by RNVG was found to be significant (p = 0.032).
Unfortunately there was found to be a significant risk of complication, with one pa-
tient having a stroke, two patients developing cardiac tamponade and three patients
developing worsening heart failure. With no change in the defined primary end-point
of improved LVEF by CMRI (when all patients randomised to RFA were considered)
and with a significant rate of complication it was concluded that RFA did not produce
sufficient benefit for it to be considered in the future treatment of patients falling into
this group.
7.3. Application to current study
The AF ablation study presents two groups of patients: those randomised to medical
therapy for whom there was little further intervention and those randomised to RFA.
These two groups offer the potential to investigate the serial reproducibility (in the group
randomised to medical therapy) of measures both of rhythm and of function as well as
the potential predictive value of these measures (in the group randomised to RFA).
The R-R interval stream and images formatted using all beats were available for fur-
ther investigation but unfortunately a backup failure meant that 19 of the list-mode
acquisitions for the patients in this study were lost, precluding some of the analysis.
1Measured using all beats
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7.4. Rhythm measures
The indices of rhythm which have been considered in this thesis can be applied to the
images acquired as part of the AF ablation study. In doing so they offer some insight
into the way that rhythm changes, principally as a result of successful RFA, but also
due to therapy and failed RFA. The serial nature of the study also offers some insight
into the reproducibility of the indices.
7.4.1. Standard linear HRV measures
Comparing the main HRV measures: mean R-R, SDRR, RMSSDrr, pRR50 and R-R
range finds a substantial difference in those patients who went into and maintained SR as
a result of RFA, but in the remainder of patients there was little change (see Table 7.2).
Several of the patients who maintained SR, demonstrated a substantial increase in mean
resting R-R to the extent that the SR group showed an average increase in resting R-R
of 17%, although those patients on medical therapy, or who returned to AF after RFA,
all showed a minimal, non-significant, change in mean resting R-R interval (0.7% and
3.5% respectively). The slowing of heart rate is an expected, and desirable, outcome of
successful RFA.
A positive change was seen in SDRR for every patient who responded suggesting that
a significant (p = 0.004) decrease in SDRR was seen. This is to be expected as there
should be much less variation in SR. The change in the other groups was not significant.
The same pattern was followed for RMSSD and pRR50. Slightly curiously, the same
is not true for R-R range for which no change was seen in the patients who underwent
RFA, although a slightly significant (p = 0.041) increase was seen in the R-R range of
the patients who had medical therapy; however, this can be attributed to the inclusion
of ectopic beats in the calculation of R-R range. When these were excluded (from both
early and late acquisitions) no significant change was seen.
7.4.2. Poincare´ measures
The R-R range for patients who maintained SR after RFA has been shown not to change
significantly (§7.4.1). Review of the Poincare´ plots for these patients demonstrates that
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All mean pre Group mean pre Group mean post post - pre p-value
Mean R-R 0.85 0.86 0.86 0.01 0.81
SDRR 0.24 0.21 0.25 0.04 0.09
RMSSD 0.34 0.40 0.35 0.05 0.17
pRR50 82.59 83.62 83.14 -0.47 0.66
R-R range 2.07 1.87 2.64 0.77 0.04
Swing 0.66 0.66 0.67 0.00 0.46
Compactness factor 9.54 10.62 11.87 1.25 0.54
Poincare´ correlation 0.01 0.01 0.03 0.02 0.95
ShanEnt 3.33 3.33 3.38 0.05 0.73
SymDyn 3.71 3.79 3.70 -0.09 0.33
SampEn 3.54 3.76 3.50 -0.34 0.001
(a) Medical therapy (N=16)
All mean pre Group mean pre Group mean post post - pre p-value
Mean R-R 0.85 0.90 0.86 -0.03 0.40
SDRR 0.24 0.26 0.24 -0.02 0.53
RMSSD 0.34 0.37 0.34 -0.03 0.48
pRR50 82.59 84.60 81.96 -2.64 0.16
R-R range 2.07 2.52 2.46 -0.06 0.95
Swing 0.66 0.67 0.66 -0.01 0.55
Compactness factor 9.54 11.67 11.55 -0.12 0.84
Poincare´ correlation 0.01 -0.03 0.00 0.03 0.54
ShanEnt 3.33 3.43 3.27 -0.16 0.12
SymDyn 3.71 3.73 3.64 -0.08 0.80
SampEn 3.54 3.81 3.49 -0.31 0.30
(b) RFA (AF) (N=11)
All mean pre Group mean pre Group mean post post - pre p-value
Mean R-R (%) 0.85 0.82 0.98 0.16 (17%) 0.16
SDRR (%) 0.24 0.29 0.12 -0.17 0.004
RMSSD (%) 0.34 0.40 0.17 -0.23 0.008
pRR50 (%) 82.59 79.53 26.04 -53.49 0.004
R-R range (s) 2.07 2.19 1.49 -0.69 0.50
Swing 0.66 0.67 0.72 0.05 0.16
Compactness factor (s−2) 9.54 6.07 1.53 -4.55 0.02
Poincare´ correlation 0.01 0.06 0.15 0.09 0.65
ShanEnt 3.33 3.29 2.01 -1.28 0.004
SymDyn 3.71 3.56 2.45 -1.12 0.01
SampEn 3.54 3.16 1.51 -1.65 0.004
(c) RFA (SR) (N=8)
Table 7.2.: Mean rhythm indices pre and post intervention in the AF ablation study. Change
(post - pre) in rhythm measures is given together with the p-value from a paired
Wilcoxon test to compare the results pre and post. (The minor discrepancies are
due to rounding errors in reporting values.)
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although patients are in SR their Poincare´ plots are, except in one case, not typical of
SR, having ectopic beats and other abnormalities of rhythm.
Three distinct patterns emerged: a single patient showed normal SR with a plot similar
to that shown in Figure 3.7. Three patients showed plots with wide distributions (type
I) such as that shown in Figure 7.1a, these plots show SR (it should be possible to
define an ellipse which tightly encompasses the majority of beats) but the R-R range
is substantial. Four patients showed plots similar to that shown in Figure 7.1b (type
II) in which there appear to be many points of focus. The dominant R-R interval lies
on the line of identity (in this example between about 0.8 s and 1.0 s) but the range of
focus points suggest regular ectopic beats which are likely to have the same aetiology,
although what that is cannot be defined from the Poincare´ plot.
Several measures related to the Poincare´ plot have been investigated in this thesis: swing ,
correlation and compactness factor . Swing , which measures the proportion of beat-to-
beat changes which follow the “long-short-long” pattern, is found not to change signif-
icantly in any of the groups. Generally, although there is a difference between SR and
AF in the population as a whole (see §3.3.3), there is no reason to expect that swing
should change when a patient changes from AF to SR as a result of RFA; although the
extent of the difference between a long beat and a short beat might be expected to be
reduced. The small variation between successive measurements for each of the patients
suggests that the measure is consistent.
Patients who maintained SR following RFA exhibited a significant decrease in com-
pactness factor , although there was no significant difference in compactness factor in
patients who were in AF at the end of the study. This change is to be expected as com-
pactness factor measures are significantly different for patients in AF compared with SR
(§3.3.2). Although there was significant decrease in compactness factor (suggesting that
the Poincare´ plot becomes more compact) the compactness factor for patients in SR af-
ter RFA was substantially greater than in the general SR population (6.4 /s2 compared
with 0.8 /s2 in the SR population - see §3.3.2).
No significant change was seen in the Poincare´ correlation coefficient for any of the
groups, although variation in correlation coefficient was substantial and of the same order
of magnitude as the correlation coefficient. This suggests that there is little consistency
in this measure. See Figure 7.2.
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Figure 7.1.: Typical examples of the two main types of Poincare´ plot for patients in SR
following RFA in AF ablation study.
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Figure 7.2.: Change in Poincare´ correlation coefficient between a patient being accepted on
the study and at follow-up (6 to 9 months later).
7.4.3. Entropy measures
Three different measures of entropy were investigated: Sample entropy, SampEn; Shan-
non entropy, ShanEnt ; and entropy of symbolic dynamics, SymDyn. Of these the most
important result was found in SampEn, this result can be seen in Figure 7.3. There
is a clear separation, when considering the SampEnbefore intervention, between the
majority of the responders (those patients who maintained SR after ablation) and the
remainder of the patients. When the responders to RFA are compared with those who
did not respond, a significant difference is found in the SampEn (p = 0.042). Mean
SampEn at the start of the study in those patients who responded was 3.16 while in
those patients who did not respond, but who did have RFA, the mean SampEn was
3.81. The minimum SampEn in the non-responders was 3.35 while in the responders it
was 2.03. Although the full range of SampEn is present in the responders this is not
true for the non-responders suggesting that if a patient has a SampEn of less than 3.3
they will maintain SR after RFA. This is a very small sample of patients and, while it
is statistically significant, a result of this nature needs considerably more investigation.
It is possible that in a larger patient sample there will not be such clear cut-off and
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Figure 7.3.: Showing the effect of intervention (either medical therapy or ablation) on Sam-
pEn in the patients recruited to the AF ablation study.
that two overlapping ranges would be established which suggest a likelihood of a patient
maintaining SR after RFA.
Apart from the clear separation of responders, Figure 7.3 also demonstrates that while
there is a substantial change in most of the patients who maintained SR the change
is much smaller in all the other patients although in each case the change is generally
negative suggesting that SampEn improved even with medical therapy only.
The other measures of entropy (ShanEnt and SymDyn) showed a similar pattern of
change to the more standard measures of rhythm (see Figure 7.4). ShanEnt demon-
strated a significant decrease (p = 0.004) in those patients who responded to RFA but
showed no significant change in the other patients (although there was a general trend
towards decreasing entropy). This is in keeping with the lower entropy values which are
associated with SR when compared with AF.
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Figure 7.4.: Showing the effect of intervention (either medical therapy or ablation) on Sha-
nEnt in the patients recruited to the AF ablation study.
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Figure 7.5.: Showing the effect of intervention (either medical therapy or ablation) on entropy
of SymDyn in the patients recruited to the AF ablation study.
SymDyn, which like SampEn includes some information about beat sequence, suggests
the potential for discriminating between patients who will respond to RFA. Mean Sym-
Dyn at the start of the study in the group who went on to have RFA was 3.56 in those
patients who remained in SR and 3.73 in those patients who did not. However, this
difference was not found to be statistically significant (see Figure 7.5).
A change in SymDyn that was considered statistically significant (p = 0.01) was found
in those patients who changed from AF to SR as a result of RFA, but there was no
difference for the other patients. A Bland-Altman style analysis [85] found no difference
in the measures.
Table 7.3 shows, for each patient who responded to RFA, the change in ShanEnt , Sym-
Dyn and SampEn between the initial and final assessments. It can be seen that with one
exception (SymDyn for patient 9) there was a decrease in all measures of entropy. While
the different measures of entropy give substantially different values there is a general
Clinical Application: AF Ablation 280
Patient ∆ ShanEnt ∆ SymDyn ∆ SampEn
1 -1.28 -0.81 -1.01
2 -2.03 -1.93 -3.32
3 -1.17 -1.71 -1.42
4 -2.19 -1.39 -2.20
5 -1.34 -0.04 -1.90
6 -0.88 -1.50 -1.70
7 -1.73 -1.61 -2.06
8 -0.76 -1.15 -1.02
9 -0.11 0.10 -0.23
Table 7.3.: Change (post - pre) in ShanEnt , SymDyn and SampEn between initial and final
assessments in those patients who responded to RFA and maintained SR.
tendency which suggests that they do measure a fundamental intrinsic characteristic of
the rhythm.
7.5. Relationship to varying beat selection
techniques
One of the principal aims of the AF ablation study is to restore, or at least improve,
left ventricular function. It has been shown that there is a substantial variation in
the assessment of ventricular function both in AF and SR. By applying the techniques
which have been developed in the rest of this thesis it is hoped that further insight can
be gained into the functional response of the ventricle to RFA.
There is a highly significant but very weak correlation between LVEF and beat selection
criteria in AF (§5.4); although this relationship is very weak the variation in LVEF that
can be measured on a per-patient basis is substantial. The analysis for the AF ablation
study was performed before that of the current study had been completed, but with
the knowledge that substantial variation existed in measured ejection fraction. It was
assumed that the most reproducible assessment would be that which included all beats.
This assumption has subsequently been shown to be true (§5.4.5).
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The primary end-point of the AF ablation study was LVEF measured using CMRI.
Unlike LVEF measured using RNVG this was not found to change significantly as a
result of RFA. There are good methodological reasons for the lack of change seen using
CMRI when compared with RNVG (see discussion §8.4.2) but are the variations which
are seen using RNVG likely to be real? Any changes that are seen in patients who were
in AF on follow-up should be minimal while changes seen patients who were in SR on
follow-up should reflect the physiological change involved in correcting AF to SR.
In those patients who maintained SR it seems reasonable to expect that there should be
a relationship between LVEF in SR and that in AF. The form of that relationship may
offer some insight into myocardial health in AF. Several possibilities for this relationship
exist.
1. The most likely relationship is that the LVEF for the patients in SR corresponds
to the LVEF for the equivalent beats in AF. This would seem reasonable if it is
considered that the SR beats define the “natural” beats in AF (i.e. the beats which
would occur in the absence of AF).
2. A second possibility is that the maximum measurable LVEF in AF is related to
the LVEF in SR. This would be reasonable if the maximum LVEF in AF defines
“capability” of the myocardium: the functionally impaired myocardium, whatever
the cause of impairment, will not be capable of achieving the same LVEF as a non-
impaired heart. The effect of beat variation in AF may obscure function causing
the two to appear functionally equivalent in AF.
3. A final possibility is that the variation in measured LVEF in AF is related to
the change in LVEF when the patient changes to SR. This would be a reasonable
explanation if the range of LVEF is indicative of myocardial tone: those patients
with a greater range having better tone and as a result having better LVEF when
SR is achieved.
Although only a few patients maintained SR, the AF ablation study offers the ability to
compare functional measures in those patients who remained in AF (either post RFA or
because they were treated with medical therapy). In those patients a comparison of the
mean and range of measured LVEFs offers an insight into the consistency of measures.
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Six different functional measures have been investigated in this thesis; of these only two,
LVEF and EDV/PSV , have been investigated in this study. Four measures have not
been included in the analysis. The two diastolic measures: peak filling rate (PFR) and
first third filling fraction (FTFF), while they show substantial, significant variation with
beat selection criteria in AF (see §5.9 and §5.8) are subject to such methodological error
(discussed in more detail in §8.5.7) that it is unclear to what extent they can be used.
Although there was substantial variation in systolic time, the variation was not shown to
be significant with beat selection criteria and it has therefore not been included in this
analysis as the source of variation is unclear. Pre-systolic volume has not been included
simply because it would appear to offer little additional information over LVEF and
EDV/PSV .
7.5.1. LVEF
Figure 7.6 compares LVEF at the start and on follow-up in the AF ablation study
(medical therapy and RFA patients included). In the patients for whom data were not
lost, mean LVEF in the group who remained in SR changed from 14% to 31% while in
the rest of the group LVEF changed from 18% to 20%.
For those patients who remained in SR a comparison was made of the LVEF obtained
in SR against that obtained in AF using beat selection criteria that would mimic the
beat selection criteria required to include all the beats in the SR image. This offers
only very limited insight. Unfortunately several list-mode files both at the start and
on follow-up were lost before they could be re-analysed with the defined limits. This
meant that four of the 10 patients could not be re-analysed. It was also found that in
one patient changing from AF to SR slowed the heart rate to such an extent that there
were no beats in AF which corresponded to those in SR and an image could not be
formed. In several other cases the number of beats from AF which could be included
was so low as to make the error due to the Poisson statistics of the image substantial.
The results for the patients for whom an analysis was possible are shown in Table 7.4.
The number of patients is too small for a statistical comparison but there is surprisingly
good agreement between the LVEF in three out of five of the results; however, all of
them are very limited by the number of beats which were included in AF. The conclusion
is that the first suggestion as to the relationship between LVEF and rhythm (see list on
page 281) cannot be valid because the mean R-R interval changes too greatly.
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Figure 7.6.: Showing the relationship between LVEF at start and follow-up in AF ablation
study (both medical therapy and ablation).
AF Included beats AF ED Counts AF LVEF SR LVEF
Patient 1 121 3066 29.7± 2.4 29.8
Patient 2 118 6801 15.1± 1.7 25.0
Patient 3 0 - - 19.0
Patient 4 72 4980 10.3± 2.0 12.5
Patient 5 4 94 63.9± 13.7 59.5
Patient 6 634 34270 17.8± 0.7 36.0
Table 7.4.: Comparing LVEF obtained in SR with that obtained in AF when the same beat
selection limits are applied in AF as would be required in SR to include all the
SR beats.
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Figure 7.7 shows the relationship between LVEF on follow-up, measured using all beats,
and the maximum measured LVEF at the start of the trial. Since the majority of
those patients who remained in SR lie above the line of equality it appears that the
maximum LVEF (assessed using preceding and indexed quartiles in the beat selection
criteria) underestimates the resulting LVEF. By comparison for those patients in AF
the maximum preceding LVEF appears to overestimate the measured LVEF on follow-
up. This, however, is to be expected if the overall functional capacity has not changed
since LVEF, measured using all beats, is unlikely to supply the maximum LVEF (see
Figure 5.13 in §5.4). A paired Wilcoxon which compares the rank of measures rather
than the measures themselves suggests that there is no significant difference between the
rank of the maximum LVEF in AF and that of the LVEF measured in SR. By contrast
the patients who remain in AF are found to have significantly different maximum LVEF
ranks (p = 0.0002) at the start compared to the LVEF measured using all beats on follow-
up2. This suggests that the maximum does have a predictive value in those patients who
maintained SR; however, here too the numbers are too small to offer conclusive proof
and, while there appears to be a strong correlation in SR, it is not statistically significant.
The relationship between the range of LVEFs measured on any patient at the start of the
study and the change in LVEF between the start and follow-up is shown in Figure 7.8.
Here again there appears to be a positive relationship for patients who maintain SR:
patients with a smaller range of measured LVEFs at the start of the study (in AF)
generally appear to have a smaller change. This is confirmed by the Wilcoxon analysis
which finds no difference between the ranks of LVEF range before the study and LVEF
change for patients in SR. By contrast the group of patients still in AF at the end of
the study is found to have a range of LVEF the ranks of which are significantly different
from the ranks of the change in LVEF (p = 0.00006).
The general agreement between the results of Figure 7.8 and those of the previous
Figure (7.7) is not unexpected. If the range of LVEF is indicative of tone then it is
not surprising that the maximum LVEF is also indicative of tone and therefore of the
resulting LVEF when the patient returns to SR.
A comparison of measured LVEF range and mean LVEF has been made for those patients
who remained in AF. No significant difference was found in either the ranges or the
means, p = 0.98 and p = 0.74 respectively (see Figures 7.9 and 7.10). This is particularly
2The use of the statistical test here has changed. Instead of looking for differences we are looking for
similarities. Similarities, or high correlation, suggest that an index has predictive value.
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Figure 7.7.: Shows the relationship between the maximum measured LVEF before the start
of the AF ablation trial and the resulting LVEF on follow-up. The diagonal line
shows the line of equality.
interesting because the ranges do not vary significantly which suggests that the variation
in range is not simply methodological but has its roots in a well defined physiology.
7.5.2. EDV/PSV
EDV/PSV , the fractional change between pre-systolic and end-diastolic volume has
been shown to be well correlated with beat selection criteria in AF. The variation of
this is indicative of the degree to which diastole is “interrupted”: a shorter beat will
produce a lower filling volume and vice versa. When all beats are averaged together it
is to be expected that the pre-systolic and end-diastolic volumes should be equal. This
suggests that deviations from a value of 1.00 may be indicative of the degree to which
filling is foreshortened and hence of the degree of beat-to-beat variation. Consequently
it is possible that there is a relationship between function in SR (assessed by LVEF) and
EDV/PSV in AF.
Figure 7.11 shows the relationship between mean EDV/PSV at the start of the study
and LVEF on follow up. There does not appear to be any relationship between the
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Figure 7.8.: Showing the change (post - pre) of LVEF between initial investigation and follow-
up as a function of the measured range of LVEFs for patients in the AF ablation
study.
.
Clinical Application: AF Ablation 287
Range of LVEF at start
R
an
ge
 o
f L
VE
F 
on
 fo
llo
w
 u
p
0
5
10
15
20
25
0 5 10 15 20 25
Therapy
Medical
Ablation
Figure 7.9.: Showing the range of LVEF at the start and on follow-up for patients who
remained in AF on follow-up in the AF ablation study.
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Figure 7.10.: Showing the mean of LVEF at the start and on follow-up for patients who
remained in AF on follow-up in the AF ablation study.
.
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Figure 7.11.: Showing the relationship between EDV/PSV at start and LVEF on follow-up
in the AF ablation study.
.
indices. This is confirmed by the paired Wilcoxon which finds the ranks of the indices
to be significantly different in both those patients in AF and those in SR at follow-up.
When the range of measured EDV/PSV is compared with the change in LVEF (see
Figure 7.12) there is no relationship found in those patients in SR at follow-up (paired
Wilcoxon finds the two groups to be different), but there does appear to be a weak
relationship in the group who remained in AF, substantiated by the paired Wilcoxon
(p = 0.17). This is likely to be a reflection of the weak relationship that exists between
EDV/PSV and LVEF in general (see §5.10).
When the means and ranges of EDV/PSV are compared for those patients who re-
mained in AF only, a paired Wilcoxon finds no significant difference between the groups
although visually they appear quite different (see Figures 7.13 and 7.14).
These results for EDV/PSV again corroborate the theory that this is a genuine index
with repeatable measures, but it is not at all clear that the index has any clinical
significance.
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Figure 7.12.: Showing the initial range of EDV/PSV compared with change in LVEF on
follow up in patients in the AF ablation study.
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Figure 7.13.: Showing the range of EDV/PSV at the start compared with follow-up for
patients who remained in AF on follow-up in the AF ablation study.
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Figure 7.14.: Showing the mean of EDV/PSV at the start and on follow-up for patients who
remained in AF on follow-up in the AF ablation study. To aid visualisation
this plot excludes one point, at (1.151, 1.023), which has been included in the
analysis.
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7.6. Discussion
The investigation of the behaviour of the indices of rhythm and function, which have
been employed in the rest of this thesis, in the context of the AF ablation study has had
two purposes: (1) to investigate whether there is consistency in the measures on a serial
basis, and (2) to determine whether there is any predictive value in the measures in
terms of the response of a patient to RFA. This might be expected if indices of rhythm
or function (particularly LVEF) are indicative of an underlying pathology beyond AF.
The AF ablation study offered a convenient means of testing these, but there are two
substantial problems associated with the data: the time lapse between RFA and follow-
up, and the poor response which this particular group of patients (heart failure: NYHA
class II and above) had to RFA. The study when it was originally devised expected
a 10% drop out and an 80% success rate after two ablations. The number of patients
included in the AF ablation study was designed to have an 80% power to detect a change
in ejection fraction of 6.8% between the two groups. This was based on several studies
[25, 95–98] which exhibited a success rate, in maintaining SR, of > 78%. Unfortunately
the success rate in this group of patients was considerably lower than that (50%) and
this has resulted in the statistical value being considerably reduced.
The serial comparison of indices in those patients who did not respond to RFA, or
who were treated with medical therapy showed in almost all cases (with the possible
exception of compactness factor) that there is good reproducibility of results, despite
the substantial difference (up to 9 months) in time between the initial investigation
and follow-up during which patients underwent medical therapy and in some cases two
ablation procedures.
There has been little reported work on factors which may be prognostic of the success
of RFA. A study by Richter et al. [99] suggested that patients were unlikely to return
to AF in the long term if, in the short term, AF could not be induced immediately after
RFA using decremental atrial stimulation from the proximal coronary sinus. No other
prognostic studies have been found, and Richter’s study still requires that the patient
undergo RFA. If an index indicative of the success of RFA could be found, the associated
risks might be substantially alleviated.
These investigations suggest that patients with a lower SampEn (< 3.3, calculated using
parameters of m = 1 and r = 0.02SD), are likely to remain in SR after RFA. It is also
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possible that the range of LVEF measured using different beat selection criteria may
be indicative of the change in LVEF that may be induced in patients who maintain
SR following RFA. However, although these results have been found to be statistically
significant, the very small numbers of patients involved requires that considerably more
investigation is undertaken.
7.7. Conclusion
While much of the discussion in this thesis has been essentially esoteric in nature, the
potential for some of these results (most notably those for SampEn and the range of
LVEF) to have prognostic value in RFA demonstrates the potential clinical value of such
indices and suggests areas for future investigation. These will be discussed further in
the next and final chapters.
Chapter 8.
Discussion
CALVIN AND HOBBES c©1992 Watterson. Reprinted with permission of UNIVERSAL Uclick. All rights reserved.
Summary
In which we discuss the general results of the thesis. Initially the results of the inves-
tigation into the analysis of rhythm are discussed. A brief section addressing some of
the more controversial aspects of the RNVG technique follows. It is shown how the
functional results can be generalised to other modalities before the functional results are
discussed. The chapter finishes with a discussion of some of the limitations of the study.
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8.1. Introduction
In Chapter 1 (§1.7) six hypotheses were presented. Hypotheses 1 to 3 (Page 36) are
associated with the effect that variation in beat-to-beat interval duration has on beat-to-
beat functional assessment. Hypotheses 4 to 6 are involved with describing rhythm and
the associations between the description and the beat-to-variation in function. These
hypotheses can be summarised as:
1. Irregular fluctuations in cardiac rhythm are reflected in associated variations in
beat-to-beat function.
2. These fluctuations and changes are measurable and to some extent predictable.
3. These changes will be seen in both AF and SR.
In the subsequent chapters, three areas were investigated: the form of beat-to-beat
variation in both SR and AF; the variation that can be seen in functional parameters
with differing beat selection criteria using list-mode acquired RNVG; and the relationship
between these parameters of rhythm and function. This chapter will consider some of
the implications of the results.
8.2. Describing AF
AF is poorly described. Most clinicians when presented with a patient in SR would
report the heart rate in beats per minute, equivalent to the mean R-R interval. When
presented with a patient in AF a mean heart rate might be reported with the caveat that
the rhythm is irregular. Beyond mean heart rate however, while heart rate variability
has been extensively investigated in SR [27, 100, 101] there has been little work done in
AF; it is generally simply described as “irregularly irregular”.
While some work has been done on understanding atrial electrical activity in AF from
ECG [102] and using invasive measurements [103], most characterisation of ventricular
response in AF has actually focused on assessment of ECG during SR in patients either
with paroxysmal AF or after cardioversion. In such studies rhythm measures have been
shown to be predictive of a return to AF after cardioversion (using spectral analysis of
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HRV [32]) and of entropy if the patient returns to AF (using standard temporal HRV
measures [78]).
In this thesis, three major branches of investigation have been pursued in an attempt to
provide an insight into the assessment of rhythm in AF. They are: conventional linear
measures of heart rate variability, descriptors of the Poincare´ plot, and assessment of
entropy. While the standard linear measures of HRV describe point to point changes,
the indices based on the Poincare´ plot offer global insight and the entropy measures
detail the regularity of the rhythm.
The different levels of description are perhaps better explained with an example. Con-
sider two rhythms: the first consists of a pattern of beats in which a beat of length a is
followed by a beat of length b followed by a and so on in the sequence: a, b, a, b, a, b . . ..
The second rhythm consists of a steadily decreasing sequence e.g. 1.50, 1.49, 1.48, 1.47 . . ..
Depending on the values of a and b, the two sequences may be indistinguishable in mean
and SD. RMSSD values are likely to be substantially different: in the first sequence
RMSSD will be the same as the SD, in the second sequence RMSSD will be 0.01. There
need not be any difference between the sequences in terms of pRR50 unless a and b
differ by more than 50 ms. The RR ranges will differ. These conventional linear indices
of rhythm give an insight into the immediate, point to point, variability but provide no
information about the global changes. The Poincare´ plot for the first sequence will show
two single points while the plot for the second sequence will show a straight line: clearly
demonstrating the global change. Entropy in the the first instance will be small as there
is good regularity, in the second instance, although the changes are not complex, entropy
will be very high as the state is continuously changing without ever repeating.
Although each of these will form part of a complete description of rhythm we will consider
each of them in turn.
8.2.1. Linear indices of HRV
With the exception of mean R-R interval, the traditional linear measures of HRV showed
a clear distinction between SR and AF (§3.2). This is to be expected as the beat-to-beat
variation in AF is substantially greater than that in SR, although the form (complexity
and regularity) of the changes is not made clear by these results.
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Although overlap in the histograms of mean RR for SR and AF is almost total (Fig-
ure 3.1 on Page 75), the mean RR interval was found to be significantly different in AF
(0.84± 0.34 s) from SR (0.89± 0.30 s). There were very few criteria applied in selecting
patients, and while in some cases this could be detrimental to the study it meant that a
large patient sample could be studied (see §8.7). None of the patients in AF were new
onset and therefore all of them were on some form of rate control. One of the aims of
rate control is to reduce the ventricular rate to something which is more comparable to
SR and, although significant differences were found, the rates are comparable.
The literature on heart rate variability is extensive and HRV has been shown to be
a strong marker of autonomic nervous activity in SR [27, 28, 31, 45] but very little
work has been done on AF. In this thesis linear HRV measures have been considered
not for their use as a potential marker of underlying pathology but as descriptors of
rhythm which could be used to explain functional variation. In this respect, mean RR
and SDRR, in particular, have been shown to be significant contributors to models of
functional variation (see §6.4 and the following sections in Chapter 6).
8.2.2. Poincare´ assessment
The Poincare´ plot offers a useful visual means of assessing rhythm and, since using it
in this study, it has been adopted in the department of Nuclear Cardiology at Glasgow
Royal Infirmary for use with patients with unusual rhythms. Where a larger number
of beats is available (typically collected over several hours) the histographic (or 3D)
Poincare´ plot may be of more use in assessing rhythmic variation and it has been used
in qualitative and quantitative assessments in several studies [104–106].
Van den Berg et al. [42] found that where there was clustering in the Poincare´ plot from
a 24 hour Holter recording, the patient was considerably more likely to be restored to SR
using electrical cardioversion. They calculated a clustering index based on determining
the number of peaks in a 3D (histographic) Poincare´ plot using a 25 ms grid. A similar
technique could be used in this study although there is a question as to whether a 15 min
acquisition would be sufficient to show clustering in the Poincare´ plot of a patient in
AF.
It would be of interest to investigate how the clustering, which was seen in some of those
patients who maintained SR after RFA (§7.4.2), compares with possible clustering in the
Poincare´ plot in AF. However, to do so with accuracy would require a longer acquisition
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period than was used in this study where patients typically had ∼ 1500 points in a plot,
spread out over the entire area.
Poincare´ descriptors
As discussed in the introduction (§1.3.2), many different indices have been used to
describe the Poincare´ plot. In this study two indices were considered: correlation and
compactness factor . In theory correlation would appear to be a good measure since it
is to be expected that in SR there should be a better match between successive beats
than in AF; however, while the correlation coefficient demonstrates the poor relationship
between successive beats in AF (values for r clustering around 0) many of the patients
in SR had a similar poor agreement. Considering only those patients with no ectopic
beats made no difference. This suggests that in SR the variation between beats may
be just as, if not more, random than it is in AF; RR intervals are simply more tightly
constrained.
The newly proposed measure of compactness factor clearly distinguishes between AF
and SR although reproducibility when compared sequentially in the AF ablation study
is only of the order of (∼ 10%) (see §7.4.2), suggesting that it may only offer an insight
into rhythm on a fairly coarse scale.
8.2.3. Entropy
The three calculations of entropy which have been considered involve increasing detail
of sequencing information. Although each calculation forms a family of indices, this
study has shown that there are substantial differences between measures of entropy and,
particularly in AF, only a poor correlation between most of them (see Figure 3.30 on
Page 116), although there are measures that correlate well (e.g. ShanEnt with 10 ms
bins and SampEn with r = 0.02SD and m = 0 or 1).
It is not surprising that there is such a substantial variation in the correlation of measured
entropies. At the extremes of measurement it would be possible to make selections for
the different parameters that result in wildly different results. For example if ShanEnt
were calculated from a histogram in which the bin-width incorporated all the beats
the entropy would be 0, while it would be high if the bin-width matched the temporal
resolution of the acquisition. Similarly with SampEn it should be possible to make
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Figure 8.1.: Showing the values of SampEn with r = 0.02SD and changing m. The points
are plotted against the sorted position of the values for m = 1 with the black
dots showing the changes for m = 1. Patients in both SR and AF included as a
single group.
selections of m and r which gave minimal entropy (Es = 0) or near maximal entropies
for all studies. Inevitably many of the members of the different families will not correlate
with each other or with members of other families. This is illustrated in Figure 8.1 where
changes in SampEn can be seen as m changes. If there was good agreement between the
results they would roughly parallel each other because rankings would be approximately
the same. Instead, they can be seen to cluster in different areas of the plot.
Although no guidelines exist for establishing the metrics, m and r for SampEn, the
choice of r = 0.02(SD) and m = 1 contradicts that used in most studies. Chua et al.
[107] compared both SampEn and ApEn to compare various rhythms including AF and
different forms of SR. They used values of m = 2 and r = 0.15SD for calculation of
both forms of entropy and found that in comparison to normal SR, patients in AF had
a lower entropy by both ApEn and SampEn. Although these exact parameters were not
calculated in SR and AF, values of r = 0.2SD and m = 1 were considered and found
that AF had a higher entropy than SR. Chua et al. argued that their result indicated an
inherent periodicity in AF. Although no measures of entropy in the study presented here
were found to present a higher value for SR than AF, other measures (particularly swing)
suggest that on some scale there may be a periodicity which is seen in AF but not in SR.
Lake et al. [59] suggested a semi-quantitative method for determining r and m which
led them in their study of neonates in SR to use values of m = 3 and r = 0.2SD. The
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problem with their solution is that it is dependent on the population being measured
and in the case of the current study the inclusion of two rhythms (AF and SR) in the
population would result in a choice of metrics which could not distinguish between the
rhythms. Pincus [50, 57] used values of 1 ≤ m ≤ 3 and 0.1SD ≤ r ≤ 0.25SD in his
initial introduction of ApEn, and also in an investigation of neonates in SR. In AF,
Alcaraz et al. [108] found that a choice of m = 2 and r = 0.25SD gave optimal results
although how they defined what the optimal results should be is not clear. Segerson et
al. [78] chose to use m = 2 and an unnormalised value of r = 0.043 s.
In none of the above studies was a selection of r < 0.1SD chosen. While the choice
of r = 0.02SD in this study was originally a misunderstanding on the part of the
investigators it leads to an index which distinguishes well between AF and SR, with a
comparatively wide range of measures within each rhythm type (which is to be expected
given that all patients, regardless of their state of cardiac health were included). It has
good reproducibility, clinical value (§7.4.3), and correlates well with ShanEnt suggesting
that these metrics do not produce random results. The choice of r = 0.02SD means
that the window on each R-R interval is so small as to be negligible and therefore
that SampEn, with m = 1, reflects repeating patterns of two beats of the same length
throughout the R-R interval stream.
There appears to be poor agreement between SymDyn and SampEn particularly in AF.
In SR there is generally moderate or good agreement between the measures (Figure 3.29
on Page 115) but in most cases in AF this agreement is lost (Figure 3.30). This is
simply a reflection of the metrics and the fact that SymDyn is a coarse graining tool
which reflects gross changes without subtlety. Even in AF, however, the agreement is
good where the measures compare similar metrics with r = 1SD and m = 1 or m = 2
for SampEn and for SymDyn where word length is 2. This is to be expected since a word
length of 2 corresponds to m = 1 and SymDyn divisions are fixed on a number of SDs.
The measures are not exactly the same because in SampEn the window position shifts
with the beat being investigated while in SymDyn the window has a fixed position.
Interpretation of entropy
To determine the physiological meaning of entropy it is necessary to look beyond this
study. Palazzolo et al. [53] suggested that in dogs in SR, entropy (ApEn and SymDyn)
reflects parasympathetic modulation of heart rate. Segerson et al. [78] found that
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in patients with paroxysmal AF the inter-beat correlation coefficient (ICC), which is
equivalent to the Poincare´ correlation index in this study, correlated closely with ApEn
when the patients were in AF. ICC is known to reflect parasympathetic function in SR
and Segerson et al. suggest therefore that entropy during AF may be an indicator of
autonomic function.
This study found only a weak negative correlation (ρ = −0.21) between SampEn and
Poincare´ correlation in this group of patients and while there is a moderate positive
correlation of Poincare´ correlation with LVEF in SR there is only a poor, negative
correlation in AF (§6.4 on Page 263). Despite this it is likely that entropy does provide
an assessment of autonomic function: entropy assesses the complexity of the variation
in R-R interval and it must therefore be an indicator of the ability of the AV node to
bring coordination to the apparently random electrical signals in the atria before they
are conducted to the ventricles. Since autonomic function to some extent regulates
AV nodal conduction, entropy must provide a measure of the influence of autonomic
function.
8.2.4. AV node
As discussed in the introduction (§1.2.3), investigation of LV function in AF is also an
investigation of the function of the AV node, which brings sufficient order to the action
potentials of the atria to allow coordinated contraction of the ventricle. It has been
suggested [109] that the lower envelope of the Poincare´ plot, which shows the minimum
R-R interval, indicates the AV nodal functional refractory period (FRP). Several au-
thors [110–112] have postulated the existence of dual atrio-ventricular nodal pathways
and Oka et al. [113] suggest that, although these cannot apparently be detected using
electrophysiological studies, the presence of two sectors in the Poincare´ plot is indicative
of the two pathways with the vertexes of each sector giving the FRP of the two pathways.
This would explain the presence of two clear edges in the Poincare´ plots of many of the
patients (e.g. Figure 3.10) and offers an area in which further investigation would be
desirable.
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8.2.5. Is AF chaotic?
Stein et al. [114] found that it was possible to produce a computational model of
ventricular response to AF which had statistically significant predictability in patients
with AF. This in itself suggests that AF is not wholly random and several other studies
[108, 115, 116] have also suggested that AF may not in fact be as chaotic and irregular
as is commonly suggested. Results in this study support this theory.
The dominance of points in the top-left / bottom-right of the delta-Poincare´ plot, rep-
resented by swing , in AF suggests that there is a regular pattern of longer and shorter
beats. If a change from one beat to the next has resulted in an increase in R-R interval it
is generally true that the next change will result in a shorter R-R interval and vice-versa
(§3.3.3 on Page 91). The changes are not equal in size but because heart rate has been
shown not to vary substantially over the course of the acquisition (see Table 5.35b) there
must be a general tendency towards variation about the mean R-R interval. When this
variation is quantified (without regard to the magnitude of changes) by the index which
has been termed swing in this thesis, it is clear this pattern is more dominant in AF
than in it is in SR (see §3.3.3 on Page 91).
These results suggest that AF is not in fact chaotic and, although the rhythms appear
irregular, there is a degree of patterning in them. This can also be observed in Poincare´
plots many of which show clustering, suggesting that some beat intervals are more
frequent than others.
8.2.6. New measures
Two new indices of rhythm have been introduced in this thesis: compactness factor
and swing . Compactness factor gives an assessment of the density distribution of the
Poincare´ plot. Swing gives a very general (without regard to the degree of change)
assessment of the frequency with which a beat is followed by a shorter beat, then a
longer beat, and then a shorter beat, and so on.
Although neither of them have been shown to be significant by themselves, in conjunc-
tion with other measures, notably mean RR and entropy, swing has been shown to be
indicative of the degree of variation that might be seen in LVEF, PSV , EDV/PSV and
peak filling rate. By contrast compactness factor has only been used in correlation with
systolic time where the resulting correlation was poor (see Chapter 6).
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Overall swing may prove to enhance a description of rhythm while it is unlikely that
compactness factor offers much additional information.
8.3. RNVG Technique
There are several criticisms that could be levelled at the technique which has been used
in the acquisition and analysis of RNVG in this study. The three principal issues are:
1. the use of a single region of interest for each patient
2. the treatment of ectopic beats
3. the use of variable rather than fixed time formatting.
8.3.1. Why use a single region?
There are effectively two techniques for analysing RNVGs: a dual region technique
and a single region technique. National guidelines recommend a dual region technique
although they acknowledge that a single region may be used where a pre-established
normal range has been determined[117]. A dual region technique involves separately
determining regions for end-diastolic and end-systolic LV volumes. This may be done
automatically or manually and may also involve determining regions for the LV at each
intermediate stage. Background regions may be a single, end-diastolic region, or regions
on each frame or regions at end-diastole and end-systole. Each type of background is
likely to slightly change final quantitative results.
Using a dual region technique has two advantages: it results in LVEFs which equate much
more closely to those obtained using other modalities (largely because other modalities
use techniques which more closely match the dual region technique - see above §8.4.1
& §8.4.2). The dual region technique is also more able to allow for lateral motion of
the heart which may move the LV in and out of a single region. It has two major
disadvantages: it has much poorer reproducibility because it is not only harder to draw
two regions in the same place than a single one, but it also much harder to determine
the edge of the ventricle at end-systole which adds to the poorer reproducibility. The
second disadvantage is that it is difficult (unless regions are drawn on every frame of the
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image which, practically, requires some form of automation) to determine volumetric
changes over the whole beat because there are different changes within each region and
some assumptions must be made in order to convolve them.
The single region technique that was used in this study has been described in the methods
(§4.3.3). Essentially a single LV region and background are used and the change in count
within that region is used to model the change in volume. It has two major advantages
and two disadvantages. The disadvantages are that there is no way, using a single region
technique, to account for lateral movement of the myocardium, and LVEF is substantially
underestimated in comparison with other techniques / modalities. The advantages are
that a single curve can be determined that shows volumetric changes over the whole
beat and the results have a much better reproducibility.
The department of Nuclear Cardiology in Glasgow Royal Infirmary routinely uses a single
region of interest technique in analysing RNVGs. This offered some particular benefits
for this study. The extremely large number of images that were analysed for this study
(∼ 64000) made separate regional analysis of each image impractical. By using a single
region technique the same region, which defined the greatest extent of the ventricle,
could be used on each image. (This assumes the lateral motion is either consistent on all
images for a particular patient, or negligible). This substantially reduced the amount of
work involved in analysing the images and made it possible to analyse the large data set.
While a study could be done which investigated changes in which regions of interest were
drawn on every image, it is unlikely that the results would be substantially different from
those presented in this study and would necessitate a much smaller study population.
8.3.2. Ectopic beats
Ectopic beats in this study have been treated by removing extreme outliers (§5.2) and
by considering a sub-group of patients in whom ectopic beats could not be identified
from the Poincare´ plot.
Limiting the acceptable beat length, thus removing the extreme outliers, changes the
shape of the curve, particularly in frame mode (see Figure 5.2 on Page 149). Even if
the fall off at the end of the unlimited curve is ignored, the shape of diastole appears
to change. This is purely a result of averaging beats in different bin sizes. The effect is
much less pronounced where variable time formatting is used (see Figure 1.10, Page 31).
Discussion 304
In SR the comparison of the group which excluded ectopic beats (“pure”) with the
remainder of the patients found that there was a significant variation of LVEF with
beat selection criteria in the “not pure” group which was not seen in the “pure” group
(provided there was a division on quartiles in either the preceding or indexed beat). This
suggests that the presence of ectopic beats introduces a greater beat-to-beat dependence.
Since it seems unlikely that a few beats will substantially affect the curve, particularly
using variable time formatting, this must reflect underlying pathology and suggests that
there may be a greater beat-to-beat dependence in those patients for whom an underlying
pathology may be a cause for ectopic beats. This is an area in which further investigation
may be worthwhile.
In AF there is a statistically significant (p = 0.034) difference between LVEF in the “pure”
and “not pure” groups; however, there is not any substantive difference between their
behaviour with beat selection (§5.4.3). Although this difference is statistically significant
it cannot be considered to be clinically so, and this is to some extent confirmed as there
is no difference between the ranges in the two groups.
8.3.3. Fixed vs. Variable time formatting
Most centres that perform RNVG will use fixed time formatting simply because manu-
facturers do not offer variable time formatting; although MiE recently (2010) started to
offer, and Siemens are developing, software to allow “on the fly” variable time gating.
A literature search does not reveal any studies which prefer one method over the other,
each having their own advantages and disadvantages (see §1.5.2).
In this study, with the exception of systolic volume, little difference was found between
fixed and variable time formatting in those images for which results could be obtained
using both techniques; no significant difference was found between the values of LVEF.
However, fixed time formatting substantially reduced the number of curves that could
be analysed when all the beats were used: 275 using fixed time formatting against 372
with variable time formatting (see Table 5.29); this amounts to ∼ 26% fewer patients in
fixed time.
In the case of systolic volume, significantly fewer measures (as determined by the differing
beat selection criteria) were found to be outwith the sampling error using fixed time
formatting. This was particularly pronounced in patients with AF, where there were half
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as many measures outwith the sampling error than in SR. This reflects the volumetric
blurring that is the result of using variable time formatting.
Throughout this study both techniques were investigated but results have concentrated
on those determined using variable time formatting, principally because the loss of data
which may occur with fixed time formatting makes it an inferior technique, and the
volumetric blurring is not sufficient to make a significant difference to the functional
measures (see §5.4.4, §5.5.2, §5.6.2 and §5.7.2).
The temporal distortions introduced by fixed time formatting (see §1.5.2) make it un-
suitable for assessment of diastolic function and comparison was not made between fixed
and variable time formatting for the diastolic measures.
8.4. Alternative modalities
LVEF is usually assessed from changes in volume rather than from pressure measure-
ments (see §1.1.5) and, although other modalities exist, the three most common in
assessing LVEF are echocardiography, CMRI and RNVG. Many of the results of this
thesis have an impact on the assessment of LVEF, particularly in AF, regardless of
modality. To understand this requires a brief understanding of echocardiography and
CMRI.
8.4.1. Echocardiography
In echocardiography the most common method for assessing LVEF is Simpson’s biplane
[118]. This technique involves outlining the endocardial wall of the LV on two orthogonal
views. The ventricle can then be divided into elliptical slices and the volume calculated
from each of these. If this is done at end-diastole (ED) and end-systole (ES), the
fractional difference in volumes should represent LVEF. The regions are drawn on freeze-
frame images that capture the physical position of the myocardium at a specific point
(ED or ES) in a single beat.
The technique has four problems associated with it. It assumes that a slice through the
ventricle is adequately modelled by an ellipse. This can be avoided if a three dimensional
technique is used but 3D echocardiography is still not common and delineation of the
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myocardium on multiple slices [119] is considerably more labour intensive and has a
much greater associated error. Like other techniques Simpson’s biplane requires good
delineation of the ventricle. This can be difficult given the relatively poor contrast
between the ventricular cavity and the myocardium, particularly in subjects who are
poorly echogenic. The differentiation can be improved with the use of micro-bubbles,
which increase the contrast ratio and substantially enhance the ability of the analyser
to delineate the endocardial wall. Most investigators recommend the use of a contrast
agent in determining LVEF using echocardiography in studies where serial assessment is
expected [120–123]. Because LVEF in echocardiography is determined from a single beat,
the technique assumes that any one beat is representative of all beats; this stands against
the Frank-Starling rule but it is, nevertheless, common practice to accept measurement
on a single beat as being indicative of the overall LVEF. It is generally recognised that to
compensate for beat-to-beat variations in AF, measurements of LVEF should be made
on several (typically three or four) beats and the mean of the results taken [118, 124];
however this study shows that the variation in both SR and AF can be substantial
and there is little assurance that measuring on a single, or even several, beats gives an
accurate representation of overall LVEF. The fourth substantive problem with assessing
LVEF using Simpson’s biplane technique is that it is highly dependent on the views
taken. If the view does not slice through the apex the chamber will be foreshortened
in the image. In patients who are not echogenic it may mean that it is not possible
to perform echocardiography satisfactorily with the result that assessment of LVEF is
impossible. While there is no solution for the latter, 3D imaging offers the potential to
avoid the former [124, 125].
8.4.2. CMRI
In SR, CMRI is generally considered to provide the gold standard for assessment of
LVEF. Similar techniques to those used in echocardiography are used in that the endo-
cardium is delineated on multiple slices. From these the volume of the resulting shape
can be determined with good precision and high reproducibility. In SR, it has the dis-
advantages that it is both expensive and not readily available - with MRI machines
generally being used extensively in hospitals for investigations for which other alterna-
tives do not exist. Unlike echocardiography, CMRI does not rely on a single beat but is
built up over multiple beats and thus offers an image of an average beat. To minimise
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movement distortion the image is acquired over several breath holds [126]. This may
have a significant physiological effect on cardiac function and on R-R intervals.
In AF assessment of LVEF using CMRI frequently fails. In very basic terms, CMRI
uses gating in a similar fashion to RNVG: the R-R interval is divided into frames (typi-
cally between 12 and 18) such that the final image consists of multiple frames per slice.
Each frame corresponds to a separate k-space (frequency space into which echoes from
the entire volume are recorded). Slices of each frame are reconstructed at the appro-
priate angle from their respective k-space. K-spaces are filled with data with a spatial
resolution which depends on the number of phase-encoding steps used (typically 128).
Conventionally a single phase encoding step is acquired for each beat, although more
recent developments have allowed multiple phase encoding steps to be acquired simul-
taneously. Herein lies the problem. Consider 2 sequential beats, one short, one long.
In the first beat point A on the myocardium at point, a, in the reference frame of the
scanner is involved in a signal in k-space 3 (say); in the second beat the same point, A,
on the myocardium may be at a substantially different point, b, in the reference frame
of the scanner in k-space 3, while it is at point a in the reference frame of the scanner
in k-space 5 (say). In real space this would result in a blurring of the boundaries, in a
reconstruction from k-space it results not only in a blurring of the boundaries but in a
general loss of contrast. In SR the problems that might be caused by ectopic beats can
be avoided simply by discarding the data from that beat but in AF the variation is too
great. A tight beat window in which most of the beats are discarded requires too long
an acquisition time, a wide window degrades the image - in some cases completely. The
result is that measurements using CMRI in AF may be subject to significant artifact
[127].
8.5. Assessing LV function with RNVG
It has been shown that there is substantial variation in functional measures, of which
the most important is LVEF, for any one patient in both SR and AF depending on the
beat selection criteria. This suggests that there is substantial functional change that is
dependent on the duration of both the previous and the indexed beat. This needs to be
explored further.
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8.5.1. Reproducibility
A search of any bibliographic database for LV ejection fraction and atrial fibrillation will
yield thousands of results, many of which consider the implications of a change in LVEF
or a variation from a “normal” value. In SR assessment of change in LVEF is commonly
used in monitoring the progression of disease or treatment, the use of Trastuzumab (Her-
ceptin) being a particularly relevant example. Trastuzumab is a chemotherapy agent
used in the treatment of breast cancer. It has been shown to be cardio-toxic and guide-
lines for its use recommend regular serial assessment of LVEF to monitor the effect it
may have on cardiac health [128–130]. While few, if any, patients in AF will be given
Trastuzumab therapy, the variation that has been demonstrated in this study gives cause
for concern in the serial assessment of LVEF.
In general RNVG has been shown to have good (inter- and intra-observer) reproducibility
with values typically being quoted as being between±7% and±9% [8, 131, 132], although
the department of Nuclear Cardiology in Glasgow Royal Infirmary has shown that using
a single region technique it is possible to get reproducibility as good as ±3% [133].
The reproducibility of LVEF by echocardiography is poorer than this, typically between
±10% and ±12% [8], although this can be improved with the use of contrast [121].
CMRI has a reproducibility of ±2.5% to ±7.0% in SR [134–136] and has been shown to
correlate well with invasive techniques of LVEF assessment in AF[137].
This study has shown that in both SR and AF a substantial variation in LVEF can be
measured depending simply on beat selection criteria (§5.4). This corroborates several
studies which, using echocardiography, have also found substantial variation (see §1.6).
Since all assessment of LVEF will require some form of gating, this variability will apply
to all modalities and the variation will be at least comparable to, if not greater than,
the reproducibility of LVEF measure. Measures of reproducibility will involve the same
image and are therefore independent of beat selection criteria, making beat choice an
additional source of error.
It has been clearly demonstrated in this study that in AF there is a systematic variation
of LVEF with both preceding and indexed beat criteria, and in most cases the correlation
is strong. This is not true in SR, although there are still substantial changes measurable
within an acquisition for each patient. The poor correlation in SR between preceding
beat length and LVEF suggests that while the Frank-Starling mechanism (increased
filling leads to greater force of contraction and increased LVEF) is dominant in AF it
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plays a smaller role in SR. This may be because the fluctuations in pre-systolic volume
are insufficient to trigger the mechanism; although this study has also shown that the
fluctuations in pre-systolic volume may be substantial (see Figure 5.24 on Page 204)
and, in the majority of patients, are significantly related to preceding and indexed beat
criteria.
Concentrating only on the variation with preceding and indexed beat may put too much
emphasis on the Frank-Starling effect. As was discussed in §1.1.1 there are several
different mechanisms which affect cardiac output. Patients were all imaged at roughly
the same time of day (early to mid afternoon) at rest, which ought to minimise the
effects of other influences, and the Frank-Starling law should be the most high frequency
effect; however, other influences cannot be completely ignored. The results of this study
suggest that in SR other effects play a more significant role, in comparison with the
Frank-Starling mechanism, than they do in AF.
8.5.2. LVEF Portability: SR to AF
At this point it is necessary to consider a question the answer to which has been assumed
in the rest of this thesis; namely: is it reasonable to take a measure of function (LVEF)
used in SR and apply it to patients in AF?
Few studies have investigated the prognostic value of LVEF in AF, and it is generally
assumed that LVEF has similar prognostic value in AF as it does in SR. In a study by
Pai et al. [138] LVEF and AF were found to be separate, independent predictors of five
year mortality. AF is a pathology of the atria and not of the LV and in broad terms the
results of the study described in this thesis corroborate this conclusion: mean LVEF is
reduced in patients with known MI (see Page 176) in both SR and AF and similar results
are found for patients with high blood pressure (see Page 178). Additionally this study
has shown that there is substantially greater variation in measured LVEF in AF than in
SR, highlighting the importance of establishing the criteria by which serial changes in
LVEF are measured, as the error on a measurement in AF is likely to be considerably
greater than that in SR.
Serial variation in LVEF can be minimised by accepting a very broad range of beats
which excludes only substantial outliers. There is a better consistency of results in AF
where all beats are taken than where a portion of them are taken. There is a notable
increase in the difference between immediately sequential measures of LVEF (comparing
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the first half of the acquisition against the second half) when only the “Best” beats were
taken compared to the LVEF when All beats were taken (§5.4.5). This suggests that
there is improved reproducibility when LVEF is averaged over all acquired beats, in this
case typically several hundred. It is probable, given the significant difference between
LVEF when All or “Best” beats were used compared to beat selection based on quartiles
(either preceding or indexed) (§5.4), that this difference would be further exaggerated
had the comparison been made with any of the images created using quartile ranges.
8.5.3. LVEF
At the start of Chapter 5 four questions, which have been addressed in this thesis, were
asked:
• Do functional parameters change depending on beat selection criteria?
• If functional measures do change, is there a trend in the relationship?
• Does variable time framing produce similar results for the defined functional pa-
rameters as fixed time framing?
• Given the beat selection criteria, is there self consistency for functional measures
acquired at approximately the same time?
In SR, although there was substantial variation in measured LVEF on an individual
patient basis (up to 43%, SD: 8.2%), there seemed to be no clear correlation between
either preceding or indexed beat length (quartile) and the measured LVEF.
In AF the variation in measured LVEF on a per patient basis was even more substantial
(up to 46% with a SD of 14.3%); however, there was a clear correlation with both pre-
ceding and indexed beat with the preceding beat having a greater influence on measured
LVEF than the indexed beat.
When the source of the variation of LVEF with beat selection criteria was investigated,
the maxima were found to occur when only the longest preceding beats were included
in both SR and AF, by contrast the minima occurred where only the shortest preced-
ing beats were included (see Tables 5.12 and 5.13 on Page 168) although this was a
considerably more dominant effect in AF than in SR.
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Functional dependence on preceding beat
As discussed in the introduction (§1.6) several authors have investigated the functional
dependence of one beat on the previous one and these results confirm a positive depen-
dence although the degree of variation is not predicted.
Wallis et at.[139] investigated changes in LVEF in AF with different indexed beat selec-
tions and found that there was no predictable relationship between LVEF and windowing.
He attributed this to lack of a predictable amount of ventricular filling for a given cy-
cle length. This study has attempted to address this by considering the changes with
preceding beat as a predictor of filling.
Wallis also found that there was variation with different indexed beat selection criteria,
with results varying over up to ∼ 20% (EF points) for each of his 20 patients. When
the results obtained from the set of (10%) windows that covered the complete set of
R-R intervals was averaged, the resulting LVEF was found to be approximately the
same as that achieved simply by taking all the beats. This does not agree with similar
results in this study, which found that LVEF obtained with beat selection based on each
of the indexed quartiles, without regard to the preceding beat, were significantly and
consistently greater than the results when all the beats were taken. Although Wallis use
fixed time formatting no significant difference was found, in this study, when comparing
fixed and variable time formatting and it is therefore unlikely that this is the cause of
the discrepancy between the results of the study reported here and that undertaken by
Wallis.
This study has shown preceding beat criteria to have a more dominant effect on LVEF
than indexed beat criteria. It has also shown there to be a systematic, negative relation-
ship between indexed beat criteria and LVEF - a relationship which Wallis did not see.
It is likely that the blurring effect of taking all beats both reduces the mean pre-systolic
and increases the mean end-systolic volume with the overall effect of reducing ejection
fraction as is shown in this study. While the cause of the difference in results is not
clear, the most likely reason is simply that the number of patients in Wallis’ study was
insufficient to give statistically significant results.
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Effect of pathology?
With the exception of the “pure” group, the subgroups that were investigated were
defined by very broad pathologies: whether or not a patient had had an MI; whether
the patient was being treated for high blood pressure; if they had known ischaemia; or
if they had undergone interventional treatment for ischaemia; etc.
By and large the results for the subgroups followed the results for the AF and SR groups
as a whole, although the comparison between opposing groups offers some further insight.
Since function is a marker of underlying pathology, it is to be expected that patients
with known previous MI, HBP, or ischaemia will have lower LVEFs (so too do those
who have had PCI and/or CABG although the difference is not statistically significant,
see Tables 5.14, 5.17 and 5.19). It is more surprising that the range of LVEF also
decreases significantly in SR, although not in AF (except in the ischaemic and functional
groupings). This probably reflects overall reduced ability of the heart to vary its output
as the overall elasticity of the ventricle is reduced. LVEF typically varies by ∼ 30%, the
absolute range of LVEF will be smaller if the average LVEF is smaller.
That there should be no difference in AF between LVEF in the group with positive ETTs
and those with negative ETTs is also surprising, particularly since electrical changes
normally follow functional changes in the ischaemic cascade [6].
Functional variation
Returning to the questions considered at the start of this section, assessment of LVEF
with different preceding and indexed beat criteria has shown that LVEF changes, some-
times quite substantially, with indexed and preceding beat length. In AF there is a
clear trend to these results with longer preceding beats giving higher ejection fractions.
As has previously been discussed (§8.3.3) there is little substantive difference in either
LVEF or mLVEF using fixed or variable time formatting and this study has shown that
the results for LVEF are self consistent (see §5.4.5).
These results have been shown for LVEF and for the other functional parameters as
discussed in the following sections.
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8.5.4. PSV
One of the more surprising results of this study is that there is no significant variation
on a whole group basis in pre-systolic volume, PSV , in either SR or AF despite the
changes which are seen in LVEF (§5.5). Although the changes in the whole group are
not significant, on a per patient basis the variation in PSV may be substantial (see
Figures 5.24 on Page 204 and 5.25 on Page 205). It has been shown (see Figure 5.51
on Page 247) that on a patient-by-patient basis there is good correlation between LVEF
and PSV in AF (poor correlation in SR). The better correlation in AF is likely to be
a result of the lack of an atrial component to filling which means that, unlike in SR,
ventricular emptying and filling is controlled by a single matched process. There is
poor correlation between the range of LVEF and range of PSV which reflects patient-
by-patient differences and may reflect pathology, although this has not been explored
in this thesis (e.g. do patients with high blood pressure have a different comparative
response of LVEF to PSV ?).
It is also notable that when the results for all patients are considered together, in both
SR and AF there is good negative correlation between LVEF and PSV . Better ejection
fractions appear to occur at lower PSV . This also is likely to reflect pathology in that
larger volumes may be more compliant but exert less pressure (e.g. patients with dilated
cardiomyopathy).
Statistically there was no difference between LV volume measured using variable time
formatting and that using fixed time formatting but it is notable (Figure 5.27) that
variable time formatting underestimates LV PSV when compared with fixed time for-
matting. This is clearly methodological, and is the result of the mid-range beat (fixed
time formatting) generally being longer than the mean beat. In fixed time formatting
the mid-range beat is divided into N frames while in variable time it is the mean beat
which is effectively divided into N frames thus frames in the early part of the beat have
fewer counts in variable time formatting than they do in fixed time formatting. (An
alternative way of looking at this is to consider that the same number of events occurs
in each beat but that in fixed time formatting there are typically reduced counts in the
bins towards the end of the beat).
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8.5.5. EDV/PSV
The ratio of the end-diastolic volume to the pre-systolic volume is not an index which
has been discussed in the literature. Ideally it is to be expected that a single beat will
have the same end-diastolic volume as the pre-systolic volume. However it has been
clearly shown in this study that there is substantial variation between the two in both
SR and AF. The preceding beat has no significant effect on EDV/PSV in SR but there
is a significant, if weak, correlation with indexed beat length. In AF there is a moderate
correlation with both preceding and indexed beat. The correlation with beat selection
criteria is much stronger for EDV/PSV than it is for LVEF.
Increasing EDV/PSV can occur either with decreasing PSV or with increasing EDV .
It has been argued in this thesis that end-diastolic volume is determined by the duration
of diastole. Thus PSV, the end-diastolic volume of the previous beat, is determined by
the duration of diastole in the previous beat and EDV by diastolic time in the indexed
beat.
The moderate positive correlation with preceding beat length and negative correlation
with indexed beat length confirms the hypothesis that premature contraction reduces
end-diastolic volume: a short preceding beat or a long indexed beat leads to higher
EDV/PSV , likewise a long preceding beat or a short indexed beat leads to a lower
EDV/PSV . This would suggest that there should be a fairly strong correlation between
EDV/PSV and SDRR or R-R range but this is not seen (§6.5) and indeed swing and
SampEn appear to be better descriptors of EDV/PSV .
Because EDV/PSV appears to be a marker of beat variation there is a possibility that
it will be indicative of variation in LVEF. There is good correlation between the range of
LVEF and the range of EDV/PSV but there is no clear correlation between EDV/PSV
and mEDV/PSV (see Figure 5.32 on Page 216) and a comparison of EDV/PSV ob-
tained using all beats found no clear relationship with range of LV EF so it cannot be
used as a marker for LVEF variation.
8.5.6. Systolic time
It is probably that the correlation between EDV/PSV and beat selection criteria is not
better because systolic time is not constant and therefore changes in beat length are not
completely reflected by changes in diastolic time interval. Many studies have shown that
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systolic time varies and is in itself a useful prognostic tool [140–142]. This investigation
has also shown that there is a small variation in systolic time interval with beat selection
criteria, and that in SR the variation is significant, if very weak. Typically the minimum
systolic time is ∼ 70%−75% of the maximum with slightly lower values in AF compared
to SR.
It is not absolutely clear why there should be a significance in SR and not in AF except
that the variation in overall time is so much greater in AF than in SR (shortest beat is
typically ∼ 35% of the longest beat compared with ∼ 80% in SR) that the small changes
in systolic time interval may be insignificant in comparison to the overall changes in beat
length.
8.5.7. Diastolic function
The investigation of diastolic function in this study has been very limited because it
became clear that the methodological problems associated with it are substantial. Two
measures of diastolic function were chosen: first third filling fraction (FTFF) and peak
filling rate (PFR).
There was a good correlation between FTFF and indexed beat selection criteria (§6.8).
This may be artificially introduced since the comparison is made against a changing
variable: longer beats will have longer diastolic time and hence the time to FTFF will
be longer. If filling follows a similar pattern, independent of duration, this method
will select different points on the filling curve. Since curves gradually increase during
filling the correlation between indexed beat selection and FTFF is expected but does not
necessarily have any physiological basis. To some extent this is confirmed by the much
better correlation between the range of systolic time and range of FTFF in SR when
compared to AF. In SR, while systolic time and FTFF may change on a beat-to-beat
basis the change is likely to be consistent. In AF it will not be because the point of
measurement for FTFF will fluctuate. A similar argument can be used to explain why
EDV/PSV correlates better with FTFF in AF.
It was not clear how to analyse FTFF in such a way that the methodological dependence
could be removed. A future area of study could use similar techniques to determine a
theoretical filling curve which may be followed in each beat, however such an analysis is
beyond the scope of this study.
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There was also a good correlation between LVEF and PFR (§5.10.5). While this may be
methodological, Bacharach [143] showed that filling was shorter than the time to peak
filling in fewer than 2% of cardiac cycles and Rumberger and Reed [90] found that both
peak emptying and peak filling rates in SR were dependent on end-diastolic volume.
In general a ventricle which contracts well is also likely to have good active dilation
characteristics. If the ventricle is functioning poorly on systole it is likely also to be
functioning poorly during diastole. The results here seem to support this theory and
suggest that the variations in the index may be physiological and not methodological. It
would have been useful to assess the time to peak filling as well as the PFR to determine
whether it was constant, or whether the variation was largely limited to the shorter
beats. This is a potential area for further investigation.
8.6. Clinical implications
While this study has generally shown that there are substantial variations two questions
in particular are raised:
1. In light of the variations, how should beat windows be set in the acquisition of
clinical images, both in RNVG and other modalities?
2. Is there any clinical value in assessing the variations and rhythm descriptors which
have been found here?
8.6.1. Beat windows
In order to minimise variation in sequential assessment of LVEF in AF, all beats must be
taken. This is likely to provide a low assessment of LVEF (see Figure 5.8 on Page 164)
but by removing the beat selection dependence it is likely to provide a more consistent
measure (see §5.4.5).
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8.6.2. Clinical value
Results, both in the small clinical study and when considering LVEF in the patient
subgroups (see above - §8.5.3), suggest that there may be clinical value in assessing the
mLVEF and in investigating entropy.
In the AF ablation study (Chapter 7) there was a suggestion that the range of LVEF
measurements may be indicative of the change in LVEF that will be seen if the patient
maintains SR, although the data in the study was only sufficient to suggest that a greater
range will produce a greater change in LVEF. There was also a suggestion that SampEn
may be indicative of the probability of a patient maintaining SR after RFA. (SampEn
has also been shown to have prognostic value in other areas of cardiology in both SR
and AF [77]).
8.7. Limitations of the study
There were several limitations to the study as it was carried out. The selection of patients
both in AF and SR was very broad: provided patients were identifiably in SR or AF they
were accepted into the study. This was done to maximise the data set and to provide
sub-groups of sufficient size to be statistically relevant; however there is potential for
other pathologies to be obscuring results, in particular valvular disease will affect volume
change. Unfortunately other data on pathology, etc. is not kept by the department and
it would have fallen outwith the ethics approval to gather it).
In assessing the variation of function with beat selection criteria, only predefined inter-
quartile ranges were used. This was done for two reasons: it allowed list-mode files to
be processed automatically and provided a means of normalising beat selection criteria
from one patient to the next. Perhaps a more conclusive result could have been obtained
if different criteria had been used, or if some other means of normalising data had been
achieved. Careful examination of the beat histogram for each acquisition might have
allowed beat selection which could account for groupings that could be seen in the
histogram, the use of quartiles does not discriminate between these.
There was an issue in comparing rhythm measures against functional measures. For the
reasons discussed in §2.7.2, all beats were included in the analyses of rhythm while the
functional analyses used limited data. Limiting the data would have changed the beat
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interval stream and thus changed the results obtained for the different rhythm indices.
There was no way around this problem, and it was felt that including the whole interval
stream would give a more accurate representation of the rhythm.
RNVG, as it has been used in this study, is a planar (2D) technique that is used to model
a 3D anatomy. One of the advantages of RNVG is that it is relatively geometrically
independent, since the volume of blood is directly proportional to the count rate. This
means, however, that changes in the anatomy caused by cardiac motion, other than
simple changes in volume, are poorly accounted for. While SPECT (3D) RNVG is
available it would not be possible to acquire sufficient beats at each imaging position to
sub-select beats.
Medical therapy (and in particular β-blockers) will have a significant impact both on
rhythm and function in both SR and AF. In many cases it may have a greater impact
than pathology. This thesis has not looked at the effect of therapy on either rhythm
or function. Most of the patients who have been investigated will be on a combination
of therapies and although it would be interesting to investigate the separate effects of
these it would be hard to distinguish them. Never-the-less this could be a fruitful area
for future study.
A final concern with this study is that its scope has been too great. The study considered
a very wide range of patients and functional measures. As a result it has only been
possible to develop an overview of the techniques that could be used to investigate
beat-to-beat variation between patients in detail. The small clinical study (Chapter 7)
provided some evidence that there may be value in these measurements, but further
clinical investigation is required to determine whether they have genuine value.
Chapter 9.
Conclusion
CALVIN AND HOBBES c©1994 Watterson. Reprinted with permission of UNIVERSAL Uclick. All rights reserved.
9.1. Addressing the hypotheses
This clinical physics study has predominantly been an investigation of the physics of
measurement of cardiac function. In medical imaging the heart poses a particularly
difficult challenge because, more than any other organ, it moves. In SR reasonable
assumptions can be made with regard to the regularity of the heart rate which allow
us to make accurate approximations of cardiac function. The irregularly irregular beats
of AF challenge these assumptions and require that the methods used to assess cardiac
function in SR are re-evaluated in the presence of AF. The results presented in this
thesis go a substantial way to providing that re-evaluation.
In addressing the six hypotheses detailed in §1.7 the aim of the thesis has not been to
provide a detailed clinical investigation of AF but to create a set of tools by which the
rhythmic and functional variations of the heart, and in particular the left ventricle, could
be described. In this respect the study could be considered as a pilot study (as it was
labelled in the application for ethics approval).
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Addressing each one of those hypotheses:
1. Beat-to-beat fluctuations in R-R interval are reflected in beat-to-beat
changes in cardiac function, consistent with Frank-Starling’s law of the
heart: the greater the fluctuations, the greater the variation in function.
2. A variation in function will be seen in SR but will be much more pro-
nounced in AF where the R-R fluctuation is much greater.
3. The duration of the preceding R-R interval has a substantive effect on
measures of function, in particular LVEF, both in SR and AF.
These hypotheses have been shown to be true. In AF where there are substantial beat-
to-beat fluctuations in R-R interval there is a substantial and significant variation in
measured LVEF with longer preceding beats having greater ejection fraction than shorter
ones (SD of the range of LVEF in each patient is 14.3%), variation in preceding beat
interval had a more dominant effect on LVEF than variation in the indexed beat interval.
In SR where the fluctuations in R-R interval are less extreme, there are still variations
in measured LVEF but the range of these is, generally, smaller with SD of measured
LVEF being 8.2%. In SR, the variation was not found to be significantly dependent on
either the preceding or indexed beat length.
4. AF can be reliably described using indices of rhythm which are also
applicable to SR.
A variety of different indices of rhythm have been investigated and it has been shown
that not only do the linear measures of heart rate variability such as SDRR and pRR50
clearly, and significantly, differentiate between SR and AF but so too do indices which
describe the Poincare´ plot and indices of entropy. Each of these indices has been shown
not only to separate patients in AF from those in SR, but also to differentiate between
patients in AF as well as between patients in SR.
Of the measures of entropy which have been considered, Sample entropy, SampEn, (using
metrics of r = 0.02SD and m = 1) has been shown to have the best descriptive value.
Entropy of symbolic dynamics, SymDyn, has been shown to be largely uninformative in
describing AF.
5. Measures of rhythm will have a predictive relationship with measures of
function.
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It was found that no individual measure of rhythm had substantial predictive power but
that when several measures were combined (notably SampEn, mean RR, SDRR, swing
and the correlation of the Poincare´ plot) it was possible to achieve a correlation between
rhythm and the potential variation in LVEF with a coefficient of R = 0.55 in AF and
R = 0.536 (p < 0.00001 in both cases). While good, this is insufficient to fully determine
the range of LVEF that might be obtained and suggests that there may be other factors
(particularly underlying pathology) which will also have an influence.
6. Measures of rhythm and function in AF can be shown to have clinical
utility.
Reduced variation in LVEF has been shown to be associated with myocardial infarction,
hypertension and ischaemia in AF and SR suggesting that there may be some prognostic
value in the range of measurable LVEF.
In the AF ablation study the range of measurable LVEF appeared to have the potential
to predict the degree of change in LVEF that might be seen in patients who maintained
SR. However the small numbers involved in the study made any statistical analysis
impractical and a larger study would be required to confirm this.
9.2. Impact
Although this study has used radionuclide ventriculography, RNVG, many of the results
are equally applicable to other modalities: any kind of assessment that considers car-
diac function will be affected by beat-to-beat variation. In imaging patients in AF the
significant beat-to-beat variability and concomitant variation in function suggests that
assessing function on a small selection of beats is likely to have poor reproducibility. A
more reproducible result could be achieved by selecting all beats (with the exclusion of
some extreme outliers).
After using the Poincare´ plot in this study, it has been adopted for regular use in the
department of Nuclear Cardiology in Glasgow Royal Infirmary, particularly in patients
with curious rhythms where it has proved to be very useful in determining the most
likely limits for “true” beats.
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9.3. Further areas of investigation
RNVG offers a rich seam of information about the heart in general and the LV in
particular. Many different measures which offer further insight into cardiac function
have been considered to a greater or lesser degree in SR. These include measures of
regional function, phase imaging and measures of dissynchrony. Each one of these may
be affected by beat-to-beat variation which is seen not only in AF but also in SR. From
the physics point of view there would be value in investigating whether the variation
affects the measures and whether the blurring that results from accepting all beats in
AF affects these measures.
An investigation into the effects of medical therapy on indices particularly of rhythm
would be of interest, particularly if it was performed pre and post the introduction
of the therapy. While there is a considerable amount in the literature in reference to
medical treatment and standard measures of HRV in SR, very little work has been done
investigating measures of entropy in SR or, in AF, any of the measures discussed in this
thesis.
There is a suggestion of structure in the Poincare´ plots of patients prior to RF ablation
who maintained SR, which may not be seen in patients who did not maintain AF. This
should be investigated further, using 24 Holter recordings, as should the potential for
SampEn to predict whether or not a patient will maintain SR.
This investigation has presented tools that permit the investigation of beat-to-beat vari-
ation, albeit averaged over many similar beats, of any functional measure which can be
made in RNVG or, with appropriate modification, other modalities. These tools offer
the potential for clinical study and a better understanding of atrial fibrillation.
Appendix A.
Scripts
The following are basic scripts written to extract information from files produced within
the MAPS 10000 NM system. The fundamental modifications which were made to the
list-mode formatting program cannot be included here as they are the property of Link
Medical.
A.1. Heart rate variability
An awk script to calculate basic heart rate variability results from a list of RR intervals.
Values calculated are: N, Mean RR, SDRR, RMSSDrr, RR50, RR60 , pRR50, pRR60,
shortest RR interval, longest RR interval, RR interval range, standard deviation of RR
interval averaged over 5, 10 and 20 consecutive beats.
#!/usr/bin/awk -f
########################################################################
#
# file: variability.awk
# author: Sandy Small
# description:
# Given a list of RR intervals (on STDIN) calculate some standard
# heart rate variability parameters
#
########################################################################
BEGIN {
#
# Set up some initial variables the values of which will be
# established in the script
#
RR50 = RR60 = 0
short = 60
long = 0
n5 = n10 = n20 = 1
num5 = suman5 = av5 = 0
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num10 = suman10 = av10 = 0
num20 = suman20 = av20 = 0
#
# Get study and label by piping input from a command to a variable
#
"study" | getline stdy;
"label_file -g label" | getline label;
}
{
#
# $i gives RR interval
#
for(i=1; i <= NF; i++) {
# get longest and shortest RR intervals
if ($i < short) short = $i
if ($i > long) long = $i
# Total duration will be sum of RR intervals
# Get duration + sum of squares of RR interval
# and difference
sum += $i
sumsq += $i ** 2
diff = $i - $(i+1)
# We’re only interested in the absolute value of the difference
if (diff < 0) diff *= -1
if (diff > 0.05) RR50++
if (diff > 0.06) RR60++
# Sum of difference squared
sumdiffsq += diff * diff
#
# Over 5 average
if (n5 == 5) {
av5 += $i
suman5 += (av5 / 5)
sumsqan5 += (av5 / 5)**2
num5++
av5 = 0
n5 = 1
}
else {
av5 += $i
n5++
}
#
# Over 10 average
if (n10 == 10) {
av10 += $i
suman10 += (av10 / 10)
sumsqan10 += (av10 / 10)**2
num10++
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av10 = 0
n10 = 1
}
else {
av10 += $i
n10++
}
#
# Over 20 average
if (n20 == 20) {
av20 += $i
suman20 += (av20 / 20)
sumsqan20 += (av20 / 20)**2
num20++
av20 = 0
n20 = 1
}
else {
av20 += $i
n20++
}
}
}
END {
#
# And output results
# Uncomment the next lines for header
# printf("%s,%s,%s,%s,%s,%s,%s,%s,%s,%s,%s,%s,%s,%s,%s,%s\n",
# "Study","Label","N","MeanRR","SDRR","RMSSD","RR50","RR60",
# "pRR50","pRR60",
# "RRshort","RRlong","RRrange","SDAN5","SDAN10","SDAN20")
printf("%s,%s,%d,%3.3f,%3.2f,%3.2f,%d,%d,%3.1f,%3.1f,%3.2f,
%3.2f,%3.2f,%3.3f,%3.3f,%3.3f\n",
stdy,label,NF, sum/NF, sqrt(sumsq/NF - (sum/NF)**2),
sqrt(sumdiffsq/NF),
RR50, RR60, RR50*100/NF, RR60*100/NF,
short, long, long - short,
sqrt(sumsqan5/num5 - (suman5/num5)**2),
sqrt(sumsqan10/num10 - (suman10/num10)**2),
sqrt(sumsqan20/num20 - (suman20/num20)**2))
}
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A.2. Compactness
This script calculates the compactness factor of a Poincare´ plot by determining the
maximum density in decreasing areas. Each area is moved around the previous area
taking every possible position at that step size. From this the maximum count and
hence the maximum density is determined. A new area size is established based on a
scaling factor and the position of the new area is moved around within the previous box,
etc. etc.
The compactness factor is the integral under the resulting curve. Three different integrals
are calculated: the direct integral, the integral under a curve normalised to the maximum
measured count density and the integral of the normalised curve plotted against the log
of the area.
#!/usr/bin/perl
#
########################################################################
#
# File: poincare_density.pl.perl
# Author: Sandy Small
# Date:
#
########################################################################
#
# Description:
#
# Parameters:
#
# History:
#
# NC CVS ID: $Date: $ $Revision: $
########################################################################
#------------------------------------------------------------------------
# Add library
#------------------------------------------------------------------------
#------------------------------------------------------------------------
# Call Modules
#------------------------------------------------------------------------
#use Pg; # Postgres communication functions
use Getopt::Std; # Command line parsing
#------------------------------------------------------------------------
# Pragmas
#------------------------------------------------------------------------
use warnings; # Give warnings about variable use etc.
no warnings "uninitialized"; # Don’t warn about unitialized variables
# I use this "feature"
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use strict ’vars’; # Force all variables to have defined scope
#------------------------------------------------------------------------
# Global variables
#------------------------------------------------------------------------
our ($opt_l, $opt_m);
#------------------------------------------------------------------------
# Local Sub Functions
#------------------------------------------------------------------------
#------------------------------------------------------------------------
# Main program
#------------------------------------------------------------------------
#
# Major controllables
#
my $total_size = 2.4; # Defines the maximum RR interval which will be considered
# And therefore the size of the first box.
my $minsize = 0.005; # Effectively defines the pixel size (resolution) at
# which points are recorded (plotted).
my $boxscale = 0.75; # The factor by which successive boxes should be reduced
my $accuracy = 0.05; # Fraction of box size by which
# box should be moved around area looking
# for max this has a huge influence on time to run
# Ultimate limit is $minsize (since there’s no point
# in looking at fractions of pixels
#
# Some files to record stuff
# I am going to assume we are working with a MAPS study and will record
# plot information in the study, but send integrals to a complete
# recording file
#
chomp(my $disk = ‘disc‘);
chomp(my $fs = ‘filestore‘);
chomp(my $stdy = ‘study‘);
chomp(my $label = ‘label_file -g ’label’ c0‘);
my $studydir = join("/",$ENV{STUDY_DIR},$disk,$fs,$stdy);
my $gnufile = join("",$studydir,"/","denssquares_",$label,".gpl");
my $densplot = join("",$studydir,"/","densplot_",$label,".txt");
my $resfile = join("/",$ENV{HOME},"research/af/data/pcdensity.txt");
# Is this new or not so we can put header in
my $newres = (-r $resfile ? 0 : 1);
my @base;
my @results;
#
# Calculate a basic matrix at the minimum size
# Need to add 1 because indexes go from 1 not 0
#
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my $tcount = 0;
while (<>){
my @tmp = split(/\s+/);
my $x = int($tmp[0]/$minsize);
my $y = int($tmp[1]/$minsize);
$base[$x][$y]++;
$tcount++
}
#
# Find the area of maximum density within a shrinking box
# Start with the box size at total_size
#
my $maxsum = 0;
my $maxxpos = 0;
my $maxypos = 0;
my $maxdensity = 0;
my $prevdens = 0;
my $xoffsetstart = 0;
my $yoffsetstart = 0;
my $areaintegral = 0;
my $normintegral = 0;
my $normlogintegral = 0;
my $areasize = $total_size;
my $boxsize = $areasize;
#
# And off we go
#
while ($boxsize > $minsize){
my $result = {};
#
# How much should it move
# Make sure it is an integer mulitplier of $minsize since there is no
# point in smaller units
# The step size is the same in both dimensions
#
my $offsetstep = int(($boxsize * $accuracy)/$minsize) * $minsize;
#
# However it has to have a step so if it has come out as zero make
# it step by at least minsize
#
$offsetstep = $minsize if ($offsetstep == 0);
my $xoffset = 0;
#
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# Loop around x
while (1){
my $yoffset = 0;
#
# Loop around y
while (1){
my $xoff = $xoffsetstart + $xoffset;
my $yoff = $yoffsetstart + $yoffset;
my $xstart = int($xoff / $minsize);
my $ystart = int($yoff / $minsize);
my $xend = $xstart + int($boxsize / $minsize);
my $yend = $ystart + int($boxsize / $minsize);
#
# Calculate total sum in box
#
my $sum = 0;
for my $x ($xstart .. $xend){
for my $y ($ystart .. $yend){
$sum += $base[$x][$y];
}
}
if($sum > $maxsum){
$maxsum = $sum;
$maxxpos = $xoff;
$maxypos = $yoff;
}
$yoffset = $yoffset + $offsetstep;
# Break out if we’re bigger than the area
# But because of rounding errors and the fact that the box
# may not fit exactly in the area give it a little leaway
#
last if ($yoffset + $boxsize - ($boxsize * $accuracy) >= $areasize);
}
$xoffset = $xoffset + $offsetstep;
# Break out if we’re bigger than the area
last if ($xoffset + $boxsize - ($boxsize * $accuracy) >= $areasize);
}
#
# Print results
#
$result->{’areasize’} = $areasize;
$result->{’boxsize’} = $boxsize;
$result->{’count’} = $maxsum;
$result->{’density’} = $maxsum/($boxsize**2);
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$result->{’xposition’} = $maxxpos;
$result->{’yposition’} = $maxypos;
push(@results, $result);
#
# Get overall max density so that we can calculate a normalised integral
#
$maxdensity = $result->{’density’}
if ($result->{’density’} > $maxdensity);
#
# Calculate integral assuming we’re plotting against area (not side)
# Do this by approximating the area to be
# the difference between the points on the x axis * the mean of the
# densities at those two points.
# boxsize becomes areasize so these give the x points
#
$areaintegral += (($result->{’density’} + $prevdens) / 2) *
($areasize**2 - $boxsize**2) if ($prevdens != 0);
$result->{’areaintegral’} = $areaintegral;
#
# Set parameters for next round
#
$prevdens = $result->{’density’};
$areasize= $boxsize;
$xoffsetstart = $maxxpos;
$yoffsetstart = $maxypos;
$boxsize = $areasize * $boxscale;
#
# Reset holding variables
#
$maxsum = 0;
$maxxpos = 0;
$maxypos = 0;
# printf("********************%.4f, %d, %.4f, %.4f, %.4f\n",
# $result->{’boxsize’}, $result->{’count’},
# $result->{’density’}, $result->{’xposition’}, $result->{’yposition’});
}
open(RES,">> $resfile") or die "could not open $resfile for writing\n";
open(DEN,"> $densplot") or die "could not open $densplot for writing\n";
open(GNU,"> $gnufile") or die "could not open $gnufile for writing\n";
#
# Print headers
#
print(RES "basestudy, label, integral, normalised,
norm_v_log\n") if ($newres);
print(DEN "Boxsize, log_Size, Area, log_Area, Count, Density,
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Normalised density, X, Y\n");
my $prevnormdens = 0;
my $c = 1;
for my $r (@results) {
$r->{’normdensity’} = ($r->{’density’}/$maxdensity) * 100;
#
# Calculate integrals for densities normalised to max
# Do it the same way as before
#
$normintegral += ($r->{’normdensity’} + $prevnormdens)/2 *
($r->{’areasize’}**2 - $r->{’boxsize’}**2)
if ($prevnormdens != 0);
#
# Also against a log x scale - this give more prominence to smaller
# boxsize. Mulitple by 1000 so we’re working with positive numbers
# milliseconds not seconds
#
$normlogintegral += ($r->{’normdensity’} + $prevnormdens)/2 *
(log((1000 * $r->{’areasize’})**2) - log((1000 * $r->{’boxsize’})**2))
if ($prevnormdens != 0);
#
# Set the previous density to carry over
#
$prevnormdens = $r->{’normdensity’};
#
# And output results to file
#
printf(DEN "%.4f, %.4f, %.4f, %.4f, %d, %.4f, %.4f, %.4f,
%.4f, %.4f, %.4f\n",
$r->{’boxsize’}, log(1000 * $r->{’boxsize’}),
($r->{’boxsize’})**2, log((1000 *$r->{’boxsize’})**2),
$r->{’count’}, $r->{’density’}, $r->{’normdensity’},
$r->{’xposition’}, $r->{’yposition’});
printf(GNU "set object %d rect from %.4f,%.4f to
%.4f,%.4f fc ls 2 fs empty\n", $c,
$r->{’xposition’}, $r->{’yposition’},
$r->{’xposition’} + $r->{’boxsize’},
$r->{’yposition’} + $r->{’boxsize’});
#
# Increment counter
#
$c++
}
printf(RES "%s,%s,%.2f,%.2f,%.2f\n", $stdy, $label, $areaintegral,
$normintegral, $normlogintegral);
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printf("%s: %s\n", $stdy, $label);
printf("\tIntegral = %.2f\n", $areaintegral);
printf("\tNormalised Integral = %.2f\n", $normintegral);
printf("\tNormalised log Integral = %.2f\n", $normlogintegral);
exit 0
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A.3. Curve analysis
The following script calculates the end-diastolic and end-systolic points in curve data
supplied to it in the form of a string of numbers; from this the ejection fraction is
calculated.
#!/bin/awk -f
BEGIN{
ed_pt = max2_pt = 0
max = ed = max2 = 0
min_pt = es_pt = 0
es = 0;
ef = 0
}
#
# First max point (ED)
#
{
if (min_pt == 0 && $1 > ed){
ed_pt = NR
ed = min = $1
}
#
# Min point after first max found
#
if (NR > ed_pt && $1 < min){
min_pt = NR
min = $1
}
#
# True min must be followed by a change of at least 1/3 ED to ES
#
if((min_pt != 0) && (NR > min_pt) && ($1 > (ed - min)/3 + min)){
es = min
es_pt = min_pt
}
#
# If we’ve found a true minimum, what is the final max
#
if((es_pt != 0) && (NR > es_pt) && ($1 > max2)){
max2_pt = NR
max2 = $1
}
if($1 > max){
max_pt = NR
max = $1
}
}
END {
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#
# Ejection fraction is from first max point to true minimum
#
if(es_pt != 0){
ef = ((ed - es) / ed)* 100
}
if (inline == 1){
printf("%d,%d,%d,%d,%d,%d,%d,%d,%d,%d,%.2f\n", ed_pt, ed,
max2_pt, max2, es_pt, es, min_pt, min, max_pt, max, ef);
}
else {
printf("Ed_Pt:=%d\nEd:=%d\nMax2_Pt:=%d\nMax2:=%d\nEs_Pt:=%d\nEs:=%d\n
Min_Pt:=%d\nMin:=%d\nMax_Pt:=%d\nMax:=%d\nEF:=%.2f\n",
ed_pt, ed, max2_pt, max2, es_pt, es, min_pt, min, max_pt, max, ef);
}
}
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A.4. Shannon Entropy
This Perl script takes a file with line by line values representing the frequency of R-R
intervals in each bin and calculates the Shannon Entropy for that file.
#!/usr/bin/perl
#
########################################################################
#
# File: shannon_entropy.perl
# Author: Sandy Small
# Date:
#
########################################################################
#
# Description:
# Given a file corresponding to a histogram, work out the Shannon Entropy.
#
# Parameters:
# None
#
# History:
#
# CVS $Revision$ $Date$
########################################################################
#------------------------------------------------------------------------
# Add library
#------------------------------------------------------------------------
#use lib "$ENV{HOME}/perllib";
#------------------------------------------------------------------------
# Call Modules
#------------------------------------------------------------------------
use Getopt::Std; # Command line parsing
#------------------------------------------------------------------------
# Pragmas
#------------------------------------------------------------------------
use warnings; # Give warnings about variable use etc.
no warnings "uninitialized"; # Don’t warn about unitialized variables
# I use this "feature"
use strict ’vars’; # Force all variables to have defined scope
#------------------------------------------------------------------------
# Global variables
#------------------------------------------------------------------------
our ($opt_T, $opt_t, $opt_b, $opt_c,);
#------------------------------------------------------------------------
# Some functions
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#------------------------------------------------------------------------
# log Returns the natural logarithm (base e) of EXPR. If EXPR is
# omitted, returns log of $_ . To get the log of another base, use
# basic algebra: The base-N log of a number is equal to the natural log
# of that number divided by the natural log of N. For example:
# The following holds: log2(x) = ln(x) / ln(2)
# : log10(x) = ln(x) / ln(10)
sub log10 {
my $n = shift;
return log($n)/log(10);
}
sub log2 {
my $n = shift;
return log($n)/log(2);
}
#------------------------------------------------------------------------
# Main program
#------------------------------------------------------------------------
#
# Shannon Entropy is given by
# H = - sum_from_1_to_n probability of x_i * log (probability of x_i)
#
#
# We will call the states (i) the bins of the histogram.
#
# So read the values in the file into a perl array
my (@fields, @data);
while (<>) {
#
# get each field in turn
#
@fields = split /\s/, $_;
push(@data, $fields[1]);
}
my $sum;
for my $i (0 .. $#data) {
$sum += $data[$i];
}
my $entropy;
for my $i (0 .. $#data) {
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my $p = $data[$i] / $sum;
#
# If p is 0 it won’t change the entropy (defined),
# but the program will complain
# because it will try to take a log(0) so check.
#
$entropy += -1 * $p * log($p) if ($p != 0)
}
printf("%3.2f\n", $entropy);
exit 0;
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A.5. Symbolic Dynamics
This script takes a stream of R-R intervals (separated by spaces) and calculates the
position of each point in the Poincare´ plot. The list of positions are then converted into
a stream of symbols (letters) depending on where they lie in the Poincare´ plot and the
number of standard deviations (-l parameter) of all R-R intervals being used to define
areas of the plot. Frequencies of “words” of length n (defined by -m parameter) are
calculated and output to standard out. The Shannon entropy of the symbolic dynamic
sequence for those values of -l and -m can be calculated by piping the output of this
script to the Shannon entropy script defined in section A.4.
#!/usr/bin/perl
#
########################################################################
#
# File: symbolic_dynamics.perl
# Author: Sandy Small
# Date:
#
########################################################################
#
# Description:
#
# Parameters:
#
# History:
#
# NC CVS ID: $Date: $ $Revision: $
########################################################################
#------------------------------------------------------------------------
# Add library
#------------------------------------------------------------------------
#------------------------------------------------------------------------
# Call Modules
#------------------------------------------------------------------------
#use Pg; # Postgres communication functions
use Getopt::Std; # Command line parsing
#------------------------------------------------------------------------
# Pragmas
#------------------------------------------------------------------------
use warnings; # Give warnings about variable use etc.
no warnings "uninitialized"; # Don’t warn about unitialized variables
# I use this "feature"
use strict ’vars’; # Force all variables to have defined scope
#------------------------------------------------------------------------
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# Global variables
#------------------------------------------------------------------------
our ($opt_l, $opt_m);
#------------------------------------------------------------------------
# Local Sub Functions
#------------------------------------------------------------------------
#------------------------------------------------------------------------
# Main program
#------------------------------------------------------------------------
#
# Sort out command line
#
my $maxsds = 3;
my $letters = 3;
getopts(’l:m:’);
$letters = $opt_l if ($opt_l ne "") ;
$maxsds = $opt_m if ($opt_m ne "") ;
my $alphabet = "ABCDEFGHIJKLMNOPQRSTUVWXYZ";
my @vals;
#
# Put all values into an array - include all lines
#
while (<>){
my @tmp = split(/\s+/);
push(@vals, @tmp);
}
#
# Loop through once - calculating standard deviation etc
#
my ($sum, $sumsq, $diff, $sumdiffsq) = 0;
for (my $i = 1; $i<=$#vals - 1; $i++){
$sum += $vals[$i];
$sumsq += $vals[$i] ** 2;
$diff = $vals[$i] - $vals[$i+1];
$sumdiffsq += $diff ** 2;
}
my $sd = sqrt(($sumsq/($#vals + 1)) - ($sum/($#vals +1))**2);
my $rmsd = sqrt($sumdiffsq/($#vals + 1));
#
# Loop through again to get words
#
my $countshort;
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my $word;
for(my $i=1; $i<=$#vals - 1; $i++){
my $x = $vals[$i];
my $y = $vals[$i+1];
my $tmp = (($x == $y) ? 1 : ($y - $x) / $sd + (($y-$x) / abs($y-$x)));
my $posnum = int($tmp);
#
# Only go to the number of sds specified
$posnum = $maxsds if ($posnum > $maxsds);
$posnum = $maxsds * -1 if (abs($posnum) > $maxsds);
my $letnum = 13 + $posnum;
# Find the appropriate letter in the alphabet
# Actually this is semantic but its a nice thing to do
my $sym = substr($alphabet,$letnum,1);
if ($i > $letters){
$word=sprintf("%s%s", substr($word,1,$letters-1), $sym);
$countshort->{$word}++;
}
else{
$word=sprintf("%s%s", $word, $sym);
$countshort->{$word}++ if ($i == $letters);
}
}
foreach my $word (sort(keys(%$countshort))){
printf("%s\t%d\n", $word, $countshort->{$word});
}
Appendix B.
Rhythm results: supporting data
B.1. Unlimited variability results
While variability results were calculcated using the limits which were imposed on the
R-R intervals for the functional processing, other assessments of rhythm were calculated
using all the data. For comparison the results calculated from the whole data without
excluding ectopics etc. are shown here.
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Figure B.1.: Histograms showing distribution of Mean R-R and SDRR calculated using all
beats without excluding ectopics etc..
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Figure B.2.: Histograms showing distribution of RMSSDrr and pRR50 calculated using all
beats without excluding ectopics etc..
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Figure B.3.: Histogram showing distribution of R-R range calculated using all beats.
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Figure B.4.: Histogram showing the Shannon entropy calculated from the “A” view for those
patients definitely identified as being in AF and Sinus rhythm using unlimited
R-R data (without excluding ectopics etc.).
Appendix C.
Function results: supporting data
C.1. Normality
To assess whether data is normally distributed or not two plots were produced for each
data set: a histogram with superimposed normal distribution and a QQ normality plot
which plots the actual quantiles against the theoretical quantiles from a normal distri-
bution. The closer the plot is to being linear the more closely the distribution is to
being normal. None of the measures can really be described as normally distributed in
either SR or AF, although most of them approximate to it. Only one variable required
a major transformation: pre-systolic volume, where a logarithmic transformation brings
approximate normality.
Plots are as follows:
• LVEF in Figure C.1 (SR) and Figure C.2 (AF)
• Systolic time in Figure C.3 (SR) and Figure C.4 (AF)
• PSV in Figure C.5 (SR) and Figure C.6 (AF)
• log(PSV) in Figure C.7 (SR) and Figure C.8 (AF)
• EDV/PSV in Figure C.9 (SR) and Figure C.10 (AF)
• FTFF in Figure C.11 (SR) and Figure C.12 (AF)
• PFR in Figure C.13 (SR) and Figure C.14 (AF)
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Figure C.1.: SR: Showing (a) the histogram with a normal distribution overlaid and (b) the
QQ normality plot for LVEF in SR.
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Figure C.2.: AF: Showing (a) the histogram with a normal distribution overlaid and (b) the
QQ normality plot for LVEF in AF.
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Figure C.3.: SR: Showing (a) the histogram with a normal distribution overlaid and (b) the
QQ normality plot for systolic time interval in SR.
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Figure C.4.: AF: Showing (a) the histogram with a normal distribution overlaid and (b) the
QQ normality plot for systolic time interval in AF.
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Figure C.5.: SR: Showing (a) the histogram with a normal distribution overlaid and (b) the
QQ normality plot for PSV interval in SR.
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Figure C.6.: AF: Showing (a) the histogram with a normal distribution overlaid and (b) the
QQ normality plot for PSV interval in AF.
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Figure C.7.: SR: Showing (a) the histogram with a normal distribution overlaid and (b) the
QQ normality plot for logarithm of PSV interval in SR.
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Figure C.8.: AF: Showing (a) the histogram with a normal distribution overlaid and (b) the
QQ normality plot for logarithm of PSV interval in AF.
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Figure C.9.: SR: Showing (a) the histogram with a normal distribution overlaid and (b) the
QQ normality plot for EDV/PSV in SR.
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Figure C.10.: AF: Showing (a) the histogram with a normal distribution overlaid and (b)
the QQ normality plot for EDV/PSV in AF.
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Figure C.11.: SR: Showing (a) the histogram with a normal distribution overlaid and (b) the
QQ normality plot for FTFF in SR.
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Figure C.12.: AF: Showing (a) the histogram with a normal distribution overlaid and (b)
the QQ normality plot for FTFF in AF.
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Figure C.13.: SR: Showing (a) the histogram with a normal distribution overlaid and (b) the
QQ normality plot for PFR in SR.
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Figure C.14.: AF: Showing (a) the histogram with a normal distribution overlaid and (b)
the QQ normality plot for PFR in AF.
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C.2. LVEF subgroup aggregated results tables
The variation in LVEF with beat selection criteria in different clinical subgroups has
been tested and the results reported in §5.4.3. The results for the each group with
different beat selection criteria are summarised in the following tables:
• “Pure”: Table C.1 and Table C.2 (AF)
• Not “Pure”: Table C.3 (SR) and Table C.4 (AF)
• MI: Table C.5 (SR) and Table C.6 (AF)
• No MI: Table C.7 (SR) and Table C.8 (AF)
• HBP: Table C.9 (SR) and Table C.10 (AF)
• Without HBP: Table C.11 (SR) and Table C.12 (AF)
• CABG &/or PCI: Table C.13 (SR) and Table C.14 (AF)
• Without CABG &/or PCI: Table C.15 (SR) and Table C.16 (AF)
• Non-ischaemic: Table C.17 (SR) and Table C.18 (AF)
• Ischaemic: Table C.19 (SR) and Table C.20 (AF)
• Negative ETT: Table C.21 (SR) and Table C.22 (AF)
• Positive ETT: Table C.23 (SR) and Table C.24 (AF)
• Very poor and Poor function: Table C.25 (SR) and Table C.26 (AF)
• Moderate and mildly impaired function: Table C.27 (SR) and Table C.28 (AF)
• Normal function: Table C.29 (SR) and Table C.30 (AF)
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Current beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 39.5± 15.0 39.5± 15.0 41.4± 13.4 41.7± 13.4 41.2± 14.1 41.8± 14.4
Best 39.6± 14.8 39.5± 15.0 41.4± 13.4 41.8± 13.5 41.1± 14.2 41.8± 14.4
Q1 41.5± 13.3 41.4± 13.5 45.9± 11.8 46.1± 11.7 45.7± 11.8 46.4± 12.3
Q2 41.3± 13.7 41.1± 13.9 46.6± 12.1 45.1± 12.0 45.9± 11.4 46.2± 12.2
Q3 41.3± 13.9 41.2± 13.9 45.7± 12.4 45.1± 12.5 46.0± 11.9 45.8± 12.2
Q4 41.7± 14.4 41.7± 14.3 45.8± 12.9 45.2± 12.1 46.4± 12.1 45.9± 12.6
Table C.1.: SR, “pure”, LVEF: Mean ± StDev LVEF for different beat selection criteria in
SR “pure” group with variable time formatting.
Current beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 29.4± 11.4 33.6± 12.4 36.0± 11.6 35.1± 11.8 34.6± 12.1 33.5± 12.0
Best 29.3± 10.9 35.2± 11.1 39.2± 10.1 37.5± 10.6 36.5± 10.8 35.4± 10.7
Q1 29.3± 10.2 36.7± 10.3 41.6± 10.0 39.5± 9.7 39.2± 9.2 38.2± 9.4
Q2 30.4± 10.4 37.4± 11.1 43.0± 9.4 40.8± 9.7 40.2± 10.1 38.0± 10.7
Q3 32.2± 10.9 39.1± 11.5 44.7± 9.9 41.6± 10.9 41.0± 11.1 39.0± 11.0
Q4 34.7± 11.4 41.0± 12.2 44.8± 11.0 43.5± 11.9 42.1± 12.0 40.9± 11.6
Table C.2.: AF, “pure”, LVEF: Mean± StDev LVEF for different beat selection criteria in
AF “pure” group with variable time formatting.
Current beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 37.0± 14.3 37.1± 14.3 38.9± 12.7 38.9± 13.1 39.2± 13.3 39.2± 13.3
Best 37.1± 14.3 37.1± 14.3 38.9± 12.8 39.0± 13.1 39.4± 13.2 39.1± 13.2
Q1 39.3± 12.8 39.4± 12.8 44.7± 12.9 44.3± 13.1 45.5± 11.5 45.7± 11.8
Q2 39.3± 13.1 39.3± 13.2 44.5± 12.8 43.9± 13.5 43.6± 12.6 45.0± 12.6
Q3 38.7± 13.4 38.7± 13.4 43.5± 12.5 43.8± 13.0 42.9± 13.1 44.6± 12.6
Q4 39.1± 13.0 39.2± 12.8 44.3± 12.0 43.7± 12.5 44.0± 12.5 45.4± 12.6
Table C.3.: SR, “not pure”, LVEF: Mean±StDev LVEF for different beat selection criteria
in SR “not pure” group with variable time formatting.
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Current beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 27.0± 10.8 31.7± 11.3 33.6± 10.4 32.7± 11.2 32.7± 11.1 30.6± 10.9
Best 28.1± 10.0 33.3± 10.8 36.0± 10.0 35.6± 10.4 34.4± 10.9 32.6± 10.2
Q1 27.0± 9.1 33.8± 9.6 38.4± 10.7 37.0± 9.9 36.3± 9.2 34.0± 9.7
Q2 28.7± 10.1 35.1± 10.5 38.9± 10.7 38.0± 11.2 37.2± 10.7 35.8± 10.4
Q3 29.9± 10.3 36.0± 10.9 39.6± 10.2 38.6± 10.7 38.1± 11.6 35.9± 10.7
Q4 32.1± 10.6 38.0± 11.6 42.5± 11.9 40.5± 10.9 40.1± 10.8 37.6± 10.9
Table C.4.: AF, “not pure”, LVEF: Mean±StDev LVEF for different beat selection criteria
in AF “not pure” group with variable time formatting.
Current beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 31.2± 16.0 31.2± 16.0 33.7± 14.5 33.6± 15.2 33.7± 15.3 33.7± 15.6
Best 31.2± 16.0 31.2± 16.0 33.5± 14.6 33.6± 15.3 33.8± 15.2 33.7± 15.6
Q1 34.1± 14.6 33.9± 14.9 41.2± 14.6 40.4± 14.3 40.6± 13.5 42.4± 13.7
Q2 33.4± 15.2 33.4± 15.2 41.6± 13.5 39.2± 13.7 41.3± 13.7 41.0± 14.3
Q3 33.2± 15.3 33.2± 15.4 40.8± 15.2 40.9± 14.3 39.6± 14.0 40.1± 14.0
Q4 33.6± 15.5 33.9± 15.4 40.6± 15.0 40.0± 14.2 41.8± 14.6 40.4± 14.8
Table C.5.: SR, MI, LVEF: Mean ± StDev LVEF for different beat selection criteria in SR
patients with previous known MI using variable time formatting.
Current beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 26.4± 10.8 30.4± 11.9 32.0± 10.8 32.0± 11.4 31.5± 11.3 30.0± 11.3
Best 26.6± 10.0 32.0± 10.6 34.4± 9.9 34.1± 10.1 32.3± 11.0 31.7± 10.3
Q1 25.8± 9.3 33.0± 10.0 39.0± 7.8 37.2± 9.9 36.3± 8.4 34.3± 9.0
Q2 27.3± 9.9 33.6± 11.1 38.9± 9.4 38.0± 9.8 37.5± 10.3 34.6± 10.0
Q3 29.0± 10.6 35.4± 11.4 41.6± 10.1 38.5± 10.8 37.5± 11.1 35.3± 11.3
Q4 31.3± 11.2 37.4± 12.3 41.9± 10.7 40.3± 11.4 39.2± 11.4 37.7± 11.7
Table C.6.: AF, MI, LVEF: Mean± StDev LVEF for different beat selection criteria in AF
patients with previous known MI using variable time formatting.
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Current beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 40.9± 13.2 41.0± 13.2 42.4± 11.7 42.7± 11.6 42.6± 12.3 42.9± 12.3
Best 41.0± 13.1 40.9± 13.2 42.5± 11.7 42.8± 11.7 42.5± 12.3 42.9± 12.3
Q1 42.7± 11.6 42.8± 11.6 46.8± 11.2 46.9± 11.4 47.2± 10.6 47.4± 11.2
Q2 42.9± 11.7 42.8± 11.8 47.1± 11.8 46.6± 11.7 46.1± 11.1 47.3± 11.2
Q3 42.5± 12.1 42.4± 12.1 46.0± 11.1 46.0± 11.7 46.3± 11.5 47.0± 11.2
Q4 42.9± 12.1 42.9± 12.0 46.7± 11.1 46.3± 11.0 46.7± 11.0 47.8± 10.9
Table C.7.: SR, non-MI, LVEF: Mean± StDev LVEF for different beat selection criteria in
SR patients excluding those with previous known MI using variable time format-
ting.
Current beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 29.1± 11.3 33.7± 11.8 36.1± 10.9 34.7± 11.6 34.6± 11.6 33.0± 11.5
Best 29.7± 10.6 35.3± 11.0 39.0± 10.0 37.7± 10.5 37.1± 10.5 35.1± 10.4
Q1 29.3± 9.7 36.2± 9.9 40.5± 11.2 38.5± 9.9 38.5± 9.6 37.1± 9.9
Q2 30.7± 10.2 37.6± 10.5 41.7± 10.5 40.1± 10.7 39.4± 10.5 38.0± 10.6
Q3 32.0± 10.6 38.4± 11.2 42.2± 10.5 40.9± 10.8 40.5± 11.4 38.5± 10.6
Q4 34.4± 10.9 40.4± 11.8 44.6± 11.7 42.8± 11.4 42.0± 11.4 40.1± 11.2
Table C.8.: AF, non-MI, LVEF: Mean ± StDev LVEF for different beat selection criteria
in AF patients excluding those with previous known MI using variable time
formatting.
Current beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 41.3± 13.7 41.4± 13.7 41.9± 13.0 42.5± 12.9 42.6± 13.4 42.6± 13.6
Best 41.3± 13.8 41.3± 13.8 42.0± 13.0 42.6± 12.9 42.5± 13.4 42.6± 13.5
Q1 42.6± 12.6 42.6± 12.6 48.4± 12.0 47.3± 11.8 47.9± 11.1 48.0± 11.7
Q2 42.6± 13.1 42.4± 13.3 47.7± 12.8 47.0± 12.3 47.1± 11.4 49.1± 11.7
Q3 42.4± 13.5 42.3± 13.5 47.4± 12.3 46.6± 11.7 46.3± 12.4 47.7± 11.9
Q4 42.5± 13.0 42.5± 13.0 47.4± 12.0 46.8± 11.4 47.0± 10.9 48.1± 11.4
Table C.9.: SR, HBP, LVEF: Mean±StDev LVEF for different beat selection criteria in SR
patients with known hypertension using variable time formatting.
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Current beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 29.8± 11.7 34.2± 12.3 36.3± 11.5 35.7± 12.0 35.4± 12.2 33.8± 11.9
Best 30.2± 11.0 35.9± 11.2 39.1± 10.5 38.4± 10.7 37.8± 11.3 35.5± 11.2
Q1 29.3± 10.4 37.3± 10.6 42.4± 10.8 40.7± 10.6 40.1± 10.2 38.5± 10.6
Q2 31.2± 10.8 38.0± 11.3 43.3± 10.6 41.6± 11.0 40.8± 11.4 39.3± 11.3
Q3 32.8± 11.1 39.4± 11.9 44.3± 10.7 42.5± 11.5 42.4± 12.0 39.5± 12.0
Q4 35.3± 11.4 41.4± 12.2 45.7± 12.2 44.4± 11.9 43.1± 12.2 40.9± 12.1
Table C.10.: AF, HBP, LVEF: Mean ± StDev LVEF for different beat selection criteria in
AF patients with known hypertension using variable time formatting.
Current beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 36.0± 14.9 36.0± 14.9 38.7± 13.0 38.5± 13.4 38.4± 13.7 38.8± 13.9
Best 36.1± 14.8 36.0± 14.9 38.7± 13.1 38.6± 13.5 38.4± 13.6 38.7± 13.8
Q1 38.8± 13.0 38.8± 13.2 43.6± 12.0 43.9± 12.6 44.0± 11.8 44.7± 12.1
Q2 38.6± 13.4 38.6± 13.4 44.1± 12.0 43.2± 12.7 43.6± 12.1 43.6± 12.1
Q3 38.1± 13.5 38.1± 13.5 42.7± 12.2 43.5± 13.1 43.4± 12.4 43.6± 12.3
Q4 38.8± 13.9 39.0± 13.8 43.6± 12.6 43.3± 12.4 44.4± 12.9 44.3± 13.0
Table C.11.: SR, non-HBP, LVEF: Mean±StDev LVEF for different beat selection criteria
in SR patients excluding those with known hypertension using variable time
formatting.
Current beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 26.7± 10.4 31.2± 11.3 33.4± 10.3 32.1± 10.9 32.0± 10.8 30.3± 10.8
Best 27.3± 9.7 32.6± 10.5 36.0± 9.6 34.6± 9.9 33.3± 9.9 32.6± 9.5
Q1 27.1± 8.7 33.3± 8.9 38.2± 9.6 36.0± 8.8 36.0± 8.1 34.3± 8.5
Q2 28.1± 9.4 34.6± 9.9 38.8± 9.4 37.5± 9.5 37.0± 9.1 35.0± 9.4
Q3 29.4± 9.9 35.6± 10.4 39.9± 9.5 38.0± 9.7 37.2± 10.2 35.6± 9.4
Q4 31.6± 10.4 37.6± 11.5 42.0± 10.5 39.7± 10.5 39.3± 10.3 37.8± 10.3
Table C.12.: AF, non-HBP, LVEF: Mean±StDev LVEF for different beat selection criteria
in AF patients excluding those with known hypertension using variable time
formatting.
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Current beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 36.5± 16.1 36.5± 16.0 37.5± 14.9 37.7± 15.3 37.9± 16.1 37.0± 15.9
Best 36.5± 16.1 36.5± 16.1 37.3± 15.0 37.7± 15.2 38.1± 15.9 37.0± 15.8
Q1 38.0± 14.9 37.7± 15.1 43.7± 12.8 44.6± 13.4 44.9± 12.5 45.9± 13.0
Q2 37.3± 15.5 37.0± 15.7 45.4± 12.9 42.9± 14.1 45.0± 12.8 44.5± 13.3
Q3 37.5± 16.2 37.5± 16.2 44.5± 13.6 43.0± 12.8 43.3± 12.1 43.0± 12.3
Q4 37.3± 15.4 37.6± 15.2 42.8± 13.0 43.0± 13.0 44.7± 13.7 44.9± 13.6
Table C.13.: SR, CABG &/or PCI, LVEF: Mean±StDev LVEF for different beat selection
criteria in SR patients with previous CABG &/or PCI using variable time
formatting.
Current beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 28.1± 11.4 32.0± 12.7 33.4± 12.2 32.4± 12.5 32.2± 12.4 30.6± 12.5
Best 27.3± 11.4 32.5± 11.7 36.7± 11.3 33.7± 11.2 33.6± 11.7 32.4± 12.0
Q1 26.7± 11.1 33.5± 11.5 40.0± 11.6 36.2± 11.8 36.4± 10.7 35.1± 11.6
Q2 28.4± 11.4 34.4± 11.7 40.3± 11.2 38.0± 11.4 36.9± 11.6 34.5± 11.9
Q3 29.7± 11.7 36.1± 12.5 40.8± 11.7 38.1± 12.0 37.7± 12.9 35.2± 12.3
Q4 32.2± 11.7 38.1± 12.8 41.8± 12.2 40.0± 12.1 38.4± 12.3 37.0± 12.4
Table C.14.: AF, CABG &/or PCI, LVEF: Mean±StDev LVEF for different beat selection
criteria in AF patients with previous CABG &/or PCI using variable time
formatting.
Current beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 38.8± 14.2 38.8± 14.2 40.9± 12.4 41.0± 12.6 40.9± 12.9 41.4± 13.1
Best 38.8± 14.1 38.8± 14.2 41.0± 12.4 41.0± 12.7 40.9± 12.9 41.4± 13.1
Q1 41.1± 12.4 41.3± 12.4 46.1± 12.0 45.6± 12.1 45.9± 11.4 46.2± 11.8
Q2 41.2± 12.6 41.2± 12.6 45.8± 12.4 45.3± 12.2 45.1± 11.7 46.2± 12.0
Q3 40.7± 12.8 40.7± 12.8 44.8± 12.1 45.2± 12.6 45.0± 12.6 46.0± 12.2
Q4 41.3± 13.0 41.3± 13.0 45.9± 12.2 45.3± 11.8 45.7± 11.7 46.2± 12.1
Table C.15.: SR, non CABG &/or PCI, LVEF: Mean ± StDev LVEF for different beat
selection criteria in SR patients without previous CABG or PCI using variable
time formatting.
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Current beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 28.3± 11.1 32.8± 11.7 35.1± 10.8 34.2± 11.3 34.0± 11.4 32.4± 11.3
Best 29.0± 10.2 34.7± 10.7 37.8± 9.9 37.3± 10.2 36.0± 10.7 34.4± 10.1
Q1 28.5± 9.3 35.8± 9.5 40.1± 10.0 38.7± 9.2 38.2± 8.8 36.6± 9.1
Q2 29.9± 10.0 36.7± 10.6 41.1± 10.0 39.8± 10.2 39.2± 10.2 37.6± 10.0
Q3 31.4± 10.4 37.8± 11.0 42.3± 9.9 40.6± 10.5 40.0± 11.0 38.1± 10.5
Q4 33.7± 10.9 39.8± 11.8 44.2± 11.3 42.5± 11.3 41.8± 11.1 39.9± 11.1
Table C.16.: AF, non CABG &/or PCI, LVEF: Mean ± StDev LVEF for different beat
selection criteria in AF patients without previous CABG or PCI using variable
time formatting.
Current beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 47.7± 10.5 47.7± 10.5 47.6± 10.7 48.4± 10.2 48.0± 10.9 49.0± 11.2
Best 47.7± 10.5 47.7± 10.5 47.7± 10.8 48.6± 10.3 48.1± 10.9 48.8± 11.2
Q1 47.6± 10.9 47.9± 10.7 50.7± 10.3 50.7± 10.1 51.2± 9.4 51.4± 10.4
Q2 48.3± 10.7 48.3± 10.7 51.2± 10.5 51.4± 10.2 49.8± 9.8 51.1± 10.0
Q3 47.9± 11.1 47.9± 11.1 49.8± 10.6 50.5± 10.9 50.1± 10.2 50.5± 11.5
Q4 48.7± 10.8 48.8± 10.6 50.7± 10.1 50.7± 10.3 50.1± 9.8 52.1± 10.4
Table C.17.: SR, normal coronary perfusion, LVEF: Mean±StDev LVEF for different beat
selection criteria in SR patients with normal coronary perfusion using variable
time formatting.
Current beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 37.0± 9.1 42.1± 9.3 41.7± 9.4 42.4± 9.7 42.4± 9.7 40.5± 9.9
Best 35.8± 9.6 42.6± 8.8 44.3± 8.4 44.0± 8.7 44.0± 9.2 41.1± 8.7
Q1 34.6± 7.7 41.9± 8.1 46.4± 8.3 44.4± 6.6 44.1± 8.3 41.2± 8.3
Q2 36.3± 9.4 43.8± 9.0 48.8± 8.2 46.8± 9.3 45.4± 8.8 44.9± 8.5
Q3 37.9± 8.8 44.0± 9.6 48.4± 6.9 47.7± 9.5 47.6± 9.1 44.7± 9.1
Q4 41.9± 9.2 46.7± 10.1 51.2± 10.0 50.5± 9.9 47.7± 9.7 47.3± 10.2
Table C.18.: AF, normal coronary perfusion, LVEF: Mean±StDev LVEF for different beat
selection criteria in AF patients with normal coronary perfusion using variable
time formatting.
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Current beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 36.2± 14.6 36.2± 14.6 38.3± 13.0 38.3± 13.2 38.4± 13.6 38.5± 13.7
Best 36.2± 14.5 36.2± 14.6 38.2± 13.0 38.4± 13.2 38.4± 13.6 38.5± 13.7
Q1 38.6± 12.9 38.6± 13.1 43.7± 12.5 43.7± 12.6 44.0± 11.7 44.7± 12.1
Q2 38.4± 13.3 38.3± 13.4 43.9± 12.6 42.6± 12.8 43.3± 12.3 44.1± 12.6
Q3 38.1± 13.5 38.1± 13.6 43.1± 12.6 42.8± 12.8 42.9± 12.8 43.8± 12.3
Q4 38.4± 13.6 38.5± 13.5 43.5± 12.6 42.7± 12.3 43.9± 12.6 44.0± 12.6
Table C.19.: SR, ischaemic, LVEF: Mean±StDev LVEF for different beat selection criteria
in SR patients with ischaemia using variable time formatting.
Current beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 27.4± 11.0 31.7± 11.7 33.9± 10.9 32.9± 11.4 32.7± 11.4 31.1± 11.3
Best 27.9± 10.3 33.3± 10.8 36.7± 10.0 35.6± 10.4 34.5± 10.6 33.2± 10.4
Q1 27.4± 9.6 34.4± 9.9 39.1± 10.3 37.3± 9.9 36.8± 9.1 35.5± 9.7
Q2 28.8± 10.1 35.3± 10.7 39.8± 10.0 38.4± 10.2 37.8± 10.4 36.0± 10.4
Q3 30.3± 10.6 36.7± 11.2 41.1± 10.4 39.2± 10.7 38.6± 11.3 36.6± 10.8
Q4 32.6± 10.9 38.6± 11.9 42.7± 11.4 41.0± 11.2 40.2± 11.4 38.4± 11.1
Table C.20.: AF, ischaemic, LVEF: Mean±StDev LVEF for different beat selection criteria
in AF patients with ischaemia using variable time formatting.
Current beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 45.4± 9.60 45.4± 9.61 45.1± 9.73 45.9± 9.43 45.9± 10.20 46.6± 9.9
Best 45.4± 9.63 45.4± 9.61 45.2± 9.79 46.0± 9.54 45.9± 10.20 46.5± 9.89
Q1 45.3± 9.75 45.5± 9.59 50.5± 9.52 49.5± 8.38 50.0± 7.99 49.9± 8.57
Q2 45.9± 9.47 45.9± 9.46 49.8± 9.69 50.5± 9.29 49.2± 8.03 50.5± 9.11
Q3 45.7± 10.20 45.7± 10.30 48.9± 8.87 48.8± 8.67 49.2± 9.29 49.6± 9.10
Q4 46.3± 9.85 46.3± 9.77 49.1± 9.09 47.9± 8.39 50.3± 9.52 50.2± 9.85
Table C.21.: SR, negative ETT, LVEF: Mean ± StDev LVEF for different beat selection
criteria in SR patients with negative ETT using variable time formatting.
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Current beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 29.0± 11.6 33.3± 12.0 36.7± 10.8 35.7± 11.5 35.2± 11.3 33.1± 12.2
Best 30.1± 11.0 35.6± 11.3 41.0± 9.9 40.8± 10.5 38.4± 11.5 37.4± 11.7
Q1 29.3± 10.7 37.5± 10.5 45.9± 13.4 42.1± 13.5 39.6± 13.2 42.2± 12.8
Q2 31.5± 11.3 38.3± 12.1 42.8± 14.1 44.5± 12.2 43.0± 11.6 40.7± 13.4
Q3 31.7± 11.0 39.7± 11.0 45.9± 13.6 43.7± 11.8 43.0± 11.8 40.6± 12.6
Q4 34.2± 11.5 41.0± 12.1 47.9± 12.2 46.1± 12.0 43.3± 10.9 42.2± 12.4
Table C.22.: AF, negative ETT, LVEF: Mean ± StDev LVEF for different beat selection
criteria in AF patients with negative ETT using variable time formatting.
Current beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 41.8± 10.10 41.8± 10.10 42.0± 11.60 42.8± 10.90 42.19.78 41.4± 9.44
Best 41.8± 10.10 41.8± 10.10 42.0± 11.50 42.9± 10.90 42.29.79 41.4± 9.53
Q1 41.9± 11.40 41.9± 11.40 49.4± 11.00 55.4± 1.12 55.02.56 51.1± 9.77
Q2 42.8± 10.00 42.7± 10.00 48.4± 8.95 47.1± 8.85 46.87.43 44.4± 6.08
Q3 42.2± 10.20 42.2± 10.20 47.0± 6.25 45.9± 7.78 45.68.24 45.9± 8.83
Q4 41.5± 9.33 41.4± 9.23 46.8± 8.15 44.9± 8.36 42.49.47 44.1± 9.60
Table C.23.: SR, positive ETT, LVEF: Mean ± StDev LVEF for different beat selection
criteria in SR patients with positive ETT using variable time formatting.
Current beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 28.8± 11.4 34.5± 13.1 36.3± 12.0 35.2± 12.0 35.1± 12.0 33.6± 11.3
Best 28.2± 11.2 35.6± 11.4 41.4± 9.9 38.7± 9.6 36.9± 10.9 34.8± 10.4
Q1 29.9± 8.9 39.9± 8.2 44.3± 8.1 42.8± 9.4 42.0± 7.1 37.8± 8.9
Q2 30.3± 10.4 38.2± 10.8 45.5± 7.9 43.4± 8.4 42.7± 8.5 38.1± 8.8
Q3 32.1± 11.0 39.8± 11.9 46.8± 7.9 46.3± 8.5 44.0± 10.9 40.0± 10.2
Q4 34.7± 11.2 41.7± 13.1 48.2± 9.8 45.9± 11.9 43.7± 12.3 40.1± 11.7
Table C.24.: AF, positive ETT, LVEF: Mean ± StDev LVEF for different beat selection
criteria in AF patients with positive ETT using variable time formatting.
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Current beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 12.9± 4.52 12.9± 4.52 15.8± 3.64 15.5± 3.13 15.3± 3.54 15.5± 3.47
Best 13.1± 4.39 12.9± 4.52 15.7± 3.62 15.6± 3.10 15.3± 3.55 15.5± 3.37
Q1 16.0± 3.45 15.9± 3.48 18.2± 3.10 19.1± 4.25 18.3± 2.77 22.5± 8.51
Q2 15.3± 3.14 15.1± 3.32 21.5± 4.34 17.6± 2.55 18.4± 2.26 18.5± 2.02
Q3 15.5± 3.47 15.5± 3.43 20.6± 5.67 18.0± 2.50 17.8± 3.11 17.5± 1.31
Q4 15.8± 3.72 15.9± 3.75 17.9± 5.23 17.6± 1.58 19.1± 2.12 17.1± 3.54
Table C.25.: SR, poor & very poor function, LVEF: Mean±StDev LVEF for different beat
selection criteria in SR patients with poor and very poor function using variable
time formatting.
Current beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 13.4± 3.5 15.2± 3.5 16.6± 3.4 16.1± 3.1 16.5± 3.7 15.1± 3.9
Best 13.4± 3.6 16.1± 3.5 18.5± 2.6 17.3± 2.9 18.0± 3.0 16.9± 3.2
Q1 13.3± 2.8 16.9± 3.4 NA 18.7±NA 29.1±NA 15.9±NA
Q2 14.4± 3.1 16.4± 2.8 19.2±NA 18.6± 3.0 19.2± 3.5 20.6± 3.8
Q3 15.5± 3.5 17.9± 3.2 21.2± 1.3 20.7± 3.5 20.8± 4.7 19.8± 4.1
Q4 17.4± 4.1 20.0± 4.4 22.6± 3.7 22.3± 5.0 22.2± 5.2 20.5± 5.1
Table C.26.: AF, poor & very poor function, LVEF: Mean±StDev LVEF for different beat
selection criteria in AF patients with poor and very poor function using variable
time formatting.
Current beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 32.1± 5.93 32.1± 5.94 32.2± 6.32 32.5± 6.45 32.5± 6.24 32.8± 6.17
Best 32.1± 5.94 32.0± 5.94 32.2± 6.15 32.6± 6.51 32.4± 6.20 32.9± 6.25
Q1 32.2± 6.14 32.2± 6.20 34.6± 7.81 34.5± 6.91 34.5± 6.34 34.9± 5.93
Q2 32.7± 6.27 32.7± 6.24 35.4± 8.04 34.0± 6.56 34.7± 6.84 35.2± 6.91
Q3 32.3± 6.08 32.3± 6.06 34.3± 6.49 34.2± 6.44 34.4± 6.74 34.0± 6.35
Q4 32.7± 6.15 32.7± 6.12 34.2± 6.41 34.7± 6.55 34.1± 5.97 34.7± 6.57
Table C.27.: SR, moderate & mildly impaired function, LVEF: Mean±StDev LVEF for dif-
ferent beat selection criteria in SR patients with moderate and mildly impaired
function using variable time formatting.
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Current beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 26.7± 5.7 30.5± 5.7 31.2± 5.8 31.2± 5.8 31.0± 5.9 29.5± 6.0
Best 26.2± 5.8 30.8± 5.9 32.9± 5.7 32.0± 5.8 31.2± 5.8 30.0± 5.8
Q1 24.3± 5.5 29.5± 5.5 32.8± 7.5 31.3± 5.9 31.7± 5.5 29.8± 5.6
Q2 26.7± 5.5 31.7± 5.7 33.6± 5.7 33.7± 6.3 32.8± 6.0 31.6± 6.1
Q3 28.6± 5.6 33.5± 6.1 35.5± 6.3 34.9± 6.3 34.2± 6.4 32.5± 6.0
Q4 31.5± 5.8 35.9± 6.5 38.0± 6.5 37.2± 6.9 36.5± 6.5 35.3± 6.7
Table C.28.: AF, moderate & mildly impaired function, LVEF:Mean±StDev LVEF for dif-
ferent beat selection criteria in AF patients with moderate and mildly impaired
function using variable time formatting.
Current beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 49.8± 8.30 49.8± 8.31 49.4± 8.57 50.0± 8.43 50.4± 8.60 50.9± 8.57
Best 49.8± 8.34 49.8± 8.33 49.5± 8.58 50.0± 8.53 50.4± 8.53 50.8± 8.54
Q1 49.8± 8.60 49.9± 8.52 51.9± 8.70 51.8± 8.88 51.7± 8.16 52.5± 9.03
Q2 50.1± 8.48 50.1± 8.52 52.1± 9.12 52.1± 8.60 51.8± 8.27 52.6± 8.72
Q3 50.2± 8.76 50.2± 8.77 51.4± 9.15 52.1± 8.93 52.0± 8.31 52.2± 8.73
Q4 50.6± 8.50 50.6± 8.45 51.7± 9.01 51.7± 8.51 52.4± 8.48 52.5± 8.40
Table C.29.: SR, normal function, LVEF: Mean ± StDev LVEF for different beat selection
criteria in SR patients with normal function using variable time formatting.
Current beat
All Best Q1 Q2 Q3 Q4
Preceding
beat
All 42.1± 6.5 47.5± 6.3 47.4± 6.2 47.9± 6.3 47.9± 6.7 45.9± 7.0
Best 40.8± 6.7 46.5± 6.0 47.2± 5.9 47.0± 6.2 47.0± 6.8 45.1± 7.0
Q1 37.9± 7.0 44.2± 6.7 47.3± 7.2 45.5± 7.4 45.2± 7.4 43.8± 7.5
Q2 41.5± 6.7 47.4± 6.3 49.4± 6.9 48.8± 6.5 48.5± 6.7 47.0± 7.2
Q3 43.8± 6.6 49.6± 6.6 50.9± 6.4 50.9± 6.4 50.9± 7.2 48.3± 7.2
Q4 46.7± 6.4 52.4± 6.9 54.6± 7.2 53.4± 7.2 52.9± 7.0 51.2± 6.7
Table C.30.: AF, normal function, LVEF: Mean± StDev LVEF for different beat selection
criteria in AF patients with normal function using variable time formatting.
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C.3. Patient-by-patient regression by time
In the body of the text patient-by-patient regression has been done against quartile
which matches the group regression; however, on a patient-by-patient basis it is also
possible to regress by time. A summary of this is given in tables as follows:
• LVEF in Table C.31
• PSV in Table C.32
• EDV/PSV in Table C.33
• Systolic time in Table C.34
• FTFF in Table C.35
• PFR in Table C.36
Preceding Indexed Mean ± SD (+ve) N (+ve) Mean ± SD (-ve) N (-ve) NC
All (Fixed) Q1 - Q4 0.81± 0.14 128 0.78± 0.13 40 4
Best (Fixed) Q1 - Q4 0.80± 0.14 130 0.76± 0.14 47 4
Q1 - Q4 All (Fixed) 0.77± 0.15 108 0.77± 0.16 51 7
Q1 - Q4 Best (Fixed) 0.78± 0.15 100 0.76± 0.15 56 6
Q1 - Q4 Q1 - Q4 0.58± 0.14 34 (p), 36(i) 48 (p), 22(i) 38
(a) SR
Preceding Indexed Mean ± SD (+ve) N (+ve) Mean ± SD (-ve) N (-ve) NC
All (Fixed) Q1 - Q4 0.72± 0.16 28 0.76± 0.15 116 7
Best (Fixed) Q1 - Q4 0.71± 0.13 16 0.78± 0.14 90 26
Q1 - Q4 All (Fixed) 0.86± 0.12 299 NA 0 13
Q1 - Q4 Best (Fixed) 0.84± 0.13 192 0.64± 0.04 2 34
Q1 - Q4 Q1 - Q4 0.73± 0.14 171 (p), 26(i) 0 (p), 147(i) 55
(b) AF
Table C.31.: LVEF: showing the regression results by time on a patient-by-patient basis for
PSV in (a) SR, and (b) AF. Mean regression coefficient is divided into those
which showed a positive association (“+ve”) and those which showed a negative
association (“-ve”). The mean is calculated only for those patients for whom
the result was significant (at p < 0.05). In multiple regression line “(i)” and
“(p)” represented indexed and preceding respectively in multiple regression and
the mean R2 value calculated for all patients. Total numbers of patients: 371
in SR (308 for multiple regression), 357 in AF (303 for multiple regression).
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Preceding Indexed Mean ± SD (+ve) N (+ve) Mean ± SD (-ve) N (-ve) NC
All (Fixed) Q1 - Q4 0.87± 0.13 200 0.79± 0.15 34 4
Best (Fixed) Q1 - Q4 0.87± 0.13 201 0.78± 0.15 34 4
Q1 - Q4 All (Fixed) 0.84± 0.14 167 0.76± 0.15 48 7
Q1 - Q4 Best (Fixed) 0.83± 0.14 160 0.76± 0.15 46 6
Q1 - Q4 Q1 - Q4 0.72± 0.16 60 (p), 106(i) 55 (p), 9(i) 38
(a) SR
Preceding Indexed Mean ± SD (+ve) N (+ve) Mean ± SD (-ve) N (-ve) NC
All (Fixed) Q1 - Q4 0.96± 0.07 334 0.99±NA 1 7
Best (Fixed) Q1 - Q4 0.95± 0.07 243 NA 0 26
Q1 - Q4 All (Fixed) 0.81± 0.13 128 0.81± 0.12 34 13
Q1 - Q4 Best (Fixed) 0.77± 0.14 69 0.76± 0.16 34 34
Q1 - Q4 Q1 - Q4 0.90± 0.10 149 (p), 227(i) 76 (p), 0(i) 55
(b) AF
Table C.32.: PSV: showing the regression results by time on a patient-by-patient basis for
PSV in (a) SR, and (b) AF. Mean regression coefficient shows is divided into
those which showed a positive association (“+ve”) and those which showed a
negative association (“-ve”). The mean is calculated only for those patients
for whom the result was significant. In multiple regression line “(i)” and “(p)”
represented indexed and preceding respectively in multiple regression and the
mean R2 value calculated for all patients. Total numbers of patients: 371 in
SR (308 for multiple regression), 357 in AF (303 for multiple regression).
Function results: supporting data 365
Preceding Indexed Mean ± SD (+ve) N (+ve) Mean ± SD (-ve) N (-ve) NC
All (Fixed) Q1 - Q4 0.76± 0.14 53 0.76± 0.14 91 4
Best (Fixed) Q1 - Q4 0.75± 0.15 56 0.77± 0.15 100 4
Q1 - Q4 All (Fixed) 0.78± 0.14 74 0.78± 0.13 56 7
Q1 - Q4 Best (Fixed) 0.78± 0.14 73 0.77± 0.14 57 6
Q1 - Q4 Q1 - Q4 0.61± 0.17 29 (p), 16(i) 22 (p), 35(i) 38
(a) SR
Preceding Indexed Mean ± SD (+ve) N (+ve) Mean ± SD (-ve) N (-ve) NC
All (Fixed) Q1 - Q4 0.79± 0.13 281 NA 0
Best (Fixed) Q1 - Q4 0.79± 0.14 191 0.74± 0.09 4 26
Q1 - Q4 All (Fixed) 0.81± 0.09 4 0.80± 0.13 210 13
Q1 - Q4 Best (Fixed) 0.77± 0.15 15 0.80± 0.15 118 34
Q1 - Q4 Q1 - Q4 0.69± 0.14 12 (p), 164(i) 151 (p), 0(i) 55
(b) AF
Table C.33.: EDV/PSV : showing the regression results by time on a patient-by-patient
basis for EDV/PSV in (a) SR, and (b) AF. Mean regression coefficient shows is
divided into those which showed a positive association (“+ve”) and those which
showed a negative association (“-ve”). The mean is calculated only for those
patients for whom the result was significant. In multiple regression line “(i)”
and “(p)” represented indexed and preceding respectively in multiple regression
and the mean R2 value calculated for all patients. Total numbers of patients:
371 in SR (308 for multiple regression), 357 in AF (303 for multiple regression).
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Preceding Indexed Mean ± SD (+ve) N (+ve) Mean ± SD (-ve) N (-ve) NC
All (Fixed) Q1 - Q4 0.85± 0.16 120 0.68± 0.13 30 5
Best (Fixed) Q1 - Q4 0.89± 0.15 122 0.68± 0.12 25 5
Q1 - Q4 All (Fixed) 0.83± 0.15 101 0.70± 0.12 48 9
Q1 - Q4 Best (Fixed) 0.84± 0.15 103 0.71± 0.13 47 8
Q1 - Q4 Q1 - Q4 0.61± 0.18 13 (p), 23(i) 15 (p), 5(i) 40
(a) SR
Preceding Indexed Mean ± SD (+ve) N (+ve) Mean ± SD (-ve) N (-ve) NC
All (Fixed) Q1 - Q4 0.77± 0.15 69 0.74± 0.16 52 7
Best (Fixed) Q1 - Q4 0.78± 0.14 36 0.74± 0.14 33 26
Q1 - Q4 All (Fixed) 0.77± 0.14 91 0.76± 0.15 41 13
Q1 - Q4 Best (Fixed) 0.77± 0.15 71 0.80± 0.13 32 36
Q1 - Q4 Q1 - Q4 0.55± 0.16 14 (p), 5(i) 11 (p), 8(i) 55
(b) AF
Table C.34.: Systolic time: showing the regression results by time on a patient-by-patient
basis for systolic time in (a) SR, and (b) AF. Mean regression coefficient shows is
divided into those which showed a positive association (“+ve”) and those which
showed a negative association (“-ve”). The mean is calculated only for those
patients for whom the result was significant. In multiple regression line “(i)”
and “(p)” represented indexed and preceding respectively in multiple regression
and the mean R2 value calculated for all patients. Total numbers of patients:
371 in SR (308 for multiple regression), 357 in AF (303 for multiple regression).
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Preceding Indexed Mean ± SD (+ve) N (+ve) Mean ± SD (-ve) N (-ve) NC
All (Fixed) Q1 - Q4 0.77± 0.15 117 0.72± 0.13 25 4
Best (Fixed) Q1 - Q4 0.77± 0.14 114 0.73± 0.14 23 4
Q1 - Q4 All (Fixed) 0.74± 0.14 95 0.70± 0.13 26 8
Q1 - Q4 Best (Fixed) 0.74± 0.13 89 0.69± 0.13 28 6
Q1 - Q4 Q1 - Q4 0.51± 0.23 76 (p), 107(i) 78 (p), 46(i) 21
(a) SR
Preceding Indexed Mean ± SD (+ve) N (+ve) Mean ± SD (-ve) N (-ve) NC
All (Fixed) Q1 - Q4 0.85± 0.12 305 0.99±NA 1 7
Best (Fixed) Q1 - Q4 0.85± 0.12 219 NA 0 27
Q1 - Q4 All (Fixed) 0.82± 0.15 22 0.76± 0.15 95 14
Q1 - Q4 Best (Fixed) 0.79± 0.15 30 0.79± 0.15 68 34
Q1 - Q4 Q1 - Q4 0.71± 0.18 64 (p), 221(i) 158 (p), 4(i) 28
(b) AF
Table C.35.: FTFF: showing the regression results by time on a patient-by-patient basis for
FTFF in (a) SR, and (b) AF. Mean regression coefficient shows is divided into
those which showed a positive association (“+ve”) and those which showed a
negative association (“-ve”). The mean is calculated only for those patients
for whom the result was significant. In multiple regression line “(i)” and “(p)”
represented indexed and preceding respectively in multiple regression and the
mean R2 value calculated for all patients. Total numbers of patients: 371 in
SR (308 for multiple regression), 357 in AF (303 for multiple regression).
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Preceding Indexed Mean ± SD (+ve) N (+ve) Mean ± SD (-ve) N (-ve) NC
All (Fixed) Q1 - Q4 0.68± 0.12 50 0.69± 0.13 21 4
Best (Fixed) Q1 - Q4 0.65± 0.12 57 0.70± 0.12 21 4
Q1 - Q4 All (Fixed) 0.68± 0.09 46 0.61± 0.09 23 8
Q1 - Q4 Best (Fixed) 0.68± 0.11 44 0.63± 0.09 26 6
Q1 - Q4 Q1 - Q4 0.41± 0.19 58(p),49(i) 35(p), 42(i) 21
(a) SR
Preceding Indexed Mean ± SD (+ve) N (+ve) Mean ± SD (-ve) N (-ve) NC
All (Fixed) Q1 - Q4 0.71± 0.12 108 0.75± 0.16 17 7
Best (Fixed) Q1 - Q4 0.71± 0.13 56 0.73± 0.18 13 27
Q1 - Q4 All (Fixed) 0.74± 0.13 61 0.70± 0.09 12 14
Q1 - Q4 Best (Fixed) 0.77± 0.14 42 0.72± 0.11 14 34
Q1 - Q4 Q1 - Q4 0.49± 0.21 79 (p), 89(i) 29 (p), 22(i) 28
(b) AF
Table C.36.: PFR: showing the regression results by time on a patient-by-patient basis for
PFR in (a) SR, and (b) AF. Mean regression coefficient shows is divided into
those which showed a positive association (“+ve”) and those which showed a
negative association (“-ve”). The mean is calculated only for those patients
for whom the result was significant. In multiple regression line “(i)” and “(p)”
represented indexed and preceding respectively in multiple regression and the
mean R2 value calculated for all patients. Total numbers of patients: 371 in
SR (308 for multiple regression), 357 in AF (303 for multiple regression).
Appendix D.
Rhythm vs. Function Appendix
D.1. Correlations
The correlation between rhythm and variation in functional indices reported in chapter 6
(§6.2) was calculated using the standard deviation as the index of variation for the
functional indicies. An alternative would be to consider the range (max - min), the
results of such a calculation shown in Figure D.1 for SR and Figure D.2 for AF are
similar but not the same.
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Function measurement range
Age
Mean RR
SDRR
RMSSD
pRR50
RR Range
Correlation
Compactness
Shannon E
Symdyn E
Sample E
Swing
−0.26 * 0.11 * −0.1 −0.24 * −0.2 * −0.27 *
0.25 * 0 0.3 * 0.31 * 0.3 * 0.33 *
0.01 0 0.14 * 0.07 0.16 * 0.06 
0.18 * 0.01 0.22 * 0.27 * 0.26 * 0.3 *
0.12 * 0.07 0.25 * 0.21 * 0.24 * 0.22 *
0.22 * 0 0.07 0.23 * 0.14 * 0.28 *
0.1 * 0.02 0.18 * 0.18 * 0.2 * 0.23 *
0.06 0.01 0.21 * 0.13 * 0.15 * 0.16 *
0.06 0.1 0.27 * 0.14 * 0.19 * 0.23 *
0.12 * 0.04 0.19 * 0.21 * 0.23 * 0.26 *
−0.02 0.24 * 0.3 * 0.01 0.15 * 0.1 *
−0.03 0.11 * 0.09 −0.06 −0.13 * 0 
ED
V/
PS
V
PS
 vo
l
ES
 ti
m
e
LV
EF FT
F
PF
R
Correlation
rho
1.0
0.9
0.7
0.5
0.3
0.1
0.0
−0.1
−0.3
−0.5
−0.7
−0.9
−1.0
Figure D.1.: Showing the correlation between measures of RR variability and the range of
measures of function (per patient) in SR.
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Function measurement range
Age
Mean RR
SDRR
RMSSD
pRR50
RR Range
Correlation
Compactness
Shannon E
Symdyn E
Sample E
Swing 0.06 −0.11 * −0.05 0.07 −0.04 −0.13 *
0.1 * −0.19 * 0.1 0.25 * 0.07 0.12 *
0.19 * 0.13 * −0.03 0.09 0.25 * 0.24 *
0.08 −0.19 * 0.08 0.26 * 0.09 0.1 
0.08 0.07 0.14 * 0.16 * 0.09 −0.01 
−0.11 * 0.14 * 0.05 −0.15 * 0.06 0.09 
−0.08 0.14 * 0.18 * 0.11 * 0.25 * 0.03 
0.03 0.14 * 0.17 * 0.16 * 0.3 * 0.15 *
−0.06 0.25 * 0.18 * 0.11 * 0.34 * 0.19 *
−0.08 0.25 * 0.16 * 0.1 * 0.34 * 0.18 *
−0.34 * 0.25 * 0.2 * −0.15 * 0.22 * 0.16 *
0.09 0.15 * 0.08 −0.04 0.16 * 0.24 *
ED
V/
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V
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 vo
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 ti
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e
LV
EF FT
F
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R
Correlation
rho
1.0
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−1.0
Figure D.2.: Showing the correlation between measures of RR variability and the range of
measures of function (per patient) in AF.
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Glossary
SampEn Calculation of entropy based on the conditional probability of matching a
sequence of beats of length m within the beat interval stream. Each beat must
match within a window of width r.
awk A data driven programming language designed for processing text based data files,
generally applying the same transformation to each line of a file.
compactness factor A number indicating the spread of density over a plot. The smaller
the number the more concentrated the points are in the Poincare´ plot.
compactness factor by log As with compactness factor this is a number indicating the
spread of density over a plot but the calculation of the integral is against log(area)
instead of against the area. This gives more emphasis to changes in density over a
smaller area. The smaller the number the more concentrated the points are in the
Poincare´ plot.
delta Poincare´ A plot of the difference between the indexed beat and the preceding
beat (RRi−RRi−1) against the difference between the preceding beat and the one
before that (RRi−1 −RRi−2).
ectopic Abnormal; in this thesis it refers to a beat which does not have the standard
morphology for that patient.
Ejection Fraction The fraction of end-diastolic volume expelled from the relevant car-
diac chamber during systole.
gated A multi-frame image file which shows the change in the heart in several image
frames over a representative beat.
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Lorenz plot An alternative name for Poincare´ plot.
Mean NN The mean NN interval, where NN is the RR interval between adjacent QRS
complexes from normal sinus node depolarisations.
NN range The difference between the longest and shortest NN interval (as described
for mean NN).
NN50 The number of differences greater than 50ms between sucessive intervals.
pNN50 The percentage number of differences between sucessive intervals of greater than
50ms as a fraction of the notal number of NN intervals.
Poincare´ plot Plot of indexed RR interval against the next RR interval.
RMSSD The square root of the mean squared difference between sucessive NN intervals.
SDANNx The standard deviation of the average of NN intervals over x beats.
SDNN The standard deviation of the NN interval.
sinus rhythm Normal regular cardiac rhythm.
symbolic dynamics Mathematical technique for “coarse graining” a system whereby
states of the system are represented by symbols. The sequence of symbols represents
the dynamic variation of the system.
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